128794-94-5 | Mycophenolate mofetil

Packsize	Purity	Availability	Price	Discounted Price
50mg	98%	in stock	$16.00	$11.00
250mg	98%	in stock	$19.00	$13.00
1g	98%	in stock	$25.00	$17.00
5g	98%	in stock	$37.00	$26.00
10g	98%	in stock	$65.00	$45.00
25g	98%	in stock	$105.00	$74.00
100g	98%	in stock	$297.00	$208.00

Description

• Catalog Number: AA44390
• Chemical Name: Mycophenolate mofetil
• CAS Number: 128794-94-5
• Molecular Formula: C23H31NO7
• Molecular Weight: 433.4947
• MDL Number: MFCD00867568
• SMILES: COc1c(C/C=C(/CCC(=O)OCCN2CCOCC2)C)c(O)c2c(c1C)COC2=O

Computed Properties

• Complexity: 646
• Covalently-Bonded Unit Count: 1
• Defined Bond Stereocenter Count: 1
• Heavy Atom Count: 31
• Hydrogen Bond Acceptor Count: 8
• Hydrogen Bond Donor Count: 1
• Rotatable Bond Count: 10
• XLogP3: 3.2

Literature

• Comparative analysis the binding affinity of mycophenolic sodium and meprednisone with human serum albumin: Insight by NMR relaxation data and docking simulation.

  Chemico-biological interactions 20160325

• Effect of Penicillium mycotoxins on the cytokine gene expression, reactive oxygen species production, and phagocytosis of bovine macrophage (BoMacs) function.

  Toxicology in vitro : an international journal published in association with BIBRA 20151225

• The effects of drugs with immunosuppressive or immunomodulatory activities on xenobiotics-metabolizing enzymes expression in primary human hepatocytes.

  Toxicology in vitro : an international journal published in association with BIBRA 20150801

• Utilization of human nuclear receptors as an early counter screen for off-target activity: a case study with a compendium of 615 known drugs.

  Toxicological sciences : an official journal of the Society of Toxicology 20150601

• Effects of mycophenolic acid alone and in combination with its metabolite mycophenolic acid glucuronide on rat embryos in vitro.

  Archives of toxicology 20130201

• Population pharmacokinetics of unbound mycophenolic acid in pediatric and young adult patients undergoing allogeneic hematopoietic cell transplantation.

  Journal of clinical pharmacology 20121101

• A limited sampling schedule to estimate mycophenolic Acid area under the concentration-time curve in hematopoietic cell transplantation recipients.

  Journal of clinical pharmacology 20121101

• Successful handling of autoimmunity in X-linked thrombocytopenia (XLT) using mycophenolate mofetil.

  Pediatric blood & cancer 20121101

• The treatment of autoimmune hepatitis.

  Current clinical pharmacology 20121101

• Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis.

  Annals of the rheumatic diseases 20121101

• Efficacy of mycophenolate mofetil in adolescent patients with lupus nephritis: evidence from a two-phase, prospective randomized trial.

  Lupus 20121101

• Effect of mycophenolic acid on trans-plasma membrane electron transport and electric potential in virus-infected plant tissue.

  Plant physiology and biochemistry : PPB 20121101

• Kidney transplant outcomes are related to tacrolimus, mycophenolic acid and prednisolone exposure in the first week.

  Transplant international : official journal of the European Society for Organ Transplantation 20121101

• Therapeutic advances in myositis.

  Current opinion in rheumatology 20121101

• Mucous membrane pemphigoid: recent advances.

  Current opinion in ophthalmology 20121101

• Microscopic features associated with mycophenolate mofetil in gastric and colonic biopsies.

  Histopathology 20121101

• Lower 12-hour trough concentrations of mycophenolic acid in patients with active systemic vasculitides taking mycophenolate mofetil.

  The Journal of rheumatology 20121101

• Synthetic lethality for linking the mycophenolate mofetil mode of action with molecular disease and drug profiles.

  Molecular bioSystems 20121030

• Management and outcome of BK viremia in renal transplant recipients: a prospective single-center study.

  Transplantation 20121027

• A clinically feasible approach to induce delayed tolerance in recipients of prior kidney or vascularized composite allotransplants.

  Transplantation 20121015

• Effect of mild diarrhea on tacrolimus exposure.

  Transplantation 20121015

• Late calcineurin inhibitor withdrawal prevents progressive left ventricular diastolic dysfunction in renal transplant recipients.

  Transplantation 20121015

• Bullous pemphigoid associated with type 1 diabetes mellitus responsive to mycophenolate mofetil.

  The Journal of dermatology 20121001

• The impact of prophylactic antiviral agents and statin administration on graft longevity in kidney allograft recipients.

  Immunopharmacology and immunotoxicology 20121001

• Antiviral or proviral action of mycophenolic acid in hepatitis B infection?

  Hepatology (Baltimore, Md.) 20121001

• Identification of factors affecting tacrolimus level and 5-year clinical outcome in kidney transplant patients.

  Basic & clinical pharmacology & toxicology 20121001

• Multicenter experience using total lymphoid irradiation and antithymocyte globulin as conditioning for allografting in hematological malignancies.

  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20121001

• Mycophenolate mofetil-related pancolitis in a kidney transplant recipient.

  Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 20121001

• Nonstandard drugs and feasible new interventions for autoimmune hepatitis: part I.

  Inflammation & allergy drug targets 20121001

• Modulation of lymphocyte function in vivo via inhibition of calcineurin or purine synthesis in patients with atopic dermatitis.

  The Journal of investigative dermatology 20121001

• Incidence and risk factors associated with de novo autoimmune hepatitis after liver transplantation.

  Liver international : official journal of the International Association for the Study of the Liver 20121001

• Calcineurin inhibitor sparing with mycophenolate mofetil in liver transplantion: a systematic review of randomized controlled trials.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20121001

• Effects of sotrastaurin, mycophenolic acid and everolimus on human B-lymphocyte function and activation.

  Transplant international : official journal of the European Society for Organ Transplantation 20121001

• ABO-incompatible kidney transplantation in elderly patients over 60 years of age.

  International urology and nephrology 20121001

• Enteric-coated mycophenolate sodium immunosuppression in renal transplant patients: efficacy and dosing.

  Transplantation reviews (Orlando, Fla.) 20121001

• De novo GTP biosynthesis is critical for virulence of the fungal pathogen Cryptococcus neoformans.

  PLoS pathogens 20121001

• Treatment of idiopathic membranous nephropathy.

  Journal of the American Society of Nephrology : JASN 20120928

• Tacrolimus-based, steroid-free regimens in renal transplantation: 3-year follow-up of the ATLAS trial.

  Transplantation 20120915

• Conversion from tacrolimus/mycophenolic acid to tacrolimus/leflunomide to treat cutaneous warts in a series of four pediatric renal allograft recipients.

  Transplantation 20120915

• Inosine monophosphate dehydrogenase polymorphisms and renal allograft outcome.

  Transplantation 20120915

• Inosine 5'-monophosphate dehydrogenase activity as a biomarker in the field of transplantation.

  Clinica chimica acta; international journal of clinical chemistry 20120908

• The influence of UGT polymorphisms as biomarkers in solid organ transplantation.

  Clinica chimica acta; international journal of clinical chemistry 20120908

• Mycophenolate mofetil (MMF) does not slow the progression of subclinical atherosclerosis in SLE over 2 years.

  Rheumatology international 20120901

• Immunogenicity of meningococcus C vaccination in a patient with atypical hemolytic uremic syndrome (aHUS) on eculizumab therapy.

  Pediatric transplantation 20120901

• Central pontine myelinolysis: a case report and clinical-pathological review.

  Pediatric transplantation 20120901

• Unrelated cord blood transplantation for newly diagnosed patients with severe acquired aplastic anemia using a reduced-intensity conditioning: high graft rejection, but good survival.

  Bone marrow transplantation 20120901

• Population pharmacokinetics of mycophenolic acid and dose optimization with limited sampling strategy in liver transplant children.

  British journal of clinical pharmacology 20120901

• Post-transplantation encapsulating peritoneal sclerosis in a pediatric patient.

  Pediatric nephrology (Berlin, Germany) 20120901

• Steroid avoidance with early intensified dosing of enteric-coated mycophenolate sodium: a randomized multicentre trial in kidney transplant recipients.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20120901

• All wrapped up and nowhere to flow.

  The American journal of medicine 20120901

• Mycophenolate mofetil inhibits hepatitis C virus replication in human hepatic cells.

  Virus research 20120901

• Combination of N-methylisatin-β-thiosemicarbazone derivative (SCH16) with ribavirin and mycophenolic acid potentiates the antiviral activity of SCH16 against Japanese encephalitis virus in vitro.

  Letters in applied microbiology 20120901

• Applications of ultrasound to enhance mycophenolic acid production.

  Ultrasound in medicine & biology 20120901

• Effect of immunosuppressive drugs on spontaneous DNA repair in human peripheral blood mononuclear cells.

  Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20120901

• Everolimus and enteric-coated mycophenolate sodium ab initio after liver transplantation: midterm results.

  Transplantation proceedings 20120901

• Significance of mycophenolate monitoring in liver transplant recipients: toward the cut-off level.

  Transplantation proceedings 20120901

• Using mycophenolate mofetil in steroid-resistant nephrotic syndrome.

  Iranian journal of kidney diseases 20120901

• Mycophenolate mofetil for treatment of idiopathic nephrotic syndrome in children.

  Iranian journal of kidney diseases 20120901

• Drug choices in autoimmune hepatitis: part B--Nonsteroids.

  Expert review of gastroenterology & hepatology 20120901

• Opportunistic infections in myasthenia gravis treated with mycophenolate mofetil.

  Journal of neuroimmunology 20120815

• Neuromyelitis optica in a patient with pemphigus foliaceus.

  Journal of the neurological sciences 20120815

• Female spontaneously hypertensive rats have greater renal anti-inflammatory T lymphocyte infiltration than males.

  American journal of physiology. Regulatory, integrative and comparative physiology 20120815

• Bacillus anthracis inosine 5'-monophosphate dehydrogenase in action: the first bacterial series of structures of phosphate ion-, substrate-, and product-bound complexes.

  Biochemistry 20120807

• Mycophenolate mofetil inhibits macrophage infiltration and kidney fibrosis in long-term ischemia-reperfusion injury.

  European journal of pharmacology 20120805

• Omeprazole impairs the absorption of mycophenolate mofetil but not of enteric-coated mycophenolate sodium in healthy volunteers.

  Journal of clinical pharmacology 20120801

• Pregnancy outcomes after kidney transplantation-immunosuppressive therapy comparison.

  The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians 20120801

• Modulatory effect of mycophenolate mofetil on carrageenan-induced inflammation in the mouse air pouch model.

  International immunopharmacology 20120801

• Immunosuppressive drugs on inducing Ag-specific CD4(+)CD25(+)Foxp3(+) Treg cells during immune response in vivo.

  Transplant immunology 20120801

• Synthesis and biological activity of novel mycophenolic acid conjugates containing nitro-acridine/acridone derivatives.

  European journal of medicinal chemistry 20120801

• Update on systemic therapies for atopic dermatitis.

  Current opinion in allergy and clinical immunology 20120801

• Vasculitis associated with tumor necrosis factor-α inhibitors.

  Mayo Clinic proceedings 20120801

• Recent news in the treatment of lupus nephritis.

  Minerva medica 20120801

• Treatment of severe cutaneous small-vessel vasculitis with mycophenolate mofetil.

  Archives of dermatology 20120801

• Efficacy and safety of mycophenolate mofetil versus cyclophosphamide for induction therapy of lupus nephritis: a meta-analysis of randomized controlled trials.

  Drugs 20120730

• Mycophenolate versus azathioprine for kidney transplantation: a 15-year follow-up of a randomized trial.

  Transplantation 20120727

• Late evolution of kidney transplants in elderly donors and recipients receiving initial immunosuppressant treatment with daclizumab, mycophenolate mofetil, and delayed introduction of tacrolimus.

  Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20120717

• IgG4-related inflammatory pseudotumor of the central nervous system responsive to mycophenolate mofetil.

  Journal of the neurological sciences 20120715

• Evaluation of mycophenolate mofetil as a steroid-sparing agent in pemphigus: a randomized, prospective study.

  Journal of the European Academy of Dermatology and Venereology : JEADV 20120701

• Mycophenolate mofetil treatment in two children with severe polyarteritis nodosa refractory to immunosuppressant drugs.

  Rheumatology international 20120701

• The influence of immunosuppressive agents on BK virus risk following kidney transplantation, and implications for choice of regimen.

  Transplantation reviews (Orlando, Fla.) 20120701

• Everolimus in combination with cyclosporin a as pre- and posttransplantation immunosuppressive therapy in nonmyeloablative allogeneic hematopoietic stem cell transplantation.

  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20120701

• The impact of mycophenolate mofetil versus azathioprine as adjunctive therapy to cyclosporine on the rates of renal allograft loss due to glomerular disease recurrence.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20120701

• The inhibitors of nucleotide biosynthesis leflunomide, FK778, and mycophenolic acid activate hepatitis B virus replication in vitro.

  Hepatology (Baltimore, Md.) 20120701

• Efficacy of mycophenolate mofetil in severe mucocutaneous lichen planus: a retrospective review of 10 patients.

  The British journal of dermatology 20120701

• How to treat refractory arthritis in lupus?

  Joint, bone, spine : revue du rhumatisme 20120701

• Impact of the severity of acute rejection in the early phase after rat lung transplantation on the effectiveness of mycophenolate mofetil to treat chronic allograft rejection.

  European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 20120701

• [Mycophenolate mofetil: an alternative treatment for refractory autoimmune hemolytic anemia in children].

  Anales de pediatria (Barcelona, Spain : 2003) 20120701

• Childhood blepharokeratoconjunctivitis: characterising a severe phenotype in white adolescents.

  The British journal of ophthalmology 20120701

• Mycophenolate mofetil: fully utilizing its benefits for GvHD prophylaxis.

  International journal of hematology 20120701

• Recent progress in the treatment of proliferative lupus nephritis.

  The American journal of medicine 20120701

• Treatment of mucous membrane pemphigoid with the combination of mycophenolate mofetil, dapsone, and prednisolone: a case series.

  Oral surgery, oral medicine, oral pathology and oral radiology 20120701

• Methimazole-induced bullous systemic lupus erythematosus: a case report.

  Journal of Korean medical science 20120701

• Mycophenolate mofetil associated with progressive multifocal leukoencephalopathy with successful outcome.

  Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia 20120701

• Childhood nephrotic syndrome--current and future therapies.

  Nature reviews. Nephrology 20120612

• Liquid chromatography-tandem mass spectrometry method for the quantification of mycophenolic acid and its phenolic glucuronide in saliva and plasma using a standardized saliva collection device.

  Journal of chromatography. A 20120608

• Neuroimaging, biochemical and cellular evidence of protection by mycophenolate mofetil on middle cerebral artery occlusion induced injury in rats.

  European journal of pharmacology 20120605

• Mycophenolic acid-related diarrhea is not associated with polymorphisms in SLCO1B nor with ABCB1 in renal transplant recipients.

  Pharmacogenetics and genomics 20120601

• Combined introduction of anti-IL2 receptor antibodies, mycophenolic acid and tacrolimus: effect on malignancies after renal transplantation in a single-centre retrospective cohort study.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20120601

• Mycophenolic acid augments interferon-stimulated gene expression and inhibits hepatitis C Virus infection in vitro and in vivo.

  Hepatology (Baltimore, Md.) 20120601

• Inosine monophosphate dehydrogenase activity in paediatrics: age-related regulation and response to mycophenolic acid.

  European journal of clinical pharmacology 20120601

• Sirolimus protective effects on bone: the need to be demonstrated.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20120601

• Systemic immunosuppression in ocular surface stem cell transplantation: results of a 10-year experience.

  Cornea 20120601

• Cyclosporine lowering with everolimus versus mycophenolate mofetil in heart transplant recipients: long-term follow-up of the SHIRAKISS randomized, prospective study.

  The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20120601

• Changes in immune cell frequencies after cyclophosphamide or mycophenolate mofetil treatments in patients with systemic lupus erythematosus.

  Clinical rheumatology 20120601

• IgG4-related sclerosing disease of the small bowel presenting as necrotizing mesenteric arteritis and a solitary jejunal ulcer.

  The American journal of surgical pathology 20120601

• Computational insights into the inhibition of inosine 5'-monophosphate dehydrogenase by mycophenolic acid analogs: three-dimensional quantitative structure-activity relationship and molecular docking studies.

  Chemical biology & drug design 20120601

• Unrelated cord blood transplantation in adult and pediatric acute lymphoblastic leukemia: effect of minimal residual disease on relapse and survival.

  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20120601

• Leflunomide efficacy and pharmacodynamics for the treatment of BK viral infection.

  Clinical journal of the American Society of Nephrology : CJASN 20120601

• A prospective observational study of mycophenolate mofetil treatment in progressive diffuse cutaneous systemic sclerosis of recent onset.

  The Journal of rheumatology 20120601

• Mycophenolate mofetil in the therapy of uveitic macular edema--long-term results.

  Ocular immunology and inflammation 20120601

• Immunosuppressive regimen and interstitial fibrosis and tubules atrophy at 12 months postrenal transplant.

  Clinical journal of the American Society of Nephrology : CJASN 20120601

• Comparative pharmacokinetic study of two mycophenolate mofetil formulations in stable kidney transplant recipients.

  Transplant international : official journal of the European Society for Organ Transplantation 20120601

• Diminished mycophenolic acid exposure caused by omeprazole may be clinically relevant in the first week posttransplantation.

  Therapeutic drug monitoring 20120601

• Limited-sampling strategy for mycophenolic acid in renal transplant recipients reciving enteric-coated mycophenolate sodium and tacrolimus.

  Therapeutic drug monitoring 20120601

• Lupus erythematosus profundus masquerading as idiopathic orbital inflammatory syndrome.

  Orbit (Amsterdam, Netherlands) 20120601

• Mycophenolate sodium dosing in combination with tacrolimus: pharmacokinetic evaluation of a novel regimen in de novo tacrolimus-treated kidney transplant patients.

  Clinical nephrology 20120601

• Early allograft biopsies performed during delayed graft function may not be necessary under thymoglobulin induction.

  Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 20120601

• Everolimus in different combinations as maintenance immunosuppressive therapy in heart transplant recipients.

  Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 20120601

• Lichen planus in association with adult-onset still's disease successfully treated with mycophenolate mofetil.

  The Journal of rheumatology 20120601

• New immunosuppressive therapies and surgical complications after renal transplantation.

  Transplantation proceedings 20120601

• A 29-year-old renal transplant recipient with acute respiratory failure.

  The American journal of tropical medicine and hygiene 20120601

• Mycophenolic acid-related anemia and leucopenia in renal transplant recipients are related to genetic polymorphisms in CYP2C8.

  Transplantation 20120527

• Randomized trial comparing late concentration-controlled calcineurin inhibitor or mycophenolate mofetil withdrawal.

  Transplantation 20120515

• Mycophenolate mofetil for maintenance of remission in steroid-dependent autoimmune pancreatitis.

  World journal of gastroenterology 20120514

• New developments in the treatment of systemic lupus erythematosus.

  Pediatric nephrology (Berlin, Germany) 20120501

• The use of mycophenolate mofetil for the treatment of autoimmune and chronic idiopathic urticaria: experience in 19 patients.

  Journal of the American Academy of Dermatology 20120501

• Sequential maintenance therapy with cyclosporin A and mycophenolate mofetil for sustained remission of childhood steroid-resistant nephrotic syndrome.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20120501

• Trilineage myelodysplasia and hemophagocytosis associated with systemic lupus erythematosus.

  American journal of hematology 20120501

• Development of population PK model with enterohepatic circulation for mycophenolic acid in patients with childhood-onset systemic lupus erythematosus.

  British journal of clinical pharmacology 20120501

• Treatment of children with Henoch-Schönlein purpura nephritis with mycophenolate mofetil.

  Pediatric nephrology (Berlin, Germany) 20120501

• Repeat kidney biopsies fail to detect differences between azathioprine and mycophenolate mofetil maintenance therapy for lupus nephritis: data from the MAINTAIN Nephritis Trial.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20120501

• Pharmacokinetics, tolerability, and preliminary efficacy of paquinimod (ABR-215757), a new quinoline-3-carboxamide derivative: studies in lupus-prone mice and a multicenter, randomized, double-blind, placebo-controlled, repeat-dose, dose-ranging study in patients with systemic lupus erythematosus.

  Arthritis and rheumatism 20120501

• Assay validation of phosphorylated S6 ribosomal protein for a pharmacodynamic monitoring of mTOR-inhibitors in peripheral human blood.

  Cytometry. Part B, Clinical cytometry 20120501

• Pilot 24 month study to compare mycophenolate mofetil and tacrolimus in the treatment of membranous lupus nephritis with nephrotic syndrome.

  Nephrology (Carlton, Vic.) 20120501

• Investigation of the inclusion complex of β-cyclodextrin with mycophenolate mofetil.

  Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20120501

• Allogenic limbo-keratoplasty with conjunctivoplasty, mitomycin C, and amniotic membrane for bilateral limbal stem cell deficiency.

  Ophthalmology 20120501

• Penicacids A-C, three new mycophenolic acid derivatives and immunosuppressive activities from the marine-derived fungus Penicillium sp. SOF07.

  Bioorganic & medicinal chemistry letters 20120501

• Where does rituximab fit in the treatment of autoimmune mucocutaneous blistering skin disease?

  Journal of drugs in dermatology : JDD 20120501

• [Effect of mycophenolate on expression of MCP-1 and fibronectin in human mesangial cells induced by high glucose].

  Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology 20120501

• Mycophenolate mofetil for the management of autoimmune bullous diseases.

  Immunology and allergy clinics of North America 20120501

• Cardiac allograft vasculopathy compared by intravascular ultrasound sonography: everolimus to mycophenolate mofetil--one single-center experience.

  Transplantation proceedings 20120501

• Cellular function of RhoGDI-α mediates the cycling of Rac1 and the regulation of pancreatic beta cell death.

  Transplantation proceedings 20120501

• Dutch guidelines for diagnosis and therapy of proliferative lupus nephritis.

  The Netherlands journal of medicine 20120501

• Immunotherapies in rheumatologic disorders.

  The Medical clinics of North America 20120501

• Immunotherapies in neurologic disorders.

  The Medical clinics of North America 20120501

• Triple immunosuppressive therapy can accelerate the recovery of antibody-mediated pure red cell aplasia and allow successful concurrent resumption of erythropoietin.

  Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20120501

• Influence of induction modality on the outcome of deceased donor kidney transplant recipients discharged on steroid-free maintenance immunosuppression.

  Transplantation 20120427

• Long-term effects of alemtuzumab on regulatory and memory T-cell subsets in kidney transplantation.

  Transplantation 20120427

• T-cell-based immunosuppressive therapy inhibits the development of natural antibodies in infant baboons.

  Transplantation 20120427

• Transplantation with pathologic kidneys to improve the pool of donors: an example of shunt nephritis.

  Transplantation 20120427

• Late subcapsular lymphocele in a kidney graft.

  Transplantation 20120427

• Immunosuppressant and immunomodulatory treatments for multifocal motor neuropathy.

  The Cochrane database of systematic reviews 20120418

• The association of the UGT1A8, SLCO1B3 and ABCC2/ABCG2 genetic polymorphisms with the pharmacokinetics of mycophenolic acid and its phenolic glucuronide metabolite in Chinese individuals.

  Clinica chimica acta; international journal of clinical chemistry 20120411

• Clinical spectrum of CNS aquaporin-4 autoimmunity.

  Neurology 20120410

• Effective plasma concentrations of mycophenolic acid and its glucuronide in systemic lupus erythematosus patients in the remission-maintenance phase.

  Journal of clinical pharmacy and therapeutics 20120401

• Sirolimus and mycophenolate mofetil as GVHD prophylaxis in myeloablative, matched-related donor hematopoietic cell transplantation.

  Bone marrow transplantation 20120401

• Analysis of T2 intensity by magnetic resonance imaging of deep gray matter nuclei in multiple sclerosis patients: effect of immunomodulatory therapies.

  Journal of neuroimaging : official journal of the American Society of Neuroimaging 20120401

• Mycophenolate mofetil therapy for juvenile dermatomyositis with immune thrombocytopenic purpura.

  Modern rheumatology 20120401

• Mycophenolate mofetil or tacrolimus compared with intravenous cyclophosphamide in the induction treatment for active lupus nephritis.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20120401

• Mycophenolate mofetil inducing remission of lupus enteritis.

  Lupus 20120401

• Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the Lupus Nephritis Assessment with Rituximab study.

  Arthritis and rheumatism 20120401

• Early conversion to a sirolimus-based, calcineurin-inhibitor-free immunosuppression in the SMART trial: observational results at 24 and 36months after transplantation.

  Transplant international : official journal of the European Society for Organ Transplantation 20120401

• Optimal storage temperature and matrix before analyzing mycophenolic acid.

  Therapeutic drug monitoring 20120401

• An analysis of lymphocyte phenotype after steroid avoidance with either alemtuzumab or basiliximab induction in renal transplantation.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20120401

• Oral immunosuppressive medication for growing pigs in transplantation studies.

  Laboratory animals 20120401

• Mycophenolate mofetil in the treatment of chronic non-infectious, non-necrotizing scleritis.

  Ocular immunology and inflammation 20120401

• Population pharmacokinetics of mycophenolate mofetil in Thai lupus nephritis patients.

  International journal of clinical pharmacology and therapeutics 20120401

• Prospective controlled protocol for three months steroid withdrawal with tacrolimus, basiliximab, and mycophenolate mofetil in renal transplant recipients.

  Journal of Korean medical science 20120401

• Percentages of water, muscle, and bone decrease and lipid increases in early period after successful kidney transplantation: a body composition analysis.

  Transplantation proceedings 20120401

• The 4-week serum creatinine level predicts long-term renal dysfunction after adult living donor liver transplantation.

  Transplantation proceedings 20120401

• New treatment strategies in idiopathic nephrotic syndrome.

  Minerva pediatrica 20120401

• Minimal change (steroid sensitive) nephrotic syndrome in children: new aspects on pathogenesis and treatment.

  Minerva pediatrica 20120401

• Systemic treatment of adult atopic dermatitis.

  Clinical medicine (London, England) 20120401

• Durability of antibody removal following proteasome inhibitor-based therapy.

  Transplantation 20120327

• A short story of anti-rheumatic therapy. VIII. The immunodepressants.

  Reumatismo 20120319

• Human α/β hydrolase domain containing 10 (ABHD10) is responsible enzyme for deglucuronidation of mycophenolic acid acyl-glucuronide in liver.

  The Journal of biological chemistry 20120316

• Calcineurin inhibitor minimisation versus continuation of calcineurin inhibitor treatment for liver transplant recipients.

  The Cochrane database of systematic reviews 20120314

• Chimerism and tolerance without GVHD or engraftment syndrome in HLA-mismatched combined kidney and hematopoietic stem cell transplantation.

  Science translational medicine 20120307

• Prophylaxis of chronic kidney disease after liver transplantation--experience from west China.

  World journal of gastroenterology 20120307

• Successful treatment of steroid and cyclophosphamide-resistant diffuse scleroderma-associated interstitial lung disease with rituximab.

  Rheumatology international 20120301

• Mycophenolate mofetil in juvenile dermatomyositis: a case series.

  Rheumatology international 20120301

• Mycophenolate mofetil for steroid-dependent nephrotic syndrome: a phase II Bayesian trial.

  Pediatric nephrology (Berlin, Germany) 20120301

• Mycophenolate mofetil but not atorvastatin attenuates atherosclerosis in lupus-prone LDLr(-/-) mice.

  Annals of the rheumatic diseases 20120301

• Giant disseminated condylomatosis in SLE.

  Lupus 20120301

• Rituximab in relapsing or refractory ANCA-associated vasculitis: a case series of 16 patients.

  Scandinavian journal of rheumatology 20120301

• MPA: a treatment option for lymphocytic colitis and mesalamine-induced interstitial nephritis.

  Inflammatory bowel diseases 20120301

• A limited sampling strategy for the simultaneous estimation of tacrolimus, mycophenolic acid and unbound prednisolone exposure in adult kidney transplant recipients.

  Nephrology (Carlton, Vic.) 20120301

• Long-term kidney allograft function and survival in prednisone-free regimens: tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimus.

  Clinical journal of the American Society of Nephrology : CJASN 20120301

• Pulmonary arterial hypertension during systemic lupus.

  Joint, bone, spine : revue du rhumatisme 20120301

• Teratogenicity of mycophenolate confirmed in a prospective study of the European Network of Teratology Information Services.

  American journal of medical genetics. Part A 20120301

• Current status of immunosuppressive agents for solid organ transplantation in children.

  Pediatric transplantation 20120301

• Acute inflammatory syndrome with elevated procalcitonin induced by mycophenolate sodium.

  The Journal of rheumatology 20120301

• Chronic allograft dysfunction: major contributing factors.

  Iranian journal of kidney diseases 20120301

• A randomized trial with steroids and antithymocyte globulins comparing cyclosporine/azathioprine versus tacrolimus/mycophenolate mofetil (CATM2) in renal transplantation.

  Transplantation 20120227

• [Proliferation effects of sirolimus, cyclosporine A and mycophenolate mofetil on human transitional cell carcinoma cells].

  Zhonghua yi xue za zhi 20120214

• Mycophenolate or azathioprine maintenance in lupus nephritis.

  The New England journal of medicine 20120209

• Mycophenolate or azathioprine maintenance in lupus nephritis.

  The New England journal of medicine 20120209

• Interstitial nephritis and autoimmune pancreatitis: a case report.

  International urology and nephrology 20120201

• Effect of different immunosuppressive regimens on the evolution of distinct metabolic parameters: evidence from the Symphony study.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20120201

• Mycophenolate mofetil in low-risk renal transplantation in patients receiving no cyclosporine: a single-centre experience.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20120201

• Strategies to prevent or reduce acute and chronic kidney injury in liver transplantation.

  Liver international : official journal of the International Association for the Study of the Liver 20120201

• Genetic variations in the mycophenolate mofetil target enzyme are associated with acute GVHD risk after related and unrelated hematopoietic cell transplantation.

  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20120201

• Very early steroid withdrawal or complete avoidance for kidney transplant recipients: a systematic review.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20120201

• Outcome of deceased donor renal transplantation in diabetic nephropathy: a single-center experience from a developing country.

  International urology and nephrology 20120201

• A high-throughput U-HPLC-MS/MS assay for the quantification of mycophenolic acid and its major metabolites mycophenolic acid glucuronide and mycophenolic acid acyl-glucuronide in human plasma and urine.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20120201

• Effect of mycophenolate mofetil on plasma bioelements in renal transplant recipients.

  Biological trace element research 20120201

• A simplified immune suppression scheme leads to persistent micro-dystrophin expression in Duchenne muscular dystrophy dogs.

  Human gene therapy 20120201

• A Phase I study of gemtuzumab ozogamicin (GO) in combination with busulfan and cyclophosphamide (Bu/Cy) and allogeneic stem cell transplantation in children with poor-risk CD33+ AML: a new targeted immunochemotherapy myeloablative conditioning (MAC) regimen.

  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20120201

• New advances in the diagnosis and treatment of autoimmune lymphoproliferative syndrome.

  Current opinion in pediatrics 20120201

• Infiltrating cellular pattern in kidney graft biopsies translates into forkhead box protein 3 up-regulation and p16INK4α senescence protein down-regulation in patients treated with belatacept compared to cyclosporin A.

  Clinical and experimental immunology 20120201

• A multicenter, randomized trial of increased mycophenolic acid dose using enteric-coated mycophenolate sodium with reduced tacrolimus exposure in maintenance kidney transplant recipients.

  Clinical nephrology 20120201

• New and future therapies for lupus nephritis.

  Cleveland Clinic journal of medicine 20120201

• Pediatric renal transplantation in the jordanian population: the clinical outcome measures during long-term follow-up period.

  Pediatrics and neonatology 20120201

• Severe neutropenia in a renal transplant patient suggesting an interaction between mycophenolate and fenofibrate.

  Current drug safety 20120201

• Association of immunosuppressive maintenance regimens with posttransplant lymphoproliferative disorder in kidney transplant recipients.

  Transplantation 20120115

• Pharmacokinetics of tacrolimus and mycophenolate mofetil in renal transplant recipients on a corticosteroid-free regimen.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20120115

• [Allergo-immunology. Clinical immunology].

  Revue medicale suisse 20120111

• [Nephrology].

  Revue medicale suisse 20120111

• Pharmacokinetics and pharmacodynamics of mycophenolate sodium (EC-MPS) co-administered with cyclosporine in the early-phase post-kidney transplantation.

  Clinical transplantation 20120101

• Improvement of gastrointestinal symptoms after conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in liver transplant patients.

  Clinical transplantation 20120101

• Sirolimus-based regimen is associated with decreased expression of glomerular vascular endothelial growth factor.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20120101

• Long-term effects of methylprednisolone pulses and mycophenolate mofetil in IgA nephropathy patients at risk of progression.

  Journal of nephrology 20120101

• Cytoreductive treatment with clofarabine/ara-C combined with reduced-intensity conditioning and allogeneic stem cell transplantation in patients with high-risk, relapsed, or refractory acute myeloid leukemia and advanced myelodysplastic syndrome.

  European journal of haematology 20120101

• Treatment of severe pemphigus with a combination of immunoadsorption, rituximab, pulsed dexamethasone and azathioprine/mycophenolate mofetil: a pilot study of 23 patients.

  The British journal of dermatology 20120101

• Adaptive evolution of drug targets in producer and non-producer organisms.

  The Biochemical journal 20120101

• Retinal functional changes measured by microperimetry after immunosuppressive therapy in patients with Vogt-Koyanagi-Harada disease.

  European journal of ophthalmology 20120101

• Progressive multifocal leukoencephalopathy associated with mycophenolate mofetil treatment in a woman with lupus and CD4+ T-lymphocyte deficiency.

  Lupus 20120101

• Enteric-coated mycophenolate sodium in de novo and maintenance kidney-pancreas transplant recipients.

  Clinical transplantation 20120101

• Universal perioperative antimicrobial prophylaxis is not necessary in kidney transplantation.

  Clinical transplantation 20120101

• Degree of mucositis and duration of neutropenia are the major risk factors for early post-transplant febrile neutropenia and severe bacterial infections after reduced-intensity conditioning.

  European journal of haematology 20120101

• Effect of early conversion from CNI to sirolimus on outcomes in kidney transplant recipients with allograft dysfunction.

  Journal of nephrology 20120101

• Anti-α actinin antibodies as new predictors of response to treatment in autoimmune hepatitis type 1.

  Alimentary pharmacology & therapeutics 20120101

• Bayesian estimation of mycophenolate mofetil in lung transplantation, using a population pharmacokinetic model developed in kidney and lung transplant recipients.

  Clinical pharmacokinetics 20120101

• Immunosuppressive therapy for autoimmune bullous diseases.

  Clinics in dermatology 20120101

• Mycophenolate mofetil and hydroxychloroquine: an effective treatment for recalcitrant cutaneous lupus erythematosus.

  Journal of the American Academy of Dermatology 20120101

• Mycophenolate mofetil and daclizumab targeting T lymphocytes in bleomycin-induced experimental scleroderma.

  Clinical and experimental dermatology 20120101

• Production of donor-derived offspring after ovarian transplantation between Muscovy (Cairina moschata) and Pekin (Anas platyrhynchos) ducks.

  Poultry science 20120101

• The effects of mycophenolate mofetil on encapsulated peritoneal sclerosis model in rats.

  Clinical nephrology 20120101

• Cost and efficacy of immunosuppression using generic products following living donor liver transplantation in India.

  Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology 20120101

• Prevalence and outcome of focal segmental glomerulosclerosis in Iranian children with nephrotic syndrome.

  Iranian journal of kidney diseases 20120101

• Prophylactic effect of mycophenolate mofetil on early outcomes of living donor kidney transplantation.

  Iranian journal of kidney diseases 20120101

• Treatment of neuromyelitis optica: an evidence based review.

  Arquivos de neuro-psiquiatria 20120101

• Validation of an LC-MS/MS method to determine five immunosuppressants with deuterated internal standards including MPA.

  BMC clinical pharmacology 20120101

• Haemolytic-uraemic syndrome during severe lupus nephritis: efficacy of plasma exchange.

  Internal medicine journal 20120101

• Therapy of lupus nephritis: lessons learned from clinical research and daily care of patients.

  Arthritis research & therapy 20120101

• Cyclosporine or tacrolimus: which is the better partner for myfortic or cellcept?

  Transplantation proceedings 20120101

• A 6-month, open-label, multicenter clinical study in Korean de novo renal transplant patients evaluating the efficacy, safety, and tolerance of myfortic concomitantly used with tacrolimus.

  Transplantation proceedings 20120101

• Experiences of high-dose mizoribine as antimetabolite immunosuppressants for kidney transplantation.

  Transplantation proceedings 20120101

• Everolimus with reduced-dose cyclosporine versus full-dose cyclosporine and mycophenolate in de novo renal transplant patients: a 2-year single-center experience.

  Transplantation proceedings 20120101

• Early steroid withdrawal in adult kidney transplantation at a single center.

  Transplantation proceedings 20120101

• Trends in the use of immunosuppressive agents by outpatients after renal transplantation at a medical center in southern Taiwan.

  Transplantation proceedings 20120101

• Trends in maintenance immunosuppressive drugs used in taiwanese kidney transplant recipients: an analysis of the national health insurance research database.

  Transplantation proceedings 20120101

• Atacicept in combination with MMF and corticosteroids in lupus nephritis: results of a prematurely terminated trial.

  Arthritis research & therapy 20120101

• Bullous pemphigoid in a transplant recipient: is this a sign of allograft rejection?

  European journal of dermatology : EJD 20120101

• A pilot study on area under curve of mycophenolic acid as a guide for its optimal use in renal transplant recipients.

  The Indian journal of medical research 20120101

• Mycophenolate mofetil and erythromycin for bullous lupus erythematosus of childhood.

  Journal of cutaneous medicine and surgery 20120101

• Figurate erythema: an unusual presentation of the nonbullous phase of bullous pemphigoid.

  Journal of cutaneous medicine and surgery 20120101

• Mycophenolate mofetil in primary Sjögren's syndrome: a treatment option for agranulocytosis.

  Revista brasileira de reumatologia 20120101

• Conversion from everolimus with low-exposure cyclosporine to everolimus with mycophenolate sodium maintenance therapy in kidney transplant recipients: a randomized, open-label multicenter study.

  Annals of transplantation 20120101

• Pharmacokinetic monitoring of mycophenolic acid in heart transplant patients: correlation the side-effects and rejections with pharmacokinetic parameters.

  Annals of transplantation 20120101

• The value of BP230 enzyme-linked immunosorbent assay in the diagnosis and immunological follow-up of bullous pemphigoid.

  Dermatology (Basel, Switzerland) 20120101

• Mycophenolate mofetil use in the treatment of noninfectious uveitis.

  Developments in ophthalmology 20120101

• Mycophenolate as induction therapy in lupus nephritis with renal function impairment.

  American journal of nephrology 20120101

• Time dependent neuroprotection of mycophenolate mofetil: effects on temporal dynamics in glial proliferation, apoptosis, and scar formation.

  Journal of neuroinflammation 20120101

• [Mycophenolate mofetil in induction and maintenance therapy for juvenile onset severe lupus nephritis].

  Nihon Jinzo Gakkai shi 20120101

• Adjuvant treatment of recalcitrant bullous pemphigoid with immunoadsorption.

  Dermatology (Basel, Switzerland) 20120101

• Transient and intensive pharmacological immunosuppression fails to improve AAV-based liver gene transfer in non-human primates.

  Journal of translational medicine 20120101

• Enteric-coated mycophenolate sodium as a steroid-sparing agent in pemphigus treatment: a retrospective study.

  Dermatologic therapy 20120101

• Mycophenolate mofetil and FK506 have different effects on kidney allograft fibrosis in rats that underwent chronic allograft nephropathy.

  BMC nephrology 20120101

• Successful conversion to everolimus after cytomegalovirus infection in a heart transplant recipient.

  International heart journal 20120101

• Change in pharmacokinetics of mycophenolic acid as a function of age in rats and effect of coadministered amoxicillin/clavulanate.

  Biological & pharmaceutical bulletin 20120101

• Evaluation of potential interactions between mycophenolic acid derivatives and proton pump inhibitors.

  The Annals of pharmacotherapy 20120101

• A multicenter, randomized, double-blind study comparing different FK778 doses (manitimus) with tacrolimus and steroids vs. MMF with tacrolimus and steroids in renal transplantation.

  BMC nephrology 20120101

• No harmful effect of mycophenolate mofetil on liver regeneration: an experimental study.

  Transplantation proceedings 20120101

• Refractory calcinosis in a patient with dermatomyositis: response to intravenous immune globulin.

  BMJ case reports 20120101

• Immunosuppressive treatment for nephrotic idiopathic membranous nephropathy: a meta-analysis based on Chinese adults.

  PloS one 20120101

• A pilot study to examine the effect of chronic treatment with immunosuppressive drugs on mucociliary clearance in a vagotomized murine model.

  PloS one 20120101

• Pharmacokinetics of tacrolimus in adult renal transplant recipients.

  Drug metabolism and drug interactions 20120101

• A possible explanation for anemia in patients treated with mycophenolic acid.

  Transplantation 20111227

• [Therapy in IgA nephropathy--when and how to do it].

  Orvosi hetilap 20111218

• Early steroid withdrawal and optimization of mycophenolic acid exposure in kidney transplant recipients receiving mycophenolate mofetil.

  Transplantation 20111215

• Cutaneous lupus erythematosus: update of therapeutic options part II.

  Journal of the American Academy of Dermatology 20111201

• Antibody-mediated rejection presenting as allograft hydronephrosis.

  International urology and nephrology 20111201

• [Immunosuppressive treatments: mechanisms of action and clinical use].

  Nephrologie & therapeutique 20111201

• Isolated esophageal ulcerations in immunocompromised patients: mycophenolate mofetil or foscarnet, who is guilty?

  Journal of pediatric hematology/oncology 20111201

• Progressive improvement in cutaneous and extracutaneous chronic graft-versus-host disease after a 24-week course of extracorporeal photopheresis--results of a crossover randomized study.

  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20111201

• Impact of sirolimus, tacrolimus and mycophenolate mofetil on osteoclastogenesis--implications for post-transplantation bone disease.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20111201

• Evaluation of limited sampling strategies for total and free prednisolone in adult kidney transplant recipients.

  European journal of clinical pharmacology 20111201

• A retrospective analysis of clinical presentation of lupus nephritis.

  The American journal of the medical sciences 20111201

• Immunosuppressive treatment in refractory chronic inflammatory demyelinating polyradiculoneuropathy. A nationwide retrospective analysis.

  European journal of neurology 20111201

• Mycophenolate mofetil as a maintenance therapy for lupus-related diffuse alveolar hemorrhage: a case report.

  Lupus 20111201

• A randomized, multicenter study comparing steroid-free immunosuppression and standard immunosuppression for liver transplant recipients with chronic hepatitis C.

  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20111201

• Cytopenias after day 28 in allogeneic hematopoietic cell transplantation: impact of recipient/donor factors, transplant conditions and myelotoxic drugs.

  Haematologica 20111201

• Nanoparticle delivery of mycophenolic acid upregulates PD-L1 on dendritic cells to prolong murine allograft survival.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20111201

• Efficacy and safety of enteric-coated mycophenolate sodium in combination with two glucocorticoid regimens for the treatment of active lupus nephritis.

  Lupus 20111201

• Anti-NMDA receptor encephalitis: an important differential diagnosis in psychosis.

  The British journal of psychiatry : the journal of mental science 20111201

• Efficacy of postoperative immunosuppression after keratoplasty in herpetic keratitis.

  Cornea 20111201

• Maximum a posteriori Bayesian estimation of mycophenolic Acid area under the concentration-time curve: is this clinically useful for dosage prediction yet?

  Clinical pharmacokinetics 20111201

• Kinetic nomograms assist individualization of drug regimens.

  Clinical pharmacokinetics 20111201

• Mycophenolate mofetil for the induction and maintenance treatment of lupus nephritis.

  Immunotherapy 20111201

• Oseltamivir, an influenza neuraminidase inhibitor drug, does not affect the steady-state pharmacokinetic characteristics of cyclosporine, mycophenolate, or tacrolimus in adult renal transplant patients.

  Therapeutic drug monitoring 20111201

• Long-term results of therapy with mycophenolate mofetil in ocular mucous membrane pemphigoid.

  Ocular immunology and inflammation 20111201

• Cytomegalovirus colitis and viremia from mycophenolate mofetil monotherapy in birdshot chorioretinopathy.

  Ocular immunology and inflammation 20111201

• [Immunosuppressive treatment].

  Nephrologie & therapeutique 20111201

• Mycophenolate mofetil treatment of steroid-resistant idiopathic sclerosing orbital inflammation.

  Clinical & experimental ophthalmology 20111201

• Cancer rates after kidney transplantation.

  Danish medical bulletin 20111201

• Lipid profile changes during the first year after kidney transplantation: risk factors and influence of the immunosuppressive drug regimen.

  Transplantation proceedings 20111201

• Oxidative stress indices in rats under immunosuppression.

  Transplantation proceedings 20111201

• Hyperkalemic distal renal tubular acidosis caused by immunosuppressant treatment with tacrolimus in a liver transplant patient: case report.

  Transplantation proceedings 20111201

• A case of minimal change disease treated successfully with mycophenolate mofetil in a patient with systemic lupus erythematosus.

  The Korean journal of internal medicine 20111201

• Rituximab and mycophenolate combination therapy in refractory dermatomyositis with multiple autoimmune disorders.

  Journal of clinical neuromuscular disease 20111201

• Kinetically controlled drug resistance: how Penicillium brevicompactum survives mycophenolic acid.

  The Journal of biological chemistry 20111125

• Mycophenolate versus azathioprine as maintenance therapy for lupus nephritis.

  The New England journal of medicine 20111117

• Toward better treatment for lupus nephritis.

  The New England journal of medicine 20111117

• Mycophenolic acid induces ATP-binding cassette transporter A1 (ABCA1) expression through the PPARγ-LXRα-ABCA1 pathway.

  Biochemical and biophysical research communications 20111104

• Influence of MRP2 on MPA pharmacokinetics in renal transplant recipients-results of the Pharmacogenomic Substudy within the Symphony Study.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20111101

• Hot topic in hepatitis C virus research: the type of immunosuppression does not matter.

  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20111101

• Therapy of polymyositis and dermatomyositis.

  Autoimmunity reviews 20111101

• Cytomegalovirus incidence between everolimus versus mycophenolate in de novo renal transplants: pooled analysis of three clinical trials.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20111101

• Monitoring of mycophenolic acid and kidney function during combined immunosuppressive therapy.

  Clinical chemistry and laboratory medicine 20111101

• Hot-topic debate on hepatitis C virus: the type of immunosuppression matters.

  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20111101

• Brain diffuse large B-cell lymphoma in a systemic lupus erythematosus patient treated with immunosuppressive agents including mycophenolate mofetil.

  Lupus 20111101

• Effect of mycophenolate sodium in scleroderma-related interstitial lung disease.

  Clinical rheumatology 20111101

• Calcineurin inhibitors in kidney transplantation: friend or foe?

  Current opinion in nephrology and hypertension 20111101

• Uterine allotransplantation in ewes using an aortocava patch.

  Human reproduction (Oxford, England) 20111101

• FTY720 combined with tacrolimus in de novo renal transplantation: 1-year, multicenter, open-label randomized study.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20111101

• Immunosuppressant regimen based on sirolimus decreases aortic stiffness in renal transplant recipients in comparison to cyclosporine.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20111101

• The effects of cyclophosphamide and mycophenolate on end-stage renal disease and death of lupus nephritis.

  Lupus 20111101

• Generic maintenance immunosuppression in solid organ transplant recipients.

  Pharmacotherapy 20111101

• Longterm followup after tapering mycophenolate mofetil during maintenance treatment for proliferative lupus nephritis.

  The Journal of rheumatology 20111101

• [Anti-p200 pemphigoid: a spectacular response to dapsone].

  Annales de dermatologie et de venereologie 20111101

• PML and rheumatology: the contribution of disease and drugs.

  Cleveland Clinic journal of medicine 20111101

• Mycophenolate mofetil monotherapy in liver transplantation: 5-year follow-up of a prospective randomized trial.

  Transplantation 20111027

• Monitoring nonadherence and acute rejection with variation in blood immunosuppressant levels in pediatric renal transplantation.

  Transplantation 20111027

• GTP depletion synergizes the anti-proliferative activity of chemotherapeutic agents in a cell type-dependent manner.

  Biochemical and biophysical research communications 20111022

• Stochastic pulse regulation in bacterial stress response.

  Science (New York, N.Y.) 20111021

• [Drug interactions and immunosuppression in organ transplant recipients].

  Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20111018

• Results of a prospective randomized trial of sirolimus conversion in kidney transplant recipients on early corticosteroid withdrawal.

  Transplantation 20111015

• Kidney transplantation with minimized maintenance: alemtuzumab induction with tacrolimus monotherapy--an open label, randomized trial.

  Transplantation 20111015

• [Treatment of rheumatic diseases: current status and future prospective. Topics: II. Immunosuppressant/antirheumatic drugs: 9. Mycophenolate mofetil].

  Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 20111010

• Risk factors associated with kidney injury and the impact of kidney injury on overall survival in pediatric recipients following allogeneic stem cell transplant.

  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20111001

• Imatinib combined with myeloablative allogeneic hematopoietic stem cell transplantation for advanced phases of chronic myeloid leukemia.

  Leukemia research 20111001

• Should we consider MMF therapy after rituximab for nephrotic syndrome?

  Pediatric nephrology (Berlin, Germany) 20111001

• Maintenance therapy with mycophenolate mofetil after rituximab in pediatric patients with steroid-dependent nephrotic syndrome.

  Pediatric nephrology (Berlin, Germany) 20111001

• Efficacy of mycophenolate mofetil in antimalarial-resistant cutaneous lupus erythematosus.

  Journal of the American Academy of Dermatology 20111001

• Glucocorticoid-induced diabetes mellitus in patients with systemic lupus erythematosus treated with high-dose glucocorticoid therapy.

  Lupus 20111001

• Optimization of the dosing regimen of mycophenolate mofetil in pediatric liver transplant recipients.

  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20111001

• Nonparametric population modeling and Bayesian analysis.

  Pharmacological research 20111001

• Clinical trial of focal segmental glomerulosclerosis in children and young adults.

  Kidney international 20111001

• How are thiopurines used and monitored by Swedish gastroenterologists when treating patients with inflammatory bowel disease?

  Scandinavian journal of gastroenterology 20111001

• Survey of expert practice and perceptions of the supporting clinical evidence for the management of uveitis-related cataract and cystoid macular oedema.

  Ocular immunology and inflammation 20111001

• De-novo calcineurin-inhibitor-free immunosuppression with sirolimus and mycophenolate mofetil after heart transplantation: 5-year results.

  Current opinion in organ transplantation 20111001

• Nonsteroidal anti-inflammatory drugs may reduce enterohepatic recirculation of mycophenolic acid in patients with childhood-onset systemic lupus erythematosus.

  Therapeutic drug monitoring 20111001

• Mycophenolic acid differentially impacts B cell function depending on the stage of differentiation.

  Journal of immunology (Baltimore, Md. : 1950) 20111001

• Mycophenolate mofetil for the management of autoimmune bullous diseases.

  Dermatologic clinics 20111001

• Evidence-based treatments in pemphigus vulgaris and pemphigus foliaceus.

  Dermatologic clinics 20111001

• Current management strategies in paraneoplastic pemphigus (paraneoplastic autoimmune multiorgan syndrome).

  Dermatologic clinics 20111001

• Management of epidermolysis bullosa acquisita.

  Dermatologic clinics 20111001

• Fulminant ulcerative colitis despite maximal immunosuppression following liver transplantation: a case report and literature review.

  Journal of Crohn's & colitis 20111001

• Systemic drugs in patients with skin diseases.

  Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia 20111001

• An enlarging ulcer.

  The American journal of medicine 20111001

• Alemtuzumab preconditioning allows steroid-calcineurin inhibitor-free regimen in live-donor kidney transplant.

  Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 20111001

• Chronic myeloid leukemia within a year of kidney transplant with elevated alkaline phosphatase correlated with imatinib therapy.

  Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 20111001

• Plasma exchange and rituximab in the management of acute occlusive retinal vasculopathy secondary to systemic lupus erythematosus.

  Ocular immunology and inflammation 20111001

• Tolerance of enteric-coated mycophenolate sodium in combination with calcineurin inhibitor in kidney transplant recipients: Polish experience.

  Transplantation proceedings 20111001

• Cardiovascular risk in kidney transplant recipients receiving mammalian target of rapamycin inhibitors.

  Transplantation proceedings 20111001

• The status of BK polyomavirus replication in adult renal transplant recipients in northeastern Poland.

  Transplantation proceedings 20111001

• Treatment of refractory tumor necrosis factor inhibitor-induced palmoplantar pustulosis: a report of 2 cases.

  Archives of dermatology 20111001

• Young male with systemic lupus erythematosus presenting with sensorineural deafness with immune suppression induced miliary tuberculosis.

  The Journal of the Association of Physicians of India 20111001

• Single dose of alemtuzumab induction with steroid-free maintenance immunosuppression in pancreas transplantation.

  Transplantation 20110927

• [New therapeutic approaches for polymyositis and dermatomyositis].

  Orvosi hetilap 20110925

• Renal graft function and low-dose cyclosporine affect mycophenolic acid pharmacokinetics in kidney transplantation.

  Transplantation 20110915

• Impact of de novo everolimus-based immunosuppression on incisional complications in heart transplantation.

  Transplantation 20110915

• Effect of conditioning regimen intensity on acute myeloid leukemia outcomes after umbilical cord blood transplantation.

  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20110901

• Mycophenolate for the treatment of autoimmune hepatitis: prospective assessment of its efficacy and safety for induction and maintenance of remission in a large cohort of treatment-naïve patients.

  Journal of hepatology 20110901

• Role of mycophenolate mofetil in the treatment of autoimmune hepatitis.

  Journal of hepatology 20110901

• Evalutation of mycophenolic acid systemic exposure by limited sampling strategy in kidney transplant recipients receiving enteric-coated mycophenolate sodium (EC-MPS) and cyclosporine.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20110901

• Outcome of idiopathic membranous nephropathy using targeted stepwise immunosuppressive treatment strategy.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20110901

• The importance of assessing medication exposure to the definition of refractory disease in systemic lupus erythematosus.

  Autoimmunity reviews 20110901

• Lenalidomide maintenance after nonmyeloablative allogeneic stem cell transplantation in multiple myeloma is not feasible: results of the HOVON 76 Trial.

  Blood 20110901

• Does MMF really slow down fibrosis of HCV recurrence in liver transplant recipients?

  Transplant international : official journal of the European Society for Organ Transplantation 20110901

• Features of synergism between mesenchymal stem cells and immunosuppressive drugs in a murine heart transplantation model.

  Transplant immunology 20110901

• Mycophenolate mofetil in the treatment of systemic lupus erythematosus.

  Current opinion in rheumatology 20110901

• Influence of immunosuppressive agents on tryptophan degradation and neopterin production in human peripheral blood mononuclear cells.

  Transplant immunology 20110901

• Evidence of an anti-inflammatory effect of mycophenolate mofetil in a murine model of pleurisy.

  Experimental lung research 20110901

• Randomized trial of immunosuppressive regimens in renal transplantation.

  Journal of the American Society of Nephrology : JASN 20110901

• Potential teratogenic effects of allopurinol: a case report.

  American journal of medical genetics. Part A 20110901

• Mycophenolate mofetil for patients with autoimmune hepatitis and overlap syndromes.

  Alimentary pharmacology & therapeutics 20110901

• Graft morphology correlates with fibroblast activity in cardiac allograft rejection.

  APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 20110901

• Amyopathic dermatomyositis presenting as skin necrosis.

  Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 20110901

• Alteration of panel-reactive antibodies following treatment with either atorvastatin or low-dose mycophenolate mofetil in sensitized hemodialysis patients.

  Iranian journal of kidney diseases 20110901

• The effect of calcineurin inhibitors on endothelial and platelet function in renal transplant patients.

  Clinical nephrology 20110901

• Improvement in chronic renal failure after mycophenolate mofetil introduction and cyclosporine dose reduction: four-year results from a cohort of heart transplant recipients.

  Transplantation proceedings 20110901

• Nitric oxide and acute phase proteins are involved in pathogenesis of mycophenolate mofetil-induced gastrointestinal disorders in rats.

  Transplantation proceedings 20110901

• Reconstruction of a severe facial defect by allotransplantation in neurofibromatosis type 1: a case report.

  Transplantation proceedings 20110901

• [Effects of mycophenolic acid on human bone marrow-derived mesenchymal stem cells in vitro].

  Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences 20110901

• Idiopathic hypertrophic pachymeningitis responsive to mycophenolate.

  Acta neurologica Belgica 20110901

• Gastrointestinal quality of life improvement of renal transplant recipients converted from mycophenolate mofetil to enteric-coated mycophenolate sodium drugs or agents: mycophenolate mofetil and enteric-coated mycophenolate sodium.

  Transplantation 20110827

• Impact of mycophenolic acid and tacrolimus on Th17-related immune response.

  Transplantation 20110827

• Mycophenolate and tacrolimus for graft-versus-host disease prophylaxis for elderly after cord blood transplantation: a matched pair comparison with tacrolimus alone.

  Transplantation 20110815

• Improved rejection prophylaxis with an initially intensified dosing regimen of enteric-coated mycophenolate sodium in de novo renal transplant recipients.

  Transplantation 20110815

• Diffuse alveolar hemorrhage as an unusual presentation of systemic lupus erythematosus.

  Rheumatology international 20110801

• Mycophenolic acid pharmacokinetics during maintenance immunosuppression in African American and Caucasian renal transplant recipients.

  Journal of clinical pharmacology 20110801

• Mycophenolic acid response biomarkers: a cell line model system-based genome-wide screen.

  International immunopharmacology 20110801

• Treatment of cutaneous lupus.

  Current rheumatology reports 20110801

• Clinical assessment and management of cytopenias in lupus patients.

  Current rheumatology reports 20110801

• Treatment of lupus nephritis.

  Current rheumatology reports 20110801

• Treatment of mild, moderate, and severe lupus erythematosus: focus on new therapies.

  Current rheumatology reports 20110801

• Lessons from a transplant patient with diarrhea, cryptosporidial infection, and possible mycophenolate mofetil-associated colitis.

  Transplant infectious disease : an official journal of the Transplantation Society 20110801

• Depletion of GTP pool is not the predominant mechanism by which ribavirin exerts its antiviral effect on Lassa virus.

  Antiviral research 20110801

• The role of mycophenolate mofetil in the management of autoimmune hepatitis and overlap syndromes.

  Alimentary pharmacology & therapeutics 20110801

• The ORION study: comparison of two sirolimus-based regimens versus tacrolimus and mycophenolate mofetil in renal allograft recipients.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20110801

• How to use mTOR inhibitors? The search goes on.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20110801

• Cervical and vaginal cancer in a woman with chronic graft-versus-host disease.

  International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 20110801

• Influence of CYP3A5 polymorphism on tacrolimus maintenance doses and serum levels after renal transplantation: age dependency and pharmacological interaction with steroids.

  Pediatric transplantation 20110801

• Long-term results of therapy with mycophenolate mofetil in chronic non-infectious uveitis.

  Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 20110801

• Pharmacokinetics-based optimal dose prediction of donor source-dependent response to mycophenolate mofetil in unrelated hematopoietic cell transplantation.

  International journal of hematology 20110801

• Mycophenolate mofetil and fundus autofluorescence in the management of recurrent punctate inner choroidopathy.

  Ocular immunology and inflammation 20110801

• Therapeutic drug monitoring for mycophenolic acid is value for (little) money.

  Clinical pharmacology and therapeutics 20110801

• Mycophenolate mofetil monitoring: is there evidence that it can improve outcomes?

  Clinical pharmacology and therapeutics 20110801

• Mycophenolate mofetil as a rescue therapy for autoimmune hepatitis patients who are not responsive to standard therapy.

  Expert review of gastroenterology & hepatology 20110801

• Rituximab in bronchiolitis obliterans after haematopoietic stem cell transplantation.

  The European respiratory journal 20110801

• Acute mixed cellular and humoral rejection of renal allograft with leucopenia.

  The Journal of the Association of Physicians of India 20110801

• Effects of mycophenolate sodium on mucociliary clearance using a bronchial section and anastomosis rodent model.

  Clinics (Sao Paulo, Brazil) 20110801

• Desensitization in HLA-incompatible kidney recipients and survival.

  The New England journal of medicine 20110728

• Everolimus for cardiac allograft vasculopathy--every patient, at any time?

  Transplantation 20110727

• Effect of everolimus introduction on cardiac allograft vasculopathy--results of a randomized, multicenter trial.

  Transplantation 20110727

• Impact of norovirus/sapovirus-related diarrhea in renal transplant recipients hospitalized for diarrhea.

  Transplantation 20110715

• Relationship of tacrolimus exposure and mycophenolate mofetil dose with renal function after renal transplantation.

  Transplantation 20110715

• Tacrolimus dosing in mycophenolate-treated patients--can we get away with less?

  Transplantation 20110715

• Profiling of a prescription drug library for potential renal drug-drug interactions mediated by the organic cation transporter 2.

  Journal of medicinal chemistry 20110714

• Tonic-clonic seizure following combined treatment of mycophenolate mofetil and acyclovir.

  Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 20110701

• [Chronic actinic dermatitis. Therapy with systemic PUVA and mycophenolate mofetil].

  Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete 20110701

• Henoch-schönlein purpura in an adult mimicking Crohn's disease and pyoderma gangrenosum.

  Digestive diseases and sciences 20110701

• Double trouble: therapeutic challenges in patients with both juvenile dermatomyositis and psoriasis.

  Archives of dermatology 20110701

• Longterm followup after tapering mycophenolate mofetil during maintenance treatment for proliferative lupus nephritis.

  The Journal of rheumatology 20110701

• Mycophenolic acid in kidney transplant patients with diabetes mellitus: does the formulation matter?

  Transplantation reviews (Orlando, Fla.) 20110701

• Numb chin syndrome as an early symptom of primary and secondary vasculitis.

  Joint, bone, spine : revue du rhumatisme 20110701

• Adult post-transplant lymphoproliferative disease in the liver graft in patients with recurrent hepatitis C.

  European journal of gastroenterology & hepatology 20110701

• Sotrastaurin, a novel small molecule inhibiting protein-kinase C: randomized phase II study in renal transplant recipients.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20110701

• Diagnostic efficiency of truncated area under the curve from 0 to 2 h (AUC₀₋₂) of mycophenolic acid in kidney transplant recipients receiving mycophenolate mofetil and concomitant tacrolimus.

  Clinical chemistry and laboratory medicine 20110701

• Performance of the Roche Total Mycophenolic Acid® assay on the Cobas Integra 400®, Cobas 6000® and comparison to LC-MS/MS in liver transplant patients.

  Clinical chemistry and laboratory medicine 20110701

• Vascularized bone marrow-based immunosuppression inhibits rejection of vascularized composite allografts in nonhuman primates.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20110701

• Education and imaging. Gastrointestinal: chronic cellcept-induced colitis.

  Journal of gastroenterology and hepatology 20110701

• Mycophenolate sodium in the treatment of mucocutaneous Behcet's diseases.

  International journal of dermatology 20110701

• Nephroquiz 6: a 67-year-old kidney transplant recipient with nephrotic-range proteinuria.

  Iranian journal of kidney diseases 20110701

• Disease-modifying drugs for systemic sclerosis: why have we not found them yet?

  Expert review of clinical immunology 20110701

• [Relative bioavailability study of two oral formulations of mycophenolate mofetil in healthy volunteers].

  Revista medica de Chile 20110701

• Randomized trial of mycophenolate mofetil versus enteric-coated mycophenolate sodium in primary renal transplantation with tacrolimus and steroid avoidance: four-year analysis.

  Transplantation 20110615

• Intracellular GTP level determines cell's fate toward differentiation and apoptosis.

  Toxicology and applied pharmacology 20110615

• Cyclophosphamide and lupus nephritis: when, how, for how long?

  Clinical reviews in allergy & immunology 20110601

• Long-term remission of recurrent severe anemia as a result of parvovirus B19 infection in a pediatric renal transplant recipient.

  Pediatric transplantation 20110601

• Ulcerative cutaneous polyarteritis nodosa treated with mycophenolate mofetil and pentoxifylline.

  The Journal of dermatological treatment 20110601

• The persistent challenge of lupus nephritis.

  Clinical reviews in allergy & immunology 20110601

• Long-term care following paediatric liver transplantation.

  Archives of disease in childhood. Education and practice edition 20110601

• Steroid withdrawal in renal transplant patients: the Irish experience.

  Irish journal of medical science 20110601

• New therapies in steroid-sensitive and steroid-resistant idiopathic nephrotic syndrome.

  Pediatric nephrology (Berlin, Germany) 20110601

• Combination therapy with diltiazem plus CsA/MMF/Pred or CsA/Aza/Pred triple immunosuppressive regimens for use in clinical kidney transplantation in Northwestern China.

  European journal of clinical pharmacology 20110601

• Severe generalized pustular psoriasis treated with mycophenolate mofetil.

  The Journal of dermatology 20110601

• Long-term experience of mycophenolate mofetil for treatment of diffuse cutaneous systemic sclerosis.

  Annals of the rheumatic diseases 20110601

• Individual dosing regimen of mycophenolate mofetil in lupus patients: comment on the article by Zahr et al.

  Arthritis and rheumatism 20110601

• Impact of maintenance immunosuppressive regimens--balance between graft protective suppression of immune functions and a near physiological immune response.

  Transplant international : official journal of the European Society for Organ Transplantation 20110601

• The influence of pharmacogenetics and cofactors on clinical outcomes in kidney transplantation.

  Expert opinion on drug metabolism & toxicology 20110601

• Terminal ileitis in a renal transplanted patient: could it be infectious ileitis, Crohn's disease, or pharmacological toxicity?

  Inflammatory bowel diseases 20110601

• Enteric-coated mycophenolate sodium versus cyclosporin A as long-term treatment in adult patients with severe atopic dermatitis: a randomized controlled trial.

  Journal of the American Academy of Dermatology 20110601

• Successful neutrophil engraftment by reduced use of granulocyte colony-stimulating factor after allogeneic hematopoietic stem cell transplantation with mycophenolate mofetil for graft-versus-host disease prophylaxis.

  International journal of hematology 20110601

• Large scale analysis of routine dose adjustments of mycophenolate mofetil based on global exposure in renal transplant patients.

  Therapeutic drug monitoring 20110601

• CYP3A5 genotype is not related to the intrapatient variability of tacrolimus clearance.

  Therapeutic drug monitoring 20110601

• Monitoring of mycophenolic acid predose concentrations in the maintenance phase more than one year after renal transplantation.

  Therapeutic drug monitoring 20110601

• [Vasculitis].

  Deutsche medizinische Wochenschrift (1946) 20110601

• Combination treatment with corticosteroid, cyclosporine A, and mycophenolate in refractory nephrotic syndrome.

  Clinical nephrology 20110601

• Sirolimus: not so sparing in the Spare-the-Nephron trial.

  Kidney international 20110601

• Immunosuppressive and cytotoxic therapy: pharmacology, toxicities, and monitoring.

  Seminars in respiratory and critical care medicine 20110601

• Reduction of gastrointestinal complications in renal graft recipients after conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium.

  Transplantation proceedings 20110601

• [Mycophenolate mofetil as a novel treatment for lupus nephritis].

  Harefuah 20110601

• Induction treatment with rabbit antithymocyte globulin versus basiliximab in renal transplant recipients with planned early steroid withdrawal.

  Pharmacotherapy 20110601

• [Pyoderma gangrenosum in dorsum of right foot].

  Medicina clinica 20110528

• Mycophenolate mofetil decreases atherosclerotic lesion size by depression of aortic T-lymphocyte and interleukin-17-mediated macrophage accumulation.

  Journal of the American College of Cardiology 20110524

• Mycophenolate mofetil initiation in renal transplant patients at different times posttransplantation: the TranCept Switch study.

  Transplantation 20110515

• Tacrolimus and mycofenolate mofetil as GvHD prophylaxis following nonmyeloablative conditioning and unrelated hematopoietic SCT for adult patients with advanced hematologic diseases.

  Bone marrow transplantation 20110501

• Mycophenolate mofetil impairs transduction of single-stranded adeno-associated viral vectors.

  Human gene therapy 20110501

• Inhibition of T-cell activation and proliferation by mycophenolic acid in patients awaiting liver transplantation: PK/PD relationships.

  Pharmacological research 20110501

• The proton pump inhibitor pantoprazole and its interaction with enteric-coated mycophenolate sodium in transplant recipients.

  The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20110501

• Development of a Bayesian estimator for the therapeutic drug monitoring of mycophenolate mofetil in children with idiopathic nephrotic syndrome.

  Pharmacological research 20110501

• Long-term, maintenance MMF monotherapy improves the fibrosis progression in liver transplant recipients with recurrent hepatitis C.

  Transplant international : official journal of the European Society for Organ Transplantation 20110501

• Mycophenolate mofetil-induced pseudotumor cerebri in a boy with autoimmune lymphoproliferative disease.

  Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 20110501

• Mycophenolic acid induces adipocyte-like differentiation and reversal of malignancy of breast cancer cells partly through PPARγ.

  European journal of pharmacology 20110501

• Single application of low-dose mycophenolate mofetil-OX7-immunoliposomes ameliorates experimental mesangial proliferative glomerulonephritis.

  The Journal of pharmacology and experimental therapeutics 20110501

• A systematic review of randomized controlled trials for pemphigus vulgaris and pemphigus foliaceus.

  Journal of the American Academy of Dermatology 20110501

• Management of autoimmune hepatitis.

  Current opinion in gastroenterology 20110501

• Reduced-dose tacrolimus with mycophenolate mofetil vs. standard-dose tacrolimus in liver transplantation: a randomized study.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20110501

• Guidance for liver transplant immunosuppression.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20110501

• Mycophenolate mofetil in pediatric renal transplantation: a single center experience.

  Pediatric transplantation 20110501

• Bilateral trans-humeral arm transplantation: result at 2 years.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20110501

• Mild rhabdomyolysis after renal transplantation.

  Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia 20110501

• 'Immuknow' to measurement of cell-mediated immunity in renal transplant recipients undergoing short-term evaluation.

  Transplantation proceedings 20110501

• Switch from twice-daily tacrolimus (Prograf) to once-daily prolonged-release tacrolimus (Advagraf) in kidney transplantation.

  Transplantation proceedings 20110501

• Thyroid status and kidney transplantation outcomes.

  Transplantation proceedings 20110501

• The use of a polymeric sealant for prevention of posttransplantation lymphocele.

  Transplantation proceedings 20110501

• Double endocrine neoplasia in a renal transplant recipient: case report and review of the literature.

  Transplantation proceedings 20110501

• [Remission induced by dose-reduction of immunosuppressants alone in a patient with post-transplant lymphoproliferative disorder of central nervous system origin].

  [Rinsho ketsueki] The Japanese journal of clinical hematology 20110501

• Mesenchymal stem cells together with mycophenolate mofetil inhibit antigen presenting cell and T cell infiltration into allogeneic heart grafts.

  Transplant immunology 20110415

• Safety and efficacy of intensified versus standard dosing regimens of enteric-coated mycophenolate sodium in de novo renal transplant patients.

  Transplantation 20110415

• Neuromyelitis optica: an update.

  Journal of the neurological sciences 20110415

• Th17 cells in alemtuzumab-treated patients: the effect of long-term maintenance immunosuppressive therapy.

  Transplantation 20110415

• Canine bone marrow-derived mesenchymal stromal cells suppress alloreactive lymphocyte proliferation in vitro but fail to enhance engraftment in canine bone marrow transplantation.

  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20110401

• Systemic lupus erythematosus in a 3-month old male presenting as thrombocytopenia.

  Lupus 20110401

• Rituximab in the treatment of acute cellular rejection of renal allograft with CD20-positive clusters in the infiltrate.

  Clinical and experimental nephrology 20110401

• Mycophenolate, clinical pharmacokinetics, formulations, and methods for assessing drug exposure.

  Transplantation reviews (Orlando, Fla.) 20110401

• Mycophenolate mofetil-based immunosuppression with sirolimus in renal transplantation: a randomized, controlled Spare-the-Nephron trial.

  Kidney international 20110401

• Cyclosporine alters correlation between free and total mycophenolic acid in kidney transplant recipients in the initial phase.

  Journal of clinical pharmacy and therapeutics 20110401

• Polymorphisms in CYP3A5, CYP3A4, and ABCB1 are not associated with cyclosporine pharmacokinetics nor with cyclosporine clinical end points after renal transplantation.

  Therapeutic drug monitoring 20110401

• A possible simplification for the estimation of area under the curve (AUC₀₋₁₂) of enteric-coated mycophenolate sodium in renal transplant patients receiving tacrolimus.

  Therapeutic drug monitoring 20110401

• How delayed graft function impacts exposure to mycophenolic acid in patients after renal transplantation.

  Therapeutic drug monitoring 20110401

• Oral ulcers associated with mycophenolate mofetil use in a renal transplant recipient.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20110401

• Mycophenolate mofetil monotherapy in the management of paediatric uveitis.

  Eye (London, England) 20110401

• Cryoglobulinemic membranoproliferative glomerulonephritis: beyond conventional therapy.

  Clinical nephrology 20110401

• Can the nephron be spared?

  Kidney international 20110401

• Steroid avoidance reduce the cost of morbidities after live-donor renal allotransplants: a prospective, randomized, controlled study.

  Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 20110401

• Pediatric aspects of therapeutic drug monitoring of mycophenolic acid in renal transplantation.

  Transplantation reviews (Orlando, Fla.) 20110401

• Mycophenolate monitoring in liver, thoracic, pancreas, and small bowel transplantation: a consensus report.

  Transplantation reviews (Orlando, Fla.) 20110401

• Therapeutic drug monitoring of mycophenolates in kidney transplantation: report of The Transplantation Society consensus meeting.

  Transplantation reviews (Orlando, Fla.) 20110401

• Fatal cutaneous Strongyloidiasis as a side effect of Pemphigus foliaceus treatment with mycophenolate mofetil.

  Journal of drugs in dermatology : JDD 20110401

• BK viremia surveillance after kidney transplant: single-center experience during a change from cyclosporine-to lower-dose tacrolimus-based primary immunosuppression regimen.

  Transplant infectious disease : an official journal of the Transplantation Society 20110401

• Use of mycophenolate mofetil in patients received allogeneic hematopoietic stem cell transplantation in Japan.

  International journal of hematology 20110401

• Therapeutic drug monitoring of mycophenolates: why make simple things complicated?

  Transplantation reviews (Orlando, Fla.) 20110401

• Evaluation of efficacy and safety of mycophenolate sodium in patients with de novo and maintenance renal transplantation: results of a multicenter, prospective, observational study.

  Transplantation proceedings 20110401

• A comparison of mycophenolate mofetil with mycophenolate sodium in renal transplant recipients on tacrolimus-based treatment.

  Transplantation proceedings 20110401

• An additional patient with mycophenolate mofetil embryopathy: cardiac and facial analyses.

  American journal of medical genetics. Part A 20110401

• Mycophenolate mofetil may be effective in CNS sarcoidosis but not in sarcoid myopathy.

  Neurology 20110329

• Therapeutic drug monitoring of mycophenolic acid after lung transplantation--is it clinically relevant?

  Transplantation 20110327

• Pharmacokinetic drug interaction of mycophenolate with co-amoxiclav in renal transplant patients.

  Transplantation 20110327

• Steroid withdrawal in kidney transplantation: the subgroup fallacy.

  Transplantation 20110315

• Preventing relapses in antineutrophil cytoplasmic antibody-associated vasculitis.

  JAMA 20110309

• Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial.

  Lancet (London, England) 20110305

• Inosine monophosphate dehydrogenase (IMPDH) activity as a pharmacodynamic biomarker of mycophenolic acid effects in pediatric kidney transplant recipients.

  Journal of clinical pharmacology 20110301

• Therapeutic ladder for pemphigus vulgaris: emphasis on achieving complete remission.

  Journal of the American Academy of Dermatology 20110301

• Comparison of MMF efficacy and safety in paediatric vs. adult renal transplantation: subgroup analysis of the randomised, multicentre FDCC trial.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20110301

• Interstitial lung disease in systemic sclerosis.

  Autoimmunity reviews 20110301

• Polyoma virus-associated progressive multifocal leukoencephalopathy after renal transplantation: regression following withdrawal of mycophenolate mofetil.

  Pediatric transplantation 20110301

• Population pharmacokinetics of mycophenolic acid in pediatric renal transplant patients using parametric and nonparametric approaches.

  Pharmacological research 20110301

• Identification of biomarkers that predict response to treatment of lupus nephritis with mycophenolate mofetil or pulse cyclophosphamide.

  Arthritis care & research 20110301

• Generic immunosuppressants in hematopoietic cell transplantation.

  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20110301

• Nonlinear relationship between mycophenolate mofetil dose and mycophenolic acid exposure: implications for therapeutic drug monitoring.

  Clinical journal of the American Society of Nephrology : CJASN 20110301

• Enteric-coated mycophenolate sodium as a corticosteroid-sparing agent for the treatment of autoimmune scleritis.

  Cornea 20110301

• Diabetes mellitus reduces activity of human UDP-glucuronosyltransferase 2B7 in liver and kidney leading to decreased formation of mycophenolic acid acyl-glucuronide metabolite.

  Drug metabolism and disposition: the biological fate of chemicals 20110301

• Clinical trials treating focal segmental glomerulosclerosis should measure patient quality of life.

  Kidney international 20110301

• A prospective, randomized trial of single-drug versus dual-drug immunosuppression in heart transplantation: the tacrolimus in combination, tacrolimus alone compared (TICTAC) trial.

  Circulation. Heart failure 20110301

• Early termination of a trial of mycophenolate mofetil for treatment of interstitial cystitis/painful bladder syndrome: lessons learned.

  The Journal of urology 20110301

• Duodenal villous atrophy: a cause of chronic diarrhea after solid-organ transplantation.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20110301

• Geographical variation in the response of lupus nephritis to mycophenolate mofetil induction therapy.

  Clinical nephrology 20110301

• Steroids in kidney transplant patients.

  Seminars in immunopathology 20110301

• Immunosuppressive therapy after kidney transplantation: current and new strategies.

  Minerva urologica e nefrologica = The Italian journal of urology and nephrology 20110301

• Targeted therapies in systemic lupus erythematosus: successes, failures and future.

  Annals of the rheumatic diseases 20110301

• Mycophenolic acid-mediated suppression of human CD4+ T cells: more than mere guanine nucleotide deprivation.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20110301

• [Bullous pemphigoid: a review].

  Annales de dermatologie et de venereologie 20110301

• Strategies in immunosuppression after heart transplantation: is less better?

  Circulation. Heart failure 20110301

• Comparison of basiliximab and daclizumab with triple immunosuppression in renal transplantation.

  Transplantation proceedings 20110301

• Low-dose thymoglobulin use in elderly renal transplant recipients is safe and effective induction therapy.

  Transplantation proceedings 20110301

• Mycophenolic acid dose reductions result in poor long-term renal allograft survival: comparison between mycophenolate sodium and mycophenolate mofetil.

  Transplantation proceedings 20110301

• Therapeutic drug monitoring in de novo kidney transplant receiving the modified-release once-daily tacrolimus.

  Transplantation proceedings 20110301

• Hematologic side effects of azathioprine and mycophenolate in kidney transplantation.

  Transplantation proceedings 20110301

• The role of antibiotic prophylaxis in the new era of immunosuppression.

  Transplantation proceedings 20110301

• [Intestinal thrombotic microangiopathy after liver transplantation].

  The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20110301

• Single-dose, two-way crossover, bioequivalence study of Mycophenolate mofetil 500 mg tablet under fasting conditions in healthy male subjects.

  Clinical therapeutics 20110301

• Successful kidney transplantation in highly sensitized patients.

  Frontiers of medicine 20110301

• Enteric-coated mycophenolate sodium versus mycophenolate mofetil in renal transplant recipients experiencing gastrointestinal intolerance: a multicenter, double-blind, randomized study.

  Transplantation 20110227

• Posttransplant Kaposi sarcoma and risk for deep venous thrombosis: a case-control study.

  Transplantation 20110227

• Design of an imprinted clean-up method for mycophenolic acid in maize.

  Journal of chromatography. A 20110225

• In vitro influence of fatty acids and bilirubin on binding of mycophenolic acid to human serum albumin.

  Journal of pharmaceutical and biomedical analysis 20110220

• Genetic determinants of mycophenolate-related anemia and leukopenia after transplantation.

  Transplantation 20110215

• Late adult onset of Langerhans cell histiocytosis mimicking glioblastoma multiforme.

  Journal of the neurological sciences 20110215

• Pharmacokinetics of sotrastaurin combined with tacrolimus or mycophenolic acid in de novo kidney transplant recipients.

  Transplantation 20110215

• New-onset diabetes mellitus in kidney transplant recipients discharged on steroid-free immunosuppression.

  Transplantation 20110215

• Coronary angiitis and cardiac arrest in antineutrophil cytoplasmic-antibody associated systemic vasculitis.

  Circulation 20110215

• Calcineurin inhibitor-free monotherapy in human leukocyte antigen–identical live donor renal transplantation.

  Transplantation 20110215

• Pharmacokinetics and pharmacodynamics of mycophenolic acid and their relation to response to therapy of childhood-onset systemic lupus erythematosus.

  Seminars in arthritis and rheumatism 20110201

• Mycophenolic acid inhibits natural killer cell proliferation and cytotoxic function: a possible disadvantage of including mycophenolate mofetil in the graft-versus-host disease prophylaxis regimen.

  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20110201

• Autoimmune encephalopathy presenting as a 'posterior circulation stroke'.

  Journal of neurology 20110201

• Modification of the EMIT immunoassay for the measurement of unbound mycophenolic acid in plasma.

  Clinical biochemistry 20110201

• Herpetic necrotizing retinitis following flucinolone acetonide intravitreal implant.

  Ocular immunology and inflammation 20110201

• A limited sampling strategy for estimation of the area under the curve (0 to 8 hours) of mycophenolic acid administered three times daily to liver transplant recipients.

  Upsala journal of medical sciences 20110201

• Circulating cytokines are associated with human islet graft function in type 1 diabetes.

  Clinical immunology (Orlando, Fla.) 20110201

• The pharmacokinetics of enteric-coated mycophenolate sodium and its gastrointestinal side effects in de novo renal transplant recipients of Hispanic ethnicity.

  Therapeutic drug monitoring 20110201

• Development and validation of limited sampling strategies for tacrolimus and mycophenolate in steroid-free renal transplant regimens.

  Therapeutic drug monitoring 20110201

• Calcineurin inhibitor-free immunosuppression in pediatric renal transplantation: a viable option?

  Paediatric drugs 20110201

• High dietary protein exacerbates hypertension and renal damage in Dahl SS rats by increasing infiltrating immune cells in the kidney.

  Hypertension (Dallas, Tex. : 1979) 20110201

• Safety and efficacy of tacrolimus in pediatric liver recipients.

  Pediatric transplantation 20110201

• The role of proton pump inhibitors on early mycophenolic acid exposure in kidney transplantation: evidence from the CLEAR study.

  Therapeutic drug monitoring 20110201

• Pharmacokinetic evaluation of mycophenolate mofetil for pemphigus.

  Expert opinion on drug metabolism & toxicology 20110201

• Systemic influence of immunosuppressive drugs on small and large bowel transport and barrier function.

  Transplant international : official journal of the European Society for Organ Transplantation 20110201

• Pseudo-Pelger-Huët anomaly induced by medications: a clinicopathologic study in comparison with myelodysplastic syndrome-related pseudo-Pelger-Huët anomaly.

  American journal of clinical pathology 20110201

• Update on morphea: part II. Outcome measures and treatment.

  Journal of the American Academy of Dermatology 20110201

• Current and novel therapeutics in the treatment of systemic lupus erythematosus.

  The Journal of allergy and clinical immunology 20110201

• Treatment of primary immune-mediated hemolytic anemia with mycophenolate mofetil in two cats.

  Journal of veterinary emergency and critical care (San Antonio, Tex. : 2001) 20110201

• Rituximab and lupus interstitial lung disease: friend or foe?

  International journal of rheumatic diseases 20110201

• Conversion from cyclosporine to sirolimus in chronic renal allograft dysfunction: a 4-year prospective study.

  Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 20110201

• Meningoencephalitis with Aspergillus and mycobacterium tuberculosis in a renal transplant recipient.

  Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 20110201

• Mycophenolate mofetil in primary glomerular diseases.

  The Journal of the Association of Physicians of India 20110201

• Immunosuppressive therapy in children.

  Journal of the Indian Medical Association 20110201

• The effects of early rapid corticosteroid reduction on cell-mediated immunity in kidney transplant recipients.

  Transplant immunology 20110115

• Protective effect of immunosuppressive treatment before orthotopic kidney autotransplantation.

  Transplant immunology 20110115

• Effects of plasmapheresis on mycophenolic acid concentrations.

  Transplantation 20110115

• Protective effect of mycophenolate mofetil on endothelial function in an aortic allograft model.

  Transplantation 20110115

• Association of mismatches for HLA-DR with incidence of posttransplant hip fracture in kidney transplant recipients.

  Transplantation 20110115

• UPLC MS/MS method for quantification of mycophenolic acid and metabolites in human plasma: Application to pharmacokinetic study.

  Clinica chimica acta; international journal of clinical chemistry 20110114

• Combined prednisone and mycophenolate mofetil treatment for retroperitoneal fibrosis: a case series.

  Annals of internal medicine 20110104

• Mycophenolic acid trough level monitoring: relevance in acute and chronic graft versus host disease and its relation with albumin.

  Clinical transplantation 20110101

• Delayed neutrophil engraftment in cord blood transplantation with intensive administration of mycophenolate mofetil for GVHD prophylaxis.

  Bone marrow transplantation 20110101

• Capecitabine-induced, rapid decrease of renal function due to drug dispensing error in a hospital pharmacy.

  Journal of clinical pharmacology 20110101

• Hypogammaglobulinemia and bronchiectasis in mycophenolate mofetil-treated renal transplant recipients: an emerging clinical phenomenon?

  Clinical transplantation 20110101

• Clinical and immunopathological evaluation of epidermolysis bullosa acquisita.

  Clinical and experimental dermatology 20110101

• Comparison of short-term response and long-term outcomes after initial systemic treatment of chronic graft-versus-host disease.

  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20110101

• A critical analysis of racial difference with mycophenolate mofetil (MMF) dosing, clinical outcomes and adverse effects in pediatric kidney transplant patients.

  Clinical transplantation 20110101

• Use of rituximab in combination with high-dose methotrexate in the treatment of primary central nervous system lymphoma in a mycophenolate mofetil treated patient with lupus nephritis.

  Acta oncologica (Stockholm, Sweden) 20110101

• A prospective randomized study comparing cyclosporine versus tacrolimus combined with daclizumab, mycophenolate mofetil, and steroids in heart transplantation.

  Clinical transplantation 20110101

• Desensitization for renal transplantation: depletion of donor-specific anti-HLA antibodies, preservation of memory antibodies, and clinical risks.

  Transplant international : official journal of the European Society for Organ Transplantation 20110101

• Sustained renal response to mycophenolate mofetil and CNI taper promotes survival in liver transplant patients with CNI-related renal dysfunction.

  Digestive diseases and sciences 20110101

• Immunosuppression alters disease severity in juvenile Batten disease mice.

  Journal of neuroimmunology 20110101

• Mycophenolate mofetil for induction treatment of lupus nephritis: a systematic review and metaanalysis.

  The Journal of rheumatology 20110101

• Conversion to combined mycophenolate mofetil and low-dose calcineurin inhibitor therapy for renal dysfunction in liver transplant patients: never too late?

  Digestive diseases and sciences 20110101

• The renal benefit of mycophenolate mofetil after liver transplantation.

  Clinical transplantation 20110101

• Cellular IMPDH enzyme activity is a potential target for the inhibition of Chikungunya virus replication and virus induced apoptosis in cultured mammalian cells.

  Antiviral research 20110101

• Albuminuria after renal transplantation: maintenance with sirolimus/low-dose tacrolimus vs. mycophenolate mofetil/high-dose tacrolimus.

  Clinical transplantation 20110101

• Immunosuppression with belatacept-based, corticosteroid-avoiding regimens in de novo kidney transplant recipients.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20110101

• The evolution of population pharmacokinetic models to describe the enterohepatic recycling of mycophenolic acid in solid organ transplantation and autoimmune disease.

  Clinical pharmacokinetics 20110101

• Mycophenolate mophetil therapy for chronic immune thrombocytopenic purpura resistant to steroids, immunosuppressants, and/or splenectomy in adults.

  Platelets 20110101

• Evaluation of the novel protein kinase C inhibitor sotrastaurin as immunosuppressive therapy after renal transplantation.

  Expert opinion on drug metabolism & toxicology 20110101

• Local gene delivery and methods to control immune responses in muscles of normal and dystrophic dogs.

  Methods in molecular biology (Clifton, N.J.) 20110101

• The treatment of relapse in adults with minimal change nephrotic syndrome: myths and facts.

  Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia 20110101

• Nephritic-nephrotic syndrome as a presentation of BK virus infection.

  Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia 20110101

• Good outcomes with cyclosporine very low exposure with everolimus high exposure in renal transplant patients.

  Journal of nephrology 20110101

• Alemtuzumab induction in non-hepatitis C positive liver transplant recipients.

  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20110101

• Cytomegalovirus colitis.

  Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20110101

• Mycophenolic acid inhibits replication of Japanese encephalitis virus.

  Chemotherapy 20110101

• Hypokalaemic paralysis secondary to distal renal tubular acidosis as the presenting symptom of systemic lupus erythematosus.

  Singapore medical journal 20110101

• Voltage-gated potassium channel-complex antibody-associated limbic encephalitis.

  Psychosomatics 20110101

• Effects of mycophenolate mofetil combined with corticosteroids for induction therapy of microscopic polyangiitis.

  American journal of nephrology 20110101

• Mycophenolate mofetil in treatment of childhood steroid-resistant nephrotic syndrome.

  Journal of nephrology 20110101

• Effects of ischemia and reperfusion injury on long-term graft function.

  Transplantation proceedings 20110101

• Management of bullous pemphigoid with topical steroids in the clinical practice of a single center: outcome at 6 and 12 months.

  Dermatology (Basel, Switzerland) 20110101

• Efficacy and safety of combined cyclosporin A and mycophenolate mofetil therapy in patients with cyclosporin-resistant focal segmental glomerulosclerosis.

  Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20110101

• Simultaneous determination of mycophenolic acid and its metabolites by HPLC and pharmacokinetic studies in rat plasma and bile.

  Archives of pharmacal research 20110101

• Difficult asthma and Churg-Strauss-like syndrome: a cautionary tale.

  Respirology (Carlton, Vic.) 20110101

• Switching to sirolimus monotherapy for de novo tumors after liver transplantation. A preliminary experience.

  Hepato-gastroenterology 20110101

• Pharmacokinetic variability of mycophenolic acid and its glucuronide in systemic lupus erythematosus patients in remission maintenance phase.

  Biological & pharmaceutical bulletin 20110101

• Nephrotic syndrome and idiopathic membranous nephropathy associated with autosomal-dominant polycystic kidney disease.

  TheScientificWorldJournal 20110101

• Systemic therapy of atopic dermatitis in children and adults.

  Current problems in dermatology 20110101

• Differential kidney proteome profiling in a murine model of renal fibrosis under treatment with mycophenolate mofetil.

  Pathobiology : journal of immunopathology, molecular and cellular biology 20110101

• Calcineurin inhibitor-based and free regimens have distinct gene expression patterns in subclinical graft fibrosis.

  Annals of transplantation 20110101

• Steroid-free maintenance of islet allografts using mycophenolate mofetil and cyclosporine in the non-human primate.

  Annals of transplantation 20110101

• Very late onset lymphoproliferative disorders occurring over 10 years post-renal transplantation: PTLD.Int. Survey.

  Hematology/oncology and stem cell therapy 20110101

• Rituximab therapy for Wegener's granulomatosis refractory to conventional treatment.

  Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20110101

• Invasive pulmonary aspergillosis after living donor liver transplantation should be eradicated or not? A case report.

  Transplantation proceedings 20110101

• Early monitoring of the human polyomavirus BK replication and sequencing analysis in a cohort of adult kidney transplant patients treated with basiliximab.

  Virology journal 20110101

• [Immunoglobulin A nephropaty: clinical practice guidelines].

  Medicina 20110101

• A new class of IMP dehydrogenase with a role in self-resistance of mycophenolic acid producing fungi.

  BMC microbiology 20110101

• Virtual high-throughput screening identifies mycophenolic acid as a novel RNA capping inhibitor.

  PloS one 20110101

• A successful 4S heart transplantation.

  The Canadian journal of cardiology 20110101

• Two decades of experience in mucormycosis after kidney transplantation.

  Annals of transplantation 20110101

• Systemic treatment of pediatric atopic dermatitis with azathioprine and mycophenolate mofetil.

  Pediatric dermatology 20110101

• Mycophenolate mofetil as a novel immunosuppressant in the treatment of neuro-Behçet's disease with parenchymal involvement: presentation of four cases.

  Clinical and experimental rheumatology 20110101

• Linear IgA/IgG bullous dermatosis: successful treatment with dapsone and mycophenolate mofetil.

  Anais brasileiros de dermatologia 20110101

• Mycophenolate mofetil monotherapy in liver transplant recipients.

  Clinical transplantation 20110101

• Long-term prognosis of pemphigus in Korea: retrospective analysis of 199 patients.

  Dermatology (Basel, Switzerland) 20110101

• Combined treatment with antioxidants and immunosuppressants on cytokine release by human peripheral blood mononuclear cells - chemically injured keratocyte reaction.

  Molecular vision 20110101

• Sample size requirements for studies of treatment effects on beta-cell function in newly diagnosed type 1 diabetes.

  PloS one 20110101

• [Immunotherapy mechanisms in glomerulonephritis].

  Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia 20110101

• Association of UDP-glucuronosyltransferase 1A9 (UGT1A9) gene polymorphism with kidney allograft function.

  Annals of transplantation 20110101

• Immunosuppressive regimens containing generic mycophenolate mofetil (Myfenax) in de novo renal transplant recipients--preliminary results of 6-month observation.

  Annals of transplantation 20110101

• Pre-transplant mycophenolate mofetil pharmacokinetics in Mexican children.

  Proceedings of the Western Pharmacology Society 20110101

• The International Registry on Hand and Composite Tissue Transplantation.

  Transplantation 20101227

• Customized mycophenolate dosing based on measuring inosine-monophosphate dehydrogenase activity significantly improves patients' outcomes after renal transplantation.

  Transplantation 20101227

• Effect of calcineurin inhibitors in the outcome of liver transplantation in hepatitis C virus-positive recipients.

  Transplantation 20101215

• Proliferative glomerulonephritis in lupus patients with human immunodeficiency virus infection: a difficult clinical challenge.

  Seminars in arthritis and rheumatism 20101201

• Correlation between pharmacokinetics and pharmacodynamics of mycophenolic acid in liver transplant patients.

  Journal of clinical pharmacology 20101201

• Efficacy and safety of mycophenolate mofetil vs. methotrexate for the treatment of chronic plaque psoriasis.

  Journal of the European Academy of Dermatology and Venereology : JEADV 20101201

• Bullous pemphigoid in a patient with suspected non-Herlitz junctional epidermolysis bullosa.

  Clinical and experimental dermatology 20101201

• Long-term outcomes--mycophenolate mofetil treatment for lupus nephritis with addition of tacrolimus for resistant cases.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20101201

• Inhibition of microglial and astrocytic inflammatory responses by the immunosuppressant mycophenolate mofetil.

  Neuropathology and applied neurobiology 20101201

• Cytomegalovirus risk factors in renal transplantation with modern immunosuppression.

  Transplant infectious disease : an official journal of the Transplantation Society 20101201

• Oral cyclophosphamide is on the verge of extinction as therapy for severe autoimmune diseases (especially lupus): should nephrologists care?

  Nephron. Clinical practice 20101201

• Mycophenolate mofetil-induced agranulocytosis in a renal transplant recipient.

  Clinical and experimental nephrology 20101201

• Frontal fibrosing alopecia: a clinical review of 36 patients.

  The British journal of dermatology 20101201

• Pharmacogenetics of the mycophenolic acid targets inosine monophosphate dehydrogenases IMPDH1 and IMPDH2: gene sequence variation and functional genomics.

  British journal of pharmacology 20101201

• Restoration of retinal architecture following systemic immunosuppression in birdshot chorioretinopathy.

  Ocular immunology and inflammation 20101201

• The administration of low doses of rituximab followed by hydroxychloroquine, prednisone and low doses of mycophenolate mofetil is an effective therapy in Latin American patients with active systemic lupus erythematosus.

  Autoimmunity reviews 20101201

• Mycophenolate mofetil treatment in children and adolescents with lupus.

  Archives of disease in childhood 20101201

• Biomarkers of immunoregulatory status in stable liver transplant recipients undergoing weaning of immunosuppressive therapy.

  Clinical immunology (Orlando, Fla.) 20101201

• Involvement of carboxylesterase 1 and 2 in the hydrolysis of mycophenolate mofetil.

  Drug metabolism and disposition: the biological fate of chemicals 20101201

• [Interest of mycophenolate mofetil in children with membranous lupus nephritis].

  Nephrologie & therapeutique 20101201

• Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial.

  Annals of the rheumatic diseases 20101201

• Tacrolimus once daily (ADVAGRAF) versus twice daily (PROGRAF) in de novo renal transplantation: a randomized phase III study.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20101201

• The anti-fibrotic effect of mycophenolic acid-induced neutral endopeptidase.

  Journal of the American Society of Nephrology : JASN 20101201

• Population pharmacokinetic analysis of mycophenolic acid coadministered with either tasocitinib (CP-690,550) or tacrolimus in adult renal allograft recipients.

  Therapeutic drug monitoring 20101201

• Biomarker assessment of the immunomodulator effect of atorvastatin in stable renal transplant recipients and hypercholesterolemic patients.

  Molecular diagnosis & therapy 20101201

• Updates on the treatment of lupus nephritis.

  Journal of the American Society of Nephrology : JASN 20101201

• Mycophenolate mofetil vs azathioprine for remission maintenance in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized controlled trial.

  JAMA 20101201

• Therapeutic interventions for systemic vasculitis.

  JAMA 20101201

• Developmental pharmacogenetics of immunosuppressants in pediatric organ transplantation.

  Therapeutic drug monitoring 20101201

• Evaluation of limited sampling strategies for mycophenolic acid after mycophenolate mofetil intake in adult kidney transplant recipients.

  Therapeutic drug monitoring 20101201

• A decade of mycophenolate mofetil for lupus nephritis: is the glass half-empty or half-full?

  Annals of the rheumatic diseases 20101201

• Kidney graft outcomes in living-related transplantation have improved with substitution of basiliximab and mycophenolate mofetil for antithymocyte globulin and azathioprine: a single center retrospective cohort study.

  European journal of internal medicine 20101201

• [Optimal immunosuppressive therapy based on pharmacokinetics and pharmacodynamics of antimetabolites in clinical practice].

  Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20101201

• SLCO1B1 genetic polymorphism influences mycophenolic acid tolerance in renal transplant recipients.

  Pharmacogenomics 20101201

• Proteinuria among primarily sirolimus treated live-donor renal transplant recipients' long-term experience.

  Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 20101201

• The role of generics in kidney transplant: mycophenolate mofetil 500 versus mycophenolate: 2-year results.

  Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 20101201

• Improved gastrointestinal symptoms and quality of life after conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in renal transplant patients receiving tacrolimus.

  Journal of Korean medical science 20101201

• Desensitization protocol in highly HLA-sensitized and ABO-incompatible high titer kidney transplantation.

  Transplantation proceedings 20101201

• Low-dose steroid maintenance for renal transplant recipients.

  Transplantation proceedings 20101201

• Cyclosporine and mycophenolate mofetil 48 hours before renal transplantation enables the use of low cyclosporine doses and achieves better graft function.

  Transplantation proceedings 20101201

• Neither mycophenolate acyl-glucuronide levels nor their areas under the curve are responsible for the gastrointestinal side effects in kidney transplant recipients receiving EC-MPA: a prospective trial.

  Transplantation proceedings 20101201

• Proton pump inhibitor co-medication reduces active drug exposure in heart transplant recipients receiving mycophenolate mofetil.

  Transplantation proceedings 20101201

• Conversion from calcineurin inhibitor to either mycophenolate mofetil or sirolimus improves renal function in liver transplant recipients with chronic kidney disease: results of a prospective randomized trial.

  Transplantation proceedings 20101201

• Steroid-sparing effect of mycophenolate mofetil in the treatment of a subepidermal blistering autoimmune disease in a dog.

  Journal of the South African Veterinary Association 20101201

• Structure-activity relationships for inhibition of inosine monophosphate dehydrogenase and differentiation induction of K562 cells among the mycophenolic acid derivatives.

  Bioorganic & medicinal chemistry 20101115

• Pseudopapilledema in a pediatric kidney transplant recipient.

  Pediatric transplantation 20101101

• Living donor liver transplantation for hepatoblastoma with Beckwith-Wiedemann syndrome.

  Pediatric transplantation 20101101

• Population pharmacokinetics and pharmacogenetics of mycophenolic acid following administration of mycophenolate mofetil in de novo pediatric renal-transplant patients.

  Journal of clinical pharmacology 20101101

• Gastrointestinal symptoms impair quality of life in Italian renal transplant recipients but are under-recognized by physicians.

  Transplant international : official journal of the European Society for Organ Transplantation 20101101

• Effects of uridine diphosphate glucuronosyltransferase 2B7 and 1A7 pharmacogenomics and patient clinical parameters on steady-state mycophenolic acid pharmacokinetics in glomerulonephritis.

  European journal of clinical pharmacology 20101101

• Current topics in autoimmune hepatitis.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20101101

• Illumina-microarray analysis of mycophenolic acid-induced cell death in an insulin-producing cell line and primary rat islet cells: new insights into apoptotic pathways involved.

  Cellular signalling 20101101

• Stable hematopoietic cell engraftment after low-intensity nonmyeloablative conditioning in patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome.

  The Journal of allergy and clinical immunology 20101101

• Inosine 5'-monophosphate dehydrogenase 1 haplotypes and association with mycophenolate mofetil gastrointestinal intolerance in pediatric heart transplant patients.

  Pediatric transplantation 20101101

• Proton pump inhibitors interfere with the immunosuppressive potency of mycophenolate mofetil.

  Rheumatology (Oxford, England) 20101101

• Maintenance immunosuppressive therapy with everolimus preserves humoral immune responses.

  Kidney international 20101101

• Usefulness of sirolimus-based immunosuppression in ameliorating pre-transplant renal dysfunction in patients with Chagas' heart disease.

  The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20101101

• Enteric-coated mycophenolate sodium.

  Expert opinion on drug safety 20101101

• Effect of the inosine 5'-monophosphate dehydrogenase inhibitor BMS-566419 on renal fibrosis in unilateral ureteral obstruction in rats.

  International immunopharmacology 20101101

• Histological progression of chronic renal allograft injury comparing sirolimus and mycophenolate mofetil-based protocols. A single-center, prospective, randomized, controlled study.

  Pediatric transplantation 20101101

• Treatment of small vessel primary CNS vasculitis in children: an open-label cohort study.

  The Lancet. Neurology 20101101

• Small vessel childhood primary angiitis of the CNS: first steps toward a standardised treatment regimen.

  The Lancet. Neurology 20101101

• Progressive multifocal leukoencephalopathy and newer biological agents.

  Drug safety 20101101

• Pharmacogenetic impact of UDP-glucuronosyltransferase metabolic pathway and multidrug resistance-associated protein 2 transport pathway on mycophenolic acid in thoracic transplant recipients: an exploratory study.

  Pharmacotherapy 20101101

• Late acute antibody mediated rejection after nine years of renal transplantation.

  Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia 20101101

• Influence of CYP3A5 and MDR1(ABCB1) polymorphisms on the pharmacokinetics of tacrolimus in Chinese renal transplant recipients.

  Transplantation proceedings 20101101

• Value of CYP3A5 genotyping on determining initial dosages of tacrolimus for Chinese renal transplant recipients.

  Transplantation proceedings 20101101

• Randomized trial of thymoglobulin versus alemtuzumab (with lower dose maintenance immunosuppression) versus daclizumab in living donor renal transplantation.

  Transplantation proceedings 20101101

• Patterns of injury in mycophenolate mofetil-related colitis.

  Transplantation proceedings 20101101

• Malignancies after heart transplantation: incidence, risk factors, and effects of calcineurin inhibitor withdrawal.

  Transplantation proceedings 20101101

• Can we eliminate both calcineurin inhibitors and steroids?

  Transplantation proceedings 20101101

• Assessment of efficacy and safety of FK778 in comparison with standard care in renal transplant recipients with untreated BK nephropathy.

  Transplantation 20101027

• Interferon gamma licensing of human dendritic cells in T-helper-independent CD8+ alloimmunity.

  Blood 20101021

• Nephrotic syndrome associated with graft rejection after unrelated double cord blood transplantation.

  Transplantation 20101015

• Association of systemic steroids and mycophenolate mofetil as rescue therapy for uveitic choroidal neovascularization unresponsive to the traditional immunosuppressants: interventional case series.

  International ophthalmology 20101001

• Variability in free mycophenolic acid exposure in adult liver transplant recipients during the early posttransplantation period.

  Journal of clinical pharmacology 20101001

• Vogt-Koyanagi-Harada disease occurring during interferon-alpha and ribavirin therapy for chronic hepatitis C virus infection.

  International ophthalmology 20101001

• Mycophenolate mofetil reduces alveolar inflammation, acute rejection and graft loss due to bronchiolitis obliterans syndrome after lung transplantation.

  Pulmonary pharmacology & therapeutics 20101001

• Treatment of the post-ischaemic inflammatory syndrome of diabetic nephropathy.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20101001

• Incidence, severity, and etiology of drug-induced acute pancreatitis.

  Digestive diseases and sciences 20101001

• Mycophenolate mofetil for interstitial lung disease in dermatomyositis.

  Arthritis care & research 20101001

• Mycophenolate mofetil: a possible therapeutic agent for children with juvenile dermatomyositis.

  Arthritis care & research 20101001

• Mycophenolate mofetil in systemic sclerosis-associated interstitial lung disease.

  Clinical rheumatology 20101001

• Rapid resolution of persistent mycophenolate mofetil-induced diarrhoea with a single dose of infliximab.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20101001

• Immunosuppression with mycophenolate mofetil attenuates the development of hypertension and albuminuria in deoxycorticosterone acetate-salt hypertensive rats.

  Clinical and experimental pharmacology & physiology 20101001

• Treatment of inflammatory muscle disease in adults.

  Joint, bone, spine : revue du rhumatisme 20101001

• Interstitial lung disease in rheumatoid arthritis.

  Current rheumatology reports 20101001

• Can mycophenolic acid dose requirement during the first transplant help predict dosing for the second transplant?

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20101001

• An effective immunotherapy regimen for VGKC antibody-positive limbic encephalitis.

  Journal of neurology, neurosurgery, and psychiatry 20101001

• The use of original ex vivo immunoadsorption and 'multi-manner' apheresis in ABO/H-mismatched kidney transplants--A phase II clinical study.

  Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis 20101001

• Simultaneous determination of ochratoxin A, mycophenolic acid and fumonisin B(2) in meat products.

  Analytical and bioanalytical chemistry 20101001

• In vitro and in vivo immunomodulatory effects of cobalt protoporphyrin administered in combination with immunosuppressive drugs.

  Transplant immunology 20101001

• Differences in clearance of mycophenolic acid among renal transplant recipients, hematopoietic stem cell transplant recipients, and patients with autoimmune disease.

  Therapeutic drug monitoring 20101001

• Mycophenolic acid suppresses human pterygium and normal tenon fibroblast proliferation in vitro.

  The British journal of ophthalmology 20101001

• Population pharmacokinetics of mycophenolic acid and metabolites in patients with glomerulonephritis.

  Therapeutic drug monitoring 20101001

• Establishment of high-performance liquid chromatography and enzyme multiplied immunoassay technology methods for determination of free mycophenolic acid and its application in Chinese liver transplant recipients.

  Therapeutic drug monitoring 20101001

• [Bullous pemphigoid].

  Presse medicale (Paris, France : 1983) 20101001

• Population pharmacokinetics of mycophenolic acid in children and young people undergoing blood or marrow and solid organ transplantation.

  British journal of clinical pharmacology 20101001

• Renal failure five years after lung transplantation due to polyomavirus BK-associated nephropathy.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20101001

• Mycophenolate mofetil: a possible cause of hemophagocytic syndrome following renal transplantation?

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20101001

• [Cicatricial pemphigoid, mucous membrane pemphigoid].

  Presse medicale (Paris, France : 1983) 20101001

• Effectiveness of mycophenolic acid in refractory pyoderma gangrenosum.

  Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 20101001

• The actual management of pemphigus.

  Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia 20101001

• Extended-release tacrolimus therapy in de novo kidney transplant recipients: single-center experience.

  Transplantation proceedings 20101001

• Pharmacokinetics of once- versus twice-daily tacrolimus formulations in kidney transplant patients receiving expanded criteria deceased donor organs: a single-center, randomized study.

  Transplantation proceedings 20101001

• Mycophenolate acid vs mycophenolate mofetil therapy.

  Transplantation proceedings 20101001

• Mycophenolate mofetil for the treatment of autoimmune hepatitis in patients refractory or intolerant to conventional therapy.

  Canadian journal of gastroenterology = Journal canadien de gastroenterologie 20101001

• Pre-transplant pharmacokinetic profiling and tacrolimus requirements post-transplant.

  Nephrology (Carlton, Vic.) 20101001

• ABO-incompatible kidney transplantation.

  Danish medical bulletin 20101001

• How to critically appraise and apply meta-analyses in clinical practice.

  International journal of rheumatic diseases 20101001

• The impact of IL2ra induction therapy in kidney transplantation using tacrolimus- and mycophenolate-based immunosuppression.

  Transplantation 20100927

• The pharmacological efficacy of mycophenolic acid before and after renal transplantation as estimated by the lymphocyte immunosuppressant sensitivity test (LIST).

  Immunopharmacology and immunotoxicology 20100901

• MTX or mycophenolate mofetil with CsA as GVHD prophylaxis after reduced-intensity conditioning PBSCT from HLA-identical siblings.

  Bone marrow transplantation 20100901

• A 50% reduction in cyclosporine exposure in stable renal transplant recipients: renal function benefits.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20100901

• Preoperative introduction and maintenance immunosuppression therapy of oral-only tacrolimus, mycophenolate mofetil and steroids reduce acute rejection episodes after lung transplantation.

  European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 20100901

• Favorable outcome in a case of Mycoplasma pneumoniae-associated crescentic glomerulonephritis.

  Pediatric nephrology (Berlin, Germany) 20100901

• Efficacy and safety of conversion of mycophenolate mofetil to enteric-coated mycophenolate sodium in Mexican renal transplant children.

  Pediatric transplantation 20100901

• Diarrhoea and weight loss in an immunosuppressed patient.

  Gut 20100901

• Analysis on the infection among patients with nephrotic syndromes and systemic vasculitis treated with mycophenolate mofetil.

  Clinical rheumatology 20100901

• Reversal of TNP-470-induced endothelial cell growth arrest by guanine and guanine nucleosides.

  The Journal of pharmacology and experimental therapeutics 20100901

• Polymorphisms in type I and II inosine monophosphate dehydrogenase genes and association with clinical outcome in patients on mycophenolate mofetil.

  Pharmacogenetics and genomics 20100901

• Differential usefulness of biomarkers thymus and activation-regulated chemokine and soluble CD30 during enteric coated mycophenolate sodium and cyclosporine therapy in atopic dermatitis.

  Journal of the American Academy of Dermatology 20100901

• Post-transplantation lymphoproliferative disorder after liver transplantation: report of 5 cases among more than 550 liver transplants in Iran.

  Archives of Iranian medicine 20100901

• Lupus cystitis in an Omani girl.

  Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia 20100901

• Crystallization and preliminary X-ray analysis of mycophenolic acid-resistant and mycophenolic acid-sensitive forms of IMP dehydrogenase from the human fungal pathogen Cryptococcus.

  Acta crystallographica. Section F, Structural biology and crystallization communications 20100901

• Bone disease in renal transplantation and pleotropic effects of vitamin D therapy.

  Transplantation proceedings 20100901

• Introduction of mycophenolate mofetil in maintenance liver transplant recipients: what can we expect? Results of a 10-year experience.

  Transplantation proceedings 20100901

• Comparative bioavailability of two oral formulations of mycophenolate mofetil in healthy adult Uruguayan subjects: a case of highly variable rate of drug absorption.

  International journal of clinical pharmacology and therapeutics 20100901

• Rapamycin and MPA, but not CsA, impair human NK cell cytotoxicity due to differential effects on NK cell phenotype.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20100901

• Allotransplantation of cryopreserved parathyroid tissue for severe hypocalcemia in a renal transplant recipient.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20100901

• Nodular sclerochoroidopathy simulating choroidal malignancy.

  Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye 20100830

• Mycophenolic acid may delay allograft fibrosis by inhibiting transforming growth factor-beta1-induced activation of Nox-2 through the nuclear factor-kappaB pathway.

  Transplantation 20100827

• Early and late effects of the immunosuppressants rapamycin and mycophenolate mofetil on UV carcinogenesis.

  International journal of cancer 20100815

• Correlation of IMPDH1 gene polymorphisms with subclinical acute rejection and mycophenolic acid exposure parameters on day 28 after renal transplantation.

  Basic & clinical pharmacology & toxicology 20100801

• High within-patient variability in the clearance of tacrolimus is a risk factor for poor long-term outcome after kidney transplantation.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20100801

• Treating pemphigus vulgaris with prednisone and mycophenolate mofetil: a multicenter, randomized, placebo-controlled trial.

  The Journal of investigative dermatology 20100801

• Comment on: A prospective open-label study of mycophenolate mofetil for the treatment of diffuse systemic sclerosis.

  Rheumatology (Oxford, England) 20100801

• Effects of the intensity of immunosuppressive therapy on outcome of treatment for CMV disease in organ transplant recipients.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20100801

• Pharmacokinetics of mycophenolic acid in severe lupus nephritis.

  Kidney international 20100801

• Sirolimus and mycophenolate as combination prophylaxis in corneal transplant recipients at high rejection risk.

  American journal of ophthalmology 20100801

• Post-transplant lymphoproliferative disorder presenting as multiple myeloma.

  American journal of hematology 20100801

• Mycophenolic acid displays IMPDH-dependent and IMPDH-independent effects on renal fibroblast proliferation and function.

  Therapeutic drug monitoring 20100801

• Population pharmacokinetics analysis of mycophenolic acid in adult kidney transplant patients with chronic graft dysfunction.

  Therapeutic drug monitoring 20100801

• An investigation into the bias between liquid chromatography-tandem mass spectrometry and an enzyme multiplied immunoassay technique for the measurement of mycophenolic acid.

  Therapeutic drug monitoring 20100801

• Successful treatment of mycophenolate mofetil in a child with refractory Evans syndrome.

  Journal of pediatric hematology/oncology 20100801

• Evidence-based pemphigus treatment?

  The Journal of investigative dermatology 20100801

• A randomized trial and the treatment of pemphigus vulgaris.

  The Journal of investigative dermatology 20100801

• In rat renal fibroblasts, mycophenolic acid inhibits proliferation and production of the chemokine CCL2, stimulated by tumour necrosis factor-alpha.

  British journal of pharmacology 20100801

• Comparison of the therapeutic effects of leflunomide and mycophenolate mofetil in the treatment of immunoglobulin A nephropathy manifesting with nephrotic syndrome.

  International journal of clinical pharmacology and therapeutics 20100801

• Iatrogenic immunodeficiency-associated lymphoproliferative disease of the Hodgkin lymphoma-like variant in a patient treated with mycophenolate mofetil for autoimmune hepatitis.

  American journal of hematology 20100801

• Islet transplantation in type 1 diabetics using an immunosuppressive protocol based on the anti-LFA-1 antibody efalizumab.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20100801

• Keratoprosthesis in autoimmune disease.

  Ocular immunology and inflammation 20100801

• Therapeutic drug monitoring of mycophenolic acid: a potential treatment for lupus nephritis.

  Kidney international 20100801

• Prenatal exposure to mycophenolate mofetil: an updated estimate.

  Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC 20100801

• Determination of mycophenolic acid and its phenyl glucuronide in human plasma, ultrafiltrate, blood, DBS and dried plasma spots.

  Bioanalysis 20100801

• Major histocompatibility complex class 1 chain-related antigen a antibodies: sensitizing events and impact on renal graft outcomes.

  Transplantation 20100727

• Renal function, efficacy, and safety of sirolimus and mycophenolate mofetil after short-term calcineurin inhibitor-based quadruple therapy in de novo renal transplant patients: one-year analysis of a randomized multicenter trial.

  Transplantation 20100727

• [Effect of mycophenolic acid on maturation, endocytotic capacity and allostimulatory properties of human myeloid dendritic cell].

  Zhonghua yi xue za zhi 20100720

• Enteric-coated mycophenolate sodium versus mycophenolate mofetil maintenance immunosuppression: outcomes analysis of the United Network for Organ Sharing/Organ Procurement and Transplantation Network database.

  Transplantation 20100715

• Evaluation of the mycophenolic acid exposure estimation methods used in the APOMYGERE, FDCC, and Opticept trials.

  Transplantation 20100715

• Evaluation of posttransplant methotrexate to facilitate engraftment in the canine major histocompatibility complex-haploidentical nonmyeloablative transplant model.

  Transplantation 20100715

• A randomized phase II trial comparing tacrolimus and mycophenolate mofetil to tacrolimus and methotrexate for acute graft-versus-host disease prophylaxis.

  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20100701

• Mycophenolic acid attenuates tumor necrosis factor-alpha-induced endothelin-1 production in human aortic endothelial cells.

  Atherosclerosis 20100701

• The efficacy of low-dose mycophenolate mofetil for treatment of lupus nephritis in Taiwanese patients with systemic lupus erythematosus.

  Clinical rheumatology 20100701

• Mycophenolate mofetil attenuates plaque inflammation in patients with symptomatic carotid artery stenosis.

  Atherosclerosis 20100701

• Refractory insulin allergy: pancreas transplantation or immunosuppressive therapy alone?

  Transplant international : official journal of the European Society for Organ Transplantation 20100701

• Mycophenolic acid suppresses granulopoiesis by inhibition of interleukin-17 production.

  Kidney international 20100701

• Regioselective glucuronidation of tanshinone iia after quinone reduction: identification of human UDP-glucuronosyltransferases, species differences, and interaction potential.

  Drug metabolism and disposition: the biological fate of chemicals 20100701

• Combination therapy of mycophenolate mofetil and tacrolimus in lupus nephritis.

  Lupus 20100701

• Mycophenolic acid and intravenous immunoglobulin exert an additive effect on cell proliferation and apoptosis in the mixed lymphocyte reaction.

  Transplant immunology 20100701

• The occurrence of diarrhea not related to the pharmacokinetics of MPA and its metabolites in liver transplant patients.

  European journal of clinical pharmacology 20100701

• The CLEAR study: a 5-day, 3-g loading dose of mycophenolate mofetil versus standard 2-g dosing in renal transplantation.

  Clinical journal of the American Society of Nephrology : CJASN 20100701

• Mycophenolic acid area under the curve correlates with disease activity in lupus patients treated with mycophenolate mofetil.

  Arthritis and rheumatism 20100701

• Good outcomes with mycophenolate-cyclosporine-based induction protocol in children with severe proliferative lupus nephritis.

  Lupus 20100701

• Efficacy and adverse events of mycophenolate mofetil versus cyclophosphamide for induction therapy of lupus nephritis: systematic review and meta-analysis.

  Medicine 20100701

• High dose epoetin beta in the first weeks following renal transplantation and delayed graft function: Results of the Neo-PDGF Study.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20100701

• Thymoglobulin induction and sirolimus versus tacrolimus in kidney transplant recipients receiving mycophenolate mofetil and steroids.

  Transplantation 20100627

• Assessing renal function with daclizumab induction and delayed tacrolimus introduction in liver transplant recipients.

  Transplantation 20100627

• Triazole-linked inhibitors of inosine monophosphate dehydrogenase from human and Mycobacterium tuberculosis.

  Journal of medicinal chemistry 20100624

• Renal allograft failure predictors after PAK transplantation: results from the New England Collaborative Association of Pancreas Programs.

  Transplantation 20100615

• Combined posttransplant prophylactic IVIg/anti-CD 20/plasmapheresis in kidney recipients with preformed donor-specific antibodies: a pilot study.

  Transplantation 20100615

• Individualized monitoring of nuclear factor of activated T cells-regulated gene expression in FK506-treated kidney transplant recipients.

  Transplantation 20100615

• [Lupus-nephritis--diagnosis and treatment].

  Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20100603

• Post-renal transplant surgical complications with newer immunosuppressive drugs: mycophenolate mofetil vs. m-TOR inhibitors.

  International urology and nephrology 20100601

• Acute measles infection triggering an episode of liver transplant rejection.

  International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 20100601

• Cyclosporine, tacrolimus and sirolimus retain their distinct toxicity profiles despite low doses in the Symphony study.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20100601

• Treatment of anti-glutamic acid decarboxylase antibody-associated limbic encephalitis with mycophenolate mofetil.

  Journal of neurology 20100601

• Is mycophenolate mofetil superior to pulse intravenous cyclophosphamide for induction therapy of proliferative lupus nephritis in Egyptian patients?

  Clinical and experimental nephrology 20100601

• Chronic inflammatory demyelinating polyneuropathy responsive to mycophenolate mofetil therapy.

  Journal of neurology, neurosurgery, and psychiatry 20100601

• Assessment of tissue fibrosis in skin biopsies from patients with systemic sclerosis employing confocal laser scanning microscopy: an objective outcome measure for clinical trials?

  Rheumatology (Oxford, England) 20100601

• Prediction of intravenous cyclosporine area under the concentration-time curve after allogeneic stem cell transplantation.

  Therapeutic drug monitoring 20100601

• Pharmacokinetics of mycophenolic acid and its glucuronidated metabolites in stable islet transplant recipients.

  Therapeutic drug monitoring 20100601

• Does tacrolimus, in comparison with sirolimus, increase mycophenolic acid exposure in kidney transplant recipients?

  Clinical pharmacology and therapeutics 20100601

• Hypokalemic paralysis as primary presentation of Fanconi syndrome associated with Sjögren syndrome.

  Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 20100601

• Target enzyme activity as a biomarker for immunosuppression.

  Therapeutic drug monitoring 20100601

• Progress in pediatric kidney transplantation.

  Therapeutic drug monitoring 20100601

• Everolimus plus reduced-exposure CsA versus mycophenolic acid plus standard-exposure CsA in renal-transplant recipients.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20100601

• Long-term outcome of living related renal transplantation in a patient with short bowel syndrome.

  The Tohoku journal of experimental medicine 20100601

• [Rheumatology 2010].

  Deutsche medizinische Wochenschrift (1946) 20100601

• Risk of diarrhoea in a long-term cohort of renal transplant patients given mycophenolate mofetil: the significant role of the UGT1A8 2 variant allele.

  British journal of clinical pharmacology 20100601

• Enteric-coated mycophenolate sodium in the treatment of refractory pemphigus.

  International journal of dermatology 20100601

• Ramsay Hunt syndrome in renal transplantation recipient: a case report.

  Transplantation proceedings 20100601

• [Childhood onset systemic lupus erythematosus: how does it must be treated in 2010?].

  Archives de pediatrie : organe officiel de la Societe francaise de pediatrie 20100601

• Mycophenolate mofetil therapy in a child with Churg-Strauss syndrome.

  Pediatrics international : official journal of the Japan Pediatric Society 20100601

• Mycophenolate mofetil in minimal change nephrosis.

  The West Indian medical journal 20100601

• TDM for mycophenolic acid at no extra cost.

  Transplantation 20100527

• Cost-effectiveness analysis of individualized mycophenolate mofetil dosing in kidney transplant patients in the APOMYGRE trial.

  Transplantation 20100527

• Maintenance immunosuppressive agents as risk factors for BK virus nephropathy: the need for true drug exposure measurements.

  Transplantation 20100527

• Conversion to sirolimus in African American renal allograft recipients undergoing early steroid withdrawal: intermediate-term risks and benefits.

  Transplantation 20100515

• Mycophenolic acid inhibits the phosphorylation of NF-kappaB and JNKs and causes a decrease in IL-8 release in H2O2-treated human renal proximal tubular cells.

  Chemico-biological interactions 20100514

• Mycophenolate mofetil for the management of steroid-refractory acute graft vs host disease.

  Bone marrow transplantation 20100501

• Mycophenolate mofetil therapy for children with steroid-resistant nephrotic syndrome.

  Pediatric nephrology (Berlin, Germany) 20100501

• Effects of mycophenolate mofetil on acute ischaemia-reperfusion injury in rats and its consequences in the long term.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20100501

• Genetic polymorphisms influence mycophenolate mofetil-related adverse events in pediatric heart transplant patients.

  The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20100501

• Induction and maintenance therapy for lupus nephritis: a systematic review and meta-analysis.

  Lupus 20100501

• Benefit of immune monitoring in heart transplant patients using ATP production in activated lymphocytes.

  The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20100501

• Mycophenolate: dual utility in rare conditions of HIV infection complicating lupus.

  Lupus 20100501

• Lung transplantation under a tacrolimus/mycophenolate mofetil-based immunosuppressive regimen results in low titers of HLA and MICA IgG antibodies which are not related to development of BOS.

  The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20100501

• Lupus nephritis: where are we now?

  Current opinion in rheumatology 20100501

• Mycophenolic acid differentially affects dendritic cell maturation induced by tumor necrosis factor-alpha and lipopolysaccharide through a different modulation of MAPK signaling.

  Molecular immunology 20100501

• The accumulated experience with the use of mycophenolate mofetil in primary glomerulonephritis.

  Expert opinion on investigational drugs 20100501

• Mycophenolate mofetil in AChR-antibody-positive myasthenia gravis: outcomes in 102 patients.

  Muscle & nerve 20100501

• Mycophenolate mofetil modifies kidney tubular injury and Foxp3+ regulatory T cell trafficking during recovery from experimental ischemia-reperfusion.

  Transplant immunology 20100501

• Combination therapy with mycophenolate mofetil and prednisone in steroid-resistant idiopathic membranoproliferative glomerulonephritis.

  Clinical nephrology 20100501

• Protective effect of mycophenolate mofetil on mercuric chloride-induced nephrotoxicity in rats.

  Methods and findings in experimental and clinical pharmacology 20100501

• De novo everolimus-based therapy in renal transplant recipients: effect on proteinuria and renal prognosis.

  Transplantation proceedings 20100501

• Superior efficacy of enteric-coated mycophenolate vs mycophenolate mofetil in de novo transplant recipients: pooled analysis.

  Transplantation proceedings 20100501

• [Duodenal villous atrophy associated with Mycophenolate mofetil: report of one case].

  Revista medica de Chile 20100501

• Basiliximab versus daclizumab combined with triple immunosuppression in deceased donor renal transplantation: a prospective, randomized study.

  Transplantation 20100427

• Interleukin-15 receptor blockade in non-human primate kidney transplantation.

  Transplantation 20100427

• Impact of immunosuppressants on the therapeutic efficacy of in vitro-expanded CD4+CD25+Foxp3+ regulatory T cells in allotransplantation.

  Transplantation 20100427

• Mycophenolic acid inhibits albumin-induced MCP-1 expression in renal tubular epithelial cells through the p38 MAPK pathway.

  Molecular biology reports 20100401

• Prophylaxis with mycophenolate mofetil and CsA can decrease the incidence of severe acute GVHD after antithymocyte globulin-based reduced-intensity preparative regimen and allo-SCT from HLA-matched unrelated donors.

  Bone marrow transplantation 20100401

• Failure to preserve beta-cell function with mycophenolate mofetil and daclizumab combined therapy in patients with new- onset type 1 diabetes.

  Diabetes care 20100401

• Treatment of primary angiitis of the central nervous system in childhood with mycophenolate mofetil.

  Rheumatology (Oxford, England) 20100401

• A reliable limited sampling strategy for the estimation of mycophenolic acid area under the concentration time curve in adult renal transplant patients in the stable posttransplant period.

  Therapeutic drug monitoring 20100401

• Reduced intensity conditioning prior to allogeneic stem cell transplantation in first complete remission is effective in patients with acute myeloid leukemia and an intermediate-risk karyotype.

  International journal of hematology 20100401

• Therapeutic drug monitoring of mycophenolate mofetil and enteric-coated mycophenolate sodium in patients with systemic lupus erythematosus.

  Expert opinion on pharmacotherapy 20100401

• Mycophenolic acid estimation by pooled sampling: a novel strategy.

  Therapeutic drug monitoring 20100401

• Mycophenolic acid exposure in high- and low-weight renal transplant patients after dosing with mycophenolate mofetil in the Opticept trial.

  Therapeutic drug monitoring 20100401

• A high risk of life-threatening infectious complications in mycophenolate mofetil treatment for acute or chronic graft-versus-host disease.

  International journal of hematology 20100401

• Cost-benefit of steroid avoidance in renal transplant patients: a prospective randomized study.

  Scandinavian journal of urology and nephrology 20100401

• Successful treatment of antiN-methyl-d-aspartate receptor limbic encephalitis in a 22-monthold child with plasmapheresis and pharmacological immunomodulation.

  Archives of disease in childhood 20100401

• Eosinophilic fasciitis in a pediatric patient.

  Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 20100401

• Pharmacokinetic and pharmacodynamic analysis of enteric-coated mycophenolate sodium: limited sampling strategies and clinical outcome in renal transplant patients.

  British journal of clinical pharmacology 20100401

• Population pharmacokinetics and Bayesian estimator of mycophenolic acid in children with idiopathic nephrotic syndrome.

  British journal of clinical pharmacology 20100401

• [Prophylactic effect of CsA, MTX, MMF combined with ATG on GVHD in patients underwent unrelated peripheral blood hematopoietic stem cell transplantation].

  Zhongguo shi yan xue ye xue za zhi 20100401

• Mycophenolic acid trough level measurements and clinical outcomes in kidney transplantation recipients on a fixed dose (1.5 g/d) of mycophenolate mofetil in Korea.

  Transplantation proceedings 20100401

• Preemptive therapy in adult liver transplant recipients in CMV-endemic area.

  Transplantation proceedings 20100401

• Pharmacokinetics of mycophenolic acid in living donor liver transplantation.

  Transplantation proceedings 20100401

• Combined sirolimus-calcineurin inhibitor immunosuppressive therapy in simultaneous heart and kidney transplantation: a retrospective analysis of a single hospital's experience.

  Transplantation proceedings 20100401

• The survival of heart transplant recipients using cyclosporine and everolimus is not inferior to that using cyclosporine and mycophenolate.

  Transplantation proceedings 20100401

• Long-term outcome of patients with lupus nephritis: a single center experience.

  Bosnian journal of basic medical sciences 20100401

• Mycophenolate mofetil for the treatment of chronic dermatitis: an open-label study of 16 patients.

  Journal of drugs in dermatology : JDD 20100401

• Comparing an early corticosteroid/late calcineurin-free immunosuppression protocol to a sirolimus-, cyclosporine A-, and prednisone-based regimen for pancreas-kidney transplantation.

  Transplantation 20100327

• Renal transplant patients at high risk of acute rejection benefit from adequate exposure to mycophenolic acid.

  Transplantation 20100315

• Sample cleanup-free determination of mycophenolic acid and its glucuronide in serum and plasma using the novel technology of ultra-performance liquid chromatography-electrospray ionization tandem mass spectrometry.

  Talanta 20100315

• Mycophenolate mofetil treatment in dogs with serologically diagnosed acquired myasthenia gravis: 27 cases (1999-2008).

  Journal of the American Veterinary Medical Association 20100315

• Fatal acute pancreatitis complicated by pancreatic pseudocysts in a patient with systemic lupus erythematosus.

  Rheumatology international 20100301

• An age-dependent pharmacokinetic study of intravenous and oral mycophenolate mofetil in combination with tacrolimus for GVHD prophylaxis in pediatric allogeneic stem cell transplantation recipients.

  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20100301

• Corticosteroid avoidance in adult kidney transplant recipients under rabbit anti-T-lymphocyte globulin, mycophenolate mofetil and delayed cyclosporine microemulsion introduction.

  Transplant international : official journal of the European Society for Organ Transplantation 20100301

• Diffuse large B-cell lymphoma of the central nervous system in mycophenolate mofetil-treated patients with systemic lupus erythematosus.

  Lupus 20100301

• Mycophenolate pharmacokinetics and association with response to acute graft-versus-host disease treatment from the Blood and Marrow Transplant Clinical Trials Network.

  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20100301

• Mycophenolate mofetil in children with steroid/cyclophosphamide-resistant nephrotic syndrome.

  Pediatric nephrology (Berlin, Germany) 20100301

• Long-term study of mycophenolate mofetil treatment in IgA nephropathy.

  Kidney international 20100301

• Mycophenolate mofetil for ocular inflammation.

  American journal of ophthalmology 20100301

• Mycophenolate mofetil in Takayasu's arteritis.

  Clinical rheumatology 20100301

• Efficacy and safety of mycophenolate mofetil for lichen planopilaris.

  Journal of the American Academy of Dermatology 20100301

• Mycophenolate mofetil for induction and maintenance of remission in microscopic polyangiitis with mild to moderate renal involvement--a prospective, open-label pilot trial.

  Clinical journal of the American Society of Nephrology : CJASN 20100301

• Pharmacokinetics and pharmacodynamics of intensified versus standard dosing of mycophenolate sodium in renal transplant patients.

  Clinical journal of the American Society of Nephrology : CJASN 20100301

• Bioequivalence testing of immunosuppressants: concepts and misconceptions.

  Kidney international. Supplement 20100301

• Neuromuscular complication after liver transplant in children: a single-center experience.

  Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 20100301

• Pharmacogenetic influences on mycophenolate therapy.

  Pharmacogenomics 20100301

• Induction with basiliximab in renal transplantation.

  Transplantation proceedings 20100301

• Influence of mycophenolate mofetil on preservation of kidney function in liver transplant patients.

  Transplantation proceedings 20100301

• Improvement of renal function after conversion to mycophenolate mofetil combined with low-level calcineurin inhibitor in liver transplant recipients with chronic renal dysfunction.

  Transplantation proceedings 20100301

• Mycophenolate mofetil 500-mg tablet under fasting conditions: single-dose, randomized-sequence, open-label, four-way replicate crossover, bioequivalence study in healthy subjects.

  Clinical therapeutics 20100301

• Patch testing in patients treated with systemic immunosuppression and cytokine inhibitors.

  Contact dermatitis 20100301

• Mycophenolate induced diarrhoea.

  The Journal of the Association of Physicians of India 20100301

• Mycophenolate mofetil versus enteric-coated mycophenolate sodium: a large, single-center comparison of dose adjustments and outcomes in kidney transplant recipients.

  Transplantation 20100227

• Bullous pemphigoid associated with acute renal allograft rejection.

  Transplantation 20100215

• Combined immunosuppressive and antibiotic therapy improves bacterial clearance and survival of polymicrobial septic peritonitis.

  Shock (Augusta, Ga.) 20100201

• Randomized trial of cyclosporine and tacrolimus therapy with steroid withdrawal in living-donor renal transplantation: 5-year follow-up.

  Transplant international : official journal of the European Society for Organ Transplantation 20100201

• Lower incidence of cytomegalovirus infection with everolimus versus mycophenolate mofetil in de novo cardiac transplant recipients: a randomized, multicenter study.

  Transplant infectious disease : an official journal of the Transplantation Society 20100201

• An inosine 5'-monophosphate dehydrogenase 2 single-nucleotide polymorphism impairs the effect of mycophenolic acid.

  The pharmacogenomics journal 20100201

• Improved growth and cardiovascular risk after late steroid withdrawal: 2-year results of a prospective, randomised trial in paediatric renal transplantation.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20100201

• Epididymal abscess in renal transplant: uncommon presentation of Klebsiella septicemia.

  Clinical and experimental nephrology 20100201

• Feasibility of, and critical paths for mycophenolate mofetil Bayesian dose adjustment: pharmacological re-appraisal of a concentration-controlled versus fixed-dose trial in renal transplant recipients.

  Pharmacological research 20100201

• Inhibition of intestinal and hepatic glucuronidation of mycophenolic acid by Ginkgo biloba extract and flavonoids.

  Drug metabolism and disposition: the biological fate of chemicals 20100201

• Calcineurin inhibitors affect B cell antibody responses indirectly by interfering with T cell help.

  Clinical and experimental immunology 20100201

• Tubular toxicity in sirolimus- and cyclosporine-based transplant immunosuppression strategies: an ancillary study from a randomized controlled trial.

  American journal of kidney diseases : the official journal of the National Kidney Foundation 20100201

• Early outcomes using alemtuzumab induction in lung transplantation.

  Interactive cardiovascular and thoracic surgery 20100201

• Tubular epithelial cell and podocyte apoptosis with de novo sirolimus based immunosuppression in renal allograft recipients with DGF.

  Histology and histopathology 20100201

• Investigation of the crossreactivity of mycophenolic acid glucuronide metabolites and of mycophenolate mofetil in the Cedia MPA assay.

  Therapeutic drug monitoring 20100201

• Mycophenolic acid predose concentrations and renal function in a mouse model for progressive renal fibrosis.

  Therapeutic drug monitoring 20100201

• Clinical predictors of proteinuria after conversion to sirolimus in kidney transplant recipients.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20100201

• Consensus report on therapeutic drug monitoring of mycophenolic acid in solid organ transplantation.

  Clinical journal of the American Society of Nephrology : CJASN 20100201

• Treatment with mycophenolate mofetil followed by recombinant human erythropoietin in patients with low-risk myelodysplastic syndromes resistant to erythropoietin treatment.

  Haematologica 20100201

• ANCA-associated vasculitides: advances in pathophysiology and treatment.

  The Netherlands journal of medicine 20100201

• Evaluation of inosin-5'-monophosphate dehydrogenase activity during maintenance therapy with tacrolimus.

  Journal of clinical pharmacy and therapeutics 20100201

• Congenital malformations with low-dose mycophenolate mofetil after kidney transplantation.

  Nephrology (Carlton, Vic.) 20100201

• [Chronic graft-versus-host disease with multiple serositis after bone marrow transplantation from non-inherited maternal antigen-complementary sibling donor].

  [Rinsho ketsueki] The Japanese journal of clinical hematology 20100201

• Pemphigus vulgaris--still a difficult disease to treat.

  International journal of dermatology 20100201

• Screening for de novo anti-human leukocyte antigen antibodies in nonsensitized kidney transplant recipients does not predict acute rejection.

  Transplantation 20100127

• Predicting renal failure after liver transplantation from measured glomerular filtration rate: review of up to 15 years of follow-up.

  Transplantation 20100127

• Cyclosporine lowering with everolimus or mycophenolate to preserve renal function in heart recipients: a randomized study.

  Transplantation 20100127

• Metabolic long-term follow-up of functioning simultaneous pancreas-kidney transplantation versus pancreas transplantation alone: insights and limitations.

  Transplantation 20100115

• Combination immunosuppressant therapy for patients with chronic refractory immune thrombocytopenic purpura.

  Blood 20100107

• Inflammation-associated gene transcription and expression in mouse lungs induced by low molecular weight compounds from fungi from the built environment.

  Chemico-biological interactions 20100105

• Oral ulcers after a transplant.

  The British journal of oral & maxillofacial surgery 20100101

• The effects and mechanisms of mycophenolate mofetil on pulmonary arterial hypertension in rats.

  Rheumatology international 20100101

• Thymoglobulin, CYA and mycophenolate mofetil as GVHD prophylaxis for reduced-intensity unrelated donor hematopoietic cell transplantation: beneficial effect seen on chronic GVHD.

  Bone marrow transplantation 20100101

• Rapidly progressing glomerulonephritis secondary to henoch-schonlein purpura treated with mycophenolate mofetil: a case report with atypical etiology and presentation.

  American journal of therapeutics 20100101

• Late conversion of tacrolimus to sirolimus in a prednisone-free immunosuppression regimen in renal transplant patients.

  Clinical transplantation 20100101

• Survival of corneal allografts following topical treatment with the immunomodulator mycophenolate mofetil.

  Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde 20100101

• Acute rejection after paediatric heart transplantation: far less common and less severe.

  Transplant international : official journal of the European Society for Organ Transplantation 20100101

• The use of low-dose cyclophosphamide followed by AZA/MMF treatment in childhood lupus nephritis.

  Pediatric nephrology (Berlin, Germany) 20100101

• The acyl glucuronide metabolite of mycophenolic acid induces tubulin polymerization in vitro.

  Clinical biochemistry 20100101

• Acute rejection in low-toxicity regimens: clinical impact and risk factors in the Symphony study.

  Clinical transplantation 20100101

• Influenza virus vaccination in kidney transplant recipients: serum antibody response to different immunosuppressive drugs.

  Clinical transplantation 20100101

• Impact of daclizumab, low-dose cyclosporine, mycophenolate mofetil and steroids on renal function after kidney transplantation.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20100101

• Mycophenolate in the remission induction of a patient with acquired haemophilia A.

  Haemophilia : the official journal of the World Federation of Hemophilia 20100101

• Effect of the inosine 5'-monophosphate dehydrogenase inhibitor BMS-566419 on rat cardiac allograft rejection.

  International immunopharmacology 20100101

• Use of two validated in vitro tests to assess the embryotoxic potential of mycophenolic acid.

  Archives of toxicology 20100101

• The role of organic anion-transporting polypeptides and their common genetic variants in mycophenolic acid pharmacokinetics.

  Clinical pharmacology and therapeutics 20100101

• Mycophenolate mofetil and intravenous cyclophosphamide are similar as induction therapy for class V lupus nephritis.

  Kidney international 20100101

• Tacrolimus combined with two different corticosteroid-free regimens compared with a standard triple regimen in renal transplantation: one year observational results.

  Clinical transplantation 20100101

• A prospective, randomized, multicenter study evaluating early corticosteroid withdrawal with Thymoglobulin in living-donor kidney transplantation.

  Clinical transplantation 20100101

• Influence of race/ethnicity on response to lupus nephritis treatment: the ALMS study.

  Rheumatology (Oxford, England) 20100101

• Limited sampling strategies for predicting area under the concentration-time curve of mycophenolic acid in islet transplant recipients.

  The Annals of pharmacotherapy 20100101

• Influence of selective immunosuppressive drugs on the healing of exposed dogs' dental pulp capped with mineral trioxide aggregate.

  Journal of endodontics 20100101

• Effect of mycophenolate mofetil therapy on the phenotypic profile of peripheral blood leukocyte populations in psoriatic patients.

  European journal of dermatology : EJD 20100101

• New warnings about immunosuppressive drugs.

  The American journal of nursing 20100101

• Nonrenal disease activity following mycophenolate mofetil or intravenous cyclophosphamide as induction treatment for lupus nephritis: findings in a multicenter, prospective, randomized, open-label, parallel-group clinical trial.

  Arthritis and rheumatism 20100101

• Randomized trial of early corticosteroid reduction vs. regular-dose corticosteroid maintenance in combination with tacrolimus and mycophenolate mofetil in living donor kidney transplant recipients: the Brazilian CORRETA trial.

  Clinical transplantation 20100101

• Randomized crossover study to assess the inter- and intrasubject variability of morning mycophenolic acid concentrations from enteric-coated mycophenolate sodium and mycophenolate mofetil in stable renal transplant recipients.

  Clinical transplantation 20100101

• Combined mycophenolate mofetil and prednisone therapy in tamoxifen- and prednisone-resistant Reidel's thyroiditis.

  Thyroid : official journal of the American Thyroid Association 20100101

• A clinical assessment of mycophenolate drug monitoring after liver transplantation.

  Clinical transplantation 20100101

• Monitoring of mycophenolate acid in serum or plasma using LC tandem mass spectrometry.

  Methods in molecular biology (Clifton, N.J.) 20100101

• Inosine monophosphate dehydrogenase variability in renal transplant patients on long-term mycophenolate mofetil therapy.

  British journal of clinical pharmacology 20100101

• Malignancy concerns with psoriasis treatments using phototherapy, methotrexate, cyclosporin, and biologics: facts and controversies.

  Clinics in dermatology 20100101

• Induction and maintenance therapy in proliferative lupus nephritis.

  Journal of nephrology 20100101

• [Induction treatment by combining immunoglobulins, plasmapheresis and rituximab in hypersensitive patients receiving cadaveric renal allograft].

  Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20100101

• Treatment of acrodermatitis continua of Hallopeau with TNF-blocking agents: case report and review.

  Dermatology (Basel, Switzerland) 20100101

• Therapeutic drug monitoring of mycophenolic acid in patients with psoriasis.

  European journal of dermatology : EJD 20100101

• Pediatric idiopathic nephrotic syndrome: treatment strategies in steroid dependent and steroid resistant forms.

  Current medicinal chemistry 20100101

• Bioequivalence and pharmacokinetic comparison of two mycophenolate mofetil formulations in healthy Chinese male volunteers: an open-label, randomized-sequence, single-dose, two-way crossover study.

  Clinical therapeutics 20100101

• Mycophenolate mofetil-related gastrointestinal mucosal injury in multivisceral transplantation.

  Transplantation proceedings 20100101

• Evaluation of late immunologic parameters among renal transplant recipients induced with Campath-1H.

  Transplantation proceedings 20100101

• Effectiveness and cost of replacing a calcineurin inhibitor with sirolimus to slow the course of chronic kidney disease in renal allografts.

  Transplantation proceedings 20100101

• Pancreas transplantation: experience at University of Texas, Houston.

  Transplantation proceedings 20100101

• Comparison of dissolution properties of 2 enteric-coated formulations containing mycophenolate sodium: Myfortic vs Femulan.

  Transplantation proceedings 20100101

• Impact of mycophenolate mofetil on wound complications and lymphoceles after kidney transplantation.

  Kidney & blood pressure research 20100101

• Successful treatment of resistant antiglomerular basement membrane antibody positivity with mycophenolic acid.

  Internal medicine (Tokyo, Japan) 20100101

• [Effectiveness and safety of rituximab in pemphigus vulgaris].

  Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20100101

• Ovarian function is preserved in women with severe systemic lupus erythematosus after a 6-month course of cyclophosphamide followed by mycophenolate mofetil.

  Clinical and experimental rheumatology 20100101

• [Toxic effect of immunosuppression agent Everolimus on insuloma cells and pancreatic islets of SD rat].

  Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition 20100101

• The chemistry of mycophenolic acid--synthesis and modifications towards desired biological activity.

  Current medicinal chemistry 20100101

• Pulmonary toxicity associated with sirolimus following kidney transplantation: computed tomography findings.

  Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20100101

• Successful treatment with mycophenolate mofetil of four Japanese patients with pemphigus vulgaris.

  European journal of dermatology : EJD 20100101

• Triple therapy with ursodeoxycholic acid, budesonide and mycophenolate mofetil in patients with features of severe primary biliary cirrhosis not responding to ursodeoxycholic acid alone.

  Gastroenterologie clinique et biologique 20100101

• Triple therapy for patients with primary biliary cirrhosis with progressive disease despite ursodeoxycholic acid: another step forward.

  Gastroenterologie clinique et biologique 20100101

• [Immunosuppressive agents in Dermatology].

  Anais brasileiros de dermatologia 20100101

• [Ocular side effects of steroids and other immunosuppressive agents].

  Therapie 20100101

• Functional and structural changes in end-stage kidney disease due to glomerulonephritis induced by the recombinant alpha3(IV)NC1 domain.

  Experimental animals 20100101

• Different immunosuppressive combinations on T-cell regulation in renal transplant recipients.

  American journal of nephrology 20100101

• Treatment of primary systemic vasculitis with the inosine monophosphate dehydrogenase inhibitor mycophenolic acid.

  Nephron. Clinical practice 20100101

• Comparison of therapeutic efficacy between bortezomib and combination treatment of prednisolone and mycophenolate mofetil on nephritis in NZB/WF1 mice.

  Clinical and experimental rheumatology 20100101

• [Change in regulations for dispensing immunosuppressants to patients who have undergone a kidney transplant].

  Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20100101

• Adjuvant drugs in autoimmune bullous diseases, efficacy versus safety: Facts and controversies.

  Clinics in dermatology 20100101

• Early brief treatment with losartan plus mycophenolate mofetil provides lasting renoprotection in a renal ablation model.

  American journal of nephrology 20100101

• Recalcitrant pemphigus vulgaris responding to systemic tacrolimus.

  Dermatology (Basel, Switzerland) 20100101

• [Diagnosis and management of small vessel vasculitides].

  Duodecim; laaketieteellinen aikakauskirja 20100101

• Mycophenolate mofetil in the treatment of adults with advanced rheumatoid arthritis: three 24-week, randomized, double-blind, placebo- or ciclosporin-controlled trials.

  Clinical drug investigation 20100101

• Bullous lupus: an unusual initial presentation of systemic lupus erythematosus in an adolescent girl.

  Pediatric dermatology 20100101

• Mycophenolic acid in rheumatology: mechanisms of action and severe adverse events.

  Reumatismo 20100101

• Treatment of lupus nephritis by mycophenolate mofetil.

  Kidney & blood pressure research 20100101

• Ecthyma-gangrenosum-like bullous pemphigoid.

  Dermatology (Basel, Switzerland) 20100101

• Severe stomatitis complicating immune-suppressive switch after cardiac transplantation.

  Acta chirurgica Belgica 20100101

• Similar early complication rate in simultaneous pancreas and kidney recipients on tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimus immunosuppressive regimens.

  Transplantation proceedings 20100101

• Alemtuzumab with rapid steroid taper in simultaneous kidney and pancreas transplantation: comparison to induction with antithymocyte globulin.

  Transplantation proceedings 20100101

• Pancreata from pediatric donors restore insulin independence in adult insulin-dependent diabetes mellitus recipients.

  Transplantation proceedings 20100101

• ET-Kyoto ductal injection and density-adjusted purification combined with potent anti-inflammatory strategy facilitated single-donor islet transplantation: case reports.

  Transplantation proceedings 20100101

• Calcineurin inhibitors in renal transplantation still needed but in reduced doses: a review.

  Transplantation proceedings 20100101

• [Case of MMF monotherapy for membranous nephropathy].

  Nihon Jinzo Gakkai shi 20100101

• Bullous pemphigoid in late childhood successfully treated with mycophenolate mofetil as an adjuvant therapy.

  Pediatric dermatology 20100101

• Overexpression of inosine 5'-monophosphate dehydrogenase type II mediates chemoresistance to human osteosarcoma cells.

  PloS one 20100101

• Study protocol: a pilot study to determine the safety and efficacy of induction-therapy, de novo MPA and delayed mTOR-inhibition in liver transplant recipients with impaired renal function. PATRON-study.

  BMC nephrology 20100101

• Reliability of mycophenolic acid monitoring by an enzyme multiplied immunoassay technique.

  Clinical laboratory 20100101

• Skin cancer after renal transplantation: Results of a multicenter study in Iran.

  Annals of transplantation 20100101

• Bullous systemic lupus erythematosus responding to mycophenolate mofetil.

  European journal of dermatology : EJD 20100101

• Effect of mycophenolate mofetil on cerulein-induced acute pancreatitis.

  European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes 20100101

• Effects of mycophenolate mofetil on proliferation and mucin-5AC expression in human conjunctival goblet cells in vitro.

  Molecular vision 20100101

• Reduced-intensity conditioning using fludarabine and antithymocyte globulin alone allows stable engraftment in a patient with dyskeratosis congenita.

  Acta haematologica 20100101

• Mycophenolate mofetil as maintenance therapy for proliferative lupus nephritis: a long-term observational prospective study.

  Arthritis research & therapy 20100101

• [Producers of mycophenolic acid in ensiled and grain feeds].

  Prikladnaia biokhimiia i mikrobiologiia 20100101

• [Immunosuppressive therapies for refractory nephrotic syndrome].

  Nihon Jinzo Gakkai shi 20100101

• [Treatment with rituximab for a patient with p-ANCA glomerulonephritis, alveolar bleeding and multiple relapses during haemodialysis].

  Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20100101

• Antiproliferative properties of mycophenolic acid on human retinal pigment epithelial cells in vitro.

  Klinika oczna 20100101

• [Birdshot chorioretinopathy--case report].

  Oftalmologia (Bucharest, Romania : 1990) 20100101

• CAPD-related peritonitis after renal transplantation.

  Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis 20100101

• Steady-state mycophenolate mofetil pharmacokinetic parameters enable prediction of systemic lupus erythematosus clinical flares: an observational cohort study.

  Arthritis research & therapy 20100101

• Posttransplant lymphoproliferative disorders of the central nervous system after kidney transplantation: single center experience over 40 years. Two case reports.

  Neurologia medico-chirurgica 20100101

• [Mycophenolate mofetil for the treatment of lupus nephritis. The case of lupus nephritis--class IV according to WHO--treated with mycophenolate mofetil].

  Annales Academiae Medicae Stetinensis 20100101

• Generalised lymphadenopathy as the first manifestation of lupus nephritis.

  BMJ case reports 20100101

• Beçhet's disease: a rare cause of rectovaginal fistula.

  BMJ case reports 20100101

• Effective immune restoration after immunosuppressant discontinuation in a lupus patient presenting progressive multifocal leukoencephalopathy.

  Journal of the neurological sciences 20091215

• Therapy with mycophenolate mofetil for refractory acute and chronic GVHD.

  Bone marrow transplantation 20091201

• Intravenous immunoglobulin as add on treatment with mycophenolate mofetil in severe myositis.

  Autoimmunity reviews 20091201

• Efficacy and safety of long-term mycophenolate sodium therapy in pemphigus vulgaris.

  Journal of the European Academy of Dermatology and Venereology : JEADV 20091201

• Transfer from ciclosporin to mycophenolate-sirolimus immunosuppression for chronic renal disease after heart transplantation: safety and efficacy of two regimens.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20091201

• Prompt plasmapheresis successfully rescue pulmonary-renal syndrome caused by ANCA-negative microscopic polyangiitis.

  Clinical rheumatology 20091201

• Antiapoptotic and neuroprotective effects of mycophenolate mofetil after acute spinal cord injury in young rats.

  Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 20091201

• Calculated withdrawal of low-dose immunosuppression based on a detailed immunological monitoring after kidney transplantation between monocygotic twins.

  Transplant immunology 20091201

• Antioxidant effects of mycophenolate mofetil in a murine pleurisy model.

  Transplant immunology 20091201

• High-performance liquid chromatography-mass spectroscopy/mass spectroscopy method for simultaneous quantification of total or free fraction of mycophenolic acid and its glucuronide metabolites.

  Therapeutic drug monitoring 20091201

• Scleritis and systemic disease association in a community-based referral practice.

  American journal of ophthalmology 20091201

• Mycophenolate mofetil versus azathioprine in organ transplantation.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20091201

• A prospective open-label study of mycophenolate mofetil for the treatment of diffuse systemic sclerosis.

  Rheumatology (Oxford, England) 20091201

• Age-related variability of mycophenolate mofetil exposure in stable pediatric liver transplant recipients and influences of donor characteristics.

  Therapeutic drug monitoring 20091201

• Pharmacokinetic role of protein binding of mycophenolic acid and its glucuronide metabolite in renal transplant recipients.

  Journal of pharmacokinetics and pharmacodynamics 20091201

• Impact of sirolimus on the recurrence of hepatocellular carcinoma after liver transplantation.

  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20091201

• Potential differences in kidney allograft outcomes between ethnicities when converting to sirolimus base immunosuppression.

  Transplantation proceedings 20091201

• Enteric-coated mycophenolate sodium reduces gastrointestinal symptoms in renal transplant patients.

  Transplantation proceedings 20091201

• Mycophenolate mofetil versus enteric-coated mycophenolate sodium after simultaneous pancreas-kidney transplantation.

  Transplantation proceedings 20091201

• Validation of limited sampling strategy for estimation of mycophenolic acid exposure during the first year after heart transplantation.

  Transplantation proceedings 20091201

• Experience with mycophenolate mofetil as maintenance therapy in five pediatric patients with severe systemic lupus erythematosus.

  Klinische Padiatrie 20091201

• [Severe adult atopic dermatitis: treatment with mycophenolate mofetil in 8 patients].

  Actas dermo-sifiliograficas 20091201

• Pediatric renal transplantation: a single-center experience in northeast Thailand.

  Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20091201

• Localized bullous pemphigoid in a patient with primary lymphoedema tarda.

  Clinical and experimental dermatology 20091201

• Effect of telmisartan, valsartan and candesartan on mycophenolate mofetil pharmacokinetics in Japanese renal transplant recipients.

  Journal of clinical pharmacy and therapeutics 20091201

• [Prediction of mycophenolic acid exposure in renal transplantation recipients by artificial neural network].

  Yao xue xue bao = Acta pharmaceutica Sinica 20091201

• Inhibition of polyomavirus BK-specific T-Cell responses by immunosuppressive drugs.

  Transplantation 20091127

• Analysis of mycophenolic acid in dried blood spots using reversed phase high performance liquid chromatography.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20091115

• Mycophenolate mofetil use is associated with prolonged graft survival after kidney transplantation.

  Transplantation 20091115

• Pharmacokinetic interaction between sodium valproate and mycophenolate in renal allograft recipients.

  Transplantation 20091115

• Multicriteria optimization methodology in development of HPLC separation of mycophenolic acid and mycophenolic acid glucuronide in human urine and plasma.

  Journal of pharmaceutical and biomedical analysis 20091101

• Mycophenolate mofetil for autoimmune hepatitis: a single practice experience.

  Digestive diseases and sciences 20091101

• Mycophenolate mofetil (MMF) following penetrating high-risk keratoplasty: long-term results of a prospective, randomised, multicentre study.

  Eye (London, England) 20091101

• Severe acute fibrinous and organizing pneumonia (AFOP) causing ventilatory failure: successful treatment with mycophenolate mofetil and corticosteroids.

  Respiratory medicine 20091101

• Successful treatment of severe or methotrexate-resistant juvenile localized scleroderma with mycophenolate mofetil.

  Rheumatology (Oxford, England) 20091101

• Cryptosporidiosis in paediatric renal transplantation.

  Pediatric nephrology (Berlin, Germany) 20091101

• Inosine monophosphate dehydrogenase activity depends on plasma concentrations of mycophenolic acid and its glucuronides in kidney transplant recipients.

  Clinica chimica acta; international journal of clinical chemistry 20091101

• Disease-modifying treatment in systemic sclerosis: current status.

  Current opinion in rheumatology 20091101

• Oral cyclophosphamide for lupus glomerulonephritis: an underused therapeutic option.

  Clinical journal of the American Society of Nephrology : CJASN 20091101

• Endoscopic gastric submucosal transplantation of islets (ENDO-STI): technique and initial results in diabetic pigs.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20091101

• Mycophenolate mofetil and calcineurin-inhibitor reduction: recent progress.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20091101

• Everolimus but not mycophenolate mofetil therapy is associated with soluble HLA-G expression in heart transplant patients.

  The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20091101

• Mycophenolate sodium increases cyclosporine blood levels in renal transplant recipients.

  Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia 20091101

• Determination of residual cell culture media components by MEKC.

  Electrophoresis 20091101

• A prospective randomized open study in liver transplant recipients: daclizumab, mycophenolate mofetil, and tacrolimus versus tacrolimus and steroids.

  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20091101

• Comparison of pharmacokinetics of mycophenolic acid and its metabolites between living donor liver transplant recipients and deceased donor liver transplant recipients.

  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20091101

• Thymoglobulin induction in liver transplant recipients with a tacrolimus, mycophenolate mofetil, and steroid immunosuppressive regimen: a five-year randomized prospective study.

  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20091101

• Hepatitis: new hope for difficult cases of autoimmune hepatitis.

  Nature reviews. Gastroenterology & hepatology 20091101

• Long-term outcomes of keratolimbal allograft for total limbal stem cell deficiency using combined immunosuppressive agents and correction of ocular surface deficits.

  Archives of ophthalmology (Chicago, Ill. : 1960) 20091101

• Evaluation of tolerability and ability to increase immunosuppression in renal transplant patients converted from mycophenolate mofetil to enteric-coated mycophenolate sodium.

  Transplantation proceedings 20091101

• Extended mycophenolate mofetil administration beyond day 30 in allogeneic hematopoietic stem cell transplantation as preemptive therapy for severe graft-versus-host disease.

  Transplantation proceedings 20091101

• Acute graft-versus-host-disease in kidney transplantation: case report and review of literature.

  Transplantation proceedings 20091101

• Host-guest chemistry of dendrimer-drug complexes. 3. Competitive binding of multiple drugs by a single dendrimer for combination therapy.

  The journal of physical chemistry. B 20091029

• Monitoring of the immunomodulatory effect of CP-690,550 by analysis of the JAK/STAT pathway in kidney transplant patients.

  Transplantation 20091027

• Determination of total, free and saliva mycophenolic acid with a LC-MS/MS method: application to pharmacokinetic study in healthy volunteers and renal transplant patients.

  Journal of pharmaceutical and biomedical analysis 20091015

• Factors associated with progression of interstitial fibrosis in renal transplant patients receiving tacrolimus and mycophenolate mofetil.

  Transplantation 20091015

• Early onset neutropenia after mycophenolate mofetil in systemic sclerosis.

  Rheumatology international 20091001

• Long-term efficacy of mycophenolate mofetil in a case of refractory antisynthetase syndrome.

  Joint, bone, spine : revue du rhumatisme 20091001

• Differences in baseline lymphocyte counts and autoreactivity are associated with differences in outcome of islet cell transplantation in type 1 diabetic patients.

  Diabetes 20091001

• Increased mycophenolic acid exposure in stable kidney transplant recipients on tacrolimus as compared with those on sirolimus: implications for pharmacokinetics.

  Clinical pharmacology and therapeutics 20091001

• Immunosuppression improves blood pressure and endothelial function in a rat model of pregnancy-induced hypertension.

  American journal of hypertension 20091001

• Membranous lupus nephritis in Chinese children--a case series and review of the literature.

  Pediatric nephrology (Berlin, Germany) 20091001

• Phenotypic consequences of purine nucleotide imbalance in Saccharomyces cerevisiae.

  Genetics 20091001

• EC-MPS permits lower gastrointestinal symptom burden despite higher MPA exposure in patients with severe MMF-related gastrointestinal side-effects.

  Fundamental & clinical pharmacology 20091001

• Mycophenolate mofetil as a treatment of steroid dependent Cogan's syndrome in childhood.

  International journal of pediatric otorhinolaryngology 20091001

• Immunosuppressive drugs and Tregs: a critical evaluation!

  Clinical journal of the American Society of Nephrology : CJASN 20091001

• Nonmyeloablative allogeneic hematopoietic stem cell transplantation as immunotherapy for pancreatic cancer.

  Pancreas 20091001

• Limited sampling strategies drawn within 3 hours postdose poorly predict mycophenolic acid area-under-the-curve after enteric-coated mycophenolate sodium.

  Therapeutic drug monitoring 20091001

• Inosine monophosphate dehydrogenase messenger RNA expression is correlated to clinical outcomes in mycophenolate mofetil-treated kidney transplant patients, whereas inosine monophosphate dehydrogenase activity is not.

  Therapeutic drug monitoring 20091001

• Genetic polymorphisms of MRP2 and UGT2B7 and gastrointestinal symptoms in renal transplant recipients taking mycophenolic acid.

  Therapeutic drug monitoring 20091001

• No impact of age on dose-adjusted pharmacokinetics of tacrolimus, mycophenolic acid and prednisolone 1 month after renal transplantation.

  European journal of clinical pharmacology 20091001

• Oral beclomethasone dipropionate for the treatment of gastrointestinal chronic graft-versus-host disease.

  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20091001

• Two sampling time profiles for the abbreviated estimation of mycophenolic acid area under the curve in adult renal transplant recipients treated with mycophenolate mofetil and concomitant tacrolimus.

  Journal of clinical pharmacy and therapeutics 20091001

• Gelatinous transformation of the bone marrow in systemic lupus erythematosus.

  Lupus 20091001

• Primary angiitis of the central nervous system: response to mycophenolate mofetil.

  Journal of neurology, neurosurgery, and psychiatry 20091001

• Bioavailability of mycophenolate mofetil and enteric-coated mycophenolate sodium is differentially affected by pantoprazole in healthy volunteers.

  Journal of clinical pharmacology 20091001

• Can we personalize treatment for kidney diseases?

  Clinical journal of the American Society of Nephrology : CJASN 20091001

• Mycophenolate mofetil therapy for childhood-onset steroid dependent nephrotic syndrome after long-term cyclosporine: extended experience in a single center.

  Clinical nephrology 20091001

• Safety and tolerance of sodium mycophenolate in patients after renal transplantation--an observational study.

  Transplantation proceedings 20091001

• Optimal mycophenolic acid and mycophenolic acid glucuronide levels at the early period after kidney transplantation are the key contributors to improving long-term outcomes.

  Transplantation proceedings 20091001

• Immunosuppression with low-dose daclizumab in liver transplant recipients with impaired kidney function: a single-center experience.

  Transplantation proceedings 20091001

• Etiologic agents of bacteremia in the early period after simultaneous pancreas-kidney transplantation.

  Transplantation proceedings 20091001

• Human mesenchymal stem cells and immunosuppressive drug interactions in allogeneic responses: an in vitro study using human cells.

  Transplantation proceedings 20091001

• Differential effect of cyclosporine and mycophenolic acid on the human regulatory T cells and TH-17 cells balance.

  Transplantation proceedings 20091001

• Outcomes with conversion from calcineurin inhibitors to sirolimus after renal transplantation in the context of steroid withdrawal or steroid continuation.

  Transplantation 20090915

• Cryptococcal meningitis in a patient treated with infliximab and mycophenolate mofetil for Behcet's disease.

  International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 20090901

• [Non necrotizing bacterial cellulitis and bacteriemia due to Shewanella putrefaciens].

  La Revue de medecine interne 20090901

• Steroid refractory CD4+ T cells in patients with sight-threatening uveitis.

  Investigative ophthalmology & visual science 20090901

• Mycophenolic acid inhibits maturation and function of human dendritic cells and B cells.

  Human immunology 20090901

• Monotherapy rapamycin allows an increase of CD4 CD25 FoxP3 T cells in renal recipients.

  Transplant international : official journal of the European Society for Organ Transplantation 20090901

• UGT1A9 -275T>A/-2152C>T polymorphisms correlate with low MPA exposure and acute rejection in MMF/tacrolimus-treated kidney transplant patients.

  Clinical pharmacology and therapeutics 20090901

• Conversion from mycophenolate mofetil to delayed formulation in pediatric renal transplantation: higher mycophenolic acid predose level but no changes in the immune biomarkers.

  Pediatric transplantation 20090901

• Mycophenolic acid (cellcept and myofortic) induced injury of the upper GI tract.

  The American journal of surgical pathology 20090901

• Two new members of mycophenolic acid family from Penicillium brevicompactum Dierckx.

  The Journal of antibiotics 20090901

• Drug interactions in transplant patients: what everyone should know.

  Current opinion in nephrology and hypertension 20090901

• Co-administration of grapefruit juice increases bioavailability of tacrolimus in liver transplant patients: a prospective study.

  European journal of clinical pharmacology 20090901

• Immunosuppressive drugs have different effect on B lymphocyte subsets and IgM antibody production in immunized BALB/c mice.

  Autoimmunity 20090901

• Pharmacokinetics of mycophenolic acid administered 3 times daily after hematopoietic stem cell transplantation with reduced-intensity regimen.

  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20090901

• AZA/tacrolimus is associated with similar outcomes as MMF/tacrolimus among renal transplant recipients.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20090901

• Limited sampling strategies for mycophenolic acid in solid organ transplantation: a systematic review.

  Expert opinion on drug metabolism & toxicology 20090901

• Is EC-MPS effective in reducing GI toxicity of MPA? At what price?

  Pediatric transplantation 20090901

• De novo inflammatory bowel disease after pediatric orthotopic liver transplant: a case report.

  Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 20090901

• Late fulminant posterior reversible encephalopathy syndrome after liver transplant.

  Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 20090901

• Long-term renal function in liver transplant recipients and impact of immunosuppressive regimens (calcineurin inhibitors alone or in combination with mycophenolate mofetil): the TRY study.

  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20090901

• Post-influenza vaccination vasculitides: a possible new entity.

  Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 20090901

• ANCA-associated vasculitis following influenza vaccination: causal association or mere coincidence?

  Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 20090901

• Modifying cyclosporine associated renal allograft dysfunction.

  Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia 20090901

• Treatment of neuromyelitis optica with mycophenolate mofetil: retrospective analysis of 24 patients.

  Archives of neurology 20090901

• Could prophylactic monoclonal antibody improve kidney graft survival?

  Transplantation proceedings 20090901

• Mycophenolate mofetil dose reduction in renal transplant recipients: a 5-year follow-up study.

  Transplantation proceedings 20090901

• Osteoporosis and related risk factors in renal transplant recipients.

  Transplantation proceedings 20090901

• Upper gastrointestinal bleeding during the first month after renal transplantation in the mycophenolate mofetil era.

  Transplantation proceedings 20090901

• Mycophenolic acid impedes the antigen presenting and lymph node homing capacities of human blood myeloid dendritic cells.

  Transplantation 20090827

• Comparing outcomes associated with dose manipulations of enteric-coated mycophenolate sodium versus mycophenolate mofetil in renal transplant recipients.

  Transplantation 20090827

• Successful reduction of immunosuppression in older renal transplant recipients who exhibit donor-specific regulation.

  Transplantation 20090827

• Inhibition of inosine monophosphate dehydrogenase reduces adipogenesis and diet-induced obesity.

  Biochemical and biophysical research communications 20090821

• Minimization of maintenance immunosuppression early after renal transplantation: an interim analysis.

  Transplantation 20090815

• Increased interleukin-10 production without expansion of CD4+CD25+ T-regulatory cells in early stable renal transplant patients on calcineurin inhibitors.

  Transplantation 20090815

• Is the intracellular ATP concentration of CD4+ T-Cells a predictive biomarker of immune status in stable transplant recipients?

  Transplantation 20090815

• CD127(low) expression in CD4+CD25(high) T cells as immune biomarker of renal function in transplant patients.

  Transplantation 20090815

• Efficacy of mycophenolate mofetil for steroid and cyclosporine resistant membranoproliferative glomerulonephritis type I.

  Pediatric nephrology (Berlin, Germany) 20090801

• Chronic inflammatory demyelinating polyradiculoneuropathy, in an 8-year-old girl, complicated by deafness and kidney fibrosis.

  Journal of child neurology 20090801

• Long-term outcome of idiopathic steroid-resistant nephrotic syndrome: a multicenter study.

  Pediatric nephrology (Berlin, Germany) 20090801

• Impact of immunosuppression on the incidence of early subclinical renal allograft rejection: implications for protocol biopsy policy.

  Transplant international : official journal of the European Society for Organ Transplantation 20090801

• Effect of conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium on maximum tolerated dose and gastrointestinal symptoms following kidney transplantation.

  Transplant international : official journal of the European Society for Organ Transplantation 20090801

• Polyoma BK virus-associated nephropathy in kidney-transplant patients: Effects of leflunomide on T-cell functions and disease outcome.

  International immunopharmacology 20090801

• Evaluation of vascular delivery methodologies to enhance rAAV6-mediated gene transfer to canine striated musculature.

  Molecular therapy : the journal of the American Society of Gene Therapy 20090801

• Mycophenolate mofetil is as efficacious as, but safer than, cyclophosphamide in the treatment of proliferative lupus nephritis: a meta-analysis and meta-regression.

  Rheumatology (Oxford, England) 20090801

• Mycophenolate mofetil: effects on cellular immune subsets, infectious complications, and antimicrobial activity.

  Transplant infectious disease : an official journal of the Transplantation Society 20090801

• Mycophenolic acid 12-hour area under the curve in de novo liver transplant patients given mycophenolate mofetil at fixed versus concentration-controlled doses.

  Therapeutic drug monitoring 20090801

• New insights into the pharmacokinetics and pharmacodynamics of the calcineurin inhibitors and mycophenolic acid: possible consequences for therapeutic drug monitoring in solid organ transplantation.

  Therapeutic drug monitoring 20090801

• Azathioprine in liver transplantation: a reevaluation of its use and a comparison with mycophenolate mofetil.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20090801

• Incidence, risk factors and clinical consequences of neutropenia following kidney transplantation: a retrospective study.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20090801

• Calcineurin inhibitor minimization in the Symphony study: observational results 3 years after transplantation.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20090801

• Early phase limited sampling strategy characterizing tacrolimus and mycophenolic acid pharmacokinetics adapted to the maintenance phase of renal transplant patients.

  Therapeutic drug monitoring 20090801

• Performance of the new mycophenolate assay based on IMPDH enzymatic activity for pharmacokinetic investigations and setup of Bayesian estimators in different populations of allograft recipients.

  Therapeutic drug monitoring 20090801

• Graft-versus-host disease prophylaxis with tacrolimus and mycophenolate mofetil in HLA-matched nonmyeloablative transplant recipients is associated with very low incidence of GVHD and nonrelapse mortality.

  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20090801

• Interpatient variability in IMPDH activity in MMF-treated renal transplant patients is correlated with IMPDH type II 3757T > C polymorphism.

  Pharmacogenetics and genomics 20090801

• Ribavirin analogs.

  Clinics in liver disease 20090801

• Should low-dose mycophenolate mofetil be used to prolong the response after rituximab therapy in patients with immune thrombocytopenic purpura? A case report.

  Hematology (Amsterdam, Netherlands) 20090801

• Management of childhood onset nephrotic syndrome.

  Pediatrics 20090801

• Predictive factors associated with the reversibility of post-transplantation diabetes mellitus following liver transplantation.

  Journal of Korean medical science 20090801

• Calcineurin-inhibitor-free immunosuppression based on the JAK inhibitor CP-690,550: a pilot study in de novo kidney allograft recipients.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20090801

• Sarcoidal anemia and leukopenia treated with methotrexate and mycophenolate mofetil.

  Archives of dermatology 20090801

• [The efficacy of mycophenolate mofetil for systemic lupus erythematosus].

  Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology 20090801

• Immunosuppressants: JC virus encephalopathy. Rare but fatal.

  Prescrire international 20090801

• TLI and ATG conditioning with low risk of graft-versus-host disease retains antitumor reactions after allogeneic hematopoietic cell transplantation from related and unrelated donors.

  Blood 20090730

• Pediatric kidney transplantation using a novel protocol of rapid (6-day) discontinuation of prednisone: 2-year results.

  Transplantation 20090727

• Etanercept, mycophenolate, denileukin, or pentostatin plus corticosteroids for acute graft-versus-host disease: a randomized phase 2 trial from the Blood and Marrow Transplant Clinical Trials Network.

  Blood 20090716

• Maintenance immunosuppressive agents as risk factors for BK virus nephropathy: a case-control study.

  Transplantation 20090715

• Everolimus with reduced cyclosporine versus MMF with standard cyclosporine in de novo heart transplant recipients.

  Transplantation 20090715

• Comparison of two mycophenolate mofetil dosing regimens after hematopoietic cell transplantation.

  Bone marrow transplantation 20090701

• Rituximab and mycophenolate mofetil for relapsing proliferative lupus nephritis: a long-term prospective study.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20090701

• The effectiveness and safety of mycophenolate mofetil in lupus nephritis.

  Clinical rheumatology 20090701

• Monitoring of mycophenolate mofetil in orthotopic heart transplant recipients--a systematic review.

  Transplantation reviews (Orlando, Fla.) 20090701

• Treatment of intractable pulmonary hemorrhage in two patients with childhood systemic lupus erythematosus.

  Rheumatology international 20090701

• Kidney transplantation in a recipient with anti-HLA antibody IgM positive.

  Transplant immunology 20090701

• The pharmacokinetics of mycophenolate mofetil in renal transplant recipients receiving standard-dose or low-dose cyclosporine, low-dose tacrolimus or low-dose sirolimus: the Symphony pharmacokinetic substudy.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20090701

• Clinical rejection and persistent immune regulation in kidney transplant patients.

  Transplant immunology 20090701

• Mycophenolate mofetil to the rescue in autoimmune hepatitis: a fresh sprout on the decision tree.

  Journal of hepatology 20090701

• Mycophenolate mofetil as rescue treatment for autoimmune liver disease in children: a 5-year follow-up.

  Journal of hepatology 20090701

• The impact of everolimus versus mycophenolate on blood and lymphocyte cyclosporine exposure in heart-transplant recipients.

  European journal of clinical pharmacology 20090701

• Fixed- or controlled-dose mycophenolate mofetil with standard- or reduced-dose calcineurin inhibitors: the Opticept trial.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20090701

• Mycophenolate mofetil attenuates liver ischemia/reperfusion injury in rats.

  Transplant international : official journal of the European Society for Organ Transplantation 20090701

• Tetrada of the possible mycophenolate mofetil embryopathy: a review.

  Reproductive toxicology (Elmsford, N.Y.) 20090701

• Proton pump inhibitors reduce mycophenolate exposure in heart transplant recipients-a prospective case-controlled study.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20090701

• Mycophenolate blood level monitoring: recent progress.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20090701

• Adult human mesenchymal stem cells added to corticosteroid therapy for the treatment of acute graft-versus-host disease.

  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20090701

• Tacrolimus and azathioprine versus cyclosporine and mycophenolate mofetil after lung transplantation: a retrospective cohort study.

  The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20090701

• Anti-DNA antibody induction of protein kinase C phosphorylation and fibronectin synthesis in human and murine lupus and the effect of mycophenolic acid.

  Arthritis and rheumatism 20090701

• Post transplant anaplastic large T-cell lymphoma.

  Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia 20090701

• [Mid- and long-term acute cardiac allograft rejection: clinical observation of 14 patients].

  Nan fang yi ke da xue xue bao = Journal of Southern Medical University 20090701

• Mycophenolate mofetil as therapy for pyoderma gangrenosum.

  Archives of dermatology 20090701

• [Successful treatment with intensive immunosuppressive therapy and mechanical ventilation for idiopathic pneumonia syndrome following allogeneic bone marrow transplantation].

  [Rinsho ketsueki] The Japanese journal of clinical hematology 20090701

• Mycophenolate mofetil as maintenance therapy in patients with vasculitis and renal involvement.

  Clinical nephrology 20090701

• Systemic therapies for pediatric atopic dermatitis: a review for the primary care physician.

  Pediatric annals 20090701

• Mycophenolate mofetil: An update.

  Drugs of today (Barcelona, Spain : 1998) 20090701

• Mesenchymal stem cell and immunosuppressive drug interactions.

  Transplantation 20090627

• Tacrolimus/sirolimus versus tacrolimus/mycophenolate in kidney transplantation: improved 3-year graft and patient survival in recent era.

  Transplantation 20090615

• [Mycophenolate mofetil-based calcineurin inhibitor reduced immunosuppressive protocol for the improvement of renal dysfunction after liver transplantation].

  Zhonghua yi xue za zhi 20090609

• Long-term control of cystoid macular oedema in noninfectious uveitis with Mycophenolate Mofetil.

  International ophthalmology 20090601

• Calcineurin-inhibitor free immunosuppression with mycophenolate mofetil and corticosteroids in paediatric renal transplantation improves renal allograft function without increasing acute rejection.

  Pediatric transplantation 20090601

• Renal manifestations in toddlers with Takayasu's arteritis and malignant hypertension.

  Pediatric nephrology (Berlin, Germany) 20090601

• Tacrolimus and mycophenolate mofetil as first line immunosuppression after lung transplantation.

  Transplant international : official journal of the European Society for Organ Transplantation 20090601

• Adult nemaline myopathy with trabecular muscle fibers.

  Muscle & nerve 20090601

• Combination of immunosuppressive drugs leaves specific 'fingerprint' on gene expression in vitro.

  Immunopharmacology and immunotoxicology 20090601

• Mycophenolic acid inhibits PMA-induced activation of the neutrophil respiratory burst.

  Transplant infectious disease : an official journal of the Transplantation Society 20090601

• Spectrum of histologic changes in colonic biopsies in patients treated with mycophenolate mofetil.

  Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 20090601

• Improved assay for the nonradioactive determination of inosine 5'-monophosphate dehydrogenase activity in peripheral blood mononuclear cells.

  Therapeutic drug monitoring 20090601

• Intrauterine exposure to mycophenolate mofetil and multiple congenital anomalies in a newborn: possible teratogenic effect.

  American journal of medical genetics. Part A 20090601

• Treatments for psoriasis and the risk of malignancy.

  Journal of the American Academy of Dermatology 20090601

• T-cell lymphoproliferative disorder following mycophenolate treatment for myasthenia gravis.

  Muscle & nerve 20090601

• Limited sampling strategies for therapeutic drug monitoring of mycophenolate mofetil therapy in patients with autoimmune disease.

  Therapeutic drug monitoring 20090601

• Mechanism-based enterohepatic circulation model of mycophenolic acid and its glucuronide metabolite: assessment of impact of cyclosporine dose in Asian renal transplant patients.

  Journal of clinical pharmacology 20090601

• Sterile empyematous pleural effusion in a patient with systemic lupus erythematosus: a diagnostic challenge.

  Lupus 20090601

• Reviewing the evidence for mycophenolate mofetil as a new teratogen: case report and review of the literature.

  American journal of medical genetics. Part A 20090601

• Congenital diaphragmatic hernia and microtia in a newborn with mycophenolate mofetil (MMF) exposure: phenocopy for Fryns syndrome or broad spectrum of teratogenic effects?

  American journal of medical genetics. Part A 20090601

• Impact of calcineurin inhibitors on urinary excretion of mycophenolic acid and its glucuronide in kidney transplant recipients.

  Journal of clinical pharmacology 20090601

• Recent developments in kidney transplantation--a critical assessment.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20090601

• Rapid onset of diabetic nephropathy in three renal allografts despite normoglycemia.

  Clinical nephrology 20090601

• Successful treatment of membranous glomerulonephritis with rituximab in calcineurin inhibitor-dependent patients.

  Clinical journal of the American Society of Nephrology : CJASN 20090601

• Proton pump inhibitor co-medication reduces mycophenolate acid drug exposure in heart transplant recipients.

  The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20090601

• Adverse effects of nicotine and immunosuppression on proximal tubular epithelial cell viability, tissue repair and oxidative stress gene expression.

  The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20090601

• Influence of clinical and demographic variables on mycophenolic acid pharmacokinetics in antineutrophil cytoplasmic antibody-associated vasculitis.

  The Annals of pharmacotherapy 20090601

• Newer therapies for vasculitis.

  Best practice & research. Clinical rheumatology 20090601

• Clinical impact of polymorphisms of transport proteins and enzymes involved in the metabolism of immunosuppressive drugs.

  Transplantation proceedings 20090601

• Enteric coating of mycophenolate reduces dosage adjustments.

  Transplantation proceedings 20090601

• Long-term follow-up of 100 high-risk renal transplant recipients converted from calcineurin inhibitors to sirolimus: a single center experience.

  Transplantation proceedings 20090601

• Urachal adenocarcinoma following kidney transplantation: the first case report.

  Transplantation proceedings 20090601

• [Post-transplantation malignant tumors and the challenges of immunosuppressive therapy in transplanted patients developing lymphoma. Mycophenolic acid as a possibility].

  Magyar onkologia 20090601

• Decreased acute rejection and improved renal allograft survival using sirolimus and low-dose calcineurin inhibitors without induction therapy.

  The International journal of artificial organs 20090601

• [Monitoring and adjustment of immunosuppression after heart transplantation].

  Revue medicale suisse 20090527

• Evaluation of mycophenolate mofetil for initial treatment of chronic graft-versus-host disease.

  Blood 20090521

• A randomized, doubleblind, placebo-controlled, study of single-dose rituximab as induction in renal transplantation.

  Transplantation 20090515

• Calcineurin inhibitor-free GVHD prophylaxis with sirolimus, mycophenolate mofetil and ATG in Allo-SCT for leukemia patients with high relapse risk: an observational cohort study.

  Bone marrow transplantation 20090501

• Cyclosporine concentration-dependent increase in concentration ratio of mycophenolic acid acyl and phenol glucuronides to mycophenolic acid in stable kidney transplant recipients.

  Clinical biochemistry 20090501

• The effect of rabbit anti-thymocyte globulin induction therapy on regulatory T cells in kidney transplant patients.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20090501

• UGT genotype may contribute to adverse events following medication with mycophenolate mofetil in pediatric kidney transplant recipients.

  Clinical pharmacology and therapeutics 20090501

• A comparison of mycophenolate use in Australia and Northern Europe, and the impact on the pharmaceutical benefits scheme.

  Pharmacoepidemiology and drug safety 20090501

• Influence of carboxylesterase 2 genetic polymorphisms on mycophenolic acid pharmacokinetics in Japanese renal transplant recipients.

  Xenobiotica; the fate of foreign compounds in biological systems 20090501

• Experience of mycophenolate mofetil in 10 patients with autoimmune-related interstitial lung disease demonstrates promising effects.

  The American journal of the medical sciences 20090501

• Effect of mycophenolate acyl-glucuronide on human recombinant type 2 inosine monophosphate dehydrogenase.

  Clinical chemistry 20090501

• Seronegative autoimmune hepatitis presenting after diagnosis of coeliac disease: a case report.

  European journal of gastroenterology & hepatology 20090501

• Pharmacodynamic evaluation of the first dose of mycophenolate mofetil before kidney transplantation.

  Clinical journal of the American Society of Nephrology : CJASN 20090501

• Mycophenolate mofetil combined with tacrolimus and minidose methotrexate after unrelated donor bone marrow transplantation with reduced-intensity conditioning.

  International journal of hematology 20090501

• Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis.

  Journal of the American Society of Nephrology : JASN 20090501

• Vacuolar myelopathy associated with optic neuropathy in an HIV-negative, immunosuppressed liver transplant recipient.

  Journal of neurology, neurosurgery, and psychiatry 20090501

• Synergistic effect of mycophenolate mofetil and angiotensin-converting enzyme inhibitor in patients with chronic allograft nephropathy.

  Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 20090501

• Does mycophenolate mofetil prevent extra-renal flares in systemic lupus erythematosus? Results from an observational study of patients in a single practice treated for up to 5 years.

  Lupus 20090501

• What is the value of mycophenolate mofetil as induction and maintenance therapy in lupus nephritis?

  Current opinion in rheumatology 20090501

• ITI with high-dose FIX and combined immunosuppressive therapy in a patient with severe haemophilia B and inhibitor.

  Hamostaseologie 20090501

• Isomorphic disposition of chronic graft-versus-host disease in striae distensae.

  Journal of the European Academy of Dermatology and Venereology : JEADV 20090501

• Efficacy on renal function of early conversion from cyclosporine to sirolimus 3 months after renal transplantation: concept study.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20090501

• Enhanced detection in capillary electrophoresis: example determination of serum mycophenolic acid.

  Electrophoresis 20090501

• [Sclerodermiform chronic graft-versus-host disease after allogenic peripheral blood stem-cell transplantation].

  Deutsche medizinische Wochenschrift (1946) 20090501

• Prospective clinical trial comparing two immunosuppressive regimens, tacrolimus and mycophenolate mofetil versus everolimus and low-dose cyclosporine, in de novo renal transplant recipients: results at 6 months follow-up.

  Transplantation proceedings 20090501

• Cardiovascular risk profile in kidney transplant recipients treated with two immunosuppressive regimens: tacrolimus and mycophenolate mofetil versus everolimus and low-dose cyclosporine.

  Transplantation proceedings 20090501

• Posttransplant proteinuria associated with everolimus.

  Transplantation proceedings 20090501

• Enteric-coated mycophenolate sodium: one-way conversion from mycophenolate mofetil and de novo use in stable liver transplant recipients.

  Transplantation proceedings 20090501

• A case of coloboma in a newborn to a woman taking mycophenolate mofetil in pregnancy after kidney transplantation.

  Transplantation proceedings 20090501

• Micophenolat Mofetil versus Azathioprine: effects on renal graft function in early posttransplant period.

  Bosnian journal of basic medical sciences 20090501

• Health-related quality of life of patients receiving low-toxicity immunosuppressive regimens: a substudy of the Symphony Study.

  Transplantation 20090427

• Sirolimus in kidney transplantation indications and practical guidelines: de novo sirolimus-based therapy without calcineurin inhibitors.

  Transplantation 20090427

• Conversion from calcineurin inhibitor to mycophenolate mofetil-based immunosuppression changes the frequency and phenotype of CD4+FOXP3+ regulatory T cells.

  Transplantation 20090415

• Sirolimus to replace calcineurin inhibitors? Too early yet.

  Lancet (London, England) 20090411

• Use of mycophenolate mofetil in inflammatory bowel disease.

  World journal of gastroenterology 20090407

• Mycophenolate mofetil therapy in uveitis: analysis of eight cases in a tertiary ophthalmic care centre in India.

  International ophthalmology 20090401

• A novel multidrug therapy for difficult cyclosporine-resistant focal segmental glomerulosclerosis.

  Pediatric nephrology (Berlin, Germany) 20090401

• Immunosuppressive therapy and post-transplant malignancy.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20090401

• Safe conversion of mycophenolate mofetil to azathioprine in kidney transplant recipients with sirolimus-based immunosuppression.

  Nephrology (Carlton, Vic.) 20090401

• Steatorrhoea complicating post-infectious diarrhoea in a renal transplant patient on mycophenolate mofetil therapy.

  Clinical and experimental nephrology 20090401

• C1q nephropathy and minimal change nephrotic syndrome.

  Pediatric nephrology (Berlin, Germany) 20090401

• Mycophenolic acid inhibits oleic acid-induced mesangial cell activation through both cellular reactive oxygen species and inosine monophosphate dehydrogenase 2 pathways.

  Pediatric nephrology (Berlin, Germany) 20090401

• Relevance of cytotoxic alloreactivity under different immunosuppressive regimens in clinical islet cell transplantation.

  Clinical and experimental immunology 20090401

• Progressive multifocal leukoencephalopathy in a kidney transplant recipient after conversion to mycophenolic acid therapy.

  Transplant infectious disease : an official journal of the Transplantation Society 20090401

• Comparison of 3 estimation methods of mycophenolic acid AUC based on a limited sampling strategy in renal transplant patients.

  Therapeutic drug monitoring 20090401

• Clinical utility of a new enzymatic assay for determination of mycophenolic acid in comparison with an optimized LC-MS/MS method.

  Therapeutic drug monitoring 20090401

• Differential proteomic analysis of lymphocytes treated with mycophenolic acid reveals caspase 3-induced cleavage of rho GDP dissociation inhibitor 2.

  Therapeutic drug monitoring 20090401

• An atypical necrotic signal induced by immunosuppressive and anti-viral agents.

  Autophagy 20090401

• Current concepts in disease-modifying therapy for systemic sclerosis-associated interstitial lung disease: lessons from clinical trials.

  Current rheumatology reports 20090401

• A scleroderma-like cutaneous syndrome associated with a marked Th2-type immune response occurring after a prosthetic joint implant.

  Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 20090401

• Pharmacokinetics of mycophenolic acid and its glucuronide metabolites in stable adult liver transplant recipients with renal dysfunction on a low-dose calcineurin inhibitor regimen and mycophenolate mofetil.

  Therapeutic drug monitoring 20090401

• Mycophenolate mofetil is effective in reducing disease flares in systemic lupus erythematosus patients: a retrospective study.

  Lupus 20090401

• Mycophenolate mofetil in patients with systemic lupus erythematosus: a prospective pharmacokinetic study.

  Lupus 20090401

• Disseminated herpes zoster causing extensive skin necrosis.

  Lupus 20090401

• Management of chronic allograft nephropathy: a systematic review.

  Clinical journal of the American Society of Nephrology : CJASN 20090401

• Impact of immunosuppressive medication on the risk of renal allograft failure due to recurrent glomerulonephritis.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20090401

• Sirolimus-induced drug fever in a renal transplant patient: a case report.

  Transplantation proceedings 20090401

• Severe rhabdomyolysis and acute renal failure secondary to concomitant use of simvastatin with rapamycin plus tacrolimus in liver transplant patient.

  Transplantation proceedings 20090401

• Valganciclovir-induced leukopenia in liver transplant recipients: influence of concomitant use of mycophenolate mofetil.

  Transplantation proceedings 20090401

• A case report of successful long-term relapse control by protein-a immunoadsorption in an immunosuppressive-treated patient with end-stage renal disease due to Wegener's granulomatosis.

  Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 20090401

• Nephroquiz 1: cyclophosphamide or mycofenolate mofetil?

  Iranian journal of kidney diseases 20090401

• A comparison of a standard-dose prednisone regimen and mycophenolate mofetil combined with a lower prednisone dose in Chinese adults with idiopathic nephrotic syndrome who were carriers of hepatitis B surface antigen: a prospective cohort study.

  Clinical therapeutics 20090401

• Diagnosing Takayasu's arteritis with modern day radiology.

  Irish medical journal 20090401

• Mycophenolate mofetil decreases acute rejection and may improve graft survival in renal transplant recipients when compared with azathioprine: a systematic review.

  Transplantation 20090327

• Influence of immunosuppressive regimens on graft survival and secondary outcomes after kidney transplantation.

  Transplantation 20090327

• The case of azathioprine versus mycophenolate. Do different drugs really cause different transplant outcomes?

  Transplantation 20090327

• Impact of a pharmaceutical care program on liver transplant patients' compliance with immunosuppressive medication: a prospective, randomized, controlled trial using electronic monitoring.

  Transplantation 20090327

• Prospective monitoring of Epstein-Barr virus DNA in adult renal transplant recipients during the early posttransplant period: role of mycophenolate mofetil.

  Transplantation 20090327

• Rises and falls in donor-specific and third-party HLA antibody levels after antibody incompatible transplantation.

  Transplantation 20090327

• T-cell reactivity during tapering of immunosuppression to low-dose monotherapy prednisolone in HLA-identical living-related renal transplant recipients.

  Transplantation 20090327

• Prospective, randomized trial on late steroid withdrawal in pediatric renal transplant recipients under cyclosporine microemulsion and mycophenolate mofetil.

  Transplantation 20090327

• Mycophenolate and sirolimus as calcineurin inhibitor-free immunosuppression improves renal function better than calcineurin inhibitor-reduction in late cardiac transplant recipients with chronic renal failure.

  Transplantation 20090315

• Antibody titers predict clinical features of autoimmune autonomic ganglionopathy.

  Autonomic neuroscience : basic & clinical 20090312

• Benefits of conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in pediatric renal transplant patients with stable graft function.

  Pediatric transplantation 20090301

• Henoch-Schonlein Purpura with thrombocythaemia: an abnormality in Smad4 expression?

  Rheumatology international 20090301

• Remission of resistant MPGN type I with mycophenolate mofetil and steroids.

  Pediatric nephrology (Berlin, Germany) 20090301

• First experience with enteric-coated mycophenolate sodium (Myfortic) in severe recalcitrant adult atopic dermatitis: an open label study.

  The British journal of dermatology 20090301

• Immunoregulatory profiles in liver transplant recipients on different immunosuppressive agents.

  Human immunology 20090301

• Spinal cord sarcoidosis: report of seven cases.

  European journal of neurology 20090301

• An update on the use of mycophenolate mofetil in lupus nephritis and other primary glomerular diseases.

  Nature clinical practice. Nephrology 20090301

• Sjögren's syndrome with ANCA-associated crescentic extramembranous glomerulonephritis.

  Joint, bone, spine : revue du rhumatisme 20090301

• Late de novo minimal change disease in a renal allograft.

  Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia 20090301

• Insights on chronic-relapsing opsoclonus-myoclonus from a pilot study of mycophenolate mofetil.

  Journal of child neurology 20090301

• Mycophenolate mofetil monotherapy for severe side effects of calcineurin inhibitors following liver transplantation.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20090301

• Relentless placoid chorioretinitis associated with central nervous system lesions treated with mycophenolate mofetil.

  Archives of ophthalmology (Chicago, Ill. : 1960) 20090301

• [Recent investigations on the basis of pathogenesis of SLE and new therapeutic approaches].

  Nihon rinsho. Japanese journal of clinical medicine 20090301

• Successful conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium (myfortic) in liver transplant patients with gastrointestinal side effects.

  Transplantation proceedings 20090301

• Mycophenolic Acid Inhibits p38 Mitogen-Activated Protein Kinase in Human Monocyte-Derived Dendritic Cells Stimulated by Lipopolysaccharide.

  Transplantation proceedings 20090301

• Induction of porcine regulatory cells by mycophenolic Acid-treated dendritic cells.

  Transplantation proceedings 20090301

• Lichen planopilaris: update on diagnosis and treatment.

  Seminars in cutaneous medicine and surgery 20090301

• [Prolonged complete clinical remission in patients with severe pemphigus vulgaris after cycles of intravenous cyclophosphamide].

  Actas dermo-sifiliograficas 20090301

• [Epidemiology of pemphigus in the Hospital Universitario Virgen Macarena, Seville, Spain, 2005-2006].

  Actas dermo-sifiliograficas 20090301

• Calcineurin inhibitor sparing with mycophenolate in kidney transplantation: a systematic review and meta-analysis.

  Transplantation 20090227

• [A 55-year-old woman with thymoma and hypogammaglobulinemia (Good syndrome), ulcerative colitis, and cytomegalovirus infection].

  Medizinische Klinik (Munich, Germany : 1983) 20090215

• [Correlation of mycophenolic acid pharmacokinetic parameters with clinical events in kidney transplant patients treated with mycophenolate mofetil].

  Zhonghua yi xue za zhi 20090203

• Long-term graft outcome in patients with chronic allograft nephropathy after immunosuppression modifications.

  Clinical and experimental nephrology 20090201

• Role of mycophenolate mofetil in remission maintenance after a successful response to rituximab.

  Pediatric nephrology (Berlin, Germany) 20090201

• Suppression of early and chronic BK polyoma virus replication by mycophenolic acid in Vero cells.

  Transplant international : official journal of the European Society for Organ Transplantation 20090201

• Medication-induced upper gastrointestinal tract injury.

  Journal of clinical pathology 20090201

• Enteric-coated mycophenolate sodium in de novo pediatric renal transplant patients.

  Pediatric nephrology (Berlin, Germany) 20090201

• Expression of IMPDH1 is regulated in response to mycophenolate concentration.

  International immunopharmacology 20090201

• Current therapies for lupus nephritis in an ethnically heterogeneous cohort.

  The Journal of rheumatology 20090201

• The RhoGDI-alpha/JNK signaling pathway plays a significant role in mycophenolic acid-induced apoptosis in an insulin-secreting cell line.

  Cellular signalling 20090201

• How did cyclophosphamide become the drug of choice for lupus nephritis?

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20090201

• A fast ultra-performance liquid chromatography method for simultaneous quantification of mycophenolic acid and its phenol- and acyl-glucuronides in human plasma.

  Therapeutic drug monitoring 20090201

• Regulation of IL2 and NUCB1 in mononuclear cells treated with acyl glucuronide of mycophenolic acid reveals effects independent of inosine monophosphate dehydrogenase inhibition.

  Therapeutic drug monitoring 20090201

• Delayed introduction of reduced-dose tacrolimus, and renal function in liver transplantation: the 'ReSpECT' study.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20090201

• A limited sampling strategy for estimating mycophenolic acid area under the curve in adult heart transplant patients treated with concomitant cyclosporine.

  Journal of clinical pharmacy and therapeutics 20090201

• [Tuberculosis risk among patients with systemic diseases].

  Presse medicale (Paris, France : 1983) 20090201

• Evaluating the effects of immunosuppressants on human immunity using cytokine profiles of whole blood.

  Cytokine 20090201

• Mycophenolate mofetil in dermatology.

  Journal of the American Academy of Dermatology 20090201

• Mycophenolate mofetil for the treatment of juvenile onset SLE: a multicenter study.

  Lupus 20090201

• Promising progression-free survival for patients low and intermediate grade lymphoid malignancies after nonmyeloablative umbilical cord blood transplantation.

  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20090201

• Pharmacokinetics, efficacy, and safety of mycophenolate mofetil in combination with standard-dose or reduced-dose tacrolimus in liver transplant recipients.

  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20090201

• Population pharmacokinetics of mycophenolic acid and its 2 glucuronidated metabolites in kidney transplant recipients.

  Journal of clinical pharmacology 20090201

• Squamous cell carcinomas in 2 patients with diffuse scleroderma treated with mycophenolate mofetil.

  The Journal of rheumatology 20090201

• Development of liquid chromatographic method for simultaneous determination of mycophenolate mofetil and its degradation product mycophenolic acid in dosage form.

  Journal of chromatographic science 20090201

• Wilson's disease followed by liver transplant in a 20-year-old female: considerations for bone health--case report and review of the literature.

  Connecticut medicine 20090201

• Tacrolimus pharmacokinetic drug interactions: effect of prednisone, mycophenolic acid or sirolimus.

  Fundamental & clinical pharmacology 20090201

• Therapeutic monitoring of mycophenolate in transplantation: is it justified?

  Current drug metabolism 20090201

• Monthly screening for polyoma virus eliminates BK nephropathy and preserves renal function.

  Surgical infections 20090201

• Mycophenolate mofetil dosage modifications following gastrointestinal complications in renal transplant patients.

  Expert review of pharmacoeconomics & outcomes research 20090201

• Is mycophenolate more than just an immunosuppressant?--An overview.

  Indian journal of biochemistry & biophysics 20090201

• Mycophenolate: miscarriage and birth defects.

  Prescrire international 20090201

• [Ischemia-reperfusion injury in kidney transplantation from non-heart beating donor--do antioxidants or antiinflammatory drugs play any role?].

  Rozhledy v chirurgii : mesicnik Ceskoslovenske chirurgicke spolecnosti 20090201

• A systematic approach to minimizing wound problems for de novo sirolimus-treated kidney transplant recipients.

  Transplantation 20090127

• Treatment of CNS sarcoidosis with infliximab and mycophenolate mofetil.

  Neurology 20090127

• Mycophenolate mofetil for the treatment of autoimmune diseases: hype or hope?

  Swiss medical weekly 20090124

• Clinical experience with mycophenolate mofetil in systemic autoimmune conditions refractory to common immunosuppressive therapies.

  Swiss medical weekly 20090124

• Immunosuppressant and immunomodulatory treatments for multifocal motor neuropathy.

  The Cochrane database of systematic reviews 20090121

• Interventions for haemolytic uraemic syndrome and thrombotic thrombocytopenic purpura.

  The Cochrane database of systematic reviews 20090121

• Could mycophenolate mofetil combined with benazapril delay tubulointerstitial fibrosis in 5/6 nephrectomized rats?

  Chinese medical journal 20090120

• Immunomodulatory effects of BXL-01-0029, a less hypercalcemic vitamin D analogue, in human cardiomyocytes and T cells.

  Experimental cell research 20090115

• Alemtuzumab induction and antibody-mediated kidney rejection after simultaneous pancreas-kidney transplantation.

  Transplantation 20090115

• Rapamycin instead of mycophenolate mofetil or azathioprine in treatment of post-renal transplantation urothelial carcinoma.

  Chinese medical journal 20090105

• [Autoimmune myelofibrosis with dermatomyositis].

  La Revue de medecine interne 20090101

• Minimization protocols in pancreas transplantation.

  Transplant international : official journal of the European Society for Organ Transplantation 20090101

• Immunosuppression without calcineurin inhibition: optimization of renal function in expanded criteria donor renal transplantation.

  Clinical transplantation 20090101

• Mycophenolic acid inhibits the autocrine PDGF-B synthesis and PDGF-BB-induced mRNA expression of Egr-1 in rat mesangial cells.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20090101

• Combination of CsA, MTX and low-dose, short-course mycophenolate mofetil for GVHD prophylaxis.

  Bone marrow transplantation 20090101

• Prospective trial of mycophenolate mofetil-cyclosporine A prophylaxis for acute GVHD after G-CSF stimulated allogeneic bone marrow transplantation with HLA-identical sibling donors in patients with severe aplastic anemia and hematological malignancies.

  Clinical transplantation 20090101

• Influence of HLA disparity, immunosuppressive regimen used, and type of kidney allograft on production of anti-HLA class-I antibodies after transplant and occurrence of rejection.

  Immunopharmacology and immunotoxicology 20090101

• Calcineurin inhibitor minimization, withdrawal and avoidance protocols after kidney transplantation.

  Transplant international : official journal of the European Society for Organ Transplantation 20090101

• The effect of mycophenolate mofetil on primary and secondary treatment of primary glomerulonephritis and lupus nephritis.

  International urology and nephrology 20090101

• A randomized trial of basiliximab with three different patterns of cyclosporin A initiation in renal transplant from expanded criteria donors and at high risk of delayed graft function.

  Clinical transplantation 20090101

• HPLC-UV assay for monitoring total and unbound mycophenolic acid concentrations in children.

  Biomedical chromatography : BMC 20090101

• Acute renal failure secondary to oxalosis in a recipient of a simultaneous kidney-pancreas transplant: was mycophenolate the cause?

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20090101

• Proliferative lupus nephritis in a patient with systemic lupus erythematosus and longstanding secondary amyloid nephropathy.

  Clinical rheumatology 20090101

• Calcineurin-inhibitor minimization protocols in heart transplantation.

  Transplant international : official journal of the European Society for Organ Transplantation 20090101

• Mycophenolate mofetil treatment for IgA nephropathy: a meta-analysis.

  American journal of nephrology 20090101

• Inosine 5'-monophosphate dehydrogenase.

  Advances in enzymology and related areas of molecular biology 20090101

• Measurement of mycophenolic acid and its glucuronide using a novel rapid liquid chromatography-electrospray ionization tandem mass spectrometry assay.

  Clinical biochemistry 20090101

• Cost comparison between mycophenolate mofetil and cyclophosphamide-azathioprine in the treatment of lupus nephritis.

  The Journal of rheumatology 20090101

• Emergency department presentation of heart transplant recipients with acute heart failure.

  Heart failure clinics 20090101

• Antibody-mediated rejection: treatment alternatives and outcomes.

  Transplantation reviews (Orlando, Fla.) 20090101

• Efficacy of a negative conversion trial and subsequent living donor kidney transplant outcome in recipients with a positive lymphocyte crossmatch.

  Nephron. Clinical practice 20090101

• Investigation of immunological approaches to enhance engraftment in a 1 Gy TBI canine hematopoietic stem cell transplantation model.

  Experimental hematology 20090101

• Determination of human teratogenicity by the astute clinician method: review of illustrative agents and a proposal of guidelines.

  Birth defects research. Part A, Clinical and molecular teratology 20090101

• Pharmacokinetics of mycophenolic acid in patients with lupus nephritis.

  Pharmacotherapy 20090101

• Calcineurin inhibitor minimization protocols in liver transplantation.

  Transplant international : official journal of the European Society for Organ Transplantation 20090101

• Severe insulin resistance due to anti-insulin antibodies: response to plasma exchange and immunosuppressive therapy.

  Diabetic medicine : a journal of the British Diabetic Association 20090101

• Study of kidney function impairment after reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation. A single-center experience.

  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20090101

• Preclinical support for combination therapy in the treatment of autoimmunity with atacicept.

  Toxicologic pathology 20090101

• Orogenital ulcers in a liver transplant recipient: discerning between mycophenolate-mofetil-induced complication and Behcet's disease.

  Clinical transplantation 20090101

• Longitudinal evaluation of mycophenolic acid pharmacokinetics in pediatric kidney transplant recipients. The role of post-transplant clinical and therapeutic variables.

  Clinical transplantation 20090101

• Mycophenolate mofetil in high-risk patients with primary glomerulonephritis: results of a 1-year prospective study.

  Nephron. Clinical practice 20090101

• Sirolimus-based rescue therapy after rejection in liver transplantation.

  Clinical transplantation 20090101

• The association between MMF and risk of progressive renal dysfunction and death in adult liver transplant recipients with HCV.

  Clinical transplantation 20090101

• Two yr mycophenolate mofetil plus low-dose calcineurin inhibitor for renal dysfunction after liver transplant.

  Clinical transplantation 20090101

• The impact of functioning pancreas-kidney transplantation and pancreas alone transplantation on the lipid metabolism of statin-naïve diabetic patients.

  Clinical transplantation 20090101

• Acute renal failure following the use of rosiglitazone in a chronic kidney disease patient.

  Singapore medical journal 20090101

• Effect of oral fructose load on serum uric acid and lipids in kidney transplant recipients treated with cyclosporine or tacrolimus.

  Transplantation proceedings 20090101

• Treatment of mediastinal fibrosis with mycophenolate mofetil.

  Respiration; international review of thoracic diseases 20090101

• Interstitial lung disease as a presenting manifestation of microscopic polyangiitis successfully treated with mycophenolate mofetil.

  Clinical and experimental rheumatology 20090101

• [ANCA associated vasculitis and PRGN].

  Nihon Jinzo Gakkai shi 20090101

• [Treatment of rapidly progressive glomerulonephritis].

  Nihon Jinzo Gakkai shi 20090101

• [Regulatory T cells in kidney transplant recipients].

  Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia 20090101

• The necrotic signal induced by mycophenolic acid overcomes apoptosis-resistance in tumor cells.

  PloS one 20090101

• The role of pH in the glucuronidation of raloxifene, mycophenolic acid and ezetimibe.

  Molecular pharmaceutics 20090101

• Relationship between renal resistance index and renal function in liver transplant recipients after cessation of calcineurin inhibitor.

  Clinical transplantation 20090101

• The influence of commonly used immunosuppressive drugs on the small bowel functions - a comparative experimental study.

  Annals of transplantation 20090101

• Different effects of FK506, rapamycin, and mycophenolate mofetil on glucose-stimulated insulin release and apoptosis in human islets.

  Cell transplantation 20090101

• Ischemia-reperfusion injury in kidney transplantation from non-heart-beating donor--do antioxidants or antiinflammatory drugs play any role?

  Bratislavske lekarske listy 20090101

• Renal impairment after liver transplantation - a pilot trial of calcineurin inhibitor-free vs. calcineurin inhibitor sparing immunosuppression in patients with mildly impaired renal function after liver transplantation.

  European journal of medical research 20090101

• A comparison of mycophenolate mofetil with ciclosporine for the treatment of chronic plaque-type psoriasis.

  Dermatology (Basel, Switzerland) 20090101

• There is a choice for immunosuppressive drug nephrotoxicity: Is it time to change?

  Journal of nephrology 20090101

• Mycophenolic acid exposure after administration of mycophenolate mofetil in the presence and absence of cyclosporin in renal transplant recipients.

  Clinical pharmacokinetics 20090101

• Use of enteric-coated mycophenolate sodium in liver transplant patients with intestinal intolerance caused by mycophenolate mofetil.

  Clinical transplantation 20090101

• Mycophenolate mofetil therapy for sarcoidosis-associated uveitis.

  Ocular immunology and inflammation 20090101

• Mycophenolate mofetil-induced colitis in children.

  Journal of clinical gastroenterology 20090101

• Mycophenolate pharmacokinetics and pharmacodynamics in belatacept treated renal allograft recipients - a pilot study.

  Journal of translational medicine 20090101

• Evaluation of the genetic background of standard-immunosuppressant-related toxicity in a cohort of 200 paediatric renal allograft recipients--a retrospective study.

  Annals of transplantation 20090101

• Mycophenolate mofetil as second line immunosuppressant in Myasthenia gravis--a long-term prospective open-label study.

  European journal of medical research 20090101

• Higher tacrolimus trough levels on days 2-5 post-renal transplant are associated with reduced rates of acute rejection.

  Clinical transplantation 20090101

• Pharmacokinetic modelling of the plasma protein binding of mycophenolic acid in renal transplant recipients.

  Clinical pharmacokinetics 20090101

• [Reversible posterior leukoencephalopathy induced by tacrolimus in a renal transplant patient].

  Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20090101

• Combination of everolimus and tacrolimus in kidney transplant patients with intolerance to mycophenolate mofetil/mycophenolic acid.

  Transplantation proceedings 20090101

• Graft outcome and mycophenolic acid trough level monitoring in kidney transplantation.

  Transplantation proceedings 20090101

• Inadequate mycophenolic acid exposure and acute rejection in kidney transplantation.

  Transplantation proceedings 20090101

• Intracellular ATP levels in CD4+ lymphocytes are a risk marker of rejection and infection in renal graft recipients.

  Transplantation proceedings 20090101

• Anti-HLA antibodies posttransplantation in children: do we know what it means?

  Transplantation proceedings 20090101

• Cytomegalovirus infection renal transplant recipients: risk factors and outcome.

  Transplantation proceedings 20090101

• Use of mycophenolate mofetil in liver transplantation: Andalusian Liver Registry.

  Transplantation proceedings 20090101

• Switching from mycophenolate mofetil to enteric-coated mycophenolate sodium in liver transplant patients with gastrointestinal complications.

  Transplantation proceedings 20090101

• Use of mycophenolate sodium in stable renal transplant recipients in Spain: preliminary results of the MIDATA study.

  Transplantation proceedings 20090101

• The prevalence of uridine diphosphate-glucuronosyltransferase 1A9 (UGT1A9) gene promoter region single-nucleotide polymorphisms T-275A and C-2152T and its influence on mycophenolic acid pharmacokinetics in stable renal transplant patients.

  Transplantation proceedings 20090101

• Mycophenolate mofetil absorption quotient: interest to clinical practice.

  Transplantation proceedings 20090101

• Optimization of immunosuppression by switching from azathioprine to enteric-coated mycophenolate sodium in stable kidney transplant patients.

  Transplantation proceedings 20090101

• Everolimus represents an advance in immunosuppression for patients who have developed cancer after renal transplantation.

  Transplantation proceedings 20090101

• Use of basiliximab induction in low-immunological risk renal transplant recipients receiving tacrolimus-based immunosuppression.

  Transplantation proceedings 20090101

• Comparison of inosine-monophosphate-dehydrogenase activity in patients with enteric-coated mycophenolate sodium or mycophenolate mofetil after renal transplantation.

  Transplantation proceedings 20090101

• Calcineurin inhibitor-free immunosuppressive strategy in elderly recipients of renal allografts from deceased donors: 1-year results from a prospective single center trial.

  Transplantation proceedings 20090101

• Leflunomide therapy for polyomavirus-induced allograft nephropathy: efficient BK virus elimination without increased risk of rejection.

  Transplantation proceedings 20090101

• Combined mycophenolate mofetil and minimal dose calcineurin inhibitor therapy in liver transplant patients: clinical results of a prospective randomized study.

  Transplantation proceedings 20090101

• Modified release tacrolimus in de novo immunosuppression after simultaneous pancreas-kidney transplantation--a first single-center experience.

  Transplantation proceedings 20090101

• Maintenance immunosuppression with mycophenolate mofetil: long-term efficacy and safety after heart transplantation.

  Transplantation proceedings 20090101

• The impact of pancreas and kidney transplant on cardiovascular risk factors (analyzed by mode of immunosuppression and exocrine drainage).

  Clinical transplantation 20090101

• Pharmacokinetic modelling and development of Bayesian estimators for therapeutic drug monitoring of mycophenolate mofetil in reduced-intensity haematopoietic stem cell transplantation.

  Clinical pharmacokinetics 20090101

• [Efficacy and safety of cyclosporin A withdrawal in children long after kidney transplantation].

  Terapevticheskii arkhiv 20090101

• [Controversial issues in the Giornale Italiano di Nefrologia: how to treat patients with focal segmental glomerular sclerosis].

  Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia 20090101

• Mutagenicity of immunosuppressive medications among renal transplant recipients.

  American journal of nephrology 20090101

• Limited sampling models and Bayesian estimation for mycophenolic acid area under the curve prediction in stable renal transplant patients co-medicated with ciclosporin or sirolimus.

  Clinical pharmacokinetics 20090101

• [The effect of mycophenolate mofetil and azathioprine on gingival enlargement associated with cyclosporin A use in kidney transplant patients].

  Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20090101

• Highly successful and low-cost desensitization regime for sensitized living donor renal transplant recipients.

  Renal failure 20090101

• Graves' disease associated with primary systemic sclerosis.

  Orbit (Amsterdam, Netherlands) 20090101

• Hyperferritinemia in a woman with systemic lupus erythematosus, severe nephritis and an iron-rich intraspinal schwannoma mimicking lupus myelopathy.

  Clinical and experimental rheumatology 20090101

• Two-year follow-up of the pharmacokinetics of immunosuppressive drugs in a neonate who underwent heart transplantation.

  The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians 20090101

• Mycophenolate sodium for immunosuppressive treatment in uveitis.

  Ocular immunology and inflammation 20090101

• Safety of mycophenolate mofetil monotherapy in patients after liver transplantation.

  Annals of transplantation 20090101

• Mycophenolate mofetil versus Rapamycin in Han: SPRD rats with Polycystic Kidney Disease.

  Biological research 20090101

• Bortezomib in kidney transplant desensitization: a case report.

  Clinical transplants 20090101

• Bortezomib successfully reduces monoclonal serum free light chain levels in a patient with recurrent myeloma and cast nephropathy in the renal transplant.

  Clinical transplants 20090101

• Patient outcomes in two steroid-free regimens using tacrolimus monotherapy after daclizumab induction and tacrolimus with mycophenolate mofetil in liver transplantation.

  Transplantation 20081227

• Immune response to rabies vaccination in pediatric transplant patients.

  Pediatric transplantation 20081201

• Can pediatric steroid-free renal transplantation improve growth and metabolic complications?

  Pediatric transplantation 20081201

• Prevention of diabetes: effect of mycophenolate mofetil and anti-CD25 on onset of diabetes in the DRBB rat.

  Pediatric diabetes 20081201

• Long-term risk of malignancy among patients treated with immunosuppressive agents for ocular inflammation: a critical assessment of the evidence.

  American journal of ophthalmology 20081201

• Increased incidence of infections following the late introduction of mycophenolate mofetil in renal transplant recipients.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20081201

• Inhibitory effect of mycophenolic acid on the replication of infectious pancreatic necrosis virus and viral hemorrhagic septicemia virus.

  Antiviral research 20081201

• Effects of mycophenolate mofetil for patients with crescentic lupus nephritis.

  Nephrology (Carlton, Vic.) 20081201

• Pharmacodynamics of mycophenolic acid in CD4+ cells: a single-dose study of IMPDH and purine nucleotide responses in healthy individuals.

  Therapeutic drug monitoring 20081201

• Simultaneous heart and kidney transplantation from a single donor.

  European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 20081201

• Mycophenolate mofetil as second line therapy in autoimmune hepatitis?

  The American journal of gastroenterology 20081201

• Comparison of pharmacokinetics of mycophenolic acid and its glucuronide between patients with lupus nephritis and with kidney transplantation.

  Therapeutic drug monitoring 20081201

• Mycophenolic derivatives from Eupenicillium parvum.

  Journal of natural products 20081201

• The immunosuppressor mycophenolic acid kills activated lymphocytes by inducing a nonclassical actin-dependent necrotic signal.

  Journal of immunology (Baltimore, Md. : 1950) 20081201

• Comparison of a new enzymatic assay with a high-performance liquid chromatography/ ultraviolet detection method for therapeutic drug monitoring of mycophenolic acid in adult liver transplant recipients.

  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20081201

• Renal transplantation in the modern immunosuppressive era in Spain: four-year results from a multicenter database focus on post-transplant cardiovascular disease.

  Kidney international. Supplement 20081201

• Treatment strategies for a rheumatoid arthritis patient with interstitial lung disease.

  Expert opinion on pharmacotherapy 20081201

• Individualization of immunosuppression: concepts and rationale.

  Current opinion in organ transplantation 20081201

• Mycophenolate sodium: effective treatment for therapy-refractory intestinal Behçet's disease, evaluated with enteroscopy.

  The American journal of gastroenterology 20081201

• T-cell function in maintenance renal transplant patients receiving mycophenolate mofetil and steroids with or without tacrolimus.

  Transplantation proceedings 20081201

• Therapeutic effect of Tripterygium wilfordii on proteinuria associated with sirolimus in renal transplant recipients.

  Transplantation proceedings 20081201

• Conversion to sirolimus in kidney-pancreas and pancreas transplantation.

  Transplantation proceedings 20081201

• Estimation of abbreviated mycophenolic acid area under the concentration-time curve during early posttransplant period by limited sampling strategy.

  Transplantation proceedings 20081201

• Successful renal transplantation in a patient with antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis: effect of early plasma exchange and mycophenolate mofetil.

  Transplantation proceedings 20081201

• Non-life-threatening leukopenia in a renal transplant recipient with acute overdose of mycophenolate mofetil.

  Transplantation proceedings 20081201

• Optimizing early de novo immunosuppression with sirolimus.

  Transplantation proceedings 20081201

• [Factors responsible for inter-individual variations in dosage/concentration of tacrolimus in renal transplant recipients].

  Nan fang yi ke da xue xue bao = Journal of Southern Medical University 20081201

• Models for the prediction of mycophenolic acid area under the curve using a limited-sampling strategy and an enzyme multiplied immunoassay technique in Chinese patients undergoing liver transplantation.

  Clinical therapeutics 20081201

• Two-year observation of a randomized trial on tacrolimus-based therapy with withdrawal of steroids or mycophenolate mofetil after renal transplantation.

  Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih 20081201

• [West Nile meningoencephalitis in an immunocompromised patient].

  Revue neurologique 20081201

• Influence of renal graft function on mycophenolic acid pharmacokinetics during the early period after kidney transplant.

  Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 20081201

• Mycophenolate: encephalopathy.

  Prescrire international 20081201

• Progressive multifocal leukoencephalopathy and use of mycophenolate mofetil after kidney transplantation.

  Transplantation 20081127

• A 32-year-old woman with arthralgias and severe hypotension.

  Arthritis and rheumatism 20081115

• Recovery of graft function in pediatric kidney transplantation is not affected by delayed introduction of cyclosporine.

  Transplantation 20081115

• Pharmacokinetics and immunodynamics of basiliximab in pediatric renal transplant recipients on mycophenolate mofetil comedication.

  Transplantation 20081115

• Efficacy and safety of basiliximab in pediatric renal transplant patients receiving cyclosporine, mycophenolate mofetil, and steroids.

  Transplantation 20081115

• Susceptibility of human mesenchymal stem cells to tacrolimus, mycophenolic acid, and rapamycin.

  Transplantation 20081115

• Effects of immunosuppressive drugs on purified human B cells: evidence supporting the use of MMF and rapamycin.

  Transplantation 20081115

• Mycophenolic acid inhibits cell proliferation and extracellular matrix synthesis in rat vascular smooth muscle cells through direct and indirect inhibition of cellular reactive oxygen species.

  The Journal of surgical research 20081101

• [Hypocomplementemic urticarial vasculitis].

  La Revue de medecine interne 20081101

• Mycophenolate mofetil for the treatment of uveitis.

  American journal of ophthalmology 20081101

• Pharmacogenetic effect of the UGT polymorphisms on mycophenolate is modified by calcineurin inhibitors.

  European journal of clinical pharmacology 20081101

• Association between mycophenolic acid 12-h trough levels and clinical endpoints in patients with autoimmune disease on mycophenolate mofetil.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20081101

• Mycophenolate mofetil versus cyclosporine for remission maintenance in nephrotic syndrome.

  Pediatric nephrology (Berlin, Germany) 20081101

• The critical role of plasmapheresis in ABO-incompatible renal transplantation.

  Transfusion 20081101

• Mycophenolate mofetil inhibits T-cell proliferation in kidney transplant recipients without lowering intracellular dGTP and GTP.

  Transplant international : official journal of the European Society for Organ Transplantation 20081101

• Mesenchymal stem cells can induce long-term acceptance of solid organ allografts in synergy with low-dose mycophenolate.

  Transplant immunology 20081101

• Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.

  Transplant immunology 20081101

• Therapeutic drug monitoring for mycophenolic acid in patients with autoimmune diseases.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20081101

• Risk of herpes zoster infection in patients with pemphigus on mycophenolate mofetil.

  The British journal of dermatology 20081101

• Medical treatment options for ocular myasthenia gravis.

  Current opinion in ophthalmology 20081101

• Immunosuppressive therapy for ocular diseases.

  Current opinion in ophthalmology 20081101

• Impact of immunosuppressive treatment on endothelial biomarkers after kidney transplantation.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20081101

• Sensitivity, specificity and clinical relevance of different cross-matching assays in deceased-donor renal transplantation.

  Transplant immunology 20081101

• Minimization of immunosuppression: transplant immunology.

  Transplant immunology 20081101

• Stable long-term donor engraftment following reduced-intensity hematopoietic cell transplantation for sickle cell disease.

  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20081101

• Successful outcome after nonmyeloablative allogeneic hematopoietic stem cell transplantation in patients with renal dysfunction.

  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20081101

• Influence of uridine diphosphate (UDP)-glucuronosyltransferases and ABCC2 genetic polymorphisms on the pharmacokinetics of mycophenolic acid and its metabolites in Chinese renal transplant recipients.

  Xenobiotica; the fate of foreign compounds in biological systems 20081101

• Comparison of outcome measures from a trial of mycophenolate mofetil in myasthenia gravis.

  Muscle & nerve 20081101

• Randomized prospective study of the evolution of renal function depending on the anticalcineurin used.

  Transplantation proceedings 20081101

• Mycophenolate mofetil monotherapy in patients who underwent liver transplantation for hepatitis C cirrhosis.

  Transplantation proceedings 20081101

• Efficacy and safety of mycophenolate mofetil monotherapy in liver transplant patients with renal failure induced by calcineurin inhibitors.

  Transplantation proceedings 20081101

• Preliminary experience with conversion from calcineurin inhibitors to everolimus in cardiac transplantation maintenance therapy.

  Transplantation proceedings 20081101

• Use of everolimus in de novo renal recipients: initial experience in the Greek population.

  Transplantation proceedings 20081101

• Metabolic changes following conversion from an anticalcineurin-based therapy to an everolimus-based one: a single-center experience.

  Transplantation proceedings 20081101

• [Recents advances in the pharmacology of immunosuppressive drugs used in organ transplantation].

  Medecine sciences : M/S 20081101

• Novel therapeutic modalities in pediatric inflammatory bowel disease.

  The Israel Medical Association journal : IMAJ 20081101

• [The effects of mycophenolate mofetil on renal interstitial fibrosis and epithelial-myofibroblast translation in adenine-induced renal failure rats].

  Zhonghua nei ke za zhi 20081101

• [Mycophenolate mofetil therapy for infant with steroid-resistant nephrotic syndrome].

  Zhonghua er ke za zhi = Chinese journal of pediatrics 20081101

• Growth and metabolites production by Penicillium brevicompactum in yoghurt.

  International journal of food microbiology 20081031

• The effect of mycophenolate mofetil and azathioprine dose on renal allograft outcome in the United kingdom.

  Transplantation 20081027

• Comparing mycophenolate mofetil regimens for de novo renal transplant recipients: the fixed-dose concentration-controlled trial.

  Transplantation 20081027

• One year follow-up of steroid-free immunosuppression plus everolimus in isolated pancreas transplantation.

  Transplantation 20081027

• Clinical reasoning: a 42-year-old man with sequential monocular visual loss.

  Neurology 20081021

• Generation of HIV-1-specific CD8+ cell responses following allogeneic hematopoietic cell transplantation.

  Blood 20081015

• Mycophenolic acid analogs with a modified metabolic profile.

  Bioorganic & medicinal chemistry 20081015

• ABO incompatible living renal transplantation with a steroid sparing protocol.

  Transplantation 20081015

• Disseminated histoplasmosis manifesting as a soft-tissue chest wall mass in a heart transplant recipient.

  Transplant infectious disease : an official journal of the Transplantation Society 20081001

• Maintenance therapy with mycophenolate mofetil for children with severe lupus nephritis after low-dose intravenous cyclophosphamide regimen.

  Pediatric nephrology (Berlin, Germany) 20081001

• Influence of CYP3A5, ABCB1 and NR1I2 polymorphisms on prednisolone pharmacokinetics in renal transplant recipients.

  Steroids 20081001

• Pilot study of mycophenolate mofetil for treatment of kidney disease due to congenital urinary tract disorders in children.

  American journal of kidney diseases : the official journal of the National Kidney Foundation 20081001

• Comparison of antimetabolite drugs as corticosteroid-sparing therapy for noninfectious ocular inflammation.

  Ophthalmology 20081001

• Mycophenolate mofetil monotherapy in membranous nephropathy: a 1-year randomized controlled trial.

  American journal of kidney diseases : the official journal of the National Kidney Foundation 20081001

• Comparison of high-performance liquid chromatography and enzyme-multiplied immunoassay technique to monitor mycophenolic acid in paediatric renal recipients.

  Pediatric nephrology (Berlin, Germany) 20081001

• Successful treatment of class V+IV lupus nephritis with multitarget therapy.

  Journal of the American Society of Nephrology : JASN 20081001

• Induction of human CD4+ regulatory T cells by mycophenolic acid-treated dendritic cells.

  Journal of leukocyte biology 20081001

• Immunosuppression in renal transplantation: some aspects for the modern era.

  Transplantation reviews (Orlando, Fla.) 20081001

• Mycophenolate mofetil promotes down-regulation of expanded B cells and production of TNF-alpha in an experimental murine model of colitis.

  Cytokine 20081001

• Successful mycophenolate mofetil therapy in nine patients with idiopathic retroperitoneal fibrosis.

  Rheumatology (Oxford, England) 20081001

• Pregnancy after transplantation.

  Transplantation reviews (Orlando, Fla.) 20081001

• Influence of drug transporters and UGT polymorphisms on pharmacokinetics of phenolic glucuronide metabolite of mycophenolic acid in Japanese renal transplant recipients.

  Therapeutic drug monitoring 20081001

• Impact of changing from cyclosporine to tacrolimus on pharmacokinetics of mycophenolic acid in renal transplant recipients with diabetes.

  Therapeutic drug monitoring 20081001

• Nephrin and podocin loss is prevented by mycophenolate mofetil in early experimental diabetic nephropathy.

  Cytokine 20081001

• Remission of proteinuria in primary glomerulonephritis: we know the goal but do we know the price?

  Nature clinical practice. Nephrology 20081001

• Multitarget therapy of lupus nephritis: base hit or home run?

  Journal of the American Society of Nephrology : JASN 20081001

• Long-term pharmacokinetics of mycophenolic acid in pediatric renal transplant recipients over 3 years posttransplant.

  Therapeutic drug monitoring 20081001

• Mycophenolate mofetil in myasthenia gravis: the unanswered question.

  Expert opinion on pharmacotherapy 20081001

• Alemtuzumab induction and steroid-free maintenance immunosuppression in pancreas transplantation.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20081001

• Hydroxamic acid derivatives of mycophenolic acid inhibit histone deacetylase at the cellular level.

  Bioscience, biotechnology, and biochemistry 20081001

• Soluble CD30 measured after lung transplantation does not predict bronchiolitis obliterans syndrome in a tacrolimus/mycophenolate mofetil-based immunosuppressive regimen.

  The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20081001

• Molecular mechanisms of cell death of mycophenolic acid-treated primary isolated rat islets: implication of mitogen-activated protein kinase activation.

  Transplantation proceedings 20081001

• Heart transplantation under cyclosporine or tacrolimus combined with mycophenolate mofetil or everolimus.

  Transplantation proceedings 20081001

• Effects of mycophenolate mofetil on chronic allograft nephropathy by affecting RHO/ROCK signal pathways.

  Transplantation proceedings 20081001

• A case report of plasma exchange, steroids, mycophenolate mofetil and cyclophosphamide in acquired factor VIII inhibitors.

  Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 20081001

• Mycophenolate mofetil in the treatment of IgA nephropathy: a systematic review.

  Singapore medical journal 20081001

• [A prospective multicenter clinical control trial on treatment of refractory nephrotic syndrome with mycophenolate mofetil in children].

  Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics 20081001

• [Immunosuppressive strategies and chronic graft dysfunction in kidney transplantation].

  Nephrologie & therapeutique 20081001

• [Effect of mycophenolate mofetil on the expression of early inflammatory reaction in diabetic rats].

  Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences 20081001

• Psoriasis and psoriatic arthritis in a patient with HIV: response to mycophenolate mofetil treatment.

  Journal of drugs in dermatology : JDD 20081001

• Posttransplant lymphoproliferative disorders in kidney transplant recipients: an Iranian multicenter experience.

  Iranian journal of kidney diseases 20081001

• Calcineurin inhibitor sparing in renal transplantation.

  Transplantation 20080927

• Determination of mycophenolic acid in meat products using mixed mode reversed phase-anion exchange clean-up and liquid chromatography-high-resolution mass spectrometry.

  Journal of chromatography. A 20080926

• Immunosuppression of experimental autoimmune myasthenia gravis by mycophenolate mofetil.

  Journal of neuroimmunology 20080915

• Refractory Waldenström's macroglobulinaemia responsive to 2-chlorodeoxyadenosine and mycophenolate mofetil.

  Leukemia research 20080901

• Delayed severe pneumonia in mycophenolate mofetil-treated patients with IgA nephropathy.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20080901

• Myfortic in pediatric transplantation.

  Pediatric transplantation 20080901

• [Treatment of proliferative glomerulonephritis of systemic lupus erythematosus. Recent development and current recommendations].

  La Revue de medecine interne 20080901

• A single center review of the use of mycophenolate mofetil in the treatment of autoimmune hepatitis.

  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20080901

• Maintaining remission in a patient with vasculitis.

  Nature clinical practice. Rheumatology 20080901

• IgA deposits along glomerular basement membranes in rapidly progressive glomerulonephritis.

  Southern medical journal 20080901

• Crohn's-like enterocolitis associated with mycophenolic acid treatment.

  Gut 20080901

• Myasthenia gravis associated with lupus nephritis.

  Lupus 20080901

• Update on the management of lupus nephritis: let the treatment fit the patient.

  Nature clinical practice. Rheumatology 20080901

• Long-term outcome of mycophenolate mofetil rescue therapy for resistant acute allograft rejection in pediatric liver transplant recipients.

  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20080901

• Ocular cicatricial pemphigoid.

  Ophthalmology 20080901

• Mycophenolate mofetil-related gastrointestinal mucosal injury: variable injury patterns, including graft-versus-host disease-like changes.

  The American journal of surgical pathology 20080901

• [Mycophenolate mofetil and cyclosporine in the treatment of steroid-dependent nephrotic syndrome with frequent relapses].

  Anales de pediatria (Barcelona, Spain : 2003) 20080901

• Effects of mycophenolic acid on human fibroblast proliferation, migration and adhesion in vitro and in vivo.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20080901

• Efficacy of risk stratification in tailoring immunosuppression regimens in kidney transplant patients at the national kidney and transplant institute.

  Transplantation proceedings 20080901

• De novo sirolimus-based regimen in Thai renal transplant recipients.

  Transplantation proceedings 20080901

• Optimal C2 concentration of cyclosporin corrected with good efficacy and safety in Asian kidney transplant recipients.

  Transplantation proceedings 20080901

• Conversion from mycophenolate mofetil to azathioprine in renal allograft [corrected] patients within the first month posttransplantation.

  Transplantation proceedings 20080901

• Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in renal transplant recipients with gastrointestinal tract disorders.

  Transplantation proceedings 20080901

• Conversion from mycophenolate mofetil to mizoribine for patients with positive polyomavirus type BK in urine.

  Transplantation proceedings 20080901

• Two cases of calcineurin inhibitor-associated reversible posterior leukoencephalopathy syndrome in renal transplant recipients.

  Transplantation proceedings 20080901

• Comment on Ibernon et al. Clin Nephrol 2008; 69: 395-401.

  Clinical nephrology 20080901

• Improved gastrointestinal symptom burden after conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in kidney transplanted children.

  Pediatric transplantation 20080901

• A simple and rapid CZE method for the analysis of mycophenolic acid and its phenol glucuronide metabolite in human serum.

  Electrophoresis 20080901

• Immunosuppression modifications and graft outcome in patients with chronic allograft nephropathy.

  Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 20080901

• Mycophenolate mofetil therapy in Taiwanese myasthenia gravis.

  Acta neurologica Taiwanica 20080901

• Enzyme immunoassay for mycophenolic acid in milk and cheese.

  Journal of agricultural and food chemistry 20080827

• Reduction in erythropoietin resistance after conversion from sirolimus to enteric coated mycophenolate sodium.

  Transplantation 20080827

• Effect on kidney graft survival of reducing or discontinuing maintenance immunosuppression after the first year posttransplant.

  Transplantation 20080815

• Myfortic (mycophenolate sodium) delayed-release tablets.

  Dermatology online journal 20080815

• Rheumatoid arthritis interstitial lung disease: mycophenolate mofetil as an antifibrotic and disease-modifying antirheumatic drug.

  Archives of internal medicine 20080811

• An international, phase III, randomized trial of mycophenolate mofetil in myasthenia gravis.

  Neurology 20080805

• A trial of mycophenolate mofetil with prednisone as initial immunotherapy in myasthenia gravis.

  Neurology 20080805

• The muddle of mycophenolate mofetil in myasthenia.

  Neurology 20080805

• [Mycophenolate mofetil in treatment of graft-versus-host disease after allogeneic hematopoietic cell transplantation: analysis of 44 cases].

  Zhonghua yi xue za zhi 20080805

• Mycophenolate mofetil after methotrexate failure or intolerance in the treatment of scleritis and uveitis.

  Ophthalmology 20080801

• Lymphocyte activation and correlation with IMPDH activity under therapy with mycophenolate mofetil.

  Clinica chimica acta; international journal of clinical chemistry 20080801

• Sonographic diagnosis of fetal malformations associated with mycophenolate mofetil exposure in utero.

  American journal of obstetrics and gynecology 20080801

• Stimulation of lymphocyte responses by angiotensin II promotes kidney injury in hypertension.

  American journal of physiology. Renal physiology 20080801

• Phase 1 dose-escalation study of CP-690 550 in stable renal allograft recipients: preliminary findings of safety, tolerability, effects on lymphocyte subsets and pharmacokinetics.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20080801

• Mycophenolate mofetil embryopathy may be dose and timing dependent.

  American journal of medical genetics. Part A 20080801

• Bis(sulfonamide) isosters of mycophenolic adenine dinucleotide analogues: inhibition of inosine monophosphate dehydrogenase.

  Bioorganic & medicinal chemistry 20080801

• Efficacy of enteric-coated mycophenolate sodium in patients with resistant-type lupus nephritis: a prospective study.

  Lupus 20080801

• Development of a predictive limited sampling strategy for estimation of mycophenolic acid area under the concentration time curve in patients receiving concomitant sirolimus or cyclosporine.

  Therapeutic drug monitoring 20080801

• AcylMPAG plasma concentrations and mycophenolic acid-related side effects in patients undergoing renal transplantation are not related to the UGT2B7-840G>A gene polymorphism.

  Therapeutic drug monitoring 20080801

• Multicenter evaluation of a new inosine monophosphate dehydrogenase inhibition assay for quantification of total mycophenolic acid in plasma.

  Therapeutic drug monitoring 20080801

• Defining algorithms for efficient therapeutic drug monitoring of mycophenolate mofetil in heart transplant recipients.

  Therapeutic drug monitoring 20080801

• Less is more, or almost as much: a 15-item quality-of-life instrument for myasthenia gravis.

  Muscle & nerve 20080801

• Monitoring mycophenolic acid pharmacokinetic parameters in liver transplant recipients: prediction of occurrence of leukopenia.

  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20080801

• Reevaluation of the effect of lamivudine therapy preoperative to prevent HBV recurrence after liver transplantation.

  Hepatobiliary & pancreatic diseases international : HBPD INT 20080801

• Mycophenolate mofetil: emerging as a potential human teratogen.

  Canadian family physician Medecin de famille canadien 20080801

• A unique presentation of bilateral central serous chorioretinopathy following bilateral renal transplantation surgery.

  Canadian journal of ophthalmology. Journal canadien d'ophtalmologie 20080801

• A case of Cogan's syndrome resolved with mycophenolate sodium.

  European journal of clinical investigation 20080801

• Long-term safety of mycophenolate mofetil and cyclosporine: a review.

  Journal of drugs in dermatology : JDD 20080801

• Conversion from sirolimus to everolimus in maintenance renal transplant recipients within a calcineurin inhibitor-free regimen: results of a 6-month pilot study.

  Clinical nephrology 20080801

• Effect of D256N and Y483D on propofol glucuronidation by human uridine 5'-diphosphate glucuronosyltransferase (UGT1A9).

  Basic & clinical pharmacology & toxicology 20080801

• [Current treatment of systemic sclerosis. Part I. Immunosuppressive treatment].

  Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 20080801

• Even low dose of mycophenolate mofetil in a mother recipient of heart transplant can seriously damage the fetus.

  Transplantation 20080727

• Application of experimental design in optimization of solid phase extraction of mycophenolic acid and mycophenolic acid glucuronide from human urine and plasma and SPE-RP-HPLC method validation.

  Journal of pharmaceutical and biomedical analysis 20080715

• Determination of mycophenolic acid glucuronide in microsomal incubations using high performance liquid chromatography-tandem mass spectrometry.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20080715

• Randomized trial of mycophenolate mofetil versus enteric-coated mycophenolate sodium in primary renal transplant recipients given tacrolimus and daclizumab/thymoglobulin: one year follow-up.

  Transplantation 20080715

• Calcineurin-inhibitor avoidance in elderly renal allograft recipients using ATG and basiliximab combined with mycophenolate mofetil.

  Transplant international : official journal of the European Society for Organ Transplantation 20080701

• Prostate cancer in renal transplant recipients.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20080701

• Successful bone marrow transplantation in a girl with Fanconi anemia and preterminal renal failure.

  Bone marrow transplantation 20080701

• Targeting mycophenolate mofetil for graft-versus-host disease prophylaxis after allogeneic blood stem cell transplantation.

  Bone marrow transplantation 20080701

• Acute renal failure secondary to oxalosis in a recipient of a simultaneous kidney-pancreas transplant: was mycophenolate the cause?

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20080701

• The treatment and prognosis of dermatomyositis: an updated review.

  Journal of the American Academy of Dermatology 20080701

• Pharmacokinetics-based optimal dose-exploration of mycophenolate mofetil in allogeneic hematopoietic stem cell transplantation.

  International journal of hematology 20080701

• Mycophenolate mofetil and triptolide alleviating airway inflammation in asthmatic model mice partly by inhibiting bone marrow eosinophilopoiesis.

  International immunopharmacology 20080701

• De novo autoimmune hepatitis after living donor liver transplantation is unlikely to be related to immunoglobulin subtype 4-related immune disease.

  Journal of gastroenterology and hepatology 20080701

• Alemtuzumab (Campath-1H) and tacrolimus monotherapy after renal transplantation: results of a prospective randomized trial.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20080701

• T cells and in situ cryoglobulin deposition in the pathogenesis of lupus nephritis.

  Clinical immunology (Orlando, Fla.) 20080701

• Tapering immunosuppressive therapy significantly improves in vivo cutaneous delayed type hypersensitivity responses.

  Transplant immunology 20080701

• De-novo [corrected] post renal transplantation inflammatory bowel disease.

  Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia 20080701

• The impact of P-glycoprotein and Mrp2 on mycophenolic acid levels in mice.

  Transplant immunology 20080701

• Corticosteroid interactions with cyclosporine, tacrolimus, mycophenolate, and sirolimus: fact or fiction?

  The Annals of pharmacotherapy 20080701

• Mycophenolate mofetil during pregnancy: some words of caution.

  Pediatrics 20080701

• Pharmacokinetics of mycophenolate mofetil and its glucuronide metabolites in healthy volunteers.

  Pharmacogenomics 20080701

• Clinicopathologic challenge. Sclerodermoid graft-versus-host disease (GVHD) with lichensclerosus-like lesions.

  International journal of dermatology 20080701

• Mycophenolate mofetil in the treatment of lupus nephritis--7 years on.

  Lupus 20080701

• A prospective multicentre study of mycophenolate mofetil combined with prednisolone as induction therapy in 213 patients with active lupus nephritis.

  Lupus 20080701

• Comparative effectiveness of azathioprine or mycophenolate mofetil as an adjuvant for the treatment of bullous pemphigoid.

  Archives of dermatology 20080701

• Clinical importance of insulin resistance after renal transplantation in patients on triple immunosuppressive therapy with cyclosporine, corticosteroids and mycophenolate mofetil.

  Prilozi 20080701

• Does the evidence support the use of mycophenolate mofetil therapeutic drug monitoring in clinical practice? A systematic review.

  Transplantation 20080627

• Cyclosporine A and Rapamycin induce in vitro cholesteryl ester transfer protein activity, and suppress lipoprotein lipase activity in human plasma.

  International journal of pharmaceutics 20080624

• Impact of immunosuppressive regimen on survival of kidney transplant recipients with hepatitis C.

  Transplantation 20080615

• Reduced exposure to calcineurin inhibitors in renal transplantation.

  The New England journal of medicine 20080605

• Reduced exposure to calcineurin inhibitors in renal transplantation.

  The New England journal of medicine 20080605

• Reduced exposure to calcineurin inhibitors in renal transplantation.

  The New England journal of medicine 20080605

• Reduced exposure to calcineurin inhibitors in renal transplantation.

  The New England journal of medicine 20080605

• Mycophenolate mofetil or standard therapy for membranous nephropathy and focal segmental glomerulosclerosis: a pilot study.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20080601

• CMV infections after two doses of daclizumab versus thymoglobulin in renal transplant patients receiving mycophenolate mofetil, steroids and delayed cyclosporine A.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20080601

• Population pharmacokinetic modelling for enterohepatic circulation of mycophenolic acid in healthy Chinese and the influence of polymorphisms in UGT1A9.

  British journal of clinical pharmacology 20080601

• Long-term efficacy and safety of a calcineurin inhibitor-free regimen in live-donor renal transplant recipients.

  Journal of the American Society of Nephrology : JASN 20080601

• Insulin-like growth factor I improves aspects of mycophenolate mofetil-impaired anastomotic healing in an experimental model.

  The British journal of surgery 20080601

• Non-steroidal and non-cytotoxic therapies for nephrotic syndrome.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20080601

• Safety and pharmacokinetics of daclizumab in pediatric renal transplant recipients.

  Pediatric transplantation 20080601

• [Pemphigus herpetiformis].

  Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete 20080601

• Efficacy of enteric-coated mycophenolate sodium in patients with active lupus nephritis.

  Nephrology (Carlton, Vic.) 20080601

• HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide.

  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20080601

• Reduced-intensity conditioning allogeneic transplantation from unrelated donors: evaluation of mycophenolate mofetil plus cyclosporin A as graft-versus-host disease prophylaxis.

  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20080601

• Update on safety during pregnancy of biological agents and some immunosuppressive anti-rheumatic drugs.

  Rheumatology (Oxford, England) 20080601

• Influence of metal cations on plasma trough concentration of mycophenolic Acid and its glucuronide in tacrolimus-treated and cyclosporine-treated kidney transplant recipients.

  Biological & pharmaceutical bulletin 20080601

• Pharmacokinetics of mycophenolic acid and its phenolic-glucuronide and ACYl glucuronide metabolites in stable thoracic transplant recipients.

  Therapeutic drug monitoring 20080601

• Mycophenolate mofetil in anti-MPO renal vasculitis: an alternative therapy in case of cyclophosphamide or azathioprine toxicity.

  Clinical nephrology 20080601

• Severe insulin resistance secondary to insulin antibodies: successful treatment with the immunosuppressant MMF.

  Pediatric diabetes 20080601

• [Therapeutic effect of allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning regimens on hematological malignancies].

  Zhongguo shi yan xue ye xue za zhi 20080601

• Molecular mechanisms of the antiangiogenic and antitumor effects of mycophenolic acid.

  Molecular cancer therapeutics 20080601

• The role of cyclosporine and mycophenolate in an orthotopic porcine-to-rat corneal xenotransplantation.

  Journal of Korean medical science 20080601

• Observation of efficacy and safety of converting the calcineurin inhibitor to sirolimus in renal transplant recipients with chronic allograft nephropathy.

  Transplantation proceedings 20080601

• The impact of conversion from mycophenolate mofetil to mycophenolate sodium among renal transplant recipients on a sirolimus-based regimen.

  Transplantation proceedings 20080601

• Sirolimus-based immunosuppressive therapy in liver transplant recipient with tacrolimus-related chronic renal insufficiency.

  Transplantation proceedings 20080601

• Beneficial outcomes of a steroid-free regimen with thymoglobulin induction in pancreas-kidney transplantation.

  Transplantation proceedings 20080601

• Rapamycin, mycophenolate mofetil, methylprednisolone, and cytotoxic T-lymphocyte-associated antigen 4 immunoglobulin-based conditioning regimen to induce partial tolerance to hind limb allografts without cytoreductive conditioning.

  Transplantation proceedings 20080601

• Acute inflammatory syndrome following introduction of mycophenolate mofetil in a patient with systemic lupus erythematosus.

  Arthritis and rheumatism 20080515

• Simultaneous determination of mycophenolic acid and its acyl and phenol glucuronide metabolites in human serum by capillary zone electrophoresis.

  Journal of pharmaceutical and biomedical analysis 20080512

• Mycophenolic acid activation of p53 requires ribosomal proteins L5 and L11.

  The Journal of biological chemistry 20080502

• IMPDH1 gene polymorphisms and association with acute rejection in renal transplant patients.

  Clinical pharmacology and therapeutics 20080501

• Anaemia and congestive heart failure early post-renal transplantation.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20080501

• Mycophenolate mofetil in the treatment of retroperitoneal fibrosis.

  Clinical rheumatology 20080501

• Transplantation of ovaries in Japanese quail (Coturnix japonica).

  Animal reproduction science 20080501

• Sirolimus-based immunosuppression following liver transplantation for hepatocellular carcinoma.

  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20080501

• Pharmacodynamic monitoring of the conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in stable kidney-allograft recipients.

  International immunopharmacology 20080501

• Successful therapy of a patient with therapy recalcitrant generalized bullous scleroderma by extracorporeal photopheresis and mycophenolate mofetil.

  Journal of the European Academy of Dermatology and Venereology : JEADV 20080501

• Islet transplantation in patients with autoimmune diabetes induces homeostatic cytokines that expand autoreactive memory T cells.

  The Journal of clinical investigation 20080501

• Effect of rapamycin therapy on coronary artery physiology early after cardiac transplantation.

  American heart journal 20080501

• Pharmacokinetics of mycophenolic acid in live donor liver transplant patients vs deceased donor liver transplant patients.

  Journal of clinical pharmacology 20080501

• The safety of mycophenolate mofetil in pregnancy.

  Expert opinion on drug safety 20080501

• Seeking approval: present and future therapies for pemphigus vulgaris.

  Current opinion in investigational drugs (London, England : 2000) 20080501

• Current treatment of lupus nephritis.

  Lupus 20080501

• Improvement of intravenous immunoglobulin therapy for bullous pemphigoid by adding immunosuppressive agents: marked improvement in depletion of circulating autoantibodies.

  Archives of dermatology 20080501

• Therapeutic alternatives for chronic urticaria: an evidence-based review, part 1.

  Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20080501

• Enteric-coated mycophenolate-sodium in heart transplantation: efficacy, safety, and pharmacokinetic compared with mycophenolate mofetil.

  Transplantation proceedings 20080501

• Negative impact of one-year anemia on long-term patient and graft survival in kidney transplant patients receiving calcineurin inhibitors and mycophenolate mofetil.

  Transplantation 20080427

• Mycophenolate mofetil prevents lethal acute liver failure in mice induced by bacille Calmette-Guérin and lipopolysaccharide.

  Journal of gastroenterology and hepatology 20080401

• Mycophenolate mofetil versus cyclophosphamide for inducing remission of ANCA vasculitis with moderate renal involvement.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20080401

• Pharmacokinetics of oral mycophenolate mofetil in combination with CsA in dogs after nonmyeloablative allogeneic hematopoietic stem cell transplantation.

  Bone marrow transplantation 20080401

• Immune suppression blocks sodium-sensitive hypertension following recovery from ischemic acute renal failure.

  American journal of physiology. Regulatory, integrative and comparative physiology 20080401

• Development of proteinuria after switch to sirolimus-based immunosuppression in long-term cardiac transplant patients.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20080401

• Trends in adult post-kidney transplant immunosuppressive use in Australia, 1991-2005.

  Nephrology (Carlton, Vic.) 20080401

• Higher mycophenolate dose requirements in children undergoing hematopoietic cell transplant (HCT).

  Journal of clinical pharmacology 20080401

• Mycophenolate mofetil for ocular myasthenia.

  Journal of neurology 20080401

• Estimation of the area under the curve for mycophenolic acid in adult renal transplant patients with concomitant tacrolimus using a limited sampling strategy.

  Journal of clinical pharmacy and therapeutics 20080401

• No pharmacokinetic interactions between mycophenolic acid and tacrolimus in renal transplant recipients.

  Journal of clinical pharmacy and therapeutics 20080401

• Mycophenolate mofetil in the treatment of ocular inflammation in ANCA-associated vasculitis.

  Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20080401

• Evaluation and management of steroid-sensitive nephrotic syndrome.

  Current opinion in pediatrics 20080401

• Evaluation and management of steroid-unresponsive nephrotic syndrome.

  Current opinion in pediatrics 20080401

• CYP3A5 genotype is not associated with a higher risk of acute rejection in tacrolimus-treated renal transplant recipients.

  Pharmacogenetics and genomics 20080401

• Pharmacokinetics of mycophenolate mofetil and sirolimus in children.

  Therapeutic drug monitoring 20080401

• Role of pharmacogenetics of immunosuppressive drugs in organ transplantation.

  Therapeutic drug monitoring 20080401

• Mycophenolate mofetil for the treatment of severe inflammatory external eye diseases.

  The British journal of ophthalmology 20080401

• Pharmacokinetics of enteric-coated mycophenolate sodium: comparative study in patients with autoimmune disease and renal allograft.

  Expert opinion on pharmacotherapy 20080401

• Idiopathic retroperitoneal fibrosis: a role for mycophenolate mofetil.

  Clinical nephrology 20080401

• [Dermatoma complicating Herpes zoster during immunosuppression].

  Deutsche medizinische Wochenschrift (1946) 20080401

• Corticosteroid reduction with tacrolimus (CORRETA) TRIAL: a prospective Brazilian multicenter, randomized trial of early corticosteroid reduction versus regular corticosteroid dosage maintenance on a tacrolimus (Prograf) and mycophenolate mofetil (Cellcept) immunosuppression regimen in kidney transplant recipients: interim analysis.

  Transplantation proceedings 20080401

• Induction immunosuppressive therapy in renal transplantation: does basiliximab make the difference?

  Transplantation proceedings 20080401

• Experience with Alemtuzumab (Campath-1H) as induction agent in renal transplantation followed by steroid-free immunosuppression.

  Transplantation proceedings 20080401

• Mycophenolate mofetil: ten years' experience of a renal transplant unit.

  Transplantation proceedings 20080401

• Immunosuppression with generic tacrolimus and mycophenolate mofetil in renal transplant recipients: preliminary report in Chile.

  Transplantation proceedings 20080401

• Influence of UDP-glucuronosyltransferase polymorphisms on mycophenolate mofetil-induced side effects in kidney transplant patients.

  Transplantation proceedings 20080401

• Conversion therapy to everolimus in renal transplant recipients: results after one year.

  Transplantation proceedings 20080401

• Leukopenia in kidney transplant patients with the association of valganciclovir and mycophenolate mofetil.

  Transplantation proceedings 20080401

• Vaginal cuff dehiscence after hysterectomy in a woman with systemic lupus erythematosus: a case report.

  The Journal of reproductive medicine 20080401

• Current target ranges of mycophenolic acid exposure and drug-related adverse events: a 5-year, open-label, prospective, clinical follow-up study in renal allograft recipients.

  Clinical therapeutics 20080401

• Satisfactory outcome despite low 2-hour postdose cyclosporine level in Iranian kidney recipients.

  Iranian journal of kidney diseases 20080401

• Impact of immunosuppressive drugs on CD4+CD25+FOXP3+ regulatory T cells: does in vitro evidence translate to the clinical setting?

  Transplantation 20080327

• Successful treatment of BK viremia using reduction in immunosuppression without antiviral therapy.

  Transplantation 20080327

• Pharmacokinetic/pharmacodynamic drug interaction between rosiglitazone and mycophenolate mofetil in kidney transplantation: a case report.

  Transplantation 20080327

• Effect of the antioxidant idebenone on adverse events under mycophenolate mofetil therapy in a rat model.

  Transplantation 20080315

• [The first case of single pancreas transplantation in Hungary].

  Orvosi hetilap 20080302

• Cinacalcet's effect on the pharmacokinetics of tacrolimus, cyclosporine and mycophenolate in renal transplant recipients.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20080301

• Preinfusion variables predict the predominant unit in the setting of reduced-intensity double cord blood transplantation.

  Bone marrow transplantation 20080301

• Therapeutic idiosyncrasy.

  Pediatric transplantation 20080301

• Stability of mycophenolic acid and glucuronide metabolites in human plasma and the impact of deproteinization methodology.

  Clinica chimica acta; international journal of clinical chemistry 20080301

• A case of indometacin-induced acute hepatitis developing into chronic autoimmune hepatitis.

  Nature clinical practice. Gastroenterology & hepatology 20080301

• Novel therapies of lupus nephritis.

  Current opinion in nephrology and hypertension 20080301

• Reversible chronic pulmonary fibrosis associated with MMF in a pediatric patient: a case report.

  Pediatric transplantation 20080301

• The role of tacrolimus in renal transplantation.

  Expert opinion on pharmacotherapy 20080301

• Performance of limited sampling strategies for predicting mycophenolic acid area under the curve in thoracic transplant recipients.

  The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20080301

• Management of steroid sensitive nephrotic syndrome: revised guidelines.

  Indian pediatrics 20080301

• Effects of inosine monophosphate dehydrogenase inhibition on high glucose-induced cellular reactive oxygen species in mesangial cells.

  Transplantation proceedings 20080301

• Effects of mycophenolic Acid on high glucose-induced fibronectin secretion and cellular reactive oxygen species in rat vascular smooth muscle cells.

  Transplantation proceedings 20080301

• Can we maintain immunosuppression avoiding nephrotoxic agents in pancreas transplantation?

  Transplantation proceedings 20080301

• Evaluation of the first 100 liver transplantations.

  The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 20080301

• The use of mycophenolate mofetil for the treatment of systemic sclerosis.

  Endocrine, metabolic & immune disorders drug targets 20080301

• Rescue immunosuppressive therapies in living-related renal allotransplant: a long-term prospective randomized evaluation.

  Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 20080301

• Contamination of fresh and ensiled maize by multiple penicillium mycotoxins.

  Phytopathology 20080301

• [Effects of valsartan, mycophenolate mofetil and their combined application on TRAIL and nuclear factor-kappaB expression in the kidneys of diabetic rats].

  Zhonghua yi xue za zhi 20080226

• Simultaneous determination of mycophenolic acid and its glucuronides in human plasma using isocratic ion pair high-performance liquid chromatography.

  Journal of pharmaceutical and biomedical analysis 20080213

• Immunosuppressive therapy for ocular mucous membrane pemphigoid strategies and outcomes.

  Ophthalmology 20080201

• Expression of inosine monophosphate dehydrogenase type I and type II after mycophenolate mofetil treatment: a 2-year follow-up in kidney transplantation.

  Clinical pharmacology and therapeutics 20080201

• Effect of mycophenolate mofetil on pulmonary function in scleroderma-associated interstitial lung disease.

  Chest 20080201

• [Mycophenolate mofetil restores renal function and spares steroids during idiopathic nephrotic syndrome in children. A cohort study].

  Nephrologie & therapeutique 20080201

• Clinically 'silent' weight loss associated with mycophenolate mofetil in pediatric renal transplant recipients.

  Pediatric transplantation 20080201

• Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation.

  Nephrology (Carlton, Vic.) 20080201

• Meta-analysis of mycophenolate mofetil in IgA nephropathy.

  Nephrology (Carlton, Vic.) 20080201

• Pyoderma gangrenosum--rebel without a cure?

  International journal of dermatology 20080201

• Successful treatment of encapsulating peritoneal sclerosis with immunosuppressive therapy.

  American journal of kidney diseases : the official journal of the National Kidney Foundation 20080201

• Treatment of lupus nephritis and primary glomerulonephritis with enteric-coated mycophenolate sodium.

  Clinical nephrology 20080201

• Evidence for neo-generation of T cells by the thymus after non-myeloablative conditioning.

  Haematologica 20080201

• Influence of lansoprazole and rabeprazole on mycophenolic acid pharmacokinetics one year after renal transplantation.

  Therapeutic drug monitoring 20080201

• Limited sampling strategy for simultaneous estimation of the area under the concentration-time curve of tacrolimus and mycophenolic acid in adult renal transplant recipients.

  Therapeutic drug monitoring 20080201

• Evaluation of MPA and MPAG removal by continuous venovenous hemodiafiltration and continuous venovenous hemofiltration.

  Therapeutic drug monitoring 20080201

• Disappearance of classic birdshot spots after immunosuppression with tacrolimus and mycophenolate mofetil.

  The British journal of ophthalmology 20080201

• Potential immunological advantage of intravenous mycophenolate mofetil with tacrolimus and steroids in primary deceased donor liver transplantation and live donor liver transplantation without antibody induction.

  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20080201

• 'Where observation is concerned, chance favors only the prepared mind'.

  Obstetrics and gynecology 20080201

• Severe facial clefts in acrofacial dysostosis: a consequence of prenatal exposure to mycophenolate mofetil?

  Obstetrics and gynecology 20080201

• Combined immunomodulatory therapy in autoimmune autonomic ganglionopathy.

  Archives of neurology 20080201

• [A case of autoimmune hemolytic anemia complicating hematopoietic cell transplantation].

  The Korean journal of laboratory medicine 20080201

• Utility of monitoring mycophenolic acid in solid organ transplant patients.

  Evidence report/technology assessment 20080201

• Expression of IMPDH1 and IMPDH2 after transplantation and initiation of immunosuppression.

  Transplantation 20080115

• Guanine nucleotide depletion inhibits pre-ribosomal RNA synthesis and causes nucleolar disruption.

  Leukemia research 20080101

• Use of mycophenolate mofetil to treat scleroderma-associated interstitial lung disease.

  Respiratory medicine 20080101

• Mycophenolate mofetil treatment of crescentic Henoch-Schönlein nephritis with IgA depositions.

  Scandinavian journal of urology and nephrology 20080101

• Glucuronidation of mycophenolic acid by Wistar and Mrp2-deficient TR- rat liver microsomes.

  Drug metabolism and disposition: the biological fate of chemicals 20080101

• Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) bone marrow transplantation using only pharmacological GVHD prophylaxis.

  Experimental hematology 20080101

• Correlation between lipid abnormalities and immunosuppressive therapy in renal transplant recipients with stable renal function.

  International urology and nephrology 20080101

• Rapid remission of steroid and mycophenolate mofetil (mmf)-resistant minimal change nephrotic syndrome after rituximab therapy.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20080101

• Mycophenolate mofetil in primary glomerulopathies.

  Kidney international 20080101

• Comparison of single bolus ATG and Basiliximab as induction therapy in presensitized renal allograft recipients receiving tacrolimus-based immunosuppressive regimen.

  Transplant immunology 20080101

• The fetal mycophenolate mofetil syndrome.

  Clinical dysmorphology 20080101

• Mycophenolate mofetil in low doses stabilizes and improves antineutrophil cytoplasmic antibody-associated vasculitis and lupus nephritis.

  Archives of medical research 20080101

• In utero exposure to mycophenolate mofetil: a characteristic phenotype?

  American journal of medical genetics. Part A 20080101

• Novel methods for tracking long-term maintenance immunosuppression regimens.

  Clinical journal of the American Society of Nephrology : CJASN 20080101

• Immune tolerance induction with mycophenolate-mofetil in two children with haemophilia B and inhibitor.

  Haemophilia : the official journal of the World Federation of Hemophilia 20080101

• Mycophenolate mofetil as the primary treatment of membranous lupus nephritis with and without concurrent proliferative disease: a retrospective study of 29 cases.

  Lupus 20080101

• Systemic lupus erythematosus: pharmacological developments and recommendations for a therapeutic strategy.

  Expert opinion on investigational drugs 20080101

• Depressive disorder associated with mycophenolate mofetil.

  Pharmacotherapy 20080101

• Oxidative stress and 'monocyte reprogramming' after kidney transplant: a longitudinal study.

  Blood purification 20080101

• Mycophenolate mofetil dose reduction for gastrointestinal intolerance is associated with increased rates of rejection in heart transplant patients.

  The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20080101

• Calcineurin inhibitor-sparing regimens in solid organ transplantation: focus on improving renal function and nephrotoxicity.

  Clinical transplantation 20080101

• A randomized trial of alemtuzumab vs. anti-thymocyte globulin induction in renal and pancreas transplantation.

  Clinical transplantation 20080101

• Influence of immunosuppressive regimens on short-term morbidity and mortality in heart transplantation.

  Clinical transplantation 20080101

• [Mycophenol acid in ocular automimmune disorders--can we optimise this therapy?].

  Klinische Monatsblatter fur Augenheilkunde 20080101

• Triple immunosuppression with tacrolimus in pediatric renal transplantation: single-center experience.

  Transplantation proceedings 20080101

• Efficacy and safety of enteric-coated mycophenolate sodium in de novo and maintenance renal transplant patients.

  Transplantation proceedings 20080101

• The use of enteric-coated mycophenolate sodium in the treatment of relapsing and steroid-dependent minimal change disease.

  Journal of nephrology 20080101

• Obesity following kidney transplantation and steroid avoidance immunosuppression.

  Clinical transplantation 20080101

• Three-year follow-up of malignancies in tacrolimus-treated renal recipients--an analysis of European multicentre studies.

  Clinical transplantation 20080101

• Early, abrupt conversion of de novo renal transplant patients from cyclosporine to everolimus: results of a pilot study.

  Clinical transplantation 20080101

• Antibody response to influenza immunization in kidney transplant recipients receiving either azathioprine or mycophenolate: a controlled trial.

  American journal of nephrology 20080101

• Coexistent psoriasis and bullous pemphigoid responding to mycophenolate mofetil monotherapy.

  Skinmed 20080101

• Pharmacokinetic study of mycophenolate mofetil in patients with systemic lupus erythematosus and design of Bayesian estimator using limited sampling strategies.

  Clinical pharmacokinetics 20080101

• Mycophenolate mofetil in chronic glomerular diseases.

  Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20080101

• After discontinuation of calcineurin inhibitors, tapering of mycophenolate mofetil further impairs donor-directed cytotoxicity.

  Clinical transplantation 20080101

• Mycophenolate mofetil vs. sirolimus in kidney transplant recipients receiving tacrolimus-based immunosuppressive regimen.

  Clinical transplantation 20080101

• A randomized trial of thymoglobulin vs. alemtuzumab (with lower dose maintenance immunosuppression) vs. daclizumab in renal transplantation at 24 months of follow-up.

  Clinical transplantation 20080101

• Use of low dose tacrolimus, mycophenolate mofetil and maintenance IL-2 receptor blockade in an islet transplant recipient.

  Clinical transplantation 20080101

• Mycophenolate mofetil.

  Indian journal of dermatology, venereology and leprology 20080101

• Adverse drug reaction driven immunosuppressive drug manipulations: a single-center comparison of enteric-coated mycophenolate sodium vs. mycophenolate mofetil.

  Clinical transplantation 20080101

• Clinical evaluation of two bilateral hand allotransplantations at six and three years follow-up.

  Chirurgie de la main 20080101

• Neuromuscular diseases.

  Reviews in neurological diseases 20080101

• Treatment of pemphigus vulgaris with mycophenolate mofetil as a steroid-sparing agent.

  European journal of dermatology : EJD 20080101

• Minocycline in combination with mycophenolate mofetil in oral mucous membrane pemphigoid.

  European journal of dermatology : EJD 20080101

• Tubulointerstitial nephritis and uveitis syndrome.

  International ophthalmology clinics 20080101

• Combination therapy with tacrolimus and mycophenolate mofetil: effects of early and late minimization of mycophenolate mofetil after renal transplant.

  Clinical transplantation 20080101

• Calcineurin inhibitor withdrawal and conversion to mycophenolate mofetil and steroids in cardiac transplant recipients with chronic renal failure: a word of caution.

  Clinical transplantation 20080101

• Factors affecting kidney-transplant outcome in recipients with lupus nephritis.

  Clinical transplantation 20080101

• Pharmacokinetics of mycophenolic acid, tacrolimus and sirolimus after gastric bypass surgery in end-stage renal disease and transplant patients: a pilot study.

  Clinical transplantation 20080101

• The role of heparin in alleviating complement-mediated acute intravascular haemolysis.

  Acta haematologica 20080101

• Sex, smell and vasculitis: Henoch-Schönlein purpura in Kallmann's syndrome.

  The West Virginia medical journal 20080101

• Lessons from two trials of mycophenolate mofetil in myasthenia gravis.

  Annals of the New York Academy of Sciences 20080101

• [Daclizumab in combination with mycophenolate mofetil and a late introduction of Tacrolimus at low doses, as a therapeutic approach in the elderly renal transplant donor-recipients pairs in kidney transplant].

  Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20080101

• Cyclophosphamide-intolerant Wegener's granulomatosis successfully treated with mycophenolate mofetil.

  Acta reumatologica portuguesa 20080101

• IMP dehydrogenase basal activity in MOLT-4 human leukaemia cells is altered by mycophenolic acid and 6-thioguanosine.

  Scandinavian journal of clinical and laboratory investigation 20080101

• Measurement of mycophenolic acid in plasma or serum by a commercial enzyme inhibition technique in comparison with a high performance liquid chromatography method.

  Clinical chemistry and laboratory medicine 20080101

• Pharmacogenetics of mycophenolate mofetil: a promising different approach to tailoring immunosuppression?

  Journal of nephrology 20080101

• Severe renal complications in chronic myelomonocytic leukemia.

  Journal of nephrology 20080101

• [Lupus nephritis treatment].

  Acta medica portuguesa 20080101

• New-onset diabetes mellitus after kidney transplantation: the role of immunosuppression.

  Transplantation proceedings 20080101

• Impact of dose reductions on efficacy outcome in heart transplant patients receiving enteric-coated mycophenolate sodium or mycophenolate mofetil at 12 months post-transplantation.

  Clinical transplantation 20080101

• Successful treatment of an elderly patient with refractory ultraviolet-A-sensitive atopic eczema with mycophenolic acid.

  Acta dermato-venereologica 20080101

• High-performance liquid chromatography method for the determination of mycophenolic acid in human plasma and application to a pharmacokinetic study of mycophenolic acid dispersible tablet.

  Arzneimittel-Forschung 20080101

• Induction therapy for pediatric focal proliferative lupus nephritis: cyclophosphamide versus mycophenolate mofetil.

  Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates & Practitioners 20080101

• Impact of gastrointestinal-related side effects on mycophenolate mofetil dosing and potential therapeutic strategies.

  Clinical transplantation 20080101

• Cocaine-induced midline destructive lesions mimicking ENT-limited Wegener's granulomatosis.

  Scandinavian journal of rheumatology 20080101

• Treatment options for proliferative lupus nephritis: an update of clinical trial evidence.

  Drugs 20080101

• [Immunosuppressors].

  Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20080101

• [Management of immune suppression in systemic diseases affecting the kidney].

  Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20080101

• Economic impact and long-term graft outcomes of mycophenolate mofetil dosage modifications following gastrointestinal complications in renal transplant recipients.

  PharmacoEconomics 20080101

• Mycophenolate mofetil versus azathioprine in the maintenance therapy of lupus nephritis.

  Renal failure 20080101

• Refractory linear IgA bullous dermatosis successfully treated with mycophenolate sodium.

  The Journal of dermatological treatment 20080101

• Enteric-coated mycophenolate sodium: a review of its use in the prevention of renal transplant rejection.

  Drugs 20080101

• Population pharmacokinetics of mycophenolic acid : a comparison between enteric-coated mycophenolate sodium and mycophenolate mofetil in renal transplant recipients.

  Clinical pharmacokinetics 20080101

• Long-term graft outcome in patients with chronic allograft dysfunction after immunosuppression modifications.

  Annals of transplantation 20080101

• Mycophenolate mofetil in liver transplant patients with calcineurin-inhibitor-induced renal impairment.

  Annals of hepatology 20080101

• Management of leukopenia in kidney and pancreas transplant recipients.

  Clinical transplantation 20080101

• [Chronic allograft dysfunction: role of immunosuppressive treatment].

  Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia 20080101

• Choroiditis in a patient with multiple sclerosis.

  Ocular immunology and inflammation 20080101

• [Therapy of lupus nephritis with mycophenolate mofetil].

  Medicinski pregled 20080101

• Persistent atypical varicella in two renal transplant patients and its relation to mycophenolic acid.

  Indian journal of dermatology, venereology and leprology 20080101

• Posttransplant diabetes mellitus in kidney allograft recipients at Shaheed Hasheminejad Hospital.

  Iranian journal of kidney diseases 20080101

• Dual inhibitors of inosine monophosphate dehydrogenase and histone deacetylases for cancer treatment.

  Journal of medicinal chemistry 20071227

• The European experience.

  Transplantation 20071227

• Reduced exposure to calcineurin inhibitors in renal transplantation.

  The New England journal of medicine 20071220

• Balancing efficacy and toxicity in kidney-transplant immunosuppression.

  The New England journal of medicine 20071220

• Improvement in 3-month patient-reported gastrointestinal symptoms after conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in renal transplant patients.

  Transplantation 20071215

• Mycophenolate mofetil for drug-induced vanishing bile duct syndrome.

  World journal of gastroenterology 20071207

• Conversion to sirolimus as primary immunosuppression attenuates the progression of allograft vasculopathy after cardiac transplantation.

  Circulation 20071204

• Sirolimus and cardiac transplantation: is it the 'magic bullet'?

  Circulation 20071204

• The new malononitrilamide immunosuppressant FK778 prolongs corneal allograft survival in the rat keratoplasty model.

  Eye (London, England) 20071201

• Etiologic agents of diarrhea in solid organ recipients.

  Transplant infectious disease : an official journal of the Transplantation Society 20071201

• Conversion to mycophenolate mofetil for modulating recurrent hepatitis C in liver transplant recipients.

  Transplant infectious disease : an official journal of the Transplantation Society 20071201

• Pharmacokinetics, safety, and efficacy of mycophenolate mofetil in combination with sirolimus or ciclosporin in renal transplant patients.

  British journal of clinical pharmacology 20071201

• Is a standard fixed dose of mycophenolate mofetil ideal for all patients?

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20071201

• Lack of association between common polymorphisms in UGT1A9 and gene expression and activity.

  Drug metabolism and disposition: the biological fate of chemicals 20071201

• A retrospective analysis of immunosuppression compliance, dose reduction and discontinuation in kidney transplant recipients.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20071201

• Influence of SLCO1B1, 1B3, 2B1 and ABCC2 genetic polymorphisms on mycophenolic acid pharmacokinetics in Japanese renal transplant recipients.

  European journal of clinical pharmacology 20071201

• Mycophenolate mofetil therapy for refractory inflammatory bowel disease.

  Inflammatory bowel diseases 20071201

• Improvement of multiple sclerosis on tacrolimus plus mycophenolate mofetil after liver transplantation. Clinical improvement of multiple sclerosis in a patient requiring liver transplantation for acute liver failure following interferon-beta therapy.

  Transplant international : official journal of the European Society for Organ Transplantation 20071201

• Treatment with mycophenolate mofetil and prednisolone for steroid-dependent nephrotic syndrome.

  Pediatric nephrology (Berlin, Germany) 20071201

• Clinically relevant immunosuppressants influence UVB-induced tumor size through effects on inflammation and angiogenesis.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20071201

• [Interdisciplinary consensus to management of lupus nephritis in Germany].

  Zeitschrift fur Rheumatologie 20071201

• Immunosuppressive agents: effects on glucose and lipid metabolism.

  Endocrinology and metabolism clinics of North America 20071201

• [Pfeifer-Weber-Christian syndrome associated with Kikuchi syndrome in infliximab therapy: development of necrotizing allergic vasculitis].

  Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete 20071201

• Prospective controlled study on mycophenolate mofetil and prednisolone in the treatment of membranous nephropathy with nephrotic syndrome.

  Nephrology (Carlton, Vic.) 20071201

• The biology behind the new therapies for SLE.

  International journal of clinical practice 20071201

• [Current treatments of dermatomyositis and polymyositis].

  Zeitschrift fur Rheumatologie 20071201

• [Modern therapy for systemic lupus erythematosus].

  Zeitschrift fur Rheumatologie 20071201

• Latest treatment strategies for membranous nephropathy.

  Expert opinion on pharmacotherapy 20071201

• Recovery of a dog from aplastic anaemia after treatment with mycophenolate mofetil.

  Australian veterinary journal 20071201

• Effect of diabetes mellitus on mycophenolate sodium pharmacokinetics and inosine monophosphate dehydrogenase activity in stable kidney transplant recipients.

  Therapeutic drug monitoring 20071201

• Validation of limited sampling strategy for the estimation of mycophenolic acid exposure in Chinese adult liver transplant recipients.

  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20071201

• Mycophenolate mofetil therapy for children with intractable nephrotic syndrome.

  Pediatrics international : official journal of the Japan Pediatric Society 20071201

• Efficacy and safety of universal valganciclovir prophylaxis combined with a tacrolimus/mycophenolate-based regimen in kidney transplantation.

  Swiss medical weekly 20071201

• A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of bullous pemphigoid.

  Archives of dermatology 20071201

• Posttransplantation conversion to sirolimus-based immunosuppression: a single center experience.

  Transplantation proceedings 20071201

• Feasibility of C2 monitoring in Korean renal transplantation.

  Transplantation proceedings 20071201

• Efficacy of C0 and C2 monitoring in adult liver transplant recipients treated with neoral, mycophenolate mofetil, and steroids.

  Transplantation proceedings 20071201

• Economic evaluation of everolimus and mycophenolate mofetil versus azathioprine in de novo heart transplantation.

  Transplantation proceedings 20071201

• Emerging treatment of atopic dermatitis.

  Clinical reviews in allergy & immunology 20071201

• [Other immunosuppressants: azathioprine (Imurel), mycophenolate mofetil (Cellcept), cyclophosphamide (Endoxan)].

  Annales de dermatologie et de venereologie 20071201

• [Development of a myasthenia crisis during interferon treatment for chronic C hepatitis].

  Gastroenterologie clinique et biologique 20071201

• Assessment of mycophenolate mofetil for treatment of frequently relapsing nephrotic syndrome in children.

  Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences 20071201

• The Cairo kidney center protocol for rapamycin-based sequential immunosuppression in kidney transplant recipients: 2-year outcomes.

  Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 20071201

• Pharmacokinetics of mycophenolic acid during the early period after renal transplant.

  Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 20071201

• Steroid avoidance in renal transplant patients maintained on a cyclosporine-based protocol.

  Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 20071201

• Steroid-avoidance immunosuppression regimen in live-donor renal allotransplant recipients: a prospective, randomized, controlled study.

  Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 20071201

• Persistent hypertension and progressive renal injury induced by salt overload after short term nitric oxide inhibition.

  Clinics (Sao Paulo, Brazil) 20071201

• Probing binding requirements of type I and type II isoforms of inosine monophosphate dehydrogenase with adenine-modified nicotinamide adenine dinucleotide analogues.

  Journal of medicinal chemistry 20071115

• Liquid chromatographic determination of mycophenolic acid and its metabolites in human kidney transplant plasma: pharmacokinetic application.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20071115

• Steroid-free maintenance immunosuppression with rapamune and low-dose neoral in pancreas transplant recipients.

  Transplantation 20071115

• Mycophenolate mofetil reduces disease activity and steroid dosage in Takayasu arteritis.

  Clinical rheumatology 20071101

• Treatment of idiopathic membranous nephropathy with the combination of steroids, tacrolimus and mycophenolate mofetil: results of a pilot study.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20071101

• High-unbound mycophenolic acid concentrations in an infant on peritoneal dialysis following hematopoietic cell transplant.

  Bone marrow transplantation 20071101

• Lentiviral vector conferring resistance to mycophenolate mofetil and sensitivity to ganciclovir for in vivo T-cell selection.

  Gene therapy 20071101

• Sirolimus versus cyclosporine in kidney recipients receiving thymoglobulin, mycophenolate mofetil and a 6-month course of steroids.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20071101

• Therapeutic monitoring of mycophenolic acid: is there clinical utility?

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20071101

• Linear IgA bullous dermatosis responsive to trimethoprim-sulfamethoxazole.

  Clinical and experimental dermatology 20071101

• Selective late steroid withdrawal after renal transplantation.

  Pediatric nephrology (Berlin, Germany) 20071101

• Biliary complications after duct-to-duct biliary reconstruction in living-donor liver transplantation: causes and treatment.

  World journal of surgery 20071101

• Individualized mycophenolate mofetil dosing based on drug exposure significantly improves patient outcomes after renal transplantation.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20071101

• Lack of benefit of early protocol biopsies in renal transplant patients receiving TAC and MMF: a randomized study.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20071101

• Epstein-Barr virus DNA load and seroconversion in pediatric renal transplantation with tacrolimus immunosuppression.

  Pediatric transplantation 20071101

• A checkpoint in the cell cycle progression as a therapeutic target to inhibit HIV replication.

  The Journal of infectious diseases 20071101

• Development of a CE method for the determination of mycophenolic acid in human plasma: a comparison with HPLC.

  Electrophoresis 20071101

• Simultaneous determination of cortisol, dexamethasone, methylprednisolone, prednisone, prednisolone, mycophenolic acid and mycophenolic acid glucuronide in human plasma utilizing liquid chromatography-tandem mass spectrometry.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20071101

• Pharmacokinetics of mycophenolate sodium and comparison with the mofetil formulation in stable kidney transplant recipients.

  Clinical journal of the American Society of Nephrology : CJASN 20071101

• Lipodystrophy and metabolic abnormalities in a case of adult dermatomyositis.

  Journal of the American Academy of Dermatology 20071101

• Clinical trial: switch to combined mycophenolate mofetil and minimal dose calcineurin inhibitor in stable liver transplant patients--assessment of renal and allograft function, cardiovascular risk factors and immune monitoring.

  Alimentary pharmacology & therapeutics 20071101

• Post-renal transplant hemolytic uremic syndrome following combination therapy with tacrolimus and everolimus.

  Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia 20071101

• A case with Listeria meningitis during administration of mycophenolate mofetil for pemphigus vulgaris.

  Journal of the European Academy of Dermatology and Venereology : JEADV 20071101

• Anti-erythropoietin antibody-mediated pure red cell aplasia in a living donor liver transplant recipient treated for hepatitis C virus.

  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20071101

• Laparoscopic incisional hernia repair after liver transplantation.

  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20071101

• Pharmacokinetics of mycophenolate mofetil in stable pediatric liver transplant recipients receiving mycophenolate mofetil and cyclosporine.

  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20071101

• Corticosteroid-free immunosuppression with daclizumab in HCV(+) liver transplant recipients: 1-year interim results of the HCV-3 study.

  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20071101

• Results of a 6-month, multicenter, open-label, prospective study concerning efficacy and safety of mycophenolate sodium in de novo kidney transplant recipients.

  Transplantation proceedings 20071101

• Alemtuzumab for giant cell hepatitis with autoimmune hemolytic anemia.

  Journal of pediatric gastroenterology and nutrition 20071101

• [Mouth ulcers induced by enteric-coated mycophenolate sodium (Myfortic].

  Annales de dermatologie et de venereologie 20071101

• Cancer after renal transplantation.

  Current opinion in nephrology and hypertension 20071101

• [Explorative study on mechanism and drug intervention for chronic allograft nephropathy induced by renal ischemia-reperfusion injury].

  Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition 20071101

• Sirolimus versus cyclosporine therapy increases circulating regulatory T cells, but does not protect renal transplant patients given alemtuzumab induction from chronic allograft injury.

  Transplantation 20071027

• Immunosuppressive agents for myasthenia gravis.

  The Cochrane database of systematic reviews 20071017

• Sensitive high-performance liquid chromatography-tandem mass spectrometry method for quantitative analysis of mycophenolic acid and its glucuronide metabolites in human plasma and urine.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20071015

• Alemtuzumab induction in deceased donor kidney transplantation.

  Transplantation 20071015

• Randomized trial of steroid-free induction versus corticosteroid maintenance among orthotopic liver transplant recipients with hepatitis C virus: impact on hepatic fibrosis progression at one year.

  Transplantation 20071015

• FTY720 versus mycophenolate mofetil in de novo renal transplantation: six-month results of a double-blind study.

  Transplantation 20071015

• Posttransplant Epstein-Barr virus related lymphoproliferative disorder with a primary cutaneous presentation.

  Dermatology online journal 20071013

• [Recent topics on diagnosis and therapy for collagen diseases].

  Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 20071010

• The BMP ligand Gbb gates the expression of synaptic homeostasis independent of synaptic growth control.

  Neuron 20071004

• Long-standing refractory polymyositis responding to mycophenolate mofetil: a case report and review of the literature.

  Clinical rheumatology 20071001

• Randomized controlled open-label trial of four treatment regimens for pemphigus vulgaris.

  Journal of the American Academy of Dermatology 20071001

• Modulation of tolerance to the transgene product in a nonhuman primate model of AAV-mediated gene transfer to liver.

  Blood 20071001

• Automated monitoring of C2 and C0 blood levels of mycophenolic acid and cyclosporine on the Abbott Architect c8000.

  Clinical biochemistry 20071001

• Methanol-associated matrix effects in electrospray ionization tandem mass spectrometry.

  Clinical chemistry 20071001

• The use of beta-D-2,6-diaminopurine dioxolane with or without mycophenolate mofetil in drug-resistant HIV infection.

  AIDS (London, England) 20071001

• Evaluation of the practicability of limited sampling strategies for the estimation of mycophenolic acid exposure in Chinese adult renal recipients.

  Therapeutic drug monitoring 20071001

• Epidermolysis bullosa acquisita and neuroendocrine pancreatic cancer - Coincidence or patho-genetic relationship?

  Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 20071001

• Randomized trial of tacrolimus monotherapy: tacrolimus in combination, tacrolimus alone compared (the TICTAC trial).

  The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20071001

• Mechanism-of-action determination of GMP synthase inhibitors and target validation in Candida albicans and Aspergillus fumigatus.

  Chemistry & biology 20071001

• Decreased incidence of acute rejection in adolescent kidney transplant recipients using antithymocyte induction and triple immunosuppression.

  Transplantation 20070927

• The immunosuppressive drug mycophenolic acid does not bind iron(II) under conditions mimicking the upper gastrointestinal environment.

  Transplantation 20070927

• Chronic inflammatory demyelinating polyradiculoneuropathy presenting as cauda equina syndrome in a diabetic.

  Journal of the neurological sciences 20070915

• Mycophenolic acid inhibits oleic acid-induced vascular smooth muscle cell activation by inhibiting cellular reactive oxygen species.

  Transplantation 20070915

• Fetal malformations associated with mycophenolate mofetil for lupus nephritis.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20070901

• Mycophenolic acid (MPA) and its glucuronide metabolites interact with transport systems responsible for excretion of organic anions in the basolateral membrane of the human kidney.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20070901

• Gastrointestinal side effects of mycophenolic acid in renal transplant patients: a reappraisal.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20070901

• Lipotoxic and inflammatory phenotypes in rats with uncontrolled metabolic syndrome and nephropathy.

  American journal of physiology. Renal physiology 20070901

• Tacrolimus exposure and evolution of renal allograft histology in the first year after transplantation.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20070901

• Mycophenolic acid as a latent agonist of PPARgamma.

  Bioorganic & medicinal chemistry letters 20070901

• Extended mycophenolate mofetil and shortened cyclosporine failed to reduce graft-versus-host disease after unrelated hematopoietic cell transplantation with nonmyeloablative conditioning.

  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20070901

• Therapeutic drug monitoring of mycophenolic acid.

  Clinical journal of the American Society of Nephrology : CJASN 20070901

• Role of mycophenolate mofetil in the treatment of lupus nephritis.

  Clinical journal of the American Society of Nephrology : CJASN 20070901

• Mycophenolate mofetil for induction therapy of lupus nephritis: a systematic review and meta-analysis.

  Clinical journal of the American Society of Nephrology : CJASN 20070901

• Treatment of Guillain-Barré syndrome with mycophenolate mofetil: a pilot study.

  Journal of neurology, neurosurgery, and psychiatry 20070901

• [Mycophenolate mofetil for induction of remission in Wegener's granulomatosis].

  Zeitschrift fur Rheumatologie 20070901

• Lack of an effect of oral iron administration on mycophenolic acid pharmacokinetics in stable renal transplant recipients.

  Pharmacotherapy 20070901

• [What is your diagnosis? Bilateral dacryoadenitis].

  Deutsche medizinische Wochenschrift (1946) 20070901

• Pharmacokinetics and pharmacodynamics in renal transplant recipients under treatment with cyclosporine and Myfortic.

  Transplantation proceedings 20070901

• Two-dose daclizumab, tacrolimus, mycophenolate mofetil, and steroid-free regimen in de novo cardiac transplant recipients: early experience.

  Transplantation proceedings 20070901

• Influence of renal insufficiency on pharmacokinetics of ACYL-glucuronide metabolite of mycophenolic acid in renal transplant patients.

  Transplantation proceedings 20070901

• Quality of life in renal transplant recipients following conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium.

  Transplantation proceedings 20070901

• Mycophenolate mofetil levels in stable kidney transplant recipients.

  Transplantation proceedings 20070901

• Variability of mycophenolate mofetil trough levels in stable kidney transplant patients.

  Transplantation proceedings 20070901

• Calcineurin inhibitor reduction based on maintenance immunosuppression with mycophenolate mofetil in renal transplant patients: POP study.

  Transplantation proceedings 20070901

• Better mycophenolic acid 12-hour trough level after enteric-coated mycophenolate sodium in patients with gastrointestinal intolerance to mycophenolate mofetil.

  Transplantation proceedings 20070901

• Clinical evolution in the first 3 months of patients after liver transplantation in maintenance phase converted from mycophenolate mofetil to mycophenolate sodium due to gastrointestinal complications.

  Transplantation proceedings 20070901

• Mycophenolate mofetil and atherosclerosis: results of animal and human studies.

  Annals of the New York Academy of Sciences 20070901

• Role of mycophenolate mofetil in the treatment of lupus nephritis.

  Annals of the New York Academy of Sciences 20070901

• Mycophenolate mofetil in lupus glomerulonephritis: effectiveness and tolerability.

  Annals of the New York Academy of Sciences 20070901

• C-440T/T-331C polymorphisms in the UGT1A9 gene affect the pharmacokinetics of mycophenolic acid in kidney transplantation.

  Pharmacogenomics 20070901

• [Benefits of mycophenolate mofetil in non-transplant kidney diseases].

  Revue medicale suisse 20070829

• Targeted inhibition of glucuronidation markedly improves drug efficacy in mice - a model.

  Biochemical and biophysical research communications 20070817

• The impact of renal allograft function on exposure and elimination of mycophenolic acid (MPA) and its metabolite MPA 7-O-glucuronide.

  Transplantation 20070815

• Sequential quadruple immunosuppression including sirolimus in extended criteria and nonheartbeating donor kidney transplantation.

  Transplantation 20070815

• Effects of a mycophenolate mofetil-based immunosuppressive regimen in Chagas' heart transplant recipients.

  Transplantation 20070815

• Use of infliximab-daclizumab combination for the treatment of acute and chronic graft-versus-host disease of the liver and gut.

  Pediatric blood & cancer 20070801

• In vivo evidence for apoptosis in the bone marrow in systemic lupus erythematosus.

  Annals of the rheumatic diseases 20070801

• Effects of adenosine monophosphate-activated kinase activators on bovine oocyte nuclear maturation in vitro.

  Molecular reproduction and development 20070801

• Can mycophenolate mofetil substitute cyclophosphamide treatment of pediatric lupus nephritis?

  Pediatric nephrology (Berlin, Germany) 20070801

• Investigation on pharmacokinetics of mycophenolic acid in Chinese adult renal transplant patients.

  British journal of clinical pharmacology 20070801

• Influence of sirolimus on proteinuria in de novo kidney transplantation with expanded criteria donors: comparison of two CNI-free protocols.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20070801

• Mycophenolate mofetil administration reduces renal inflammation, oxidative stress, and arterial pressure in rats with lead-induced hypertension.

  American journal of physiology. Renal physiology 20070801

• Mycophenolate mofetil as adjunctive therapy for MMN patients: a randomized, controlled trial.

  Brain : a journal of neurology 20070801

• Red cell aplasia and autoimmune hemolytic anemia following immunosuppression with alemtuzumab, mycophenolate, and daclizumab in pancreas transplant recipients.

  Haematologica 20070801

• A spectrum of lupus erythematosus from verrucous to systemic, coexisting with two types of porphyria.

  Journal of the European Academy of Dermatology and Venereology : JEADV 20070801

• Mycophenolate mofetil in idiopathic membranous nephropathy: a clinical trial with comparison to a historic control group treated with cyclophosphamide.

  American journal of kidney diseases : the official journal of the National Kidney Foundation 20070801

• Is cerebral involvement an occasional feature of muscle-specific kinase antibody-positive syndrome?

  European journal of neurology 20070801

• Prediction of unbound mycophenolic acid concentrations in patients after hematopoietic cell transplantation.

  Therapeutic drug monitoring 20070801

• [Benefits of mycophenolate mofetil for refractory graft-versus-host disease].

  [Rinsho ketsueki] The Japanese journal of clinical hematology 20070801

• Acridone-based inhibitors of inosine 5'-monophosphate dehydrogenase: discovery and SAR leading to the identification of N-(2-(6-(4-ethylpiperazin-1-yl)pyridin-3-yl)propan-2-yl)-2- fluoro-9-oxo-9,10-dihydroacridine-3-carboxamide (BMS-566419).

  Journal of medicinal chemistry 20070726

• The dynamics of glucose metabolism under calcineurin inhibitors in the first year after renal transplantation in nonobese patients.

  Transplantation 20070715

• Predictors of graft and patient survival in hepatitis C virus (HCV) recipients: model to predict HCV cirrhosis after liver transplantation.

  Transplantation 20070715

• Trials assess myasthenia gravis therapies.

  JAMA 20070704

• Acquired pure megakaryocytic aplasia: report of a single case treated with mycophenolate mofetil.

  American journal of hematology 20070701

• Antiproliferative and apoptotic effects of mycophenolic acid in human B-cell non-Hodgkin lymphomas.

  Leukemia research 20070701

• Level of renal function and serum erythropoietin levels independently predict anaemia post-renal transplantation.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20070701

• Mycophenolate mofetil in induction and maintenance therapy of severe lupus nephritis: a meta-analysis of randomized controlled trials.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20070701

• The cost-effectiveness of mycophenolate mofetil as firstline therapy in active lupus nephritis.

  Rheumatology (Oxford, England) 20070701

• The effect of sirolimus- or cyclosporine-based immunosuppression effects on T-cell subsets in vivo.

  Kidney international 20070701

• Renal angiotensin II concentration and interstitial infiltration of immune cells are correlated with blood pressure levels in salt-sensitive hypertension.

  American journal of physiology. Regulatory, integrative and comparative physiology 20070701

• Therapeutic drug measurement of mycophenolic acid derivatives in transplant patients.

  Clinical biochemistry 20070701

• Mycophenolate mofetil for severe childhood atopic dermatitis: experience in 14 patients.

  The British journal of dermatology 20070701

• Combined prednisone and mycophenolate mofetil treatment for retroperitoneal fibrosis.

  The Journal of urology 20070701

• Mycophenolate mofetil in autoimmune hepatitis patients not responsive or intolerant to standard immunosuppressive therapy.

  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20070701

• EBV-associated lymphoproliferative disorder of CNS associated with the use of mycophenolate mofetil.

  Neuro-oncology 20070701

• Pharmacokinetics and pharmacodynamics of mycophenolic acid after enteric-coated mycophenolate versus mycophenolate mofetil in patients with progressive IgA nephritis.

  Journal of clinical pharmacology 20070701

• Plasma concentrations of mycophenolic acid acyl glucuronide are not associated with diarrhea in renal transplant recipients.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20070701

• Limited sampling strategy for mycophenolic acid in Japanese heart transplant recipients: comparison of cyclosporin and tacrolimus treatment.

  Circulation journal : official journal of the Japanese Circulation Society 20070701

• Physical compatibility and chemical stability of mycophenolate mofetil during simulated Y-site administration with commonly coadministered drugs.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20070701

• Grafts and hepatitis C virus: maximizing the benefit.

  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20070701

• Long-term effects of calcineurin inhibitor conversion to mycophenolate mofetil on renal function after liver transplantation.

  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20070701

• Outcomes in patients with active lupus nephritis requiring immunosuppressives who never received cyclophosphamide.

  The Journal of rheumatology 20070701

• Lower risk of infectious deaths in cardiac transplant patients receiving basiliximab versus anti-thymocyte globulin as induction therapy.

  The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20070701

• Observational study with everolimus (Certican) in combination with low-dose cyclosporine in de novo heart transplant recipients.

  The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20070701

• Safety considerations with mycophenolate sodium.

  Expert opinion on drug safety 20070701

• Mycophenolate mofetil in the treatment of glomerular diseases.

  Prilozi 20070701

• Interaction and transport characteristics of mycophenolic acid and its glucuronide via human organic anion transporters hOAT1 and hOAT3.

  Biochemical pharmacology 20070630

• Development and validation of an LC/MS/MS assay for mycophenolic acid in human peripheral blood mononuclear cells.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20070615

• Alemtuzumab (Campath 1H) induction with tacrolimus monotherapy is safe for high immunological risk renal transplantation.

  Transplantation 20070615

• [Immunosuppressive therapy after human lung transplantation].

  Zhonghua wai ke za zhi [Chinese journal of surgery] 20070615

• Effects of mycophenolate mofetil, valsartan and their combined therapy on preventing podocyte loss in early stage of diabetic nephropathy in rats.

  Chinese medical journal 20070605

• Induction of remission in active anti-neutrophil cytoplasmic antibody-associated vasculitis with mycophenolate mofetil in patients who cannot be treated with cyclophosphamide.

  Annals of the rheumatic diseases 20070601

• Time-dependent clearance of mycophenolic acid in renal transplant recipients.

  British journal of clinical pharmacology 20070601

• Pure red cell aplasia associated with type I autoimmune polyglandular syndrome-successful response to treatment with mycophenolate mofetil: case report and review of literature.

  Journal of clinical pathology 20070601

• Relationship between MPA free fraction and free MPAG concentrations in heart transplant recipients based on simultaneous HPLC quantification of the target compounds in human plasma.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20070601

• Glatiramer acetate induced acute exacerbation of autoimmune hepatitis in a patient with multiple sclerosis.

  Journal of neurology 20070601

• Mycophenolate sodium for subacute cutaneous lupus erythematosus resistant to standard therapy.

  The British journal of dermatology 20070601

• Sustained AAV-mediated dystrophin expression in a canine model of Duchenne muscular dystrophy with a brief course of immunosuppression.

  Molecular therapy : the journal of the American Society of Gene Therapy 20070601

• Risk assessment in haematopoietic stem cell transplantation: GvHD prevention and treatment.

  Best practice & research. Clinical haematology 20070601

• Mycophenolate mofetil versus azathioprine for prevention of chronic allograft dysfunction in renal transplantation: the MYSS follow-up randomized, controlled clinical trial.

  Journal of the American Society of Nephrology : JASN 20070601

• Real-time PCR determination of IMPDH1 and IMPDH2 expression in blood cells.

  Clinical chemistry 20070601

• Up-date on renal fibrosis: a time for action.

  Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia 20070601

• Mycophenolate mofetil treatment for therapy-resistant glomerulopathies.

  Nephrology (Carlton, Vic.) 20070601

• Early withdrawal of calcineurin inhibitors and rescue immunosuppression with sirolimus-based therapy in renal transplant recipients with moderate to severe renal dysfunction.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20070601

• Influence of UGT1A7 and UGT1A9 intronic I399 genetic polymorphisms on mycophenolic acid pharmacokinetics in Japanese renal transplant recipients.

  Therapeutic drug monitoring 20070601

• Pharmacokinetics of mycophenolate mofetil in hematopoietic stem cell transplant recipients.

  Therapeutic drug monitoring 20070601

• Enteric-coated mycophenolate sodium provides higher mycophenolic acid predose levels compared with mycophenolate mofetil: implications for therapeutic drug monitoring.

  Therapeutic drug monitoring 20070601

• Pharmacokinetics of mycophenolic acid in liver transplant patients after intravenous and oral administration of mycophenolate mofetil.

  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20070601

• 56-Year-old man with rash, abdominal pain, and arthralgias.

  Mayo Clinic proceedings 20070601

• Efficacy and safety of enteric-coated mycophenolate sodium in de novo renal transplant recipients: pooled data from three 12-month multicenter, open-label, prospective studies.

  Transplantation proceedings 20070601

• Population pharmacokinetics of mycophenolic acid in senile Chinese kidney transplant recipients.

  Transplantation proceedings 20070601

• Anemia in the period immediately following renal transplantation.

  Transplantation proceedings 20070601

• Lack of hepatotoxicity upon sirolimus addition to a calcineurin inhibitor-based regimen in hepatitis virus-positive renal transplant recipients.

  Transplantation proceedings 20070601

• Six-year follow-up of azathioprine and mycophenolate mofetil use during the first 6 months of renal transplantation.

  Clinical nephrology 20070601

• [Mycophenolate mofetil combined with steroids: new experiences in the treatment of idiopathic retroperitoneal fibrosis].

  Vojnosanitetski pregled 20070601

• Long-term renal transplant function in recipient of simultaneous kidney and pancreas transplant maintained with two prednisone-free maintenance immunosuppressive combinations: tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimus.

  Transplantation 20070527

• Implementation of a Protocol for ABO-incompatible kidney transplantation--a three-center experience with 60 consecutive transplantations.

  Transplantation 20070515

• Rituximab therapy for acute humoral rejection after kidney transplantation.

  Transplantation 20070515

• Effects of gastric emptying on oral mycophenolic acid pharmacokinetics in stable renal allograft recipients.

  British journal of clinical pharmacology 20070501

• Simultaneous LC-MS-MS determination of cyclosporine A, tacrolimus, and sirolimus in whole blood as well as mycophenolic acid in plasma using common pretreatment procedure.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20070501

• Alterations in cytoskeletal protein expression by mycophenolic acid in human mesangial cells requires Rac inactivation.

  Biochemical pharmacology 20070501

• In vitro evidence for a direct antifibrotic role of the immunosuppressive drug mycophenolate mofetil.

  The Journal of pharmacology and experimental therapeutics 20070501

• Efficacy and safety of 'rescue therapy' with mycophenolate mofetil in resistant primary glomerulonephritis--a multicenter study.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20070501

• Mycophenolate mofetil in a case of relapsed, refractory thrombotic thrombocytopenic purpura.

  European journal of haematology 20070501

• Aplastic anaemia as an autoimmune complication of thymoma.

  British journal of haematology 20070501

• Long-term survival of kidneys transplanted from live A2 donors to O and B recipients.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20070501

• Influence of the UGT2B7 promoter region and exon 2 polymorphisms and comedications on Acyl-MPAG production in vitro and in adult renal transplant patients.

  Pharmacogenetics and genomics 20070501

• Sirolimus is not always responsible for new-onset proteinuria after conversion for chronic allograft nephropathy.

  Pediatric transplantation 20070501

• MMF to EC-MPS conversion: what makes the difference?

  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20070501

• Novel oral agents for multiple sclerosis.

  Current neurology and neuroscience reports 20070501

• [Antisynthetase syndrome with good response to mycophenolate mofetil].

  Revista clinica espanola 20070501

• Low-dose versus high-dose cyclosporine induction protocols in renal transplantation.

  Transplantation proceedings 20070501

• Bioavailability of a new generic formulation of mycophenolate mofetil MMF 500 versus CellCept in healthy adult volunteers.

  Transplantation proceedings 20070501

• Changing treatment protocol from azathioprine to mycophenolate mofetil: decrease in renal dysfunction, increase in infections.

  Transplantation proceedings 20070501

• Optimization of immunosuppressive drug monitoring in children.

  Transplantation proceedings 20070501

• De novo Crohn's disease in a renal transplant recipient.

  Transplantation proceedings 20070501

• Conversion to combined therapy with sirolimus and mycophenolate mofetil improved renal function in stable renal transplant recipients.

  Journal of the Formosan Medical Association = Taiwan yi zhi 20070501

• Maintenance immunosuppression with mycophenolate mofetil and corticosteroids in pediatric kidney transplantation: temporary benefit but not without risk.

  Transplantation 20070427

• Kidney transplantation with sirolimus and mycophenolate mofetil-based immunosuppression: 5-year results of a randomized prospective trial compared to calcineurin inhibitor drugs.

  Transplantation 20070415

• Five-year outcome in pediatric patients with mycophenolate mofetil-based renal transplantation.

  Transplantation 20070415

• Successful treatment of oral linear IgA disease using mycophenolate.

  Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 20070401

• Mycophenolate mofetil for maintenance of remission in idiopathic retroperitoneal fibrosis.

  Rheumatology (Oxford, England) 20070401

• Azathioprine, UV light, and skin cancer in organ transplant patients--do we have an answer?

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20070401

• Fifteen-year remission of a steroid-resistant nephrotic syndrome sustained by cyclosporine A.

  Pediatric nephrology (Berlin, Germany) 20070401

• Anti-IL2 induction in liver transplantation with 93% rejection-free patient and graft survival at 18 months.

  The Journal of surgical research 20070401

• Use of mycophenolic acid in non-transplant renal diseases.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20070401

• No recurrence of Kaposi's sarcoma in a case of renal retransplantation under a calcineurin inhibitor free immunosuppressive regimen: first report.

  Transplant international : official journal of the European Society for Organ Transplantation 20070401

• Treatment of bullous pemphigoid with enteric-coated mycophenolate sodium.

  Journal of the European Academy of Dermatology and Venereology : JEADV 20070401

• Pharmacokinetic and pharmacodynamic comparison of enteric-coated mycophenolate sodium and mycophenolate mofetil in maintenance renal transplant patients.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20070401

• Effects of immunosuppressive drugs on in vitro neogenesis of human islets: mycophenolate mofetil inhibits the proliferation of ductal cells.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20070401

• Monitoring of inosine monophosphate dehydrogenase activity as a biomarker for mycophenolic acid effect: potential clinical implications.

  Therapeutic drug monitoring 20070401

• Limited sampling strategy for the estimation of mycophenolic acid area under the plasma concentration-time curve in adult patients undergoing liver transplant.

  Therapeutic drug monitoring 20070401

• Therapeutic drug monitoring of mycophenolic acid: does it improve patient outcome?

  Expert opinion on drug metabolism & toxicology 20070401

• [Peripheral blood stem cell transplantation for 53 patients with malignant hematologic diseases].

  Ai zheng = Aizheng = Chinese journal of cancer 20070401

• Conversion from a calcineurin inhibitor-based immunosuppressive regimen to everolimus in renal transplant recipients: effect on renal function and proteinuria.

  Transplantation proceedings 20070401

• Therapeutic drug monitoring of mycophenolic acid in kidney transplant patients: a abbreviated sampling strategy.

  Transplantation proceedings 20070401

• Report of the experience with enteric-coated sodium mycophenolate in a de novo population of kidney transplant recipients at high risk for delayed graft function.

  Transplantation proceedings 20070401

• Converting to a generic formulation of mycophenolate mofetil in stable kidney transplant recipients: 1 year of drug surveillance and outcome.

  Transplantation proceedings 20070401

• Oral ulcers produced by mycophenolate mofetil in two liver transplant patients.

  Transplantation proceedings 20070401

• Tacrolimus (Pan Graf) in live related renal transplantation: an initial experience of 101 recipients in India.

  Transplantation proceedings 20070401

• [Clinical evidence of therapy of IgA nephropathy].

  Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics 20070401

• [Clinical application and side effects of immunosuppressant].

  Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics 20070401

• [Clinical presentations and pathologic features of 25 cases of infant nephrotic syndrome].

  Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics 20070401

• [Neurosarcoidosis treated with mycophenolate mofetil: two cases].

  Revue neurologique 20070401

• Clinical features and risk factors of pure red cell aplasia following major ABO-incompatible allogeneic hematopoietic stem cell transplantation.

  Hematology (Amsterdam, Netherlands) 20070401

• A novel variant L263F in human inosine 5'-monophosphate dehydrogenase 2 is associated with diminished enzyme activity.

  Pharmacogenetics and genomics 20070401

• Epithelial-to-mesenchymal transition of human proximal tubular epithelial cells: effects of rapamycin, mycophenolate, cyclosporin, azathioprine, and methylprednisolone.

  Transplantation 20070327

• Mycophenolate mofetil may allow cyclosporine and steroid sparing in de novo heart transplant patients.

  Transplantation 20070315

• Mycophenolate mofetil inhibits tumor growth and angiogenesis in vitro but has variable antitumor effects in vivo, possibly related to bioavailability.

  Transplantation 20070315

• Impact of long-term therapy with FTY720 or mycophenolate mofetil on cardiac conduction and rhythm in stable adult renal transplant patients.

  Transplantation 20070315

• Mycophenolate mofetil - as an adjunctive immunosuppressive therapy in refractory myasthenia gravis: The Singapore experience.

  Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 20070301

• Effects of mycophenolate mofetil on cisplatin-induced renal dysfunction in rats.

  Cancer chemotherapy and pharmacology 20070301

• Mycophenolate mofetil in diffuse cutaneous systemic sclerosis--a retrospective analysis.

  Rheumatology (Oxford, England) 20070301

• Mycophenolate mofetil treatment in resistant myositis.

  Rheumatology (Oxford, England) 20070301

• Clear graft survival and immune reactions following emergency keratoplasty.

  Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 20070301

• Proteins identified as targets of the acyl glucuronide metabolite of mycophenolic acid in kidney tissue from mycophenolate mofetil treated rats.

  Biochimie 20070301

• Ribavirin and mycophenolic acid markedly potentiate the anti-hepatitis B virus activity of entecavir.

  Antiviral research 20070301

• Antiviral activity of tiazofurin and mycophenolic acid against Grapevine leafroll-associated virus 3 in Vitis vinifera explants.

  Antiviral research 20070301

• Very early steroid withdrawal in simultaneous pancreas-kidney transplants.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20070301

• Gender-related differences in mycophenolate mofetil-induced gastrointestinal toxicity in rats.

  Drug metabolism and disposition: the biological fate of chemicals 20070301

• Kinetic characterization of inosine monophosphate dehydrogenase of Leishmania donovani.

  Molecular and biochemical parasitology 20070301

• Influence of UGT1A8 and UGT2B7 genetic polymorphisms on mycophenolic acid pharmacokinetics in Japanese renal transplant recipients.

  European journal of clinical pharmacology 20070301

• Immunosuppression for dual kidney transplantation with marginal organs: the old is better yet.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20070301

• One-year results with extended-release tacrolimus/MMF, tacrolimus/MMF and cyclosporine/MMF in de novo kidney transplant recipients.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20070301

• Mycophenolate mofetil/sirolimus compared to other common immunosuppressive regimens in kidney transplantation.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20070301

• Cyclosporine sparing with mycophenolate mofetil, daclizumab and corticosteroids in renal allograft recipients: the CAESAR Study.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20070301

• Calcineurin inhibitor-free protocols: risks and benefits.

  Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia 20070301

• Proliferation signal inhibitors in cardiac transplantation.

  Current opinion in cardiology 20070301

• Discontinuation of mycophenolate mofetil from a tacrolimus-based triple regimen 2 months after renal transplantation: a comparative randomized, multicentre study.

  Transplant international : official journal of the European Society for Organ Transplantation 20070301

• Pediatric renal transplantation with mycophenolate mofetil immunosuppression in a single center from Mexico.

  Pediatric transplantation 20070301

• Improved long-term graft function in kidney transplant recipients with donor antigen-specific hyporeactivity.

  Pediatric transplantation 20070301

• Influence of oral application of mycophenolic acid on the clinical health status of sheep.

  Journal of veterinary medicine. A, Physiology, pathology, clinical medicine 20070301

• Relationship between acute rejection and cyclosporine or mycophenolic acid levels in Japanese heart transplantation.

  Circulation journal : official journal of the Japanese Circulation Society 20070301

• The impact of UGT1A8, UGT1A9, and UGT2B7 genetic polymorphisms on the pharmacokinetic profile of mycophenolic acid after a single oral dose in healthy volunteers.

  Clinical pharmacology and therapeutics 20070301

• Mycophenolate mofetil and intravenous dexamethasone in the treatment of persistent lupus myelitis.

  The Journal of rheumatology 20070301

• Elective conversion from CellCept to Myfortic under control of mycophenolic acid concentration in stable heart transplant recipients.

  The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20070301

• Reduced-exposure cyclosporine is safe and efficacious in de novo renal transplant recipients treated with enteric-coated mycophenolic acid and basiliximab.

  Clinical nephrology 20070301

• [Case report: a series of autoimmune diseases].

  Gastroenterologie clinique et biologique 20070301

• Missing the forest for the trees.

  Journal of hospital medicine 20070301

• Neurotoxicity that may mimic progressive multifocal leukoencephalopathy in patient with transplanted kidney.

  Collegium antropologicum 20070301

• Immunosuppression strategies in kidney transplantation.

  Medicine and health, Rhode Island 20070301

• Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in maintenance renal transplant recipients receiving tacrolimus: clinical, pharmacokinetic, and pharmacodynamic outcomes.

  Transplantation 20070227

• Human ribosomal protein L7 displays an ER binding property and is involved in ribosome-ER association.

  FEBS letters 20070220

• Systemic lupus erythematosus.

  Lancet (London, England) 20070217

• Liver transplantation in HIV-HCV coinfected patients: a case-control study.

  Transplantation 20070215

• Mycophenolate mofetil in the treatment of uveitis in children.

  The British journal of ophthalmology 20070201

• Simple reversed-phase liquid chromatographic assay for simultaneous quantification of free mycophenolic acid and its glucuronide metabolite in human plasma.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20070201

• Unexpected rate of severe leucopenia with the association of mycophenolate mofetil and valganciclovir in kidney transplant recipients.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20070201

• Immune suppression prevents renal damage and dysfunction and reduces arterial pressure in salt-sensitive hypertension.

  American journal of physiology. Heart and circulatory physiology 20070201

• CYP3A5 genotype markedly influences the pharmacokinetics of tacrolimus and sirolimus in kidney transplant recipients.

  Clinical pharmacology and therapeutics 20070201

• [Revision of the recommendations of the Commission on Pharmacotherapy of the German Society for Rheumatology. Comment on the use of mycophenolic acid for systemic lupus erythematosus].

  Zeitschrift fur Rheumatologie 20070201

• Mycophenolate mofetil promotes prolonged improvement of renal dysfunction after pediatric liver transplantation: experience of a single center.

  Pediatric transplantation 20070201

• Successful treatment of oral erosive lichen planus with mycophenolate mofetil.

  Journal of the European Academy of Dermatology and Venereology : JEADV 20070201

• Reconsidering treatment options in childhood uveitis.

  The British journal of ophthalmology 20070201

• Mycophenolate mofetil is associated with altered expression of chronic renal transplant histology.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20070201

• Validation of immunological biomarkers for the pharmacodynamic monitoring of immunosuppressive drugs in humans.

  Therapeutic drug monitoring 20070201

• Concentrations of mycophenolic acid and glucuronide metabolites under concomitant therapy with cyclosporine or tacrolimus.

  Therapeutic drug monitoring 20070201

• The magnitude and time course of changes in mycophenolic acid 12-hour predose levels during antibiotic therapy in mycophenolate mofetil-based renal transplantation.

  Therapeutic drug monitoring 20070201

• Effect of acidification on protein binding of mycophenolic acid.

  Therapeutic drug monitoring 20070201

• Polymerase chain reaction (PCR) identification of Penicillium brevicompactum, a grape contaminant and mycophenolic acid producer.

  Food additives and contaminants 20070201

• Simple high performance liquid chromatographic assay for mycophenolic acid in renal transplant patients.

  Journal of pharmaceutical and biomedical analysis 20070117

• Mycophenolate mofetil and C-reactive protein in renal transplant recipients.

  Transplantation 20070115

• Treatment of early mixed cellular and humoral renal allograft rejection with tacrolimus and mycophenolate mofetil.

  Kidney international 20070101

• Mycophenolate mofetil therapy for moderate to severe atopic dermatitis.

  Clinical and experimental dermatology 20070101

• A prospective study on the use of mycophenolate mofetil in children with cyclosporine-dependent nephrotic syndrome.

  Pediatric nephrology (Berlin, Germany) 20070101

• Total and free mycophenolic acid and its 7-O-glucuronide metabolite in Chinese adult renal transplant patients: pharmacokinetics and application of limited sampling strategies.

  European journal of clinical pharmacology 20070101

• Anti-CD20 antibody treatment in refractory Class IV lupus nephritis.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20070101

• Mycophenolate acid inhibits endothelial NAD(P)H oxidase activity and superoxide formation by a Rac1-dependent mechanism.

  Hypertension (Dallas, Tex. : 1979) 20070101

• Mycophenolic acid is a new Nox2 inhibitor.

  Hypertension (Dallas, Tex. : 1979) 20070101

• Switch to 1.5 grams MMF monotherapy for CNI-related toxicity in liver transplantation is safe and improves renal function, dyslipidemia, and hypertension.

  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20070101

• Offspring produced from orthotopic transplantation of chicken ovaries.

  Poultry science 20070101

• Neonatal anemia and hydrops fetalis after maternal mycophenolate mofetil use.

  Journal of perinatology : official journal of the California Perinatal Association 20070101

• Effect of certain immunosuppressants on non-specific immunity cells in murine corneal grafts: study on early phases after transplantation.

  Physiological research 20070101

• Highly variable mycophenolate mofetil bioavailability following nonmyeloablative hematopoietic cell transplantation.

  Journal of clinical pharmacology 20070101

• Mycophenolate mofetil substitution for cyclosporine-dependent myasthenia gravis and nephrotoxicity.

  Internal medicine journal 20070101

• Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients.

  Clinical pharmacokinetics 20070101

• Combination of IFN beta-1a (Avonex) and mycophenolate mofetil (Cellcept) in multiple sclerosis.

  European journal of neurology 20070101

• Vascular remodeling 1 year after cardiac transplantation.

  The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20070101

• Pharmacokinetics of mycophenolic acid and determination of area under the curve by abbreviated sampling strategy in Chinese liver transplant recipients.

  Clinical pharmacokinetics 20070101

• Noninfectious gastrointestinal (GI) complications of mycophenolic acid therapy: a consequence of local GI toxicity?

  Transplantation proceedings 20070101

• Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in stable maintenance renal transplant patients: pooled results from three international, multicenter studies.

  Transplantation proceedings 20070101

• Lipid profile during azathioprine or mycophenolate mofetil combinations with cyclosporine and steroids.

  Transplantation proceedings 20070101

• In vitro study of antiviral activity of mycophenolic acid on Brazilian orthobunyaviruses.

  Intervirology 20070101

• A pilot study on tacrolimus treatment in membranous or quiescent lupus nephritis with proteinuria resistant to angiotensin inhibition or blockade.

  Lupus 20070101

• Mycophenolate mofetil: what is its place in the treatment of autoimmune rheumatic diseases?

  Autoimmunity reviews 20070101

• Inferior results with basis immunosuppression with sirolimus in kidney transplantation.

  The Netherlands journal of medicine 20070101

• Pharmacokinetics and variability of mycophenolic acid from enteric-coated mycophenolate sodium compared with mycophenolate mofetil in de novo heart transplant recipients.

  Clinical transplantation 20070101

• Calcineurin inhibitor-free immunosuppression in dual kidney transplantation from elderly donors.

  Clinical transplantation 20070101

• Early steroid withdrawal therapy in renal transplant recipients: a steroid-free sirolimus and CellCept-based calcineurin inhibitor-minimization protocol.

  Clinical transplantation 20070101

• Efficacy and safety of enteric-coated mycophenolate sodium in renal transplant patients with diabetes mellitus: post hoc analyses from three clinical trials.

  Clinical transplantation 20070101

• Is it worth using daclizumab induction therapy with mycophenolate mofetil-based immunosuppressive regimens in live related donor kidney transplantation? A long-term follow up.

  International urology and nephrology 20070101

• Human clinical trials in lupus nephritis.

  Seminars in nephrology 20070101

• Influence of cytochrome P450 (CYP) 3A5 polymorphisms on the pharmacokinetics of lansoprazole enantiomers in CYP2C19 extensive metaboliser renal transplant recipients.

  Clinical drug investigation 20070101

• Primary splenic marginal zone lymphoma with florid granulomatous reaction--a case report and review of literature.

  Pathology, research and practice 20070101

• Renal function with cyclosporine C2 monitoring, enteric-coated mycophenolate sodium and basiliximab: a 12-month randomized trial in renal transplant recipients.

  Clinical transplantation 20070101

• Current management of lupus nephritis: popular misconceptions.

  Lupus 20070101

• Exploring new territory: considering the future.

  Lupus 20070101

• Exploring new territory: the move towards individualised treatment.

  Lupus 20070101

• Pharmacokinetics of mycophenolic acid and estimation of exposure using multiple linear regression equations in Chinese renal allograft recipients.

  Clinical pharmacokinetics 20070101

• Pharmacokinetics of enteric-coated mycophenolate sodium in stable liver transplant recipients.

  Clinical transplantation 20070101

• Treatment of IgA nephropathy: corticosteroids, tonsillectomy, and mycophenolate mofetil.

  Contributions to nephrology 20070101

• Sequential immunosuppressive therapy in progressive IgA nephropathy.

  Contributions to nephrology 20070101

• Difference between pharmacokinetics of mycophenolic acid (MPA) in rats and that in humans is caused by different affinities of MRP2 to a glucuronized form.

  Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques 20070101

• David against Goliath: may we target and defeat interstitial lung disease in systemic sclerosis?

  Clinical and experimental rheumatology 20070101

• A pilot study of mycophenolate mofetil combined to intravenous methylprednisolone pulses and oral low-dose glucocorticoids in severe early systemic sclerosis.

  Clinical and experimental rheumatology 20070101

• [Leukopenia in kidney transplantation resulting from the interaction between mycophenolate mofetil and valganciclovir].

  Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20070101

• Eruptive pseudoangiomatosis: report of an adult case and unifying hypothesis of the pathogenesis of paediatric and adult cases.

  Dermatology (Basel, Switzerland) 20070101

• Reduced intensity transplantation for metastatic renal cell cancer with 2-year follow-up.

  Journal of immunotherapy (Hagerstown, Md. : 1997) 20070101

• [Living related liver transplantation - analysis of the first 102 cases].

  Medycyna wieku rozwojowego 20070101

• Association of treatment with 15-deoxyspergualin and BK virus nephropathy in kidney allograft recipients.

  Clinical transplantation 20070101

• Steroid minimization in liver transplant recipients: impact on hepatitis C recurrence and post-transplant diabetes.

  Clinical transplantation 20070101

• Clinical outcomes of renal transplant recipients treated with enteric-coated mycophenolic acid vs. mycophenolate mofetil as a switch agent using a primary steroid-free rapamune and microemulsion cyclosporine protocol.

  Clinical transplantation 20070101

• Acute hepatitis following mycophenolate mofetil administration for ANCA-positive vasculitis.

  Scandinavian journal of rheumatology 20070101

• Immunosuppression for lung transplantation: evidence to date.

  Drugs 20070101

• Red blood cell anemia in a patient with pemphigus vulgaris induced by the use of mycophenolate mofetil and prednisone.

  The Journal of dermatological treatment 20070101

• Idiopathic membranous nephropathy in pediatric patients: presentation, response to therapy, and long-term outcome.

  BMC nephrology 20070101

• Therapeutic monitoring of mycophenolate mofetil.

  Clinical journal of the American Society of Nephrology : CJASN 20070101

• Everolimus and mycophenolate mofetil sensitize human pancreatic cancer cells to gemcitabine in vitro: a novel adjunct to standard chemotherapy?

  European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes 20070101

• New treatment strategies for proliferative lupus nephritis: keep children in mind!

  Lupus 20070101

• Induction therapies for class IV lupus nephritis with non-inflammatory necrotizing vasculopathy: mycophenolate mofetil or intravenous cyclophosphamide.

  Lupus 20070101

• Conventional therapy of psoriatic arthritis: evidence-based review.

  Reumatismo 20070101

• [2/3 The antimetabolites (azathioprine and mycophenolate)].

  Soins; la revue de reference infirmiere 20070101

• Mycophenolate mofetil as adjuvant in pemphigus vulgaris.

  Indian journal of dermatology, venereology and leprology 20070101

• [Effects of mycophenolate mofetil in ischemic acute renal failure in rats].

  Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20070101

• [Mycophenolate mofetil in the treatment of lupus nephritis, in patients with failure, intolerance or relapses after treatment with steroids and cyclophosphamide].

  Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20070101

• [Mycophenolate mofetil intentional self-poisoning].

  Therapie 20070101

• Mycophenolate mofetil for non-renal manifestations of systemic lupus erythematosus: a systematic review.

  Scandinavian journal of rheumatology 20070101

• Mycophenolate mofetil.

  Dermatologic therapy 20070101

• Mycophenolate sodium treatment in patients with primary Sjögren syndrome: a pilot trial.

  Arthritis research & therapy 20070101

• Mycophenolate mofetil as induction and maintenance therapy for lupus nephritis: rationale and protocol for the randomized, controlled Aspreva Lupus Management Study (ALMS).

  Lupus 20070101

• The effect of mycophenolate mofetil on patients with active non-renal SLE.

  Clinical and experimental rheumatology 20070101

• Successful rescue therapy with mycophenolate mofetil in kidney transplantation improves the long-term graft survival.

  Medicina (Kaunas, Lithuania) 20070101

• [Therapy of lupus nephritis with mycophenolate mofetil].

  Medicinski pregled 20070101

• Long-term graft outcome with mycophenolate mofetil and azathioprine: A paired kidney analysis.

  Transplantation 20061227

• Randomized controlled trial of FTY720 versus MMF in de novo renal transplantation.

  Transplantation 20061227

• Pregnancy outcomes in solid organ transplant recipients with exposure to mycophenolate mofetil or sirolimus.

  Transplantation 20061227

• [Dual, triple, and quadruple oral tacrolimus-based immunosuppression regimens after orthotopic liver transplantation: a randomised comparative study of regimens].

  Zhonghua yi xue za zhi 20061226

• Immunosuppression based on mycophenolate mofetil in stable liver transplanted patients.

  International immunopharmacology 20061220

• Early steroid withdrawal protocol with basiliximab, cyclosporine and mycophenolate mofetil in renal-transplant recipients.

  International immunopharmacology 20061220

• Peripheral CD4+ CD25+ Treg cell expansion in lung transplant recipients is not affected by calcineurin inhibitors.

  International immunopharmacology 20061220

• Reccurence of Kaposi's sarcoma after increased exposure to sirolimus.

  International immunopharmacology 20061220

• Bioequivalence of enteric-coated mycophenolate sodium and mycophenolate mofetil: a meta-analysis of three studies in stable renal transplant recipients.

  Transplantation 20061215

• Peripheral blood leukocyte counts in cytomegalovirus infected heart transplant patients: impact of acute disease versus subclinical infection.

  Transplantation 20061215

• [Treatment of nephrotic syndrome in the adult].

  Orvosi hetilap 20061203

• Angiotensin II, interstitial inflammation, and the pathogenesis of salt-sensitive hypertension.

  American journal of physiology. Renal physiology 20061201

• Mycophenolate mofetil for interstitial lung disease in scleroderma.

  Rheumatology (Oxford, England) 20061201

• FTY720 versus MMF with cyclosporine in de novo renal transplantation: a 1-year, randomized controlled trial in Europe and Australasia.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20061201

• Bullous pemphigoid treatment review.

  Expert opinion on pharmacotherapy 20061201

• Effect of immunoadsorption on refractory idiopathic focal and segmental glomerulosclerosis.

  Journal of clinical apheresis 20061201

• Mycophenolate mofetil treatment improves hypertension in patients with psoriasis and rheumatoid arthritis.

  Journal of the American Society of Nephrology : JASN 20061201

• Impact of tacrolimus and mycophenolate mofetil combination on cardiovascular risk profile after kidney transplantation.

  Journal of the American Society of Nephrology : JASN 20061201

• Mycophenolate mofetil in combination with reduction of calcineurin inhibitors for chronic renal dysfunction after liver transplantation.

  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20061201

• Quantification and 24-hour monitoring of mycophenolic acid by high-performance liquid chromatography in Japanese renal transplant recipients.

  Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20061201

• Pharmacokinetics of oral mycophenolate mofetil in dog: bioavailability studies and the impact of antibiotic therapy.

  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20061201

• Mycophenolate mofetil as an alternate immunosuppressor for autoimmune lymphoproliferative syndrome.

  Journal of pediatric hematology/oncology 20061201

• The role of therapeutic drug monitoring in individualizing immunosuppressive drug therapy: recent developments.

  Therapeutic drug monitoring 20061201

• Mycophenolic acid induces islet apoptosis by regulating mitogen-activated protein kinase activation.

  Transplantation proceedings 20061201

• Establishment of an animal model with side effects induced by mycophenolate mofetil and pharmacohistological analysis of them.

  Transplantation proceedings 20061201

• Differential pharmacokinetic interaction of tacrolimus and cyclosporine on everolimus.

  Transplantation proceedings 20061201

• Rescue therapy by immunoadsorption in combination with tacrolimus and mycophenolate mofetil for C4d-positive acute humoral renal allograft rejection.

  Transplantation proceedings 20061201

• Calcineurin inhibitor avoidance versus steroid avoidance following kidney transplantation: Postoperative complications.

  Transplantation proceedings 20061201

• Short-term results under three different immunosuppressive regimens at one center.

  Transplantation proceedings 20061201

• Results of a calcineurin-inhibitor-free immunosuppressive protocol in renal transplant recipients of expanded criteria deceased donors.

  Transplantation proceedings 20061201

• Sirolimus attenuates the rate of progression of early chronic allograft nephropathy.

  Transplantation proceedings 20061201

• Immunoglobulin induction therapy in renal transplant recipients: Effects on immunoglobulin and regulatory antibody levels.

  Transplantation proceedings 20061201

• Risk factors for wound healing complications in sirolimus-treated renal transplant recipients.

  Transplantation proceedings 20061201

• A cyclosporine-based immunosuppressive regimen may be better than tacrolimus for long-term liver allograft survival in recipients transplanted for hepatitis C.

  Transplantation proceedings 20061201

• Impact of mycophenolic acid dose modifications on renal function after kidney transplantation.

  Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 20061201

• Renal function and histology in kidney transplant patients receiving tacrolimus and sirolimus or mycophenolate mofetil.

  Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 20061201

• Mycophenolic acid trough level monitoring in solid organ transplant recipients treated with mycophenolate mofetil: association with clinical outcome.

  Current medical research and opinion 20061201

• [Pharmacokinetics of mycophenolic acid in Chinese patients with liver transplant].

  Yao xue xue bao = Acta pharmaceutica Sinica 20061201

• CD4+CD25bright+ regulatory T cells can mediate donor nonreactivity in long-term immunosuppressed kidney allograft patients.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20061201

• Spotlight on: clinical development of mycophenolate mofetil in multiple sclerosis.

  Drug news & perspectives 20061201

• Combined MMF and insulin therapy prevents renal injury in experimental diabetic rats.

  Cytokine 20061201

• Case of severe refractory myasthenia gravis in HUKM.

  The Medical journal of Malaysia 20061201

• Use of the organotypic culture method to investigate drug-loaded CSF shunt.

  Journal of controlled release : official journal of the Controlled Release Society 20061128

• Mycophenolate mofetil and bronchiectasis in pediatric transplant patients.

  Transplantation 20061127

• Molecularly imprinted solid-phase extraction for rapid screening of mycophenolic acid in human plasma.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20061121

• Effects of transient immunosuppression on adenoassociated, virus-mediated, liver-directed gene transfer in rhesus macaques and implications for human gene therapy.

  Blood 20061115

• Is mycophenolate mofetil better than azathioprine in organ transplantation?

  Transplantation 20061115

• Inclusion of MPA and in a rapid multi-drug LC-tandem mass spectrometric method for simultaneous determination of immunosuppressants.

  Clinica chimica acta; international journal of clinical chemistry 20061101

• Posttransplantation anemia at 12 months in kidney recipients treated with mycophenolate mofetil: risk factors and implications for mortality.

  Journal of the American Society of Nephrology : JASN 20061101

• Impact of cyclosporine reduction with MMF: a randomized trial in chronic allograft dysfunction. The 'reference' study.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20061101

• Mycophenolic acid inhibits hepatitis C virus replication and acts in synergy with cyclosporin A and interferon-alpha.

  Gastroenterology 20061101

• Rifampin induces alterations in mycophenolic acid glucuronidation and elimination: implications for drug exposure in renal allograft recipients.

  Clinical pharmacology and therapeutics 20061101

• Conversion to enteric-coated mycophenolate sodium from various doses of mycophenolate mofetil: results of a prospective international multicenter trial in maintenance renal transplant patients receiving cyclosporine.

  Transplantation proceedings 20061101

• Tolerability of enteric-coated mycophenolate sodium to 1 year in combination with cyclosporine and corticosteroids in renal transplant recipients.

  Transplantation proceedings 20061101

• Morbidity rates with reduced mycophenolate mofetil dosage: a single-center experience.

  Transplantation proceedings 20061101

• A randomized trial comparing two corticosteroid regimens combined with mycophenolate mofetil and cyclosporine for prevention of acute renal allograft rejection.

  Transplantation proceedings 20061101

• Conversion from azathioprine to mycophenolate mofetil followed by calcineurin inhibitor minimization or elimination in patients with chronic allograft dysfunction.

  Transplantation proceedings 20061101

• A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of pemphigus.

  Archives of dermatology 20061101

• Long-term control of papular dermatitis ('dermal hypersensitivity reaction') with mycophenolate mofetil.

  Archives of dermatology 20061101

• [Cryptococcal disease and immunosuppressive treatment].

  Enfermedades infecciosas y microbiologia clinica 20061101

• Alemtuzumab (Campath-1H) induction therapy and dendritic cells: Impact on peripheral dendritic cell repertoire in renal allograft recipients.

  Transplant immunology 20061101

• [Early steroid withdrawal in pediatric renal transplantation].

  Revista medica de Chile 20061101

• Mycophenolate mofetil in children with frequently relapsing nephrotic syndrome: a report from the Southwest Pediatric Nephrology Study Group.

  Clinical journal of the American Society of Nephrology : CJASN 20061101

• Therapeutic drug monitoring of mycophenolic acid in solid organ transplant patients treated with mycophenolate mofetil: review of the literature.

  Transplantation 20061027

• Multidrug resistance protein 2 genetic polymorphisms influence mycophenolic acid exposure in renal allograft recipients.

  Transplantation 20061027

• Mycophenolate mofetil attenuates pulmonary arterial hypertension in rats.

  Biochemical and biophysical research communications 20061020

• [Manifestation of diffuse proliferative lupus nephritis in a patient treated with long-term mycophenolate mofetil].

  Deutsche medizinische Wochenschrift (1946) 20061013

• Mycophenolate mofetil is effective in reducing lupus glomerulonephritis proteinuria.

  Rheumatology international 20061001

• Quantification by liquid chromatography tandem mass spectrometry of mycophenolic acid and its phenol and acyl glucuronide metabolites.

  Clinical chemistry 20061001

• Sirolimus monotherapy versus sirolimus in combination with steroids and/or MMF for immunosuppression after liver transplantation.

  Digestive diseases and sciences 20061001

• Mycophenolic acid is a potent inhibitor of angiogenesis.

  Arteriosclerosis, thrombosis, and vascular biology 20061001

• Investigation on pharmacokinetics of mycophenolic acid in Chinese adult renal transplant patients.

  British journal of clinical pharmacology 20061001

• A comparison of the effect of ciclosporin and sirolimus on the pharmokinetics of mycophenolate in renal transplant patients.

  British journal of clinical pharmacology 20061001

• Absence of an interaction between iron and mycophenolate mofetil absorption.

  British journal of clinical pharmacology 20061001

• Mycophenolate mofetil versus sirolimus as an adjunct to calcineurin inhibition after renal transplantation.

  Nature clinical practice. Nephrology 20061001

• Clinical pharmacokinetics of mycophenolate mofetil in Japanese renal transplant recipients: A retrospective cohort study in a single center.

  Biological & pharmaceutical bulletin 20061001

• Determination of inosine monophosphate dehydrogenase activity in human CD4+ cells isolated from whole blood during mycophenolic acid therapy.

  Therapeutic drug monitoring 20061001

• Validation of an abbreviated pharmacokinetic profile for the estimation of mycophenolic acid exposure in pediatric renal transplant recipients.

  Therapeutic drug monitoring 20061001

• CEDIA mycophenolic acid assay compared with HPLC-UV in specimens from transplant recipients.

  Therapeutic drug monitoring 20061001

• Mycophenolic acid formulation affects cyclosporine pharmacokinetics in stable kidney transplant recipients.

  Therapeutic drug monitoring 20061001

• Treatment of severe chronic idiopathic urticaria with oral mycophenolate mofetil in patients not responding to antihistamines and/or corticosteroids.

  International journal of dermatology 20061001

• [Cyclosporine A in treatment of lupus nephritis resistant to cyclophosphamide and mycophenolate mofetil: a case report].

  Revista clinica espanola 20061001

• Mycophenolate mofetil and risk of developing malignancy after orthotopic heart transplantation: analysis of the transplant registry of the International Society for Heart and Lung Transplantation.

  The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20061001

• Systemic sarcoidosis after cardiac transplantation in a 9-year-old child.

  The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20061001

• Characterization of intestinal absorption and enterohepatic circulation of mycophenolic Acid and its 7-O-glucuronide in rats.

  Drug metabolism and pharmacokinetics 20061001

• Renal transplant patients with gastrointestinal intolerability to mycophenolate mofetil: conversion to enteric-coated mycophenolate sodium.

  Transplantation proceedings 20061001

• Mycophenolate mofetil tolerability and dose changes in tacrolimus-treated renal allograft recipients.

  Transplantation proceedings 20061001

• Mycophenolic Acid reaches therapeutic levels whereas mycophenolate mofetil does not.

  Transplantation proceedings 20061001

• Efficacy and safety of monotherapy with mycophenolate mofetil in liver transplantation.

  Transplantation proceedings 20061001

• Pharmacokinetic evaluation of mycophenolic acid profiles during the period immediately following an orthotopic liver transplant.

  Transplantation proceedings 20061001

• Evolutional changes in maintenance immunosuppression following heart transplantation.

  Transplantation proceedings 20061001

• [Studies on the breeding by ion implantation and cultivation of mycophenolic acid producing strain].

  Wei sheng wu xue bao = Acta microbiologica Sinica 20061001

• [Mycophenolate mofetil maintenance therapy in lupus nephritis].

  Polskie Archiwum Medycyny Wewnetrznej 20061001

• Development of de novo cancer in p53 knock-out mice is dependent on the type of long-term immunosuppression used.

  Transplantation 20060927

• Rapamycin improves lymphoproliferative disease in murine autoimmune lymphoproliferative syndrome (ALPS).

  Blood 20060915

• Mycophenolic acid inhibits mesangial cell activation through p38 MAPK inhibition.

  Life sciences 20060913

• An assessment of renal failure in an SLE cohort with special reference to ethnicity, over a 25-year period.

  Rheumatology (Oxford, England) 20060901

• Mycophenolate mofetil and tacrolimus: new therapeutic options in neuroimmunological diseases.

  Muscle & nerve 20060901

• Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in liver transplant patients presenting gastrointestinal disorders: a pilot study.

  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20060901

• Adenovirus-mediated gene therapy to restore expression and functionality of multiple UDP-glucuronosyltransferase 1A enzymes in Gunn rat liver.

  The Journal of pharmacology and experimental therapeutics 20060901

• Influence of nonsynonymous polymorphisms of UGT1A8 and UGT2B7 metabolizing enzymes on the formation of phenolic and acyl glucuronides of mycophenolic acid.

  Drug metabolism and disposition: the biological fate of chemicals 20060901

• Characterization of rat intestinal microsomal UDP-glucuronosyltransferase activity toward mycophenolic acid.

  Drug metabolism and disposition: the biological fate of chemicals 20060901

• Pharmacokinetics of mycophenolic acid and its glucuronidated metabolites in stable lung transplant recipients.

  The Annals of pharmacotherapy 20060901

• Pathogenesis and treatment of systemic lupus erythematosus nephritis.

  Current opinion in rheumatology 20060901

• Value of therapeutic drug monitoring of MMF therapy in pediatric transplantation.

  Pediatric transplantation 20060901

• Treatment strategies in pediatric solid organ transplant recipients with calcineurin inhibitor-induced nephrotoxicity.

  Pediatric transplantation 20060901

• Immune-mediated hemolytic anemia in pediatric renal transplantation.

  Pediatric transplantation 20060901

• Mycophenolate mofetil and sirolimus combination in renal transplantation.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20060901

• An unusual case of urticaria and nephrotic syndrome.

  American journal of kidney diseases : the official journal of the National Kidney Foundation 20060901

• Neuroregeneration in composite tissue allografts: effect of low-dose FK506 and mycophenolate mofetil immunotherapy.

  Plastic and reconstructive surgery 20060901

• Limited sampling strategy for predicting area under the concentration-time curve of mycophenolic acid in adult lung transplant recipients.

  Pharmacotherapy 20060901

• Initial experience with ABO-incompatible live donor renal transplantation.

  Journal of the Formosan Medical Association = Taiwan yi zhi 20060901

• Comparison of transplanted kidney function in patients on two different doses of mycophenolate mofetil.

  Transplantation proceedings 20060901

• Mycophenolate mofetil (Cellcept) in pediatric renal transplantation.

  Transplantation proceedings 20060901

• Comparison of enteric-coated mycophenolate sodium with mycophenolate mofetil in living renal allograft transplantation.

  Transplantation proceedings 20060901

• Pharmacokinetics of mycophenolic acid and its glucuronide after a single and multiple oral dose of mycophenolate mofetil in Chinese renal transplantation recipients.

  Transplantation proceedings 20060901

• Therapeutic drug monitoring of mycophenolic acid can be used as predictor of clinical events for kidney transplant recipients treated with mycophenolate mofetil.

  Transplantation proceedings 20060901

• Effects of azathioprine and mycophenolate mofetil-immunosuppressive regimens on the erythropoietic system of renal transplant recipients.

  Transplantation proceedings 20060901

• Conversion from cyclosporine to mycophenolate mofetil improves expression of A20 in the rat kidney allografts undergoing chronic rejection.

  Transplantation proceedings 20060901

• Comparison of cyclosporine versus mycophenolate mofetil on expression of Fractalkine and CX3CR1 in chronic allograft nephropathy.

  Transplantation proceedings 20060901

• Effect of mycophenolate mofetil monotherapy on T-cell functions and inosine monophosphate dehydrogenase activity in patients undergoing a kidney transplantation.

  Transplantation proceedings 20060901

• Corticosteroids and kidney transplantation.

  Clinical journal of the American Society of Nephrology : CJASN 20060901

• Effect of prednisone versus no prednisone as part of maintenance immunosuppression on long-term renal transplant function.

  Clinical journal of the American Society of Nephrology : CJASN 20060901

• Circadian pharmacokinetics of mycophenolic Acid and implication of genetic polymorphisms for early clinical events in renal transplant recipients.

  Transplantation 20060827

• Tacrolimus/mycophenolate mofetil improved natural killer lymphocyte reconstitution one year after kidney transplant by reference to cyclosporine/azathioprine.

  Transplantation 20060827

• Mycophenolate sodium-induced hepatotoxicity: first report.

  Transplantation 20060827

• The influence of immunosuppressive drugs on T- and B-cell apoptosis via p53-mediated pathway in vitro and in vivo.

  Transplantation 20060815

• Efficacy of mycofenolate mofetil for steroid-resistant acute rejection after living donor liver transplantation.

  World journal of gastroenterology 20060814

• Novel methylenephosphophosphonate analogues of mycophenolic adenine dinucleotide. Inhibition of inosine monophosphate dehydrogenase.

  Journal of medicinal chemistry 20060810

• Mycophenolate mofetil as first-line treatment improves clinically evident early scleroderma lung disease.

  Rheumatology (Oxford, England) 20060801

• Mycophenolate mofetil impairs the integrity of colonic anastomosis.

  The Journal of surgical research 20060801

• Switching immunosuppression medications after renal transplantation--a common practice.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20060801

• Enhancement of the infectivity of SARS-CoV in BALB/c mice by IMP dehydrogenase inhibitors, including ribavirin.

  Antiviral research 20060801

• Ex vivo selection and expansion of cells based on expression of a mutated inosine monophosphate dehydrogenase 2 after HIV vector transduction: effects on lymphocytes, monocytes, and CD34+ stem cells.

  Molecular therapy : the journal of the American Society of Gene Therapy 20060801

• An isocratic high performance liquid chromatographic method for quantification of mycophenolic acid and its glucuronide metabolite in human serum using liquid-liquid extraction: application to human pharmacokinetic studies.

  Clinica chimica acta; international journal of clinical chemistry 20060801

• Unexpectedly high exposure to enteric-coated mycophenolate sodium upon once-daily dosing.

  Pediatric nephrology (Berlin, Germany) 20060801

• Unclear fever 7 weeks after renal transplantation in a 56-year-old patient.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20060801

• Use of intravenous mycophenolate mofetil for graft-versus-host disease prophylaxis in an allogeneic hematopoietic stem cell transplant recipient with an allergic reaction to cyclosporine and tacrolimus.

  Bone marrow transplantation 20060801

• Effect of mycophenolate mofetil on rat kidney grafts with prolonged cold preservation.

  Kidney international 20060801

• Azathioprine/methylprednisolone versus cyclophosphamide in proliferative lupus nephritis. A randomized controlled trial.

  Kidney international 20060801

• Daclizumab induction and maintenance steroid-free immunosuppression with mycophenolate mofetil and tacrolimus to prevent acute rejection of hepatic allografts.

  Transplant international : official journal of the European Society for Organ Transplantation 20060801

• Mannose-6-phosphate/insulin-Like growth factor-II receptors may represent a target for the selective delivery of mycophenolic acid to fibrogenic cells.

  Pharmaceutical research 20060801

• SRL-based immunosuppression vs. CNI minimization in pediatric renal transplant recipients with chronic CNI nephrotoxicity.

  Pediatric transplantation 20060801

• Mycophenolic acid inhibits SLE-associated cytokine expression and promotes apoptosis of peripheral blood mononuclear cells from patients with systemic lupus erythematosus.

  Acta pharmacologica Sinica 20060801

• Immunosuppression using the mTOR inhibition mechanism affects replacement of rat liver with transplanted cells.

  Hepatology (Baltimore, Md.) 20060801

• Gastrointestinal symptoms of Henoch-Schönlein purpura treated with mycophenolate mofetil.

  Journal of pediatric gastroenterology and nutrition 20060801

• Fully automated analytical method for mycophenolic acid quantification in human plasma using on-line solid phase extraction and high performance liquid chromatography with diode array detection.

  Therapeutic drug monitoring 20060801

• Similar efficacy and safety of enteric-coated mycophenolate sodium (EC-MPS, myfortic) compared with mycophenolate mofetil (MMF) in de novo heart transplant recipients: results of a 12-month, single-blind, randomized, parallel-group, multicenter study.

  The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20060801

• Treatment of proliferative lupus nephritis: a changing landscape.

  Kidney international 20060801

• Long-term safety and efficacy after conversion of maintenance renal transplant recipients from mycophenolate mofetil (MMF) to enteric-coated mycophenolate sodium (EC-MPA, myfortic).

  Clinical nephrology 20060801

• Long-term administration of enteric-coated mycophenolate sodium (EC-MPS; myfortic) is safe in kidney transplant patients.

  Clinical nephrology 20060801

• [Application of mycophenolate mofetil in hepatitis C patients after kidney transplantation].

  Nan fang yi ke da xue xue bao = Journal of Southern Medical University 20060801

• Absorption characteristics of EC-MPS--an enteric-coated formulation of mycophenolic sodium.

  International journal of clinical pharmacology and therapeutics 20060801

• Mycophenolate mofetil treatment in primary glomerular disease: one-year follow-up in steroid dependent and resistant nephrotic syndrome.

  Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20060801

• [Mycophenolic acid concentration profiles may select recipients with high-risk of acute rejection in renal transplant recipients].

  Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 20060801

• Combination effect of mycophenolate mofetil with mizoribine on cell proliferation assays and in a mouse heart transplantation model.

  Transplantation 20060727

• Spectroscopic characterization of copper(II) binding to the immunosuppressive drug mycophenolic acid.

  Journal of the American Chemical Society 20060726

• [A rare cause of anemia in a kidney-transplant recipient].

  Medizinische Klinik (Munich, Germany : 1983) 20060715

• Three-year observational follow-up of a multicenter, randomized trial on tacrolimus-based therapy with withdrawal of steroids or mycophenolate mofetil after renal transplant.

  Transplantation 20060715

• Calcineurin inhibitor avoidance with daclizumab, mycophenolate mofetil, and prednisolone in DR-matched de novo kidney transplant recipients.

  Transplantation 20060715

• Mycophenolate mofetil dose reductions and discontinuations after gastrointestinal complications are associated with renal transplant graft failure.

  Transplantation 20060715

• Activation of the purine salvage pathway in mononuclear cells of cardiac recipients treated with mycophenolate mofetil.

  Transplantation 20060715

• Mycophenolate mofetil is a highly effective and safe immunosuppressive agent for the treatment of uveitis : a retrospective analysis of 106 patients.

  Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 20060701

• Phosphonic acid-containing analogues of mycophenolic acid as inhibitors of IMPDH.

  Bioorganic & medicinal chemistry letters 20060701

• Sustained improvement of a girl affected with Devic's disease over 2 years of mycophenolate mofetil treatment.

  Rheumatology (Oxford, England) 20060701

• Immune suppression attenuates hypertension and renal disease in the Dahl salt-sensitive rat.

  Hypertension (Dallas, Tex. : 1979) 20060701

• Inhibition of dengue virus replication by mycophenolic acid and ribavirin.

  The Journal of general virology 20060701

• Late and early C4d-positive acute rejection: different clinico-histopathological subentities in renal transplantation.

  Kidney international 20060701

• Mycophenolate mofetil for lupus related myelopathy.

  Annals of the rheumatic diseases 20060701

• CYP3A5*3 influences sirolimus oral clearance in de novo and stable renal transplant recipients.

  Clinical pharmacology and therapeutics 20060701

• Conversion to everolimus in maintenance patients--current clinical strategies.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20060701

• Conversion to everolimus in a patient with arterial hypertension and recurrent cutaneous neoplasia--a case report.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20060701

• Change from cyclosporine to combination therapy of mycophenolic acid with the new sphingosine-1-phosphate receptor agonist, KRP-203, prevents host nephrotoxicity and transplant vasculopathy in rats.

  The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20060701

• Mycophenolate mofetil use is associated with decreased risk of late acute rejection in adult liver transplant recipients.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20060701

• Long-term renal allograft function on a tacrolimus-based, pred-free maintenance immunosuppression comparing sirolimus vs. MMF.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20060701

• Guidelines for the treatment of autoimmune neuromuscular transmission disorders.

  European journal of neurology 20060701

• Sequential study on the treatment of moderate-to-severe chronic plaque psoriasis with mycophenolate mofetil and cyclosporin.

  Journal of the European Academy of Dermatology and Venereology : JEADV 20060701

• Mycophenolate mofetil is safe, well tolerated, and preserves lung function in patients with connective tissue disease-related interstitial lung disease.

  Chest 20060701

• Rescue therapy with tacrolimus and mycophenolate mofetil does not prevent deterioration of graft function in C4d-positive chronic allograft nephropathy.

  Wiener klinische Wochenschrift 20060701

• [Living unrelated renal transplantation in an eldery couple: a case report].

  Hinyokika kiyo. Acta urologica Japonica 20060701

• Induction therapy for active lupus nephritis: mycophenolate mofetil is superior to cyclophosphamide.

  Nature clinical practice. Rheumatology 20060701

• Is mycophenolate mofetil a new treatment option in acute interstitial nephritis?

  Clinical journal of the American Society of Nephrology : CJASN 20060701

• Mycophenolate mofetil for the treatment of interstitial nephritis.

  Clinical journal of the American Society of Nephrology : CJASN 20060701

• New therapies for lupus nephritis.

  Clinical journal of the American Society of Nephrology : CJASN 20060701

• Use of benzofuran for concomitant protection of aldehyde and phenol groups in the preparation of mycophenolic acid analogues.

  The Journal of organic chemistry 20060623

• Vasculitis treatment - new therapeutic approaches.

  European journal of pediatrics 20060601

• Tacrolimus with mycophenolate mofetil (MMF) or sirolimus vs. cyclosporine with MMF in cardiac transplant patients: 1-year report.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20060601

• [New treatments for systemic diseases].

  Archives de pediatrie : organe officiel de la Societe francaise de pediatrie 20060601

• [Chronic autoimmune hemolytic anemia: toward new treatments?].

  Archives de pediatrie : organe officiel de la Societe francaise de pediatrie 20060601

• Combination antithymocyte globulin and soluble TNFalpha inhibitor (etanercept) +/- mycophenolate mofetil for treatment of steroid refractory acute graft-versus-host disease.

  Bone marrow transplantation 20060601

• Treatment of severe aplastic anaemia with combined immunosuppression: anti-thymocyte globulin, ciclosporin and mycophenolate mofetil.

  British journal of haematology 20060601

• Long-term results of tacrolimus monotherapy in cardiac transplant recipients.

  The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20060601

• Granulomatous uveitis revealing Wegener's granulomatosis.

  The Journal of rheumatology 20060601

• A limited sampling model for estimation of total and unbound mycophenolic acid (MPA) area under the curve (AUC) in hematopoietic cell transplantation (HCT).

  Therapeutic drug monitoring 20060601

• Analysis of mycophenolic acid in saliva using liquid chromatography tandem mass spectrometry.

  Therapeutic drug monitoring 20060601

• Beyond cyclosporine: a systematic review of limited sampling strategies for other immunosuppressants.

  Therapeutic drug monitoring 20060601

• Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in patients with gastrointestinal side effects: case studies.

  Progress in transplantation (Aliso Viejo, Calif.) 20060601

• Conversion from calcineurin inhibitors to sirolimus in patients with chronic renal allograft dysfunction.

  Transplantation proceedings 20060601

• Efficacy and safety of enteric-coated mycophenolate sodium (myfortic) in de novo renal transplant recipients: results of a 12-month multicenter, open-label, prospective study.

  Transplantation proceedings 20060601

• Mycophenolic acid upregulates B7-DC expression on dendritic cells, which is associated with impaired allostimulatory capacity of dendritic cells.

  Transplantation proceedings 20060601

• Mycophenolate mofetil as an immunosuppressive agent in refractory inflammatory eye disease.

  Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20060601

• Ischemic training and immunosuppressive agents reduce the intensity of ischemic reperfusion injury after kidney transplantation.

  Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 20060601

• Mycophenolate mofetil-based immunosuppressive minimization and withdrawal strategies in renal transplantation: possible risks and benefits.

  Current opinion in nephrology and hypertension 20060601

• A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.

  Clinical therapeutics 20060601

• Structure and function of the MRP2 (ABCC2) protein and its role in drug disposition.

  Expert opinion on drug metabolism & toxicology 20060601

• Switching immunosuppressive drugs in kidney transplant recipients: 'show me the evidence'.

  Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia 20060601

• Induction therapy for active lupus nephritis: mycophenolate mofetil versus cyclophosphamide.

  Nature clinical practice. Nephrology 20060601

• Patient-reported gastrointestinal symptom burden and health-related quality of life following conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium.

  Transplantation 20060515

• Identification of type 1 inosine monophosphate dehydrogenase as an antiangiogenic drug target.

  Journal of medicinal chemistry 20060504

• Recurrence of proteinuria following renal transplantation in congenital nephrotic syndrome of the Finnish type.

  Pediatric nephrology (Berlin, Germany) 20060501

• C1q nephropathy in a child with a chromosome 13 deletion.

  Pediatric nephrology (Berlin, Germany) 20060501

• Short-term outcomes of severe lupus nephritis in a cohort of predominantly African-American children.

  Pediatric nephrology (Berlin, Germany) 20060501

• Wound healing complications with de novo sirolimus versus mycophenolate mofetil-based regimen in cardiac transplant recipients.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20060501

• Mycophenolate mofetil reduces intimal thickness by intravascular ultrasound after heart transplant: reanalysis of the multicenter trial.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20060501

• Sympathetic nerve activity in renal transplant patients before and after withdrawal of cyclosporine.

  Journal of hypertension 20060501

• Effects of mycophenolic acid on inosine monophosphate dehydrogenase I and II mRNA expression in white blood cells and various tissues in sheep.

  Journal of veterinary medicine. A, Physiology, pathology, clinical medicine 20060501

• Adsorption of mycophenolic acid and its phenolic glucuronide to glass, polystyrene, and polypropylene containers.

  Clinical chemistry 20060501

• Mycophenolate mofetil introduction stabilizes and subsequent cyclosporine A reduction slightly improves kidney function in pediatric renal transplant patients: a retrospective analysis.

  Pediatric transplantation 20060501

• Preventing sensitization with mycophenolate mofetil in a pediatric kidney recipient.

  Pediatric transplantation 20060501

• Preventing cardiac allograft vasculopathy: long-term beneficial effects of mycophenolate mofetil.

  The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20060501

• [Effects of different immunodepressants on the sperm parameters of kidney transplant recipients].

  Zhonghua nan ke xue = National journal of andrology 20060501

• Renoprotective effects of combination of angiotensin converting enzyme inhibitor with mycophenolate mofetil in diabetic rats.

  Inflammation research : official journal of the European Histamine Research Society ... [et al.] 20060501

• Role of maintenance immunosuppressive regimen in kidney transplant outcome.

  Clinical journal of the American Society of Nephrology : CJASN 20060501

• Mycophenolate mofetil in dermatomyositis: is it safe?

  Neurology 20060425

• Comparison of mycophenolate mofetil and azathioprine for prevention of bronchiolitis obliterans syndrome in de novo lung transplant recipients.

  Transplantation 20060415

• Improved renal function after conversion from tacrolimus/sirolimus to tacrolimus/mycophenolate mofetil in kidney transplant recipients.

  Transplantation 20060415

• Compensatory enlargement in transplant coronary artery disease: an intravascular ultrasound study.

  Chinese medical journal 20060405

• Simultaneous determination of mycophenolic acid and valproic acid based on derivatization by high-performance liquid chromatography with fluorescence detection.

  Biomedical chromatography : BMC 20060401

• Successful treatment of MuSK antibody-positive myasthenia gravis with rituximab.

  Muscle & nerve 20060401

• Immunosuppression and outcomes of patients transplanted for hepatitis C.

  Journal of hepatology 20060401

• Acute inflammatory syndrome induced by mycophenolate mofetil in a patient following kidney transplantation.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20060401

• Unrelated donor granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell transplantation after nonmyeloablative conditioning: the effect of postgrafting mycophenolate mofetil dosing.

  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20060401

• Childhood IgA-mediated epidermolysis bullosa acquisita responding to mycophenolate mofetil as a corticosteroid-sparing agent.

  Journal of the American Academy of Dermatology 20060401

• Images in emergency medicine. Pemphigus vulgaris.

  Annals of emergency medicine 20060401

• Mycophenolate mofetil-associated enterocolitis.

  Gastrointestinal endoscopy 20060401

• Simultaneous corticosteroid avoidance and calcineurin inhibitor minimization in renal transplantation.

  Transplant international : official journal of the European Society for Organ Transplantation 20060401

• Ischemic acute tubular necrosis models and drug discovery: a focus on cellular inflammation.

  Drug discovery today 20060401

• Therapeutic drug monitoring of mycophenolate mofetil in transplantation.

  Therapeutic drug monitoring 20060401

• Determination of mycophenolic acid plasma levels in renal transplant recipients co-administered sirolimus: comparison of an enzyme multiplied immunoassay technique (EMIT) and liquid chromatography-tandem mass spectrometry.

  Therapeutic drug monitoring 20060401

• Revisiting the immunomodulators tacrolimus, methotrexate, and mycophenolate mofetil: their mechanisms of action and role in the treatment of IBD.

  Inflammatory bowel diseases 20060401

• [Prevention of hepatic failure induced by BCG and lipopolysaccharide in mice using mycophenolate mofetil].

  Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20060401

• FTY720 treatment of kidney transplant patients: a differential effect on B cells, naïve T cells, memory T cells and NK cells.

  Transplant immunology 20060401

• Pharmacokinetic profiling of cyclosporine microemulsion during the first 3 weeks after simultaneous pancreas-kidney transplantation.

  Transplantation proceedings 20060401

• Antiproliferative and overadditive effects of everolimus and mycophenolate mofetil in pancreas and lung cancer cells in vitro.

  Transplantation proceedings 20060401

• Use of enteric-coated mycophenolate sodium in de novo renal transplant recipients with high incidence of delayed graft function.

  Transplantation proceedings 20060401

• Enteric-coated mycophenolate sodium experience in liver transplant patients.

  Transplantation proceedings 20060401

• Preliminary experience with mycophenolate mofetil for preservation of renal function in cardiac transplant patients with documented cyclosporine nephrotoxicity.

  Nephrology (Carlton, Vic.) 20060401

• Does mycophenolate mofetil increase the risk of cytomegalovirus infection in solid organ transplant recipients?--A mini-review.

  The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 20060401

• A randomized long-term trial of tacrolimus/sirolimus versus tacrolimums/mycophenolate versus cyclosporine/sirolimus in renal transplantation: three-year analysis.

  Transplantation 20060327

• Comparison of sequential protocol using basiliximab versus antithymocyte globulin with high-dose mycophenolate mofetil in recipients of a kidney graft from an expanded-criteria donor.

  Transplantation 20060327

• Switch from calcineurin inhibitors to sirolimus-induced renal recovery in heart transplant recipients in the midterm follow-up.

  Transplantation 20060315

• An open prospective pilot study on the use of rapamycin after penetrating high-risk keratoplasty.

  Transplantation 20060315

• [Early outcome of orthotopic heart transplantation: a report of 21 cases].

  Zhonghua wai ke za zhi [Chinese journal of surgery] 20060315

• Prevention of early renal injury by mycophenolate mofetil and its mechanism in experimental diabetes.

  International immunopharmacology 20060301

• Heart transplantation across the antibodies against HLA and ABO.

  Transplant international : official journal of the European Society for Organ Transplantation 20060301

• Explaining variability in mycophenolic acid exposure to optimize mycophenolate mofetil dosing: a population pharmacokinetic meta-analysis of mycophenolic acid in renal transplant recipients.

  Journal of the American Society of Nephrology : JASN 20060301

• Cytokine analysis to predict immunosuppression.

  Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060301

• Novel apoptosis assay to analyze immunosuppression.

  Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060301

• Individualization of mycophenolate mofetil dose in renal transplant recipients.

  Expert opinion on pharmacotherapy 20060301

• Efficacy of mycophenolic acid combined with KRP-203, a novel immunomodulator, in a rat heart transplantation model.

  The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20060301

• American Gastroenterological Association Institute medical position statement on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease.

  Gastroenterology 20060301

• American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease.

  Gastroenterology 20060301

• Coexisting subacute and systemic lupus erythematosus after terbinafine administration: successful treatment with mycophenolate mofetil.

  International journal of dermatology 20060301

• Relation of C-2 monitoring with serum lipid profile in stable renal transplant patients.

  Transplantation proceedings 20060301

• Liver pathology and cell proliferation after calcineurin inhibitors and antiproliferative drugs following partial hepatectomy in rats.

  Transplantation proceedings 20060301

• Cyclosporine drug monitoring with C0 and C2 concentrations in children with stable renal allograft function.

  Pediatric transplantation 20060301

• Pinpoint targeted immunosuppression: anti-CD20/MMF desensitization with anti-CD25 in successful ABO-incompatible kidney transplantation without splenectomy.

  Xenotransplantation 20060301

• [Pharmacokinetic model for the enterohepatic circulation of mycophenolic acid].

  Yao xue xue bao = Acta pharmaceutica Sinica 20060301

• Mycophenolate: better value through monitoring?

  Transplantation 20060227

• Sequential determination of pharmacokinetics and pharmacodynamics of mycophenolic acid in liver transplant patients treated with mycophenolate mofetil.

  Transplantation 20060227

• [Bullous pemphigoid: diagnostics and new therapeutic strategies].

  Deutsche medizinische Wochenschrift (1946) 20060224

• Mycophenolate mofetil or intravenous cyclophosphamide in lupus nephritis.

  The New England journal of medicine 20060216

• Mycophenolate mofetil or intravenous cyclophosphamide in lupus nephritis.

  The New England journal of medicine 20060216

• Posttransplant diabetes mellitus in kidney transplant recipients receiving calcineurin or mTOR inhibitor drugs.

  Transplantation 20060215

• Conversion to sirolimus and mycophenolate can attenuate the progression of bronchiolitis obliterans syndrome and improves renal function after lung transplantation.

  Transplantation 20060215

• Inosine 5'-monophosphate dehydrogenase inhibition by mycophenolic acid impairs maturation and function of dendritic cells.

  Clinica chimica acta; international journal of clinical chemistry 20060201

• Role of Mrp2 in the hepatic disposition of mycophenolic acid and its glucuronide metabolites: effect of cyclosporine.

  Drug metabolism and disposition: the biological fate of chemicals 20060201

• Mycophenolate mofetil (MMF): firing at the atherosclerotic plaque from different angles?

  Cardiovascular research 20060201

• Successful steroid-sparing treatment of renal limited sarcoidosis with mycophenolate mofetil.

  Pediatric nephrology (Berlin, Germany) 20060201

• Individualizing combination of two antiproliferative immunosuppressants with pharmacodynamic modeling of stimulated lymphocyte responses.

  Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060201

• Mycophenolate mofetil treatment of myasthenia gravis.

  The Annals of pharmacotherapy 20060201

• Within-patient variability of mycophenolic acid exposure: therapeutic drug monitoring from a clinical point of view.

  Therapeutic drug monitoring 20060201

• Pharmacokinetics of mycophenolic acid and metabolites in diabetic kidney transplant recipients.

  Therapeutic drug monitoring 20060201

• High-performance liquid chromatography method for the determination of mycophenolic acid and its acyl and phenol glucuronide metabolites in human plasma.

  Therapeutic drug monitoring 20060201

• Tacrolimus combined with mycophenolate mofetil can effectively reverse C4d-positive steroid-resistant acute rejection in Chinese renal allograft recipients.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20060201

• Pure red cell aplasia associated with concomitant use of mycophenolate mofetil and ribavirin in post-transplant recurrent hepatitis C.

  Transplant international : official journal of the European Society for Organ Transplantation 20060201

• Tacrolimus and mycophenolate mofetil after nonmyeloablative matched-sibling donor allogeneic stem-cell transplantations conditioned with fludarabine and low-dose total body irradiation.

  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20060201

• Effects of calcineurin inhibitors on pharmacokinetics of mycophenolic acid and its glucuronide metabolite during the maintenance period following renal transplantation.

  Biological & pharmaceutical bulletin 20060201

• Comparison of mycophenolic acid pharmacokinetic parameters in kidney transplant patients within the first 3 months post-transplant.

  Journal of clinical pharmacy and therapeutics 20060201

• Improved outcomes in nephrotic syndrome.

  Cleveland Clinic journal of medicine 20060201

• Protective effect of glucocorticoid-free immunosuppressive regimen in allogenic islet transplantation.

  Hepatobiliary & pancreatic diseases international : HBPD INT 20060201

• IMP dehydrogenase inhibitor mycophenolate mofetil induces caspase-dependent apoptosis and cell cycle inhibition in multiple myeloma cells.

  Molecular cancer therapeutics 20060201

• [ANCA associated glomerulonephritis: Pathogenesis, pathophysiology, and therapy].

  Nihon rinsho. Japanese journal of clinical medicine 20060201

• [Molecular action mechanisms of the therapeutic agents for kidney diseases: Immunosuppressants].

  Nihon rinsho. Japanese journal of clinical medicine 20060201

• Mycophenolate mofetil and bronchiectasis in kidney transplant patients: a possible relationship.

  Transplantation 20060127

• Treatment for acute myelogenous leukemia by low-dose, total-body, irradiation-based conditioning and hematopoietic cell transplantation from related and unrelated donors.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060120

• Five years of steroid sparing in renal transplantation with tacrolimus and mycophenolate mofetil.

  Transplantation 20060115

• Mycophenolic acid-induced replication arrest, differentiation markers and cell death of androgen-independent prostate cancer cells DU145.

  Cancer letters 20060108

• Regulation of the interaction of inosine monophosphate dehydrogenase with mycophenolic Acid by GTP.

  The Journal of biological chemistry 20060106

• 15-Deoxyspergualin and cyclophosphamide, but not mycophenolate mofetil, prolong survival and attenuate renal disease in a murine model of ANCA-associated crescentic nephritis.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20060101

• Decreased risk of acute gastrointestinal toxicity when substituting methotrexate with mycophenolate mofetil in the prevention of graft-versus-host disease in stem cell transplantation following myeloablative conditioning regimens.

  Bone marrow transplantation 20060101

• Mycophenolate mofetil in anti-neutrophil cytoplasm antibodies-associated systemic vasculitis.

  Nephron. Clinical practice 20060101

• Remission of severe relapsing or persistent lupus nephritis using mycophenolate mofetil.

  Archives of medical research 20060101

• Advances in the therapy of Wegener's granulomatosis.

  Current opinion in rheumatology 20060101

• Marked erythrocyte microcytosis under primary immunosuppression with sirolimus.

  Transplant international : official journal of the European Society for Organ Transplantation 20060101

• Mycophenolic acid clinical pharmacokinetics influenced by a cyclosporine C2 based immunosuppressive regimen in renal allograft recipients.

  Transplant international : official journal of the European Society for Organ Transplantation 20060101

• Efficacy of mycophenolate mofetil as single-agent therapy for refractory immune thrombocytopenic purpura.

  American journal of hematology 20060101

• Acquired Pelger-Huët anomaly in association with concomitant tacrolimus and mycophenolate mofetil in a liver transplant patient: a case report and review of the literature.

  Archives of pathology & laboratory medicine 20060101

• Impact of initial exposure to calcineurin inhibitors on kidney graft function of patients at high risk to develop delayed graft function.

  Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 20060101

• Localized Kaposi's sarcoma in a patient with pemphigus vulgaris.

  Journal of the European Academy of Dermatology and Venereology : JEADV 20060101

• Mycophenolate mofetil as an effective corticosteroid-sparing therapy for recalcitrant dermatomyositis.

  Archives of dermatology 20060101

• Liver enzyme abnormalities in patients with atopic dermatitis treated with mycophenolate mofetil.

  Archives of dermatology 20060101

• Mycophenolic acid 12-h trough level monitoring in renal transplantation: association with acute rejection and toxicity.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20060101

• Mycophenolate mofetil is effective and well tolerated in the treatment of refractory acute and chronic graft-versus-host disease.

  International journal of hematology 20060101

• Inosine monophosphate dehydrogenase activity in renal allograft recipients during mycophenolate treatment.

  Scandinavian journal of clinical and laboratory investigation 20060101

• Successful reversal of acute vascular rejection and cyclosporine-associated nephrotoxicity in renal allograft with combined sirolimus and mycophenolate mofetil as immunotherapy.

  Transplantation proceedings 20060101

• Individualization of immunosuppressive therapy. II. Sirolimus as a less nephrotoxic alternative to calcineurin inhibitors.

  Transplantation proceedings 20060101

• The weight of pharmacokinetic parameters for mycophenolic acid in prediction of rejection outcome: the receiver operating characteristic curve analysis.

  Transplantation proceedings 20060101

• Noninvasive evaluation of immunosuppressive drug efficacy on acute donor cell survival.

  Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 20060101

• Prospective, randomized trial of steroid withdrawal in kidney recipients treated with mycophenolate mofetil and cyclosporine.

  Clinical transplantation 20060101

• Cyclosporine withdrawal in post-renal transplant thrombotic microangiopathy.

  Clinical transplantation 20060101

• Corticosteroid-sparing strategies in renal transplantation: are we still balancing rejection risk with improved tolerability?

  Drugs 20060101

• The immunosuppressant mycophenolate mofetil improves preservation of the perforant path in organotypic hippocampal slice cultures: a retrograde tracing study.

  Hippocampus 20060101

• Mycophenylate mofetil: what role in the treatment of lupus?

  Lupus 20060101

• Mycophenolate mofetil ameliorates accelerated progressive nephropathy in rat.

  Kidney & blood pressure research 20060101

• [Lupus nephritis, mycophenolate, and cytomegalovirus infection].

  Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20060101

• Determinants of patient survival in systemic lupus erythematosus--focusing on lupus nephritis.

  Ethnicity & disease 20060101

• Use of non-absorbable polypropylene mesh for the treatment of spontaneous renal graft rupture.

  Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion 20060101

• Long-term results of mycophenolate mofetil as part of immunosuppressive induction therapy after liver transplantation.

  Clinical transplantation 20060101

• Efficacy of conventional immunosuppressive therapy in related and unrelated living renal transplantation.

  Clinical transplantation 20060101

• Two-dose basiliximab compared with two-dose daclizumab in renal transplantation: a clinical study.

  Clinical transplantation 20060101

• Hydroxychloroquine use predicts complete renal remission within 12 months among patients treated with mycophenolate mofetil therapy for membranous lupus nephritis.

  Lupus 20060101

• Quality of life comparison between corticosteroid- and-mycofenolate mofetil and corticosteroid- and-oral cyclophosphamide in the treatment of severe lupus nephritis.

  Lupus 20060101

• Role of FK778 alone or in combination with tacrolimus or mTOR inhibitors as an immunomodulator of immunofunctions: in vitro evaluation of T cell proliferation and the expression of lymphocyte surface antigens.

  International journal of immunopathology and pharmacology 20060101

• Clinical outcome of heart transplant recipients receiving tacrolimus with or without mycophenolate mofetil.

  Clinical transplantation 20060101

• Successful treatment of relapsing polychondritis with mycophenolate mofetil.

  The Journal of dermatological treatment 20060101

• Comparison of FK 506, mycophenolate mofetil, and aminoguanidine effects on delay of corneal allograft rejection in an experimental model of low-risk and high-risk keratoplasty.

  Immunopharmacology and immunotoxicology 20060101

• Overcoming the force and power of immunity: a history of immunosuppression in kidney transplantation.

  Journal of nephrology 20060101

• [Mycophenolate mofetil in treatment of childhood nephrotic syndrome--preliminary report].

  Przeglad lekarski 20060101

• Incidence of graft rejection in small bowel transplanted pigs after immunosuppression withdrawal.

  Transplantation proceedings 20060101

• No induction versus anti-IL2R induction therapy in simultaneous kidney pancreas transplantation: a comparative analysis.

  Transplantation proceedings 20060101

• Mycophenolate mofetil for chronic inflammatory demyelinating polyradiculoneuropathy: An open-label study.

  European neurology 20060101

• Effects of mycophenolic acid on high glucose-induced expression of TGF-beta and CTGF in mesangial cells.

  Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban 20060101

• Dermatomyositis.

  Clinics in dermatology 20060101

• The transmission of donor-derived malignant melanoma to a renal allograft recipient.

  Clinical transplantation 20060101

• Revival of effective and safe high-dose mizoribine for the kidney transplantation.

  Clinical transplantation 20060101

• Mycobacterium haemophilum in an immunosuppressed child.

  Pediatric dermatology 20060101

• Mycophenolic acid therapy after cyclophosphamide pulses in progressive IgA nephropathy.

  Journal of nephrology 20060101

• Sirolimus population pharmacokinetic/pharmacogenetic analysis and bayesian modelling in kidney transplant recipients.

  Clinical pharmacokinetics 20060101

• HPLC/tandem ion trap mass detector methods for determination of inosine monophosphate dehydrogenase (IMPDH) and thiopurine methyltransferase (TPMT).

  Nucleosides, nucleotides & nucleic acids 20060101

• Oral mycophenolate mofetil prevents in-stent intimal hyperplasia without edge effect.

  Angiology 20060101

• Antifibrotic actions of mycophenolic acid.

  Clinical transplantation 20060101

• Mycophenolate mofetil in liver transplantation--is monotherapy safe?

  Clinical transplantation 20060101

• A six-hour extrapolated sampling strategy for monitoring mycophenolic acid in renal transplant patients in the Indian subcontinent.

  Journal of postgraduate medicine 20060101

• Transient improvement of hypertension-induced chronic renal failure with mycophenolate mofetil treatment.

  Renal failure 20060101

• Systematic review and meta-analysis of randomised trials and cohort studies of mycophenolate mofetil in lupus nephritis.

  Arthritis research & therapy 20060101

• Failure of mycophenolate mofetil therapy in primary refractory nephrotic syndrome.

  Journal of nephrology 20060101

• Resolution of neurotoxicity and beta-cell toxicity in an islet transplant recipient following substitution of tacrolimus with MMF.

  Cell transplantation 20060101

• On the road towards strategic application of therapeutic drug monitoring of mycophenolic acid in renal allograft recipients.

  Journal of postgraduate medicine 20060101

• Population-specific limited sampling strategies for therapeutic drug monitoring of mycophenolic acid.

  Journal of postgraduate medicine 20060101

• Primary lymphoma of CNS, mycophenolate mofetil and lupus.

  Lupus 20060101

• [Cryptosporidiosis. A rare infection in renal transplantation].

  Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20060101

• Case reports: nodular vasculitis responsive to mycophenolate mofetil.

  Journal of drugs in dermatology : JDD 20060101

• Conversion from cyclosporine-based immunosuppression to tacrolimus/mycophenolate mofetil in patients with refractory and ongoing acute renal allograft rejection.

  Annals of transplantation 20060101

• A retrospective study of steroid elimination in simultaneous pancreas and preemptive kidney transplant (Sppre-Ktx) recipients.

  Annals of transplantation 20060101

• [Rescue therapy in lupus nephritis patients with mycophenolate mofetil].

  Revista de la Facultad de Ciencias Medicas (Cordoba, Argentina) 20060101

• Discontinuation of calcineurin inhibitors in heart transplant patients with end stage renal insufficiency as an alternative model of immunosuppression.

  Przeglad lekarski 20060101

• Treatment of refractory blistering autoimmune diseases with mycophenolic acid.

  The Journal of dermatological treatment 20060101

• Conversion to sirolimus.

  Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20060101

• Cyclosporine A, FK-506, 40-0-[2-hydroxyethyl]rapamycin and mycophenolate mofetil inhibit proliferation of human intrahepatic biliary epithelial cells in vitro.

  World journal of gastroenterology 20051228

• Two corticosteroid-free regimens-tacrolimus monotherapy after basiliximab administration and tacrolimus/mycophenolate mofetil-in comparison with a standard triple regimen in renal transplantation: results of the Atlas study.

  Transplantation 20051227

• Combined use of the JAK3 inhibitor CP-690,550 with mycophenolate mofetil to prevent kidney allograft rejection in nonhuman primates.

  Transplantation 20051227

• Pharmacodynamics of mycophenolate mofetil after nonmyeloablative conditioning and unrelated donor hematopoietic cell transplantation.

  Blood 20051215

• Images in clinical medicine. Pemphigus foliaceus.

  The New England journal of medicine 20051215

• Differentiation of androgen-independent prostate cancer PC-3 cells is associated with increased nuclear factor-kappaB activity.

  Cancer research 20051215

• Conversion from cyclosporine to sirolimus in stable renal transplant recipients.

  Transplantation 20051215

• Synthesis of some monocyclic analogues of mycophenolic acid via the Johnson ortho ester Claisen rearrangement.

  Bioorganic & medicinal chemistry 20051201

• A pilot study using mycophenolate mofetil in relapsing or resistant ANCA small vessel vasculitis.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20051201

• Hypersensitivity to mycophenolate mofetil in systemic lupus erythematosus: diagnostic measures and successful desensitization.

  International archives of allergy and immunology 20051201

• Pharmacokinetics of enteric-coated mycophenolate sodium in stable pediatric renal transplant recipients.

  Pediatric transplantation 20051201

• IMPACT Trial: angiographic and intravascular ultrasound observations of the first human experience with mycophenolic acid-eluting polymer stent system.

  Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 20051201

• Mycophenolic acid-eluting stent and the ABC's of stent-based immunosuppressive therapies for the prevention of restenosis.

  Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 20051201

• Influence of co-medication with sirolimus or cyclosporine on mycophenolic acid pharmacokinetics in kidney transplantation.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20051201

• Prospective registry-based observational cohort study of the long-term risk of malignancies in renal transplant patients treated with mycophenolate mofetil.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20051201

• Addition of MMF to dual immunosuppression does not increase the risk of malignant short-term death after liver transplantation.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20051201

• Alemtuzumab induction and sirolimus plus mycophenolate mofetil maintenance for CNI and steroid-free kidney transplant immunosuppression.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20051201

• Mycophenolate mofetil.

  Journal of the American Academy of Dermatology 20051201

• Thrombotic microangiopathy in marginal kidneys after sirolimus use.

  American journal of kidney diseases : the official journal of the National Kidney Foundation 20051201

• Impact of mycophenolate mofetil (MMF)-related gastrointestinal complications and MMF dose alterations on transplant outcomes and healthcare costs in renal transplant recipients.

  Clinical transplantation 20051201

• Risk factors associated with the deterioration of renal function after kidney transplantation.

  Kidney international. Supplement 20051201

• Immunosuppressive treatment and progression of histologic lesions in kidney allografts.

  Kidney international. Supplement 20051201

• High unbound mycophenolic acid concentrations in a hematopoietic cell transplantation patient with sepsis and renal and hepatic dysfunction.

  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20051201

• The effect of anti-inflammatory properties of mycophenolate mofetil on the development of lung reperfusion injury.

  The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20051201

• What is new in the therapy of ANCA-associated vasculitides? Take home messages from the 12th workshop on ANCA and systemic vasculitides.

  Clinical nephrology 20051201

• Short communication: No detrimental immunological effects of mycophenolate mofetil and HAART in treatment-naive acute and chronic HIV-1-infected patients.

  AIDS research and human retroviruses 20051201

• Basiliximab and mycophenolate mofetil in combination with low-dose cyclosporine and methylprednisolone effectively prevent acute rejection in kidney transplant recipients.

  Transplantation proceedings 20051201

• Tuberculosis after conversion from azathioprine to mycophenolate mofetil in a long-term renal transplant recipient.

  Transplantation proceedings 20051201

• Late developing C4d-positive humoral renal allograft rejection associated with withdrawal of mycophenolate mofetil.

  Transplantation proceedings 20051201

• Clinical pharmacokinetics of tacrolimus after the first oral administration in combination with mycophenolate mofetil and prednisone in Chinese renal transplant recipients.

  Transplantation proceedings 20051201

• Anti-interleukin 2 receptor antibodies and mycophenolate mofetil for treatment of steroid-resistant rejection in adult liver transplantation.

  Transplantation proceedings 20051201

• Pharmacodynamic monitoring of the conversion of cyclosporine to tacrolimus in heart and lung transplant recipients.

  Transplantation proceedings 20051201

• Renal allograft tolerance in DLA-identical and haploidentical dogs after nonmyeloablative conditioning and transient immunosuppression with cyclosporine and mycophenolate mofetil.

  Transplantation proceedings 20051201

• Clinical application of population pharmacokinetic methods developed for immunosuppressive drugs.

  Therapeutic drug monitoring 20051201

• Mycophenolic acid plasma trough level: correlation with clinical outcome.

  Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 20051201

• Intravenous mycophenolate mofetil with low-dose oral tacrolimus and steroid induction for live donor liver transplantation.

  Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 20051201

• Post transplant Kaposi's sarcoma among Nigerians: a report of two cases.

  African journal of medicine and medical sciences 20051201

• Clinical and genetic risk factors for posttransplant diabetes mellitus in adult renal transplant recipients treated with tacrolimus.

  Transplantation 20051127

• Composite tissue allotransplantation: development of a preclinical model in nonhuman primates.

  Transplantation 20051127

• Prolonged allogeneic marrow engraftment following nonmyeloablative conditioning using 100 cGy total body irradiation and pentostatin before and pharmacological immunosuppression after transplantation.

  Transplantation 20051127

• Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis.

  The New England journal of medicine 20051124

• Mycophenolate mofetil for lupus nephritis.

  The New England journal of medicine 20051124

• Posttransplant lymphoproliferative disorder among renal transplant patients in relation to the use of mycophenolate mofetil.

  Transplantation 20051115

• In vitro prevention of cyclosporin-induced cell contraction by mycophenolic acid.

  Life sciences 20051112

• Studies on the targeted delivery of the antifibrogenic compound mycophenolic acid to the hepatic stellate cell.

  Journal of hepatology 20051101

• Chronic allograft nephropathy and mycophenolate mofetil introduction in paediatric renal recipients.

  Pediatric nephrology (Berlin, Germany) 20051101

• Humoral immune response after kidney transplantation is enhanced by acute rejection and urological obstruction and is down-regulated by mycophenolate mofetil treatment.

  Transplant international : official journal of the European Society for Organ Transplantation 20051101

• A case of acute humoral rejection in liver transplantation: successful treatment with plasmapheresis and mycophenolate mofetil.

  Transplant international : official journal of the European Society for Organ Transplantation 20051101

• Sirolimus-associated hepatotoxicity in the kidney graft recipient.

  Transplant international : official journal of the European Society for Organ Transplantation 20051101

• Inflammation and caspase activation in long-term renal ischemia/reperfusion injury and immunosuppression in rats.

  Kidney international 20051101

• Kidney immune cell infiltration and oxidative stress contribute to prenatally programmed hypertension.

  Kidney international 20051101

• Enteric-coated mycophenolate sodium for transplant immunosuppression.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20051101

• Effects of mycophenolate mofetil on cardiac allograft survival and cardiac allograft vasculopathy in miniature swine.

  The Annals of thoracic surgery 20051101

• [Current status of therapeutic drug monitoring for immunosuppressive drugs].

  Nihon rinsho. Japanese journal of clinical medicine 20051101

• Dissection of the molecular basis of mycophenolate resistance in Saccharomyces cerevisiae.

  Yeast (Chichester, England) 20051101

• Freedom from graft vessel disease in heart and combined heart- and kidney-transplanted patients treated with tacrolimus-based immunosuppression.

  The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20051101

• Successful treatment of idiopathic orbital inflammation with mycophenolate mofetil.

  American journal of ophthalmology 20051101

• Relationship of mycophenolic acid exposure to clinical outcome after hematopoietic cell transplantation.

  Clinical pharmacology and therapeutics 20051101

• Calcineurin-inhibitor-sparing immunosuppressive protocols.

  Transplantation proceedings 20051101

• Updated metaanalysis of steroid withdrawal in renal transplant patients on calcineurin inhibitor and mycophenolate mofetil.

  Transplantation proceedings 20051101

• Pharmacokinetics of mycophenolate mofetil in kidney transplant patients with renal insufficiency.

  Transplantation proceedings 20051101

• Efficacy and safety of mycophenolate mofetil as part of induction therapy in liver transplantation.

  Transplantation proceedings 20051101

• A few memories from the beginning..

  Transplantation 20051015

• Mechanisms of action of mycophenolate mofetil in preventing acute and chronic allograft rejection.

  Transplantation 20051015

• Review of major clinical trials with mycophenolate mofetil in renal transplantation.

  Transplantation 20051015

• Mycophenolate mofetil in pediatric renal transplantation.

  Transplantation 20051015

• The impact of mycophenolate mofetil on long-term outcomes in kidney transplantation.

  Transplantation 20051015

• Toxicity-sparing protocols using mycophenolate mofetil in renal transplantation.

  Transplantation 20051015

• Review of major clinical trials with mycophenolate mofetil in cardiac transplantation.

  Transplantation 20051015

• The rationale for and limitations of therapeutic drug monitoring for mycophenolate mofetil in transplantation.

  Transplantation 20051015

• Malignancy after transplantation.

  Transplantation 20051015

• Use of mycophenolate mofetil in autoimmune and renal diseases.

  Transplantation 20051015

• Mycophenolate mofetil: a decade of clinical experience.

  Transplantation 20051015

• [Crohn's disease--standards of treatment 2004].

  Praxis 20051012

• Severe, refractory type II essential mixed cryoglobulinemia treated with 2-chlorodeoxyadenosine and mycophenolate mofetil.

  Rheumatology international 20051001

• Glomerular abundance of nephrin and podocin in experimental nephrotic syndrome: different effects of antiproteinuric therapies.

  American journal of physiology. Renal physiology 20051001

• Mycophenolate mofetil therapy in frequently relapsing steroid-dependent and steroid-resistant nephrotic syndrome of childhood: current status and future directions.

  Pediatric nephrology (Berlin, Germany) 20051001

• Mycophenolate mofetil for the treatment of acute and chronic steroid-refractory graft-versus-host disease.

  Annals of hematology 20051001

• Mycophenolate mofetil (MMF) vs placebo in patients with moderately advanced IgA nephropathy: a double-blind randomized controlled trial.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20051001

• An investigation of human and rat liver microsomal mycophenolic acid glucuronidation: evidence for a principal role of UGT1A enzymes and species differences in UGT1A specificity.

  Drug metabolism and disposition: the biological fate of chemicals 20051001

• Questionnaire-based evaluation of gastrointestinal disorders in de novo renal-transplant patients receiving either mycophenolate mofetil or enteric-coated mycophenolate sodium.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20051001

• Reduction of proteinuria with mycophenolate mofetil in predominantly membranous lupus nephropathy.

  Rheumatology (Oxford, England) 20051001

• Steroid sparing strategies in renal transplantation.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20051001

• Empiric therapy of autoimmune hepatitis with mycophenolate mofetil: comparison with conventional treatment for refractory disease.

  Journal of clinical gastroenterology 20051001

• Mycophenolate mofetil for the treatment of primary biliary cirrhosis in patients with an incomplete response to ursodeoxycholic acid.

  Journal of clinical gastroenterology 20051001

• Diagnosis and treatment of kidney disease.

  Best practice & research. Clinical rheumatology 20051001

• Three-year efficacy and safety results from a study of everolimus versus mycophenolate mofetil in de novo renal transplant patients.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20051001

• Comparison of sirolimus with low-dose tacrolimus versus sirolimus-based calcineurin inhibitor-free regimen in live donor renal transplantation.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20051001

• Alemtuzumab induction and prednisone-free maintenance immunotherapy in kidney transplantation: comparison with basiliximab induction--long-term results.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20051001

• Ultra-late antibody-mediated rejection 30 years after a living-related renal allograft.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20051001

• Polyoma virus nephropathy in native kidneys after lung transplantation.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20051001

• Results of one-year follow-up of steroid-free immunosuppression in pediatric renal transplant patients.

  Pediatric transplantation 20051001

• Nonmyeloablative conditioning with busulfan before matched littermate bone marrow transplantation results in reversal of the disease phenotype in canine leukocyte adhesion deficiency.

  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20051001

• Post-liver transplantation de novo hepatitis with overlap features.

  Pathology international 20051001

• Genetic and nongenetic determinants of between-patient variability in the pharmacokinetics of mycophenolic acid.

  Clinical pharmacology and therapeutics 20051001

• The impact of uridine diphosphate-glucuronosyltransferase 1A9 (UGT1A9) gene promoter region single-nucleotide polymorphisms T-275A and C-2152T on early mycophenolic acid dose-interval exposure in de novo renal allograft recipients.

  Clinical pharmacology and therapeutics 20051001

• Best single time points to predict the area-under-the-curve in long-term heart transplant patients taking mycophenolate mofetil in combination with cyclosporine or tacrolimus.

  The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20051001

• Randomized controlled trial of pulse intravenous cyclophosphamide versus mycophenolate mofetil in the induction therapy of proliferative lupus nephritis.

  Nephrology (Carlton, Vic.) 20051001

• Successful treatment of refractory thrombocytopenia with mycophenolate mofetil in a patient with systemic lupus erythematosus.

  Journal of Korean medical science 20051001

• Impact of mycophenolate mofetil intolerance on early results of kidney transplantation.

  Transplantation proceedings 20051001

• Experience with sirolimus for calcineurin minimization/elimination in pancreas-after-kidney transplantation.

  Transplantation proceedings 20051001

• Metabolic effect of sirolimus versus mycophenolate mofetil on pancreatic graft function in the early posttransplant period.

  Transplantation proceedings 20051001

• Mycophenolate mofetil in organ transplantation: focus on metabolism, safety and tolerability.

  Expert opinion on drug metabolism & toxicology 20051001

• Comparison of steroid avoidance in tacrolimus/mycophenolate mofetil and tacrolimus/sirolimus combination in kidney transplantation monitored by surveillance biopsy.

  Transplantation 20050927

• Long-term outcome of adding mycophenolate mofetil to tacrolimus for nephrotoxicity following liver transplantation.

  Transplantation 20050927

• Recipient age and mycophenolate mofetil as the main determinants of outcome after steroid withdrawal: analysis of long-term follow-up in renal transplantation.

  Transplantation 20050927

• Indications of mycophenolate mofetil in liver transplantation.

  Transplantation 20050927

• Tolerability of cyclosphosphamide and methotrexate induction immunosuppression in nonhuman primates.

  Toxicology 20050915

• Efficacy of mycophenolate mofetil in pediatric patients with steroid-dependent nephrotic syndrome.

  Pediatric nephrology (Berlin, Germany) 20050901

• Inflammatory and cytotoxic responses in mouse lungs exposed to purified toxins from building isolated Penicillium brevicompactum Dierckx and P. chrysogenum Thom.

  Toxicological sciences : an official journal of the Society of Toxicology 20050901

• Validation of a high-performance liquid chromatography method for the measurement of mycophenolic acid and its glucuronide metabolites in plasma.

  Clinical biochemistry 20050901

• Mycophenolate mofetil prevents the development of experimental autoimmune myocarditis.

  Journal of molecular and cellular cardiology 20050901

• Relapse of lupus nephritis more than 10 years after complete remission.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20050901

• Sirolimus in combination with tacrolimus is associated with worse renal allograft survival compared to mycophenolate mofetil combined with tacrolimus.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20050901

• Proteinuria developing after clinical islet transplantation resolves with sirolimus withdrawal and increased tacrolimus dosing.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20050901

• Therapeutic drug monitoring for everolimus in heart transplant recipients: flawed model or a model for future use?

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20050901

• Mycophenolate mofetil ameliorates nephropathy in the obese Zucker rat.

  Kidney international 20050901

• Hypertension in Page (cellophane-wrapped) kidney is due to interstitial nephritis.

  Kidney international 20050901

• Rapid response of IgA pemphigus of the subcorneal pustular dermatosis subtype to treatment with adalimumab and mycophenolate mofetil.

  Journal of the American Academy of Dermatology 20050901

• Outcomes after combination photodynamic therapy and immunosuppression for inflammatory subfoveal choroidal neovascularisation.

  The British journal of ophthalmology 20050901

• Characterizing the role of enterohepatic recycling in the interactions between mycophenolate mofetil and calcineurin inhibitors in renal transplant patients by pharmacokinetic modelling.

  British journal of clinical pharmacology 20050901

• Evaluation of renal function in liver transplant recipients receiving daclizumab (Zenapax), mycophenolate mofetil, and a delayed, low-dose tacrolimus regimen vs. a standard-dose tacrolimus and mycophenolate mofetil regimen: a multicenter randomized clinical trial.

  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20050901

• Pharmacokinetics of mycophenolic acid in Chinese kidney transplant patients.

  Journal of Zhejiang University. Science. B 20050901

• A multicenter, prospective, randomized, double-blind trial of basiliximab in heart transplantation.

  The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20050901

• Morphological findings in lymphatic tissues of sheep following oral application of the immunosuppressive mycotoxin mycophenolic acid.

  Mycopathologia 20050901

• [Treatment of chronic actinic dermatitis with mycophenolate mofetil].

  Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 20050901

• Sirolimus as primary immunosuppression agent in kidney transplant recipients: Akdeniz University experience.

  Transplantation proceedings 20050901

• Tacrolimus plus low-dose mycophenolate mofetil in renal transplant recipients: better 2-year graft and patient survival than with a higher mycophenolate mofetil dose.

  Transplantation proceedings 20050901

• Mycophenolate mofetil in pediatric renal transplantation.

  Transplantation proceedings 20050901

• Single daily dose administration of cyclosporine in renal transplant recipients: a preliminary report.

  Transplantation proceedings 20050901

• Early acute rejection episodes in renal transplantation in relation to immunosuppression protocols: an audit of 100 cases.

  Transplantation proceedings 20050901

• Observations on quadruple immunosuppression maintenance therapy using rapamycin, low-dose cyclosporine, mycophenolate mofetil, and prednisone following ATG induction.

  Transplantation proceedings 20050901

• Effect of cyclosporine, mycophenolate mofetil, and their combination with steroids on apoptosis in a human cultured monocytic U937 cell line.

  Transplantation proceedings 20050901

• A randomized trial of three renal transplant induction antibodies: early comparison of tacrolimus, mycophenolate mofetil, and steroid dosing, and newer immune-monitoring.

  Transplantation 20050827

• Bone quality in swine composite tissue allografts: effects of combination immunotherapy.

  Transplantation 20050827

• Kaposi's sarcoma after renal transplantation.

  The New England journal of medicine 20050825

• Primary CNS lymphoma complicating treatment of myasthenia gravis with mycophenolate mofetil.

  Neurology 20050823

• A prospective, randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: results at 1 year.

  Transplantation 20050815

• Two-year reduction of panel reactive human leukocyte antigen antibodies in children receiving mycophenolate mofetil after valved allograft placement.

  Transplantation 20050815

• Mycophenolate mofetil slows progression in anti-thy1-induced chronic renal fibrosis but is not additive to a high dose of enalapril.

  American journal of physiology. Renal physiology 20050801

• Predictive factors of acute rejection after early cyclosporine withdrawal in renal transplant recipients who receive mycophenolate mofetil: results from a prospective, randomized trial.

  Journal of the American Society of Nephrology : JASN 20050801

• Mychophenolate mofetil increased chagas disease reactivation in heart transplanted patients: comparison between two different protocols.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20050801

• Use of mycophenolate in the treatment of autoimmune hepatitis.

  Liver international : official journal of the International Association for the Study of the Liver 20050801

• Transplant immunosuppressive agents in non-transplant chronic autoimmune hepatitis: the Canadian association for the study of liver (CASL) experience with mycophenolate mofetil and tacrolimus.

  Liver international : official journal of the International Association for the Study of the Liver 20050801

• Efficacy and cardiovascular safety of daclizumab, mycophenolate mofetil, tacrolimus, and early steroid withdrawal in renal transplant recipients: a multicenter, prospective, pilot trial.

  Clinical transplantation 20050801

• Increased risk of post-transplant diabetes mellitus despite early steroid discontinuation in Hispanic kidney transplant recipients.

  Clinical transplantation 20050801

• Randomized calcineurin inhibitor cross over study to measure the pharmacokinetics of co-administered enteric-coated mycophenolate sodium.

  Clinical transplantation 20050801

• Mycophenolate mofetil alleviates persistent proteinuria in IgA nephropathy.

  Kidney international 20050801

• Mycophenolate mofetil in islet cell transplant: variable pharmacokinetics but good correlation between total and unbound concentrations.

  Journal of clinical pharmacology 20050801

• A dance teacher with kidney-pancreas transplant and diarrhoea: what is the cause?

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20050801

• Cyclosporine monitoring with 2-hour postdose levels in heart transplant recipients.

  Therapeutic drug monitoring 20050801

• Determinants of mycophenolic acid levels after renal transplantation.

  Therapeutic drug monitoring 20050801

• Early discontinuation of steroids is safe and effective in pediatric kidney transplant recipients.

  Pediatric transplantation 20050801

• Mycophenolate mofetil suspension in pediatric renal transplantation: three-year data from the tricontinental trial.

  Pediatric transplantation 20050801

• Population pharmacokinetics of mycophenolic acid during the first week after renal transplantation.

  European journal of clinical pharmacology 20050801

• Mycophenolate mofetil therapy for inflammatory eye disease.

  Ophthalmology 20050801

• Treatment of focal segmental glomerulosclerosis.

  Expert opinion on pharmacotherapy 20050801

• Trough levels of mycophenolic acid and its glucuronidated metabolite in renal transplant recipients.

  International journal of clinical pharmacology and therapeutics 20050801

• [Establishment of rhesus model for haploidentical hematopoietic stem cell transplantation with nonmyeloablative conditioning].

  Zhongguo shi yan xue ye xue za zhi 20050801

• [Kinetic patterns of cytokine expressions in H-2 haploidentical nonmyeloablative bone marrow transplantation in mice].

  Zhongguo shi yan xue ye xue za zhi 20050801

• Mycophenolate mofetil in neuropsychiatric systemic lupus erythematosus.

  Indian journal of medical sciences 20050801

• Mycophenolic acid inhibits syncytium formation accompanied by reduction of gp120 expression.

  The Journal of antibiotics 20050801

• The use of mycophenolate mofetil in treating patients with non responding aplastic anemia.

  The Medical journal of Malaysia 20050801

• Steroids can be safely withdrawn from cyclosporine and mycophenolate mofetil-treated renal allograft recipients: long-term results.

  Transplantation 20050727

• Everolimus versus mycophenolate mofetil in the prevention of rejection in de novo renal transplant recipients: a 3-year randomized, multicenter, phase III study.

  Transplantation 20050727

• Anti-intercellular adhesion molecule-1 antibodies in sera of heart transplant recipients: a role in endothelial cell activation.

  Transplantation 20050727

• Antiproliferative profile of sirolimus and mycophenolate mofetil: impact of the SI/MPL ratio.

  International journal of cardiology 20050720

• Mycophenolate mofetil for renal dysfunction in liver transplant recipients on cyclosporine or tacrolimus: randomized, prospective, multicenter pilot study results.

  Transplantation 20050715

• Body weight alterations under early corticosteroid withdrawal and chronic corticosteroid therapy with modern immunosuppression.

  Transplantation 20050715

• IgG immunoadsorption reduces systemic lupus erythematosus activity and proteinuria: a long term observational study.

  Annals of the rheumatic diseases 20050701

• Mycophenolate mofetil in steroid/cyclosporine-dependent/resistant nephrotic syndrome.

  Pediatric nephrology (Berlin, Germany) 20050701

• Cyclosporine withdrawal from a mycophenolate mofetil-containing immunosuppressive regimen: results of a five-year, prospective, randomized study.

  Journal of the American Society of Nephrology : JASN 20050701

• Efficacy of mycophenolate mofetil in adult refractory auto-immune cytopenias: a single center preliminary study.

  European journal of haematology 20050701

• Treatment of stiff person syndrome with rituximab.

  Journal of neurology, neurosurgery, and psychiatry 20050701

• Mycophenolate mofetil combination therapy improves long-term outcomes after liver transplantation in patients with and without hepatitis C.

  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20050701

• A phase I/II study of mycophenolate mofetil in combination with cyclosporine for prophylaxis of acute graft-versus-host disease after myeloablative conditioning and allogeneic hematopoietic cell transplantation.

  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20050701

• Mycophenolate mofetil in the management of alloimmune hemolytic anemia in ABO-compatible but non-identical pediatric liver transplantation.

  Journal of pediatric gastroenterology and nutrition 20050701

• Short-term treatment with mycophenolic acid and tacrolimus is tolerogenic for INS-1 cell clone transplantation and the deleterious effects of the drugs are limited: in vivo and in vitro studies.

  The Journal of endocrinology 20050701

• Higher exposure to mycophenolic acid with sirolimus than with cyclosporine cotreatment.

  Clinical pharmacology and therapeutics 20050701

• Drug interaction between mycophenolate mofetil and rifampin: possible induction of uridine diphosphate-glucuronosyltransferase.

  Clinical pharmacology and therapeutics 20050701

• [Mycophenolic acid induced apoptosis in T lymphocytic cells Molt-4 and its mechanism].

  Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences 20050701

• Mycophenolate mofetil as an adjuvant therapy for classic and endemic pemphigus foliaceus.

  The Journal of dermatology 20050701

• Daclizumab to prevent rejection after cardiac transplantation.

  The New England journal of medicine 20050630

• Improved outcomes after ABO-incompatible living-donor kidney transplantation after 4 weeks of treatment with mycophenolate mofetil.

  Transplantation 20050627

• Pharmacological therapy of lupus nephritis.

  JAMA 20050622

• [Mycophenolate mofetil--a new therapeutic agent for chronic autoimmune diseases].

  Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20050616

• An immune reconstitution syndrome-like illness associated with Cryptococcus neoformans infection in organ transplant recipients.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20050615

• Association of circulating interleukin (IL)-12- and IL-10-producing dendritic cells with time posttransplant, dose of immunosuppression, and plasma cytokines in renal-transplant recipients.

  Transplantation 20050615

• FTY720, a novel immunomodulator: efficacy and safety results from the first phase 2A study in de novo renal transplantation.

  Transplantation 20050615

• Mycophenolate mofetil for renal dysfunction after pediatric liver transplantation.

  Transplantation 20050615

• Recurrent IgA nephropathy after renal transplantation despite immunosuppressive regimens with mycophenolate mofetil.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20050601

• Cyclosporine A and mycophenolate mofetil vs cyclosporine A and methotrexate for graft-versus-host disease prophylaxis after stem cell transplantation from HLA-identical siblings.

  Bone marrow transplantation 20050601

• Effects of mycophenolic acid on endothelial cells.

  International immunopharmacology 20050601

• Randomized clinical trial of daclizumab induction and delayed introduction of tacrolimus for recipients of non-heart-beating kidney transplants.

  The British journal of surgery 20050601

• Heart transplant recipient clinical profile improvement following mycophenolate mofetil late incorporation into the treatment schedule.

  Clinical transplantation 20050601

• A calcineurin antagonist-free induction/maintenance strategy for immunosuppression in elderly recipients of renal allografts from elderly cadaver donors: long-term results from a prospective single centre trial.

  Clinical transplantation 20050601

• Steroid avoidance versus steroid withdrawal after simultaneous pancreas-kidney transplantation.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20050601

• Clinical significance of an early protocol biopsy in living-donor renal transplantation: ten-year experience at a single center.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20050601

• Reduction of CMV disease with steroid-free immunosuppresssion in simultaneous pancreas-kidney transplant recipients.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20050601

• A prospective randomized trial of steroid-free maintenance regimens in kidney transplant recipients--an interim analysis.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20050601

• Pharmacokinetics and bioavailability of mycophenolic acid after intravenous administration and oral administration of mycophenolate mofetil to heart transplant recipients.

  Therapeutic drug monitoring 20050601

• Maximum a posteriori bayesian estimation of mycophenolic acid pharmacokinetics in renal transplant recipients at different postgrafting periods.

  Therapeutic drug monitoring 20050601

• Population pharmacokinetics of mycophenolic acid in kidney transplant pediatric and adolescent patients.

  Therapeutic drug monitoring 20050601

• Myasthenia gravis: emerging new therapy options.

  Current opinion in pharmacology 20050601

• Systemic mycophenolate mofetil avoids immune reactions in penetrating high-risk keratoplasty: preliminary results of an ongoing prospectively randomized multicentre study.

  Transplant international : official journal of the European Society for Organ Transplantation 20050601

• A randomized multicenter trial of OKT3 mAbs induction compared with intravenous cyclosporine in pediatric renal transplantation.

  Pediatric transplantation 20050601

• Long-term follow-up of patients with birdshot retinochoroidopathy treated with corticosteroid-sparing systemic immunomodulatory therapy.

  Ophthalmology 20050601

• Mycophenolate mofetil: a magic bullet for lupus?

  The Journal of rheumatology 20050601

• Mycophenolate mofetil in systemic lupus erythematosus: efficacy and tolerability in 86 patients.

  The Journal of rheumatology 20050601

• Blood cyclosporine level soon after kidney transplantation is a major determinant of rejection: insights from the Mycophenolate Steroid-Sparing Trial.

  Transplantation proceedings 20050601

• Delayed renal graft function: the influence of immunosuppression.

  Transplantation proceedings 20050601

• Comparison of long-term actual renal allograft survival in mycophenolate mofetil and azathioprine-based triple drug immunosuppression protocols.

  Transplantation proceedings 20050601

• Early experience with enteric-coated mycophenolate sodium in de novo kidney transplant recipients.

  Transplantation proceedings 20050601

• Toward the definition of immunosuppressive regimens with antitumor activity.

  Transplantation proceedings 20050601

• De novo immunosuppression with sirolimus and tacrolimus in heart transplant recipients compared with cyclosporine and mycophenolate mofetil: a one-year follow-up analysis.

  Transplantation proceedings 20050601

• Therapeutic mycophenolic acid monitoring by means of limited sampling strategy in orthotopic heart transplant patients.

  Transplantation proceedings 20050601

• Cyclosporine and sirolimus interaction in a kidney transplant patient.

  Transplantation proceedings 20050601

• Impact of mycophenolate mofetil loading on drug exposure in the early posttransplant period.

  Transplantation proceedings 20050601

• Prevention of early acute rejection with daclizumab and triple immunosuppression in cadaveric renal allograft recipients.

  Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 20050601

• Cyclosporine lymphocyte maximum level: a new alternative for cyclosporine monitoring in kidney transplantation.

  Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 20050601

• The role of mycophenolate mofetil in the treatment of leprosy reactions.

  International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association 20050601

• Improvement of renal function in pediatric heart transplant recipients treated with low-dose calcineurin inhibitor and mycophenolate mofetil.

  Transplantation 20050527

• [The influence of mycophenolate mofetil upon the maturation and allostimulatory activity of cultured dendritic cell progenitors and the effects of tolerance induction in allograft recipients].

  Zhonghua yi xue za zhi 20050525

• Response to 'Exceptional circumstances and heart transplantation' letter.

  The New Zealand medical journal 20050520

• Mycophenolate mofetil for the treatment of primary sclerosing cholangitis.

  Alimentary pharmacology & therapeutics 20050515

• Effects of mycophenolate mofetil vs cyclosporine administration on graft survival and function after islet allotransplantation in diabetic rats.

  World journal of gastroenterology 20050514

• Quantification of mycophenolic acid and glucuronide metabolite in human serum by HPLC-tandem mass spectrometry.

  Clinical chemistry 20050501

• Intensive graft-versus-host disease prophylaxis is required after unrelated-donor nonmyeloablative stem cell transplantation.

  Bone marrow transplantation 20050501

• Combining PUVA therapy with systemic immunosuppression to treat progressive diffuse morphoea.

  Clinical and experimental dermatology 20050501

• Successful treatment of linear IgA disease with mycophenolate mofetil as a corticosteroid sparing agent.

  Clinical and experimental dermatology 20050501

• The effects of renal transplantation on circulating dendritic cells.

  Clinical and experimental immunology 20050501

• Secondary effects of immunosuppressive drugs after simultaneous pancreas-kidney transplantation.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20050501

• A large, prospective, randomized, open-label, multicentre study of corticosteroid withdrawal in SPK transplantation: a 3-year report.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20050501

• Cyclosporine interacts with mycophenolic acid by inhibiting the multidrug resistance-associated protein 2.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20050501

• Rapamycin successfully treats post-transplant autoimmune hepatitis.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20050501

• Mycophenolate sodium does not reduce the incidence of GI adverse events compared with mycophenolate mofetil.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20050501

• Immunosuppressive efficacy of mycophenolate mofetil when compared with azathioprine and mizoribine against peripheral lymphocytes from renal transplant recipients.

  Transplant international : official journal of the European Society for Organ Transplantation 20050501

• Use of different immunosuppressive strategies in recipients of kidneys from nonheart-beating donors.

  Transplant international : official journal of the European Society for Organ Transplantation 20050501

• Mycophenolate mofetil as a treatment for refractory idiopathic thrombocytopenic purpura.

  Acta pharmacologica Sinica 20050501

• Mechanism of anti-human immunodeficiency virus activity of beta-D-6-cyclopropylamino-2',3'-didehydro-2',3'-dideoxyguanosine.

  Antimicrobial agents and chemotherapy 20050501

• Mucous membrane pemphigoid of the vulva.

  Obstetrics and gynecology 20050501

• Use of mycophenolate mofetil for chronic, refractory immune cytopenias in children with autoimmune lymphoproliferative syndrome.

  British journal of haematology 20050501

• [Immunosuppressants for therapy of patients with ulcerative colitis].

  Nihon rinsho. Japanese journal of clinical medicine 20050501

• Three-year results of a randomized, double-blind, controlled trial of mycophenolate mofetil versus azathioprine in cardiac transplant recipients.

  The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20050501

• Clinical and cost-effectiveness of newer immunosuppressive regimens in renal transplantation: a systematic review and modelling study.

  Health technology assessment (Winchester, England) 20050501

• Pharmacokinetic/pharmacodynamic relationships of FTY720 in kidney transplant recipients.

  Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 20050501

• [Treating chronic severe hepatitis B patients with mycophenolate mofetil].

  Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20050501

• Withdrawal of steroids: a randomized prospective study of prednisone and tacrolimus versus mycophenolate mofetil and tacrolimus in liver transplant recipients with autoimmune hepatitis.

  Transplantation proceedings 20050501

• A 'steroid-free' tacrolimus and low-dose mycophenolate mofetil primary immunosuppression does not prevent early acute rejection after liver transplantation.

  Transplantation proceedings 20050501

• Differential effects of cyclosporine and tacrolimus on mycophenolate pharmacokinetics in patients with impaired kidney function.

  Transplantation proceedings 20050501

• The influence of mycophenolate mofetil versus azathioprine and mycophenolic acid pharmacokinetics on the incidence of acute rejection and infectious complications after renal transplantation.

  Transplantation proceedings 20050501

• Regimen of tacrolimus-based immunosuppression with basiliximab, mycophenolate mofetil, and low-dose steroid reduces acute rejection in kidney transplants.

  Transplantation proceedings 20050501

• Evaluation of daclizumab to reduce delayed graft function in non-heart-beating renal transplantation: a prospective, randomized trial.

  Transplantation proceedings 20050501

• sCD30 and neopterin as risk factors of chronic renal transplant rejection: impact of cyclosporine A, tacrolimus, and mycophenolate mofetil.

  Transplantation proceedings 20050501

• Steroid withdrawal or steroid avoidance in renal transplant recipients: focus on tacrolimus-based immunosuppressive regimens.

  Transplantation proceedings 20050501

• Steroid sparing in renal transplantation with tacrolimus and mycophenolate mofetil: three-year results.

  Transplantation proceedings 20050501

• Late steroid withdrawal for renal transplant recipients on tacrolimus and MMF is safe.

  Transplantation proceedings 20050501

• Impact of steroid withdrawal on metabolic parameters in a series of 112 enteric/systemic-drained pancreatic transplants.

  Transplantation proceedings 20050501

• Lipid metabolism in renal transplant patients receiving tacrolimus/sirolimus combination therapy.

  Transplantation proceedings 20050501

• Successful conversion to rapamycin for calcineurin inhibitor-related neurotoxicity following liver transplantation.

  Transplantation proceedings 20050501

• [Pharmacotherapy of SLE].

  Nihon rinsho. Japanese journal of clinical medicine 20050501

• [Mycophenolate mofetil in renal transplantation].

  Nihon rinsho. Japanese journal of clinical medicine 20050501

• Determination of selected mycotoxins in mould cheeses with liquid chromatography coupled to tandem with mass spectrometry.

  Food additives and contaminants 20050501

• Effects of immunosuppressants on induction of regulatory cells after intratracheal delivery of alloantigen.

  Transplantation 20050427

• The effect of 2-gram versus 1-gram concentration controlled mycophenolate mofetil on renal transplant outcomes using sirolimus-based calcineurin inhibitor drug-free immunosuppression.

  Transplantation 20050427

• Immunosuppression with cyclosporine A and mycophenolate mofetil after penetrating high-risk keratoplasty: a retrospective study.

  Transplantation 20050427

• Resolution of severe MMF-related gastrointestinal adverse events following conversion to enteric-coated mycophenolate sodium.

  Transplantation 20050427

• Problems of cyclosporine absorption profiling using C2-monitoring.

  European journal of medical research 20050420

• Synergy between imatinib and mycophenolic acid in inducing apoptosis in cell lines expressing Bcr-Abl.

  Blood 20050415

• Corticosteroid-free immunosuppression with tacrolimus, mycophenolate mofetil, and daclizumab induction in renal transplantation.

  Transplantation 20050415

• Complete remission of postransplant lung metastases from hepatocellular carcinoma under therapy with sirolimus and mycophenolate mofetil.

  Transplantation 20050415

• Mycophenolate mofetil does not suppress the graft-versus-leukemia effect or the activity of lymphokine-activated killer (LAK) cells in a murine model.

  Cancer immunology, immunotherapy : CII 20050401

• Tuberculosis in renal transplant recipients on various immunosuppressive regimens.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20050401

• Mycophenolic acid-treated human dendritic cells have a mature migratory phenotype and inhibit allogeneic responses via direct and indirect pathways.

  International immunology 20050401

• Infantile systemic lupus erythematosus presenting with pulmonary hemorrhage.

  Pediatric nephrology (Berlin, Germany) 20050401

• Switch from cyclosporine A to mycophenolate mofetil in nephrotic children.

  Pediatric nephrology (Berlin, Germany) 20050401

• Long-term study of mycophenolate mofetil as continuous induction and maintenance treatment for diffuse proliferative lupus nephritis.

  Journal of the American Society of Nephrology : JASN 20050401

• Therapeutic drug monitoring for everolimus in kidney transplantation using 12-month exposure, efficacy, and safety data.

  Clinical transplantation 20050401

• Effects of mycophenolate mofetil on donor-specific antibody formation in renal transplantation.

  Clinical transplantation 20050401

• Predictors of improvement in renal function after calcineurin inhibitor withdrawal for post-liver transplant renal dysfunction.

  Clinical transplantation 20050401

• Enteric-coated mycophenolate sodium delivers bioequivalent MPA exposure compared with mycophenolate mofetil.

  Clinical transplantation 20050401

• Basiliximab lowers the cyclosporine therapeutic threshold in the early post-kidney transplant period.

  Clinical transplantation 20050401

• Rapamycin in patients with chronic renal allograft dysfunction.

  Clinical transplantation 20050401

• Cytomegalovirus prophylaxis with valganciclovir in African-American renal allograft recipients based on donor/recipient serostatus.

  Clinical transplantation 20050401

• Mycophenolate mofetil vs. azathioprine is associated with decreased acute rejection, late acute rejection, and risk for cardiovascular death in renal transplant recipients with pre-transplant diabetes.

  Clinical transplantation 20050401

• Modulation of the CXC-chemokine expression profile on tumor cells by the immunosuppressive drug mycophenolate mofetil.

  International journal of molecular medicine 20050401

• Prevention of cardiac allograft vasculopathy with Certican (everolimus): the Stanford University experience within the Certican Phase III clinical trial.

  The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20050401

• Immunosuppression and donor age with respect to severity of HCV recurrence after liver transplantation.

  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20050401

• Improved long-term allograft function in pediatric renal transplantation with mycophenolate mofetil.

  Pediatric transplantation 20050401

• The sensitized pediatric heart transplant candidate: causes, consequences, and treatment options.

  Pediatric transplantation 20050401

• Mycophenolic acid interaction with cyclosporine and tacrolimus in vitro and in vivo: evaluation of additive effects on rat blood lymphocyte function.

  Therapeutic drug monitoring 20050401

• Influence of cyclosporine on the serum concentration and biliary excretion of mycophenolic acid and 7-O-mycophenolic acid glucuronide.

  Therapeutic drug monitoring 20050401

• Predicting the usefulness of therapeutic drug monitoring of mycophenolic acid: a computer simulation.

  Therapeutic drug monitoring 20050401

• Direct transformation of a clinical isolate of Candida parapsilosis using a dominant selection marker.

  FEMS microbiology letters 20050401

• Quiz page. Posttransplantation lymphoproliferative disorder (PTLD) involving the brain and the allograft.

  American journal of kidney diseases : the official journal of the National Kidney Foundation 20050401

• Efficacy of mycophenolate mofetil in the treatment of chronic graft-versus-host disease.

  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20050401

• Chronic actinic dermatitis treated with mycophenolate mofetil.

  The British journal of dermatology 20050401

• Successful use of mycophenolate mofetil and prednisone in a 14-year-old girl with acquired hemophilia A.

  Thrombosis and haemostasis 20050401

• Peginterferon alpha-2a combination therapies in chronic hepatitis C patients who relapsed after or had a viral breakthrough on therapy with standard interferon alpha-2b plus ribavirin: a pilot study of efficacy and safety.

  Digestive diseases and sciences 20050401

• [Lung transplantation].

  Nihon rinsho. Japanese journal of clinical medicine 20050401

• Effect of new immunosuppressive regimens on cost of renal transplant maintenance immunosuppression.

  Transplantation proceedings 20050401

• Mycophenolate mofetil-induced neutropenia in liver transplantation.

  Transplantation proceedings 20050401

• Best single time points as surrogates to the tacrolimus and mycophenolic acid area under the curve in adult liver transplant patients beyond 12 months of transplantation.

  Clinical therapeutics 20050401

• Mycophenolate mofetil: a dermatologic perspective.

  Skin therapy letter 20050401

• Mycophenolate mofetil is compatible with CD28/CD154 costimulatory blockade in preventing transplant rejection.

  Transplantation 20050327

• The functional basis of mycophenolic acid resistance in Candida albicans IMP dehydrogenase.

  The Journal of biological chemistry 20050325

• Quantification of total and free mycophenolic acid in human plasma by liquid chromatography with fluorescence detection.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20050325

• Simultaneous determination of mycophenolic acid and its phenolic glucuronide in human plasma using an isocratic high-performance liquid chromatography procedure.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20050325

• Distinction and relationship between elongation rate and processivity of RNA polymerase II in vivo.

  Molecular cell 20050318

• [Necessity and safety of conversion from mycophenolate mofetil to AzA thioprine after renal transplantation].

  Zhonghua yi xue za zhi 20050316

• The influence of corticosteroids on quantitative ultrasound parameters of the calcaneus in the 1st year after renal transplantation.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20050301

• Pharmacokinetics of tacrolimus and mycophenolic acid are altered, but recover at different times during hepatic regeneration in rats.

  Drug metabolism and disposition: the biological fate of chemicals 20050301

• Mycophenolate mofetil (CellCept): an alternative therapy for autoimmune inflammatory myopathy.

  Rheumatology (Oxford, England) 20050301

• Steroid withdrawal in pediatric and adult renal transplant recipients.

  Pediatric nephrology (Berlin, Germany) 20050301

• Mycophenolate mofetil use in hepatitis B associated-membranous and membranoproliferative glomerulonephritis induces viral replication.

  The Annals of pharmacotherapy 20050301

• Immunosuppression in liver transplantation: beyond calcineurin inhibitors.

  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20050301

• Composite tissue allograft transplantation of cephalocervical skin flap and two ears.

  Plastic and reconstructive surgery 20050301

• Advancing immunosuppression therapy to counter the progression of cardiac allograft vasculopathy.

  Journal of cardiac failure 20050301

• [Immunity and immunosuppression in childhood idiopathic nephrotic syndrome].

  Archives de pediatrie : organe officiel de la Societe francaise de pediatrie 20050301

• Mycophenolic acid pharmacokinetics and related outcomes early after renal transplant.

  British journal of clinical pharmacology 20050301

• Comparison of ARF after myeloablative and nonmyeloablative hematopoietic cell transplantation.

  American journal of kidney diseases : the official journal of the National Kidney Foundation 20050301

• Mycotoxin production and postharvest storage rot of ginger (Zingiber officinale) by Penicillium brevicompactum.

  Journal of food protection 20050301

• [Prophylaxis and treatment of chronic graft versus host disease].

  Zhonghua er ke za zhi = Chinese journal of pediatrics 20050301

• Open-label, multicenter study on the safety, tolerability, and efficacy of Simulect in pediatric renal transplant recipients receiving triple therapy with cyclosporin, mycophenolate, and corticosteroids.

  Transplantation proceedings 20050301

• Long-term graft outcome of living donor renal transplantation: single center experience.

  Transplantation proceedings 20050301

• Conversion of azathioprine to mycophenolate mofetil and chronic graft failure progression.

  Transplantation proceedings 20050301

• Mycophenolate mofetil but not the type of calcineurin inhibitor (cyclosporine vs tacrolimus) influences the intragraft mRNA expression of cytokines in human kidney allograft biopsies by in situ RT-PCR analysis.

  Transplantation proceedings 20050301

• Serum TGF-beta1 correlates with chronic histopathological lesions in protocol biopsies of kidney allograft recipients.

  Transplantation proceedings 20050301

• Reduction of immunosuppressive load in renal transplant recipients with a low donor-specific cytotoxic T-lymphocyte precursor frequency is safe.

  Transplantation proceedings 20050301

• Comparative study of clinical outcome in kidney transplantation between early steroid withdrawal protocol using basiliximab, calcineurin inhibitor, and mycophenolate mofetil and triple regimen consisting of calcineurin inhibitor, mycophenolate mofetil, and steroid.

  Transplantation proceedings 20050301

• Corticosteroid avoidance ameliorates lymphocele formation and wound healing complications associated with sirolimus therapy.

  Transplantation proceedings 20050301

• A prospective, randomized, multicenter, double-blind study of early corticosteroid cessation versus long-term maintenance of corticosteroid therapy with tacrolimus and mycophenolate mofetil in primary renal transplant recipients: one year report.

  Transplantation proceedings 20050301

• Does mycophenolate mofetil increase the incidence of cytomegalovirus disease compared with azathioprine after cadaveric kidney transplantation?

  Transplantation proceedings 20050301

• Mycophenolic acid metabolite profile in renal transplant patients receiving enteric-coated mycophenolate sodium or mycophenolate mofetil.

  Transplantation proceedings 20050301

• Mycophenolate mofetil pharmacokinetic monitoring in pediatric kidney transplant recipients.

  Transplantation proceedings 20050301

• Therapeutic drug monitoring of mycophenolic acid in renal transplant recipients.

  Transplantation proceedings 20050301

• Standard dose enteric-coated mycophenolate sodium (myfortic) delivers rapid therapeutic mycophenolic acid exposure in kidney transplant recipients.

  Transplantation proceedings 20050301

• Pharmacokinetics of mycophenolic acid in kidney transplant patients receiving sirolimus versus cyclosporine.

  Transplantation proceedings 20050301

• Two-hour post-dose cyclosporine levels in renal transplantation in Argentina: a cost-effective strategy for reducing acute rejection.

  Transplantation proceedings 20050301

• Excellent results with calcineurin inhibitor-free initial immunosuppression in old recipients of old kidneys.

  Transplantation proceedings 20050301

• The safety and efficacy of early withdrawal of calcineurin inhibitors in kidney transplant recipients 6 months' posttransplant.

  Transplantation proceedings 20050301

• Multivariate analysis of the effectiveness of using antibody induction therapy according to the degree of HLA mismatches.

  Transplantation proceedings 20050301

• Cyclosporine-sparing effect of basiliximab in renal transplant recipients with mycophenolate mofetil.

  Transplantation proceedings 20050301

• Basiliximab (Simulect) reduces acute rejection among sensitized kidney allograft recipients.

  Transplantation proceedings 20050301

• Long-term administration of enteric-coated mycophenolate sodium in kidney transplant patients.

  Transplantation proceedings 20050301

• Safety and efficacy after conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium: results of a 1-year extension study.

  Transplantation proceedings 20050301

• Safety assessment of the conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in stable renal transplant recipients.

  Transplantation proceedings 20050301

• Prospective, multicenter, randomized trial to compare incidence of new-onset diabetes mellitus and glucose metabolism in patients receiving cyclosporine microemulsion versus tacrolimus after de novo kidney transplantation.

  Transplantation proceedings 20050301

• Daclizumab induction therapy associated with tacrolimus-MMF has better outcome compared with tacrolimus-MMF alone in pediatric living donor liver transplantation.

  Transplantation proceedings 20050301

• C0h/C2h monitoring of the pharmacodynamics of cyclosporin plus mycophenolate mofetil in human heart transplant recipients.

  Transplantation proceedings 20050301

• [The clinical spectrum of dermatomyositis].

  Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 20050301

• [Cancer and immunosuppression: pro- and antitumoral effects of immunosuppressive drugs].

  Nephrologie & therapeutique 20050301

• Guanine nucleotide depletion induces differentiation and aberrant neurite outgrowth in human dopaminergic neuroblastoma lines: a model for basal ganglia dysfunction in Lesch-Nyhan disease.

  Neuroscience letters 20050227

• Mycophenolate mofetil substitution for cyclosporine a in renal transplant recipients with chronic progressive allograft dysfunction: the 'creeping creatinine' study.

  Transplantation 20050227

• The treatment of lupus nephritis.

  BMJ (Clinical research ed.) 20050219

• From mechanisms to long-term benefits.

  Transplantation 20050215

• Long-term benefits of mycophenolate mofetil after heart transplantation.

  Transplantation 20050215

• Long-term benefit of mycophenolate mofetil in renal transplantation.

  Transplantation 20050215

• Low-dose mycophenolate mofetil is an effective and safe treatment to permit phased reduction in calcineurin inhibitors in chronic allograft nephropathy.

  Transplantation 20050215

• Cyclosporine-sparing effects of daclizumab in renal allograft recipients.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20050215

• Exceptional circumstances and heart transplantation.

  The New Zealand medical journal 20050211

• Recurrent focal glomerulosclerosis in pediatric renal allografts: the Miami experience.

  Pediatric nephrology (Berlin, Germany) 20050201

• Mycophenolate mofetil: how to further improve using an already successful drug?

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20050201

• Pharmacokinetic principles of immunosuppressive drugs.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20050201

• MMF and calcineurin taper in recurrent hepatitis C after liver transplantation: impact on histological course.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20050201

• The influence of norfloxacin and metronidazole on the disposition of mycophenolate mofetil.

  Journal of clinical pharmacology 20050201

• Mycophenolate mofetil and roscovitine decrease cyclin expression and increase p27(kip1) expression in anti Thy1 mesangial proliferative nephritis.

  Clinical and experimental immunology 20050201

• The need of mycophenolic acid monitoring in long-term renal transplants.

  Clinical transplantation 20050201

• Novel rescue therapy for C4d-positive acute humoral renal allograft rejection.

  Clinical transplantation 20050201

• Mycophenolate mofetil for the treatment of primary sclerosing cholangitis.

  The American journal of gastroenterology 20050201

• Mycophenolate mofetil in pediatric renal transplantation: non-induction vs. induction with basiliximab.

  Pediatric transplantation 20050201

• Improved outcome of pediatric kidney transplantations in the Netherlands -- effect of the introduction of mycophenolate mofetil?

  Pediatric transplantation 20050201

• Mycophenolate mofetil for the treatment of primary biliary cirrhosis in patients with an incomplete response to ursodeoxycholic acid.

  Journal of clinical gastroenterology 20050201

• T-cell-mediated pure red-cell aplasia in systemic lupus erythematosus: response to cyclosporin A and mycophenolate mofetil.

  American journal of hematology 20050201

• [Relationship between dose of mycophenolate mofetil and the occurrence of cytomegalovirus infection and diarrhea in renal transplant recipients].

  Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20050201

• Immunosuppressive drug monitoring - what to use in clinical practice today to improve renal graft outcome.

  Transplant international : official journal of the European Society for Organ Transplantation 20050201

• Steroid withdrawal at 3 months after kidney transplantation: a comparison of two tacrolimus-based regimens.

  Transplant international : official journal of the European Society for Organ Transplantation 20050201

• Sirolimus immunosuppression in pediatric heart transplant recipients: a single-center experience.

  The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20050201

• The influence of mycophenolate mofetil and azathioprine on the same cadaveric donor renal transplantation.

  Journal of Korean medical science 20050201

• Ex vivo modeling of the effects of mycophenolic acid on HIV infection: considerations for antiviral therapy.

  AIDS research and human retroviruses 20050201

• A micellar electrokinetic capillary chromatography method for monitoring mycophenolic acid in serum of transplant recipients.

  Die Pharmazie 20050201

• Sympathetic ophthalmia after a hyphema due to nonpenetrating trauma.

  Ocular immunology and inflammation 20050201

• [Nephrology].

  Revue medicale suisse 20050105

• Identification of the UDP-glucuronosyltransferase isoforms involved in mycophenolic acid phase II metabolism.

  Drug metabolism and disposition: the biological fate of chemicals 20050101

• Monitoring of immunosuppressive therapy in renal transplanted patients.

  Contributions to nephrology 20050101

• Hypogammaglobulinemia after heart transplantation: use of intravenous immunoglobulin replacement therapy in relapsing CMV disease.

  International immunopharmacology 20050101

• Impact of mycophenolate mofetil versus azathioprine on early recurrence of hepatitis C after liver transplantation.

  International immunopharmacology 20050101

• Conversion from cyclosporine to tacrolimus after renal transplantation improves cardiovascular risk factors.

  International immunopharmacology 20050101

• Tacrolimus/mycophenolate mofetil-based immunosuppression in aged kidney transplant. A prospective study.

  International immunopharmacology 20050101

• Nonnephrotoxic immunosuppression in patients after liver transplantation.

  International immunopharmacology 20050101

• Introduction of MMF in conjunction with stepwise reduction of calcineurin inhibitor in stable liver transplant patients with renal dysfunction.

  International immunopharmacology 20050101

• Immunosuppressant drug monitoring: is the laboratory meeting clinical expectations?

  The Annals of pharmacotherapy 20050101

• The effect of soluble complement receptor type 1 on acute humoral xenograft rejection in hDAF-transgenic pig-to-primate life-supporting kidney xenografts.

  Xenotransplantation 20050101

• Intraindividual and interindividual variations in the pharmacokinetics of mycophenolic acid in liver transplant patients.

  Journal of clinical pharmacology 20050101

• Novel strategies for steroid-refractory acute graft-versus-host disease.

  Current opinion in hematology 20050101

• Crohn's-like changes in the colon due to mycophenolate?

  Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland 20050101

• Immunosuppression: towards a logical approach in liver transplantation.

  Clinical and experimental immunology 20050101

• One-year results of basiliximab induction and tacrolimus associated with sequential steroid and MMF treatment in pediatric kidney transplant recipient.

  Transplant international : official journal of the European Society for Organ Transplantation 20050101

• Cardiac transplantation in pediatric patients: fifteen-year experience of a single center.

  The Annals of thoracic surgery 20050101

• Mycophenolate mofetil induced myopathy in a patient with lupus nephritis.

  The Journal of rheumatology 20050101

• Minimization of immunosuppressive therapy after renal transplantation: results of a randomized controlled trial.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20050101

• Applicability, tolerability and efficacy of preemptive antiviral therapy in hepatitis C-infected patients undergoing liver transplantation.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20050101

• ABO incompatible kidney transplantations without splenectomy, using antigen-specific immunoadsorption and rituximab.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20050101

• Mycoplasma hominis septic arthritis in a pediatric renal transplant recipient: case report and review of the literature.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20050101

• Tacrolimus and pure red-cell aplasia.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20050101

• Mycophenolate mofetil modulates adhesion receptors of the beta1 integrin family on tumor cells: impact on tumor recurrence and malignancy.

  BMC cancer 20050101

• Mycophenolate mofetil in lupus nephritis.

  Lupus 20050101

• [Mycophenolate: 30 years later].

  Annales de dermatologie et de venereologie 20050101

• [Cicatricial pemphigoid: treatment with mycophenolate mofetil].

  Annales de dermatologie et de venereologie 20050101

• [Infectious complications in using mofetil micofenolate in patients with renal allotransplant].

  Terapevticheskii arkhiv 20050101

• [New immunodepressant drugs for the prevention and control of kidney transplant rejection].

  Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia 20050101

• Mechanisms of action of mycophenolate mofetil.

  Lupus 20050101

• Mycophenolate mofetil and systemic lupus erythematosus: an overview.

  Lupus 20050101

• Mycophenolate mofetil in animal models of autoimmune disease.

  Lupus 20050101

• Adhesion molecules, mycophenolate mofetil and systemic lupus erythematosus.

  Lupus 20050101

• Lupus nephritis: induction therapy.

  Lupus 20050101

• Maintenance therapies for proliferative lupus nephritis: mycophenolate mofetil, azathioprine and intravenous cyclophosphamide.

  Lupus 20050101

• Mycophenolate mofetil in nonlupus glomerulonephropathy.

  Lupus 20050101

• Mycophenolate mofetil and neurological diseases.

  Lupus 20050101

• Mycophenolate mofetil and myasthenia gravis.

  Lupus 20050101

• MMF and eye disease.

  Lupus 20050101

• Mycophenolate mofetil in systemic vasculitis.

  Lupus 20050101

• Mycophenolate mofetil and skin diseases.

  Lupus 20050101

• Mycophenolate mofetil in patients with hepatitis C virus infection.

  Lupus 20050101

• Immunosuppressive activity of FTY720, sphingosine 1-phosphate receptor agonist: I. Prevention of allograft rejection in rats and dogs by FTY720 and FTY720-phosphate.

  Transplantation proceedings 20050101

• Mycophenolate mofetil inhibits intimal hyperplasia and attenuates the expression of genes favouring smooth muscle cell proliferation and migration.

  Transplantation proceedings 20050101

• Combination of hDAF-transgenic pig hearts and immunoadsorption in heterotopic xenotransplantation of immunosuppressed baboons.

  Transplantation proceedings 20050101

• [Production of mycophenolic acid by fungi of the genus Penicillium link].

  Prikladnaia biokhimiia i mikrobiologiia 20050101

• Mycophenolate sodium delayed release: prevention of renal transplant rejection.

  Drugs 20050101

• MMF for lupus nephritis as a possible first aid block.

  Nephron. Clinical practice 20050101

• Mycophenolate mofetil for remission induction in severe lupus nephritis.

  Nephron. Clinical practice 20050101

• Different effect of cyclosporine A and mycophenolate mofetil on passive Heymann nephritis in the rat.

  Nephron. Experimental nephrology 20050101

• Pharmacokinetics and pharmacodynamics of low dose mycophenolate mofetil in HIV-infected patients treated with abacavir, efavirenz and nelfinavir.

  Clinical pharmacokinetics 20050101

• Prolonged survival of rat hindlimb allografts following short-course FK506 and mycophenolate mofetil combination therapy.

  Microsurgery 20050101

• Effects of mycophenolate mofetil on key pattern of coronary restenosis: a cascade of in vitro and ex vivo models.

  BMC cardiovascular disorders 20050101

• [The first experience with sirolimus (Rapamune) after kidney transplantation in Lithuania].

  Medicina (Kaunas, Lithuania) 20050101

• Enteric-coated mycophenolate sodium: tolerability profile compared with mycophenolate mofetil.

  Drugs 20050101

• One-year angiotensin-converting enzyme inhibition plus mycophenolate mofetil immunosuppression in the course of early IgA nephropathy: a multicenter, randomised, controlled study.

  Journal of nephrology 20050101

• Quadruple immunosuppression with basiliximab, tacrolimus, mycophenolate mofetil and prednisone is safe and effective for renal transplantation.

  Clinical transplantation 20050101

• Severe skin reaction related to mycophenolate mofetil for myasthenia gravis.

  Clinical neuropharmacology 20050101

• Skin manifestations of systemic lupus erythematosus refractory to multiple treatment modalities: poor results with mycophenolate mofetil.

  Clinical and experimental rheumatology 20050101

• [Immunosuppressive drug monitoring of cyclosporine, tacrolimus, and mycophenolate mofetil in renal transplantation].

  Nihon Jinzo Gakkai shi 20050101

• [How should severe and chronic atopic dermatitis in children be managed?].

  Annales de dermatologie et de venereologie 20050101

• Mycophenolate mofetil may protect against Pneumocystis carinii pneumonia in renal transplanted patients.

  Revista do Instituto de Medicina Tropical de Sao Paulo 20050101

• A double absorption-phase model adequately describes mycophenolic acid plasma profiles in de novo renal transplant recipients given oral mycophenolate mofetil.

  Clinical pharmacokinetics 20050101

• [Outcomes of transplantation from living renal donor].

  Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20050101

• [Review of a new immunosuppressive drug: enteric-coated mycophenolate sodium (Myfortic)].

  Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20050101

• Uncommon side effect of MMF in renal transplant recipients.

  Renal failure 20050101

• Long-term follow-up of patients with birdshot retinochoroidopathy treated with systemic immunosuppression.

  Ocular immunology and inflammation 20050101

• Modulation of intra-pulmonary TGF-beta expression by mycophenolate mofetil in lupus prone MRL/lpr mice.

  Lupus 20050101

• Population pharmacokinetics of mycophenolic acid in renal transplant recipients.

  Clinical pharmacokinetics 20050101

• Impact of mycophenolate mofetil dose posttransplantation on 12-month renal function: analysis of the MOST database.

  Transplantation proceedings 20050101

• Mycophenolate mofetil monotherapy in liver transplantation.

  Transplantation proceedings 20050101

• Use of mycophenolate mofetil in liver transplantation: a literature review.

  Transplantation proceedings 20050101

• Calcineurin inhibitor-free immunosuppression in renal transplantation.

  Transplantation proceedings 20050101

• Conversion to sirolimus in a population of kidney and kidney-pancreas transplant recipients.

  Transplantation proceedings 20050101

• Combined use of tacrolimus and sirolimus in de novo renal transplant patients: current data.

  Transplantation proceedings 20050101

• Immunosuppressive drugs after simultaneous pancreas-kidney transplantation.

  Transplantation proceedings 20050101

• Corticosteroid withdrawal in simultaneous pancreas-kidney transplantation: a 3-year report.

  Transplantation proceedings 20050101

• Glucuronidation and the transport of the glucuronide metabolites in LLC-PK1 cells.

  Molecular pharmaceutics 20050101

• Clinical application of monitoring mycophenolic acid trough concentration in heart transplant recipients--single center's experience.

  Annals of transplantation 20050101

• [Evidences in immunosuppression in the maintenance of renal transplantation].

  Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20050101

• [Mycophenolate mofetil in high risk IgA glomerulonephritis].

  Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20050101

• Mycophenolate mofetil in the treatment of steroid-resistant primary focal segmental glomerulosclerosis.

  Journal of nephrology 20050101

• Treatment of pemphigus vulgaris: current and emerging options.

  American journal of clinical dermatology 20050101

• Mycophenolate mofetil in children with steroid-dependent and/or frequently relapsing nephrotic syndrome.

  Annals of Saudi medicine 20050101

• Defining the role of mycophenolate mofetil in the treatment of proliferative lupus nephritis.

  Drugs 20050101

• Severe Pneumocystis pneumonia in a renal transplant recipient after long term mycophenolate mofetil treatment.

  Revista do Instituto de Medicina Tropical de Sao Paulo 20050101

• Bullous pemphigoid following therapy with an oral beta-blocker.

  Journal of drugs in dermatology : JDD 20050101

• Mycophenolate mofetil for refractory haemolytic anemia in systemic lupus erythematosus.

  Lupus 20050101

• Does mycophenolate mofetil decrease the recurrent acute rejection in renal transplant recipients.

  International urology and nephrology 20050101

• Central nervous system lymphoma associated with mycophenolate mofetil in lupus nephritis.

  Lupus 20050101

• Does mycophenolate mofetil increase the incidence of infections in renal transplant recipients?

  Drugs under experimental and clinical research 20050101

• [Inhibition of phosphatidylethanolamine and phosphatidylinositol synthesis, alteration of the G0 and G1 cell cycle phases and spontaneous apoptosis in lymphocytes from patients under immunosuppressive treatment].

  Journal de la Societe de biologie 20050101

• [Immunosuppression for kidney transplant recipients: current strategies].

  Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion 20050101

• [Progress and perspectives in the treatment of systemic lupus erythematosus].

  Przeglad lekarski 20050101

• [Systemic management of autoimmune anterior uveitis].

  Klinika oczna 20050101

• A pilot study of calcineurin inhibitors (CNIs) and steroid avoidance immunosuppressive protocol among living donor kidney transplant recipients.

  Yonsei medical journal 20041231

• Determination of total mycophenolic acid and its glucuronide metabolite using liquid chromatography with ultraviolet detection and unbound mycophenolic acid using tandem mass spectrometry.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20041225

• Drug therapy in the heart transplant recipient: part II: immunosuppressive drugs.

  Circulation 20041221

• Differentiation of human prostate cancer PC-3 cells induced by inhibitors of inosine 5'-monophosphate dehydrogenase.

  Cancer research 20041215

• Phase I clinical trial of the inosine monophosphate dehydrogenase inhibitor mycophenolate mofetil (cellcept) in advanced multiple myeloma patients.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20041215

• Treatment of idiopathic membranoproliferative glomerulonephritis with mycophenolate mofetil and steroids.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20041201

• Fate of donor kidney: laparoscopic versus open technique.

  The Journal of urology 20041201

• In vitro study of mycophenolic acid glucuronidation.

  Drug metabolism and disposition: the biological fate of chemicals 20041201

• Mycophenolate therapy of SLE membranous nephropathy.

  Kidney international 20041201

• Characterization of a phase 1 metabolite of mycophenolic acid produced by CYP3A4/5.

  Therapeutic drug monitoring 20041201

• Comparison of liquid chromatography-tandem mass spectrometry with a commercial enzyme-multiplied immunoassay for the determination of plasma MPA in renal transplant recipients and consequences for therapeutic drug monitoring.

  Therapeutic drug monitoring 20041201

• Mycophenolic acid in diabetic renal transplant recipients: pharmacokinetics and application of a limited sampling strategy.

  Therapeutic drug monitoring 20041201

• Mycophenolic acid inhibits platelet-derived growth factor-induced reactive oxygen species and mitogen-activated protein kinase activation in rat vascular smooth muscle cells.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20041201

• Pre-transplant inosine monophosphate dehydrogenase activity is associated with clinical outcome after renal transplantation.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20041201

• Sirolimus with neoral versus mycophenolate mofetil with neoral is associated with decreased renal allograft survival.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20041201

• Extensive skeletal muscle uptake of 18F-FDG: relation to immunosuppressants?

  Journal of nuclear medicine technology 20041201

• MYSS: should we alter clinical practice?

  Lancet (London, England) 20041201

• Allogeneic hematopoietic cell transplantation for metastatic renal cell carcinoma after nonmyeloablative conditioning: toxicity, clinical response, and immunological response to minor histocompatibility antigens.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20041201

• Reduction of ICAM-1 and LFA-1-positive leukocytes in the perivascular space of arteries under mycophenolate mofetil therapy reduces rat heart transplant vasculopathy.

  The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20041201

• Mycophenolate mofetil is an effective treatment for peristomal pyoderma gangrenosum.

  Archives of dermatology 20041201

• Pharmacokinetics of immunosuppressants: a perspective on ethnic differences.

  International journal of clinical pharmacology and therapeutics 20041201

• Mycophenolate mofetil in the treatment of focal segmental glomerulosclerosis.

  Clinical nephrology 20041201

• Effect of mycophenolate mofetil on kidney graft function and body weight in patients with chronic allograft nephropathy.

  Transplantation proceedings 20041201

• Erythrocyte sodium lithium countertransport in renal transplant recipients with mycophenolate mofetil and low-dose cyclosporine.

  Transplantation proceedings 20041201

• Corticosteroid weaning in the tacrolimus and mycophenolate era in heart transplantation: clinical and neurohormonal benefits.

  Transplantation proceedings 20041201

• Initial experience with sirolimus and mycophenolate mofetil for renal rescue from cyclosporine nephrotoxicity after heart transplantation.

  Transplantation proceedings 20041201

• Experimental limb transplantation, part III: induction of tolerance in the rigorous strain combination of Brown Norway donor to Lewis recipient.

  Transplantation proceedings 20041201

• Use of EQUORAL in de novo renal transplant recipients.

  Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia 20041201

• Mutagenic and cytotoxic effects of immunosuppressive drugs on human lymphocyte cultures.

  Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 20041201

• Everolimus (Certican) 12-month safety and efficacy versus mycophenolate mofetil in de novo renal transplant recipients.

  Transplantation 20041127

• Steroid withdrawal in renal transplant patients on triple therapy with a calcineurin inhibitor and mycophenolate mofetil: a meta-analysis of randomized, controlled trials.

  Transplantation 20041127

• Sirolimus may not cause neurotoxicity in kidney and liver transplant recipients.

  Neurology 20041123

• HPLC determination of mycophenolic acid and mycophenolic acid glucuronide in human plasma with hybrid material.

  Journal of pharmaceutical and biomedical analysis 20041115

• Low-dose cyclosporine with mycophenolate mofetil induces similar calcineurin activity and cytokine inhibition as does standard-dose cyclosporine in stable renal allografts.

  Transplantation 20041115

• Low levels of mycophenolic acid induce differentiation of human neuroblastoma cell lines.

  International journal of cancer 20041101

• Conversion from cyclosporine A to mycophenolate mofetil protects recipient kidney and prevents intimal hyperplasia in rat aortic allografts.

  Transplant immunology 20041101

• Lower incidence of chronic allograft nephropathy at 1 year post-transplantation in patients treated with mycophenolate mofetil.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20041101

• Thiopurine S-methyltransferase genotype predicts azathioprine-induced myelotoxicity in kidney transplant recipients.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20041101

• Steroid sparing with tacrolimus and mycophenolate mofetil in renal transplantation.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20041101

• Mycophenolate mofetil vs azathioprine in a large population of elderly renal transplant patients.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20041101

• Severe hemolysis resulting from D incompatibility in a case of ABO-identical liver transplant.

  Transfusion 20041101

• In vitro combination of amdoxovir and the inosine monophosphate dehydrogenase inhibitors mycophenolic acid and ribavirin demonstrates potent activity against wild-type and drug-resistant variants of human immunodeficiency virus type 1.

  Antimicrobial agents and chemotherapy 20041101

• Pediatric cardiac transplantation in children with high panel reactive antibody.

  The Annals of thoracic surgery 20041101

• Selective intra-graft apoptosis and down-regulation of lymphocyte bcl-2, iNOs and CD95L expression in kidney-pancreas transplanted patients after anti-Thymoglobulin induction.

  Transplant international : official journal of the European Society for Organ Transplantation 20041101

• Long-term outcome of gastrointestinal complications in renal transplant patients treated with mycophenolate mofetil.

  Transplant international : official journal of the European Society for Organ Transplantation 20041101

• A prospective, randomized-controlled pilot study of ursodeoxycholic acid combined with mycophenolate mofetil in the treatment of primary sclerosing cholangitis.

  Alimentary pharmacology & therapeutics 20041101

• Sepsis associated with immunosuppressive medications: an evidence-based review.

  Critical care medicine 20041101

• Efficacy of conventional immunosuppressive drugs in IBD.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20041101

• Bilateral hand transplantation: bone healing under immunosuppression with tacrolimus, mycophenolate mofetil, and prednisolone.

  The Journal of hand surgery 20041101

• Remission of multiple sclerosis post-liver transplantation.

  The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 20041101

• Impact of combined mycophenolate mofetil and low-dose calcineurin inhibitor therapy on renal function, cardiovascular risk factors, and graft function in liver transplant patients: preliminary results of an open prospective study.

  Transplantation proceedings 20041101

• An exploratory study on pharmacogenetics of inosine-monophosphate dehydrogenase II in peripheral mononuclear cells from liver-transplant recipients.

  Transplantation proceedings 20041101

• Chronic cyclosporine-induced nephrotoxiciy in heart transplant patients: long-term benefits of treatment with mycophenolate mofetil and low-dose cyclosporine.

  Transplantation proceedings 20041101

• Molecular approaches to the side effects of immunosuppressive drugs.

  Transplantation 20041027

• cDNA microarray analysis reveals new candidate genes possibly linked to side effects under mycophenolate mofetil therapy.

  Transplantation 20041027

• Two-dose daclizumab induction therapy in 209 liver transplants: a single-center analysis.

  Transplantation 20041027

• Iron therapy in renal transplant recipients.

  Transplantation 20041027

• Simultaneous determination of free mycophenolic acid and its glucuronide in serum of patients under mycophenolate mophetil therapy by ion-pair reversed-phase liquid chromatography with diode array UV detection.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20041025

• Restriction of de novo nucleotide biosynthesis interferes with clonal expansion and differentiation into effector and memory CD8 T cells.

  Journal of immunology (Baltimore, Md. : 1950) 20041015

• A prospective randomized trial comparing cyclosporine and short course methotrexate with cyclosporine and mycophenolate mofetil for GVHD prophylaxis in myeloablative allogeneic bone marrow transplantation.

  Bone marrow transplantation 20041001

• The effect of sevelamer on the pharmacokinetics of cyclosporin A and mycophenolate mofetil after renal transplantation.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20041001

• Improvement in long-term graft survival in cadaveric renal transplant recipients treated with mycophenolate mofetil.

  Transplant international : official journal of the European Society for Organ Transplantation 20041001

• Mycophenolates in transplantation.

  Clinical transplantation 20041001

• Early experience with two-dose daclizumab in the prevention of acute rejection in cardiac transplantation.

  Clinical transplantation 20041001

• Long-term follow-up of pediatric transplant recipients: mycophenolic acid trough levels are not a good indicator for long-term graft function.

  Clinical transplantation 20041001

• Use of immunomodulary agents is difficult in treating autoimmune hepatitis patients.

  Journal of clinical gastroenterology 20041001

• Long-term efficacy and safety of mycophenolate mofetil in liver transplant recipients with calcineurin inhibitor-induced renal dysfunction.

  Transplant international : official journal of the European Society for Organ Transplantation 20041001

• Mycophenolate mofetil can be used as monotherapy late after liver transplantation.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20041001

• Effect of sirolimus withdrawal in patients with deteriorating renal function.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20041001

• What is the calcineurin inhibitor of choice for pediatric renal transplantation?

  Pediatric transplantation 20041001

• Current immunosuppressive agents in pediatric renal transplantation: efficacy, side-effects and utilization.

  Pediatric transplantation 20041001

• Mycophenolate mofetil and reduced doses of cyclosporine in pediatric liver transplantation with chronic renal dysfunction: changes in the immune responses.

  Pediatric transplantation 20041001

• Prevention of corneal allograft rejection in a mouse model of high risk recipients.

  The British journal of ophthalmology 20041001

• Mycophenolic acid inhibits avian reovirus replication.

  Antiviral research 20041001

• Mycophenolate mofetil treatment of a patient with hyperglobulinemic purpura.

  Journal of the American Academy of Dermatology 20041001

• Mycophenolate mofetil in IgA nephropathy.

  Kidney international 20041001

• Campath-1H in renal transplantation: The University of Wisconsin experience.

  Surgery 20041001

• [Membranous nephropathy].

  Nihon rinsho. Japanese journal of clinical medicine 20041001

• [Immunosuppressive therapy for nephrotic syndrome and strategy for adverse side effects from that therapy].

  Nihon rinsho. Japanese journal of clinical medicine 20041001

• Two inhibitors of DNA-synthesis lead to inhibition of cytokine production via a different mechanism.

  Nucleosides, nucleotides & nucleic acids 20041001

• Potential role of mycophenolate mofetil in the management of neuroblastoma patients.

  Nucleosides, nucleotides & nucleic acids 20041001

• [Immunossupresive drugs in renal transplantation].

  Polskie Archiwum Medycyny Wewnetrznej 20041001

• Cryptosporidium parvum IMP dehydrogenase: identification of functional, structural, and dynamic properties that can be exploited for drug design.

  The Journal of biological chemistry 20040924

• Highly active antiretroviral therapy with or without mycophenolate mofetil in treatment-naive HIV-1 patients.

  AIDS (London, England) 20040924

• Improved clinical outcomes in Chinese renal allograft recipients receiving lower dose immunosuppressants.

  Transplantation 20040915

• Antithymocyte globulin induction allows a prolonged delay in the initiation of cyclosporine in heart transplant patients with postoperative renal dysfunction.

  Transplantation 20040915

• Late coronary thrombosis secondary to a sirolimus-eluting stent.

  Circulation 20040914

• Prevention of glomerular crescent formation in glomerulonephritis by mycophenolate mofetil in rats.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20040901

• BCR-ABL transcripts are early predictors for hematological relapse in chronic myeloid leukemia after hematopoietic cell transplantation with reduced intensity conditioning.

  Leukemia 20040901

• To what extent does the understanding of pharmacokinetics of mycophenolate mofetil influence its prescription.

  Pediatric nephrology (Berlin, Germany) 20040901

• Mycophenolate mofetil and cyclosporine for graft-versus-host disease prophylaxis following reduced intensity conditioning allogeneic stem cell transplantation.

  Bone marrow transplantation 20040901

• Lack of correlation between MMF dose and MPA level in pediatric and young adult cardiac transplant patients: does the MPA level matter?

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20040901

• Sirolimus-induced leukocytoclastic vasculitis: the second case reported.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20040901

• Progression of lupus nephritis during treatment with mycophenolate mofetil.

  Annals of the rheumatic diseases 20040901

• Villous atrophy induced by mycophenolate mofetil in renal-transplant patients.

  Transplant international : official journal of the European Society for Organ Transplantation 20040901

• Complete but transient relief of chronic cluster headache with mycophenolate mofetil.

  Headache 20040901

• Maxillary actinomycosis in an immunocompromised patient with longstanding vasculitis treated with mycophenolate mofetil.

  The Journal of rheumatology 20040901

• Mycophenolate mofetil monotherapy in liver transplant recipients: a single center experience.

  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20040901

• Reduction of cyclosporine after introduction of mycophenolate mofetil improves chronic renal dysfunction in heart transplant recipients--the IMPROVED multi-centre study.

  European heart journal 20040901

• Identification of protein targets for mycophenolic acid acyl glucuronide in rat liver and colon tissue.

  Proteomics 20040901

• Mycophenolate mofetil in pyoderma gangrenosum.

  The Journal of dermatological treatment 20040901

• Inducible nitric oxide synthase inhibition by mycophenolic acid.

  Mini reviews in medicinal chemistry 20040901

• Selective use of mycophenolate mofetil in renal transplant patients in Indian scenario.

  Transplantation proceedings 20040901

• Pharmacokinetics of mycophenolic acid after a single and multiple oral doses of mycophenolate mofetil in Chinese renal transplant recipients.

  Transplantation proceedings 20040901

• Safety of mycophenolate mofetil versus azathioprine in renal transplantation: a systematic review.

  Transplantation proceedings 20040901

• Efficacy of mycophenolate mofetil versus azathioprine after renal transplantation: a systematic review.

  Transplantation proceedings 20040901

• Clinical experience of mycophenolate mofetil in the treatment of chronic allograft nephropathy in kidney transplantation: three-year follow-up.

  Transplantation proceedings 20040901

• The pharmacokinetics of mycophenolate mofetil in Thai kidney transplant recipients.

  Transplantation proceedings 20040901

• Correlation of mycophenolic acid pharmacokinetic parameters with side effects in Chinese kidney transplant recipients treated with mycophenolate mofetil.

  Transplantation proceedings 20040901

• Results of kidney transplantation in patients receiving MMF- or MMF and basiliximab-containing immunosuppression.

  Transplantation proceedings 20040901

• Conversion from mycophenolate mofetil to azathioprine in high-risk renal allograft recipients on cyclosporine-based immunosuppression.

  Transplantation proceedings 20040901

• Randomized trial of tacrolimus versus cyclosporine in steroid withdrawal in living donor renal transplant recipients.

  Transplantation proceedings 20040901

• C4d-positive acute humoral renal allograft rejection: rescue therapy by immunoadsorption in combination with tacrolimus and mycophenolate mofetil.

  Transplantation proceedings 20040901

• Does mycophenolate mofetil increase the incidence of infections in stable renal transplant recipients initially treated with a two-drug regimen?

  Transplantation proceedings 20040901

• Excellent outcome of ABO-incompatible living kidney transplantation under pretransplantation immunosuppression with tacrolimus, mycophenolate mofetil, and steroid.

  Transplantation proceedings 20040901

• Sequential protocols using basiliximab versus antithymocyte globulins in renal-transplant patients receiving mycophenolate mofetil and steroids.

  Transplantation 20040827

• Tacrolimus or cyclosporine: which is the better partner for mycophenolate mofetil in heart transplant recipients?

  Transplantation 20040827

• Efficacy of mycophenolate mofetil in patients with chronic immune demyelinating polyneuropathy.

  Neurology 20040824

• The use of Campath-1H as induction therapy in renal transplantation: preliminary results.

  Transplantation 20040815

• A randomized controlled trial of immunosuppression conversion for the treatment of chronic allograft nephropathy.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20040801

• Analysis of the cardiovascular risk profile in stable kidney transplant recipients after 50% cyclosporine reduction.

  Clinical transplantation 20040801

• Rapid steroid withdrawal in hepatitis C virus-positive kidney transplant recipients.

  Clinical transplantation 20040801

• Four-year follow-up of a prospective randomized trial of mycophenolate mofetil with cyclosporine microemulsion or tacrolimus following liver transplantation.

  Clinical transplantation 20040801

• Using established immunosuppressant therapy effectively: lessons from the measurement of mycophenolic acid plasma concentrations.

  Therapeutic drug monitoring 20040801

• Cyclosporin A absorption profiles in pediatric renal transplant recipients predict the risk of acute rejection.

  Therapeutic drug monitoring 20040801

• Severe toxicity associated with a markedly elevated mycophenolic acid free fraction in a renal transplant recipient.

  Therapeutic drug monitoring 20040801

• The main role of UGT1A9 in the hepatic metabolism of mycophenolic acid and the effects of naturally occurring variants.

  Drug metabolism and disposition: the biological fate of chemicals 20040801

• Initial steroid-free immunosuppression after liver transplantation in recipients with hepatitis C virus related cirrhosis.

  World journal of gastroenterology 20040801

• Therapeutic drug monitoring of sirolimus: effect of concomitant immunosuppressive therapy and optimization of drug dosing.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20040801

• Self-resolution of Epstein-Barr virus-associated B-cell lymphoma in a patient with dermatomyositis following withdrawal of mycophenolate mofetil and methotrexate.

  Journal of the American Academy of Dermatology 20040801

• Show me the money--immunosuppression in kidney transplantation.

  Lancet (London, England) 20040801

• Mycophenolate mofetil versus azathioprine for prevention of acute rejection in renal transplantation (MYSS): a randomised trial.

  Lancet (London, England) 20040801

• [Mismatched hematopoietic stem cell transplantation using GIAC protocol: report of 100 cases].

  Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 20040801

• Successful withdrawal of steroids in pediatric renal transplant recipients receiving cyclosporine A and mycophenolate mofetil treatment: results after four years.

  Transplantation 20040727

• HIV-1 seroreversion in an HIV-1-seropositive patient treated during acute infection with highly active antiretroviral therapy and mycophenolate mofetil.

  AIDS (London, England) 20040723

• Treatment of lichen planopilaris with mycophenolate mofetil.

  Dermatology online journal 20040715

• Determination of the immunosuppressant mycophenolic acid in human serum by solid-phase microextraction coupled to liquid chromatography.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20040705

• Mycophenolate mofetil treatment following renal transplantation decreases GTP concentrations in mononuclear leucocytes.

  Clinical science (London, England : 1979) 20040701

• Mycophenolate mofetil, an inhibitor of inosine monophosphate dehydrogenase, causes a paradoxical elevation of GTP in erythrocytes of renal transplant patients.

  Clinical science (London, England : 1979) 20040701

• Mycophenolate mofetil as an alternative to cyclosporine in post renal transplant thrombocytopenia.

  Pediatric nephrology (Berlin, Germany) 20040701

• Different efficacy of mycophenolate mofetil as salvage treatment for acute and chronic GVHD after allogeneic stem cell transplant.

  European journal of haematology 20040701

• Early adequate mycophenolic acid exposure is associated with less rejection in kidney transplantation.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20040701

• Acute polymyositis following renal transplantation.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20040701

• Pharmacokinetic study of mycophenolic acid in Korean kidney transplant patients.

  Journal of clinical pharmacology 20040701

• Myalgia: an uncommon or underestimated side effect of mycophenolate mophetil after transplantation?

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20040701

• FTY720 prolongs clear corneal allograft survival with a differential effect on different lymphocyte populations.

  The British journal of ophthalmology 20040701

• Human UDP-glucuronosyltransferases show atypical metabolism of mycophenolic acid and inhibition by curcumin.

  Drug metabolism and disposition: the biological fate of chemicals 20040701

• Intrarenal Renin-Angiotensin system is upregulated in experimental model of progressive renal disease induced by chronic inhibition of nitric oxide synthesis.

  Journal of the American Society of Nephrology : JASN 20040701

• Acute renal failure after nonmyeloablative hematopoietic cell transplantation.

  Journal of the American Society of Nephrology : JASN 20040701

• Effect of mycophenolate mofetil on immune response and plasma and lymphatic tissue viral load during and after interruption of highly active antiretroviral therapy for patients with chronic HIV infection: a randomized pilot study.

  Journal of acquired immune deficiency syndromes (1999) 20040701

• Immunosuppression and modulation in liver transplantation.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20040701

• [Clinical study of three-dose regimen of Zenapax in orthotopic liver transplantation].

  Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA 20040701

• Mycophenolate mofetil and oral ulcerations.

  Transplantation 20040627

• Mycophenolate mofetil prevents transplant arteriosclerosis by direct inhibition of vascular smooth muscle cell proliferation.

  Transplantation 20040615

• Sequential therapies for proliferative lupus nephritis.

  The New England journal of medicine 20040610

• Sequential therapies for proliferative lupus nephritis.

  The New England journal of medicine 20040610

• Sequential therapies for proliferative lupus nephritis.

  The New England journal of medicine 20040610

• Simple reversed-phase ion-pair liquid chromatography assay for the simultaneous determination of mycophenolic acid and its glucuronide metabolite in human plasma and urine.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20040605

• Cyclosporin A, but not tacrolimus, inhibits the biliary excretion of mycophenolic acid glucuronide possibly mediated by multidrug resistance-associated protein 2 in rats.

  The Journal of pharmacology and experimental therapeutics 20040601

• Shuttle vectors for Candida albicans: control of plasmid copy number and elevated expression of cloned genes.

  Current genetics 20040601

• Adult onset Still's disease and collapsing glomerulopathy: successful treatment with intravenous immunoglobulins and mycophenolate mofetil.

  Rheumatology (Oxford, England) 20040601

• Cyclosporine and mycophenolate mofetil prophylaxis with fludarabine and melphalan conditioning for unrelated donor transplantation: a prospective study of 22 patients with hematologic malignancies.

  Bone marrow transplantation 20040601

• Synthesis, molecular modeling, and evaluation of nonphenolic indole analogs of mycophenolic acid.

  Bioorganic & medicinal chemistry 20040601

• Physiological and metabolic actions of mycophenolate mofetil on cultured newborn rat cardiomyocytes in normoxia and in simulated ischemia.

  Fundamental & clinical pharmacology 20040601

• Effects of commonly used immunosuppressants on graft-derived fibroblasts.

  Clinical and experimental immunology 20040601

• Cytomegalovirus prophylaxis and graft outcome in solid organ transplantation: a collaborative transplant study report.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20040601

• Increased risk of thrombotic microangiopathy in patients receiving a cyclosporin-sirolimus combination.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20040601

• Outcome at 3 years with a prednisone-free maintenance regimen: a single-center experience with 349 kidney transplant recipients.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20040601

• Sirolimus-induced angioedema.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20040601

• Interleukin-2 receptor antibody (basiliximab) for immunosuppressive induction therapy after liver transplantation: a protocol with early elimination of steroids and reduction of tacrolimus dosage.

  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20040601

• Review of the immunosuppressant enteric-coated mycophenolate sodium.

  Expert opinion on pharmacotherapy 20040601

• Free mycophenolic acid should be monitored in renal transplant recipients with hypoalbuminemia.

  Therapeutic drug monitoring 20040601

• Ferrous sulfate does not affect mycophenolic acid pharmacokinetics in kidney transplant patients.

  American journal of kidney diseases : the official journal of the National Kidney Foundation 20040601

• Drug interactions between mycophenolate and cyclosporine.

  Pediatric transplantation 20040601

• Cyclosporine, tacrolimus, and mycophenolate mofetil in the treatment of inflammatory bowel disease.

  Gastroenterology clinics of North America 20040601

• Recurrent anterior uveitis in patients with Vogt-Koyanagi-Harada syndrome.

  Archives of ophthalmology (Chicago, Ill. : 1960) 20040601

• Age-dependency of mycophenolate mofetil dosing in combination with tacrolimus after pediatric renal transplantation.

  Transplantation proceedings 20040601

• Chronic allograft nephropathy: pathogenesis and management of an important posttransplant complication.

  Progress in transplantation (Aliso Viejo, Calif.) 20040601

• Future immunosuppressive agents in solid-organ transplantation.

  Progress in transplantation (Aliso Viejo, Calif.) 20040601

• Strategies to prevent chronic allograft nephropathy in kidney transplantation: focus on calcineurin inhibitors.

  Progress in transplantation (Aliso Viejo, Calif.) 20040601

• Sirolimus and mycophenolate mofetil as calcineurin inhibitor-free immunosuppression in a cardiac transplant patient with chronic renal failure.

  The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20040601

• The pp67 mRNA assay in treatment and monitoring of cytomegalovirus disease in renal transplant patients in India.

  Transplant infectious disease : an official journal of the Transplantation Society 20040601

• Autoimmune hepatitis.

  Minerva gastroenterologica e dietologica 20040601

• Portal donor-specific blood transfusion and mycophenolate mofetil allow steroid avoidance and tacrolimus dose reduction with sustained levels of chimerism in a pig model of intestinal transplantation.

  Transplantation 20040527

• Wound-healing complications after kidney transplantation: a prospective, randomized comparison of sirolimus and tacrolimus.

  Transplantation 20040527

• An update on clinical outcomes in heart and lung transplantation.

  Transplantation 20040515

• Anemia in pediatric renal transplant recipients.

  Pediatric nephrology (Berlin, Germany) 20040501

• Pseudotumor cerebri following cyclosporine A treatment in a boy with tubulointerstitial nephritis associated with uveitis.

  Pediatric nephrology (Berlin, Germany) 20040501

• Steroid-withdrawal at 3 days after renal transplantation with anti-IL-2 receptor alpha therapy: a prospective, randomized, multicenter study.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20040501

• Mycophenolate mofetil in IgA nephropathy: results of a 3-year prospective placebo-controlled randomized study.

  Kidney international 20040501

• Optimizing the immunosuppressive regimen in heart transplantation.

  The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20040501

• Paraneoplastic pemphigus secondary to fludarabine evolving into unusual oral pemphigus vegetans.

  Journal of the European Academy of Dermatology and Venereology : JEADV 20040501

• Pharmacoepidemiology of anemia in kidney transplant recipients.

  Journal of the American Society of Nephrology : JASN 20040501

• Economic evaluation of everolimus versus mycophenolate mofetil in combination with cyclosporine and prednisolone in de novo renal transplant recipients.

  Transplant international : official journal of the European Society for Organ Transplantation 20040501

• Mycophenolic mofetil reduces the HLA antibody response of children to valved allograft implantation.

  The Annals of thoracic surgery 20040501

• Clinical efficacy and toxicity profile of tacrolimus and mycophenolic acid in relation to combined long-term pharmacokinetics in de novo renal allograft recipients.

  Clinical pharmacology and therapeutics 20040501

• Mycophenolate mofetil in dysimmune neuropathies: a preliminary study.

  Muscle & nerve 20040501

• Mycophenolate mofetil in pregnancy after renal transplantation: a case of major fetal malformations.

  Obstetrics and gynecology 20040501

• Mycophenolate mofetil for the treatment of autoimmune hepatitis in patients refractory to standard therapy.

  Canadian journal of gastroenterology = Journal canadien de gastroenterologie 20040501

• Immunosuppression in pancreas transplantation: mycophenolate mofetil versus sirolimus.

  Transplantation proceedings 20040501

• Mycophenolate mofetil attenuates Walker's tumor growth when used alone, but the effect is lost when associated with cyclosporine.

  Transplantation proceedings 20040501

• Long-term outcome of sirolimus rescue in kidney-pancreas transplantation.

  Transplantation proceedings 20040501

• Does surgical technique influence outcomes after simultaneous kidney-pancreas transplantation?

  Transplantation proceedings 20040501

• Think STOP before going 'off-label'.

  Canadian journal of gastroenterology = Journal canadien de gastroenterologie 20040501

• Comparison of sirolimus-based calcineurin inhibitor-sparing and calcineurin inhibitor-free regimens in cadaveric renal transplantation.

  Transplantation 20040427

• Substitution of the conserved Arg-Tyr dyad selectively disrupts the hydrolysis phase of the IMP dehydrogenase reaction.

  Biochemistry 20040420

• Mycophenolate mofetil for remission maintenance in the treatment of Wegener's granulomatosis.

  Arthritis and rheumatism 20040415

• New drugs and dosage forms.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20040415

• Infliximab improves endothelial dysfunction in systemic vasculitis: a model of vascular inflammation.

  Circulation 20040413

• Mycophenolate mofetil prevents autoimmune glomerulonephritis and alterations of intrarenal adrenomedullin in rats.

  European journal of pharmacology 20040405

• Relationship between endomyocardial biopsy score and cyclosporine 2-h post-dose levels (C) in heart transplant patients receiving anti-thymocyte globulin induction.

  Clinical transplantation 20040401

• [IgA pemphigus. Successful treatment with mycophenolate mofetil].

  Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete 20040401

• Withdrawal of cyclosporine or tacrolimus after addition of mycophenolate mofetil in patients with chronic allograft nephropathy.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20040401

• Pemphigus: current therapy.

  Veterinary dermatology 20040401

• Development of a high pressure liquid chromatography method for the determination of mycophenolic acid and its glucuronide metabolite in small volumes of plasma from paediatric patients.

  Journal of pharmaceutical and biomedical analysis 20040401

• Monitoring mycophenolate in liver transplant recipients: toward a therapeutic range.

  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20040401

• Therapeutic monitoring of mycophenolic acid in liver transplant patients.

  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20040401

• Short sirolimus half-life in pediatric renal transplant recipients on a calcineurin inhibitor-free protocol.

  Pediatric transplantation 20040401

• Long-term results of allogeneic penetrating limbo-keratoplasty in total limbal stem cell deficiency.

  Ophthalmology 20040401

• A pilot study of tacrolimus and mycophenolate mofetil graft-versus-host disease prophylaxis in childhood and adolescent allogeneic stem cell transplant recipients.

  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20040401

• Cofactor mimics as selective inhibitors of NAD-dependent inosine monophosphate dehydrogenase (IMPDH)--the major therapeutic target.

  Current medicinal chemistry 20040401

• Effects of mycophenolic acid (MPA) treatment on expression of Fc receptor (FcRn) and polymeric immunoglobulin receptor (pIgR) mRNA in adult sheep tissues.

  Croatian medical journal 20040401

• Histological changes after the use of mycophenolate mofetil in autoimmune hepatitis.

  Human pathology 20040401

• Two lessons from the interface of genetics and medicine.

  Genetics 20040401

• [The effects of mycophenolic acid on the maturation and immunologic function of murine bone marrow-derived dendritic cells].

  Zhongguo shi yan xue ye xue za zhi 20040401

• Central retinal artery occlusion as the initial ophthalmic presentation of Susac's syndrome.

  Canadian journal of ophthalmology. Journal canadien d'ophtalmologie 20040401

• Therapeutic drug monitoring of immunosuppressant drugs by high-performance liquid chromatography-mass spectrometry.

  Therapeutic drug monitoring 20040401

• Determination of mycophenolic acid in human plasma by high-performance liquid chromatography.

  Journal of chromatography. A 20040326

• Combination therapy with sirolimus and mycophenolate mofetil: effects on the kidney and on transforming growth factor-beta1.

  Transplantation 20040315

• Sequential therapies for proliferative lupus nephritis.

  The New England journal of medicine 20040304

• Maintenance therapy for lupus nephritis--something old, something new.

  The New England journal of medicine 20040304

• Guanine nucleotide depletion triggers cell cycle arrest and apoptosis in human neuroblastoma cell lines.

  International journal of cancer 20040301

• Abbreviated mycophenolic acid AUC from C0, C1, C2, and C4 is preferable in children after renal transplantation on mycophenolate mofetil and tacrolimus therapy.

  Transplant international : official journal of the European Society for Organ Transplantation 20040301

• Tacrolimus therapy in pediatric patients with treatment-resistant nephrotic syndrome.

  Pediatric nephrology (Berlin, Germany) 20040301

• From pharmacokinetics to pharmacogenomics: a new approach to tailor immunosuppressive therapy.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20040301

• Immunosuppressive drugs as an adjuvant to HIV treatment.

  The Journal of antimicrobial chemotherapy 20040301

• Lupus nephritis: treatment with mycophenolate mofetil.

  Rheumatology (Oxford, England) 20040301

• Mycophenolate therapy in frequently relapsing minimal change disease that has failed cyclophosphamide therapy.

  American journal of kidney diseases : the official journal of the National Kidney Foundation 20040301

• Sustained suppression of peripheral blood immune functions by treatment with mycophenolate mofetil correlates with reduced severity of cardiac allograft rejection.

  The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20040301

• Renal recovery after conversion to a calcineurin inhibitor-free immunosuppression in late cardiac transplant recipients.

  European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 20040301

• Churg-Strauss syndrome: successful treatment with mycophenolate mofetil.

  The British journal of dermatology 20040301

• The use of cyclosporine in renal transplantation.

  Transplantation proceedings 20040301

• Use of cyclosporine in renal transplantation.

  Transplantation proceedings 20040301

• Cyclosporine nephrotoxicity.

  Transplantation proceedings 20040301

• Impact of cyclosporine on the development of immunosuppressive therapy in liver transplantation.

  Transplantation proceedings 20040301

• New concepts in cyclosporine pharmacokinetic and dynamic monitoring: the impact of concomitant immunosuppression on target C2 concentrations.

  Transplantation proceedings 20040301

• Clinical success of Neoral absorption profile.

  Transplantation proceedings 20040301

• Early steroid withdrawal protocol using basiliximab in kidney transplantation.

  Transplantation proceedings 20040301

• Enteric-coated mycophenolate sodium: therapeutic equivalence to mycophenolate mofetil in de novo renal transplant patients.

  Transplantation proceedings 20040301

• Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in maintenance renal transplant patients: preliminary results from the myfortic prospective multicenter study.

  Transplantation proceedings 20040301

• Enteric-coated mycophenolate sodium: safe conversion from mycophenolate mofetil in maintenance renal transplant recipients.

  Transplantation proceedings 20040301

• Petrosifungins A and B, novel cyclodepsipeptides from a sponge-derived strain of Penicillium brevicompactum.

  Journal of natural products 20040301

• Ten-year radiographic outcome in patients with rheumatoid factor positive rheumatoid arthritis treated with aggressive immunosuppressive combination therapy.

  The Journal of rheumatology. Supplement 20040301

• Therapy of IgA nephropathy with mycophenolate mofetil--report of 3 cases.

  Clinical nephrology 20040301

• Effect of antimetabolite immunosuppressants on Flaviviridae, including hepatitis C virus.

  Transplantation 20040227

• Mycophenolate mofetil and sirolimus as calcineurin inhibitor-free immunosuppression for late cardiac-transplant recipients with chronic renal failure.

  Transplantation 20040227

• Regulation of inosine monophosphate dehydrogenase type I and type II isoforms in human lymphocytes.

  Biochemical pharmacology 20040215

• Mycophenolate mofetil for Crohn's disease: short-term efficacy and long-term outcome.

  Alimentary pharmacology & therapeutics 20040215

• The effect of maintenance immunosuppression medication on the change in kidney allograft function.

  Kidney international 20040201

• Monitoring trough plasma concentrations of mycophenolate mofetil in patients with uveitis.

  Journal of clinical pharmacy and therapeutics 20040201

• Improvement of Erdheim-Chester disease in two patients by sequential treatment with vinblastine and mycophenolate mofetil.

  Clinical rheumatology 20040201

• Heart transplantation in patients with previous Fontan operations.

  The Journal of thoracic and cardiovascular surgery 20040201

• Large-scale screening of yeast mutants for sensitivity to the IMP dehydrogenase inhibitor 6-azauracil.

  Yeast (Chichester, England) 20040201

• Enteric-coated mycophenolate sodium is therapeutically equivalent to mycophenolate mofetil in de novo renal transplant patients.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20040201

• Enteric-coated mycophenolate sodium can be safely administered in maintenance renal transplant patients: results of a 1-year study.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20040201

• Treating immunobullous diseases: an update.

  Dermatology nursing 20040201

• [Immunosuppressive therapies in patients with Graves' ophthalmopathy].

  Zhonghua nei ke za zhi 20040201

• [Can platelets be synthetized from nucleotides?].

  Polskie Archiwum Medycyny Wewnetrznej 20040201

• The effect of oral iron admiinistration on mycophenolate mofetil absorption in renal transplant recipients: a randomized, controlled trial.

  Transplantation 20040127

• Mycophenolate mofetil reduces deterioration of renal function in patients with chronic allograft nephropathy. A follow-up study by the Spanish Cooperative Study Group of Chronic Allograft Nephropathy.

  Transplantation 20040127

• A randomized long-term trial of tacrolimus and sirolimus versus tacrolimus and mycophenolate mofetil versus cyclosporine (NEORAL) and sirolimus in renal transplantation. I. Drug interactions and rejection at one year.

  Transplantation 20040127

• A randomized long-term trial of tacrolimus/sirolimus versus tacrolimus/mycophenolate mofetil versus cyclosporine (NEORAL)/sirolimus in renal transplantation. II. Survival, function, and protocol compliance at 1 year.

  Transplantation 20040127

• Everolimus and mycophenolate mofetil are potent inhibitors of fibroblast proliferation after lung transplantation.

  Transplantation 20040127

• Liquid chromatographic method for simultaneous determination of mycophenolic acid and its phenol- and acylglucuronide metabolites in plasma.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20040125

• Quantification of free mycophenolic acid and its glucuronide metabolite in human plasma by liquid-chromatography using mass spectrometric and ultraviolet absorbance detection.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20040105

• p53-independent induction of p21(waf1/cip1) contributes to the activation of caspases in GTP-depletion-induced apoptosis of insulin-secreting cells.

  Cell death and differentiation 20040101

• Validation of a rapid and sensitive liquid chromatography-tandem mass spectrometry method for free and total mycophenolic acid.

  Clinical chemistry 20040101

• Effects of mycophenolic acid on IL-6 expression of human renal proximal and distal tubular cells in vitro.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20040101

• Peritubular capillary changes and C4d deposits are associated with transplant glomerulopathy but not IgA nephropathy.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20040101

• Combined standard graft-versus-host disease (GvHD) prophylaxis with mycophenolate mofetil (MMF) in allogeneic peripheral blood stem cell transplantation from unrelated donors.

  Bone marrow transplantation 20040101

• Drug immunosuppression therapy for adult heart transplantation. Part 1: immune response to allograft and mechanism of action of immunosuppressants.

  The Annals of thoracic surgery 20040101

• Mycophenolate mofetil for secondary prevention of cardiac allograft vasculopathy: influence on inflammation and progression of intimal hyperplasia.

  The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20040101

• Immunosuppressive therapy after human lung transplantation.

  The European respiratory journal 20040101

• Plasma trough levels of mycophenolic acid do not correlate with efficacy and safety of mycophenolate mofetil in psoriasis.

  The British journal of dermatology 20040101

• Pharmacokinetics and pharmacodynamics of pravastatin in pediatric and adolescent cardiac transplant recipients on a regimen of triple immunosuppression.

  Clinical pharmacology and therapeutics 20040101

• Frequently relapsing nephrotic syndrome: treatment with mycophenolate mofetil.

  Pediatric nephrology (Berlin, Germany) 20040101

• A prospective cross-over study comparing the effect of mycophenolate versus azathioprine on allograft function and viral load in liver transplant recipients with recurrent chronic HCV infection.

  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20040101

• The NIH pulse cyclophosphamide regime: the end of an era?

  Lupus 20040101

• Mycophenolate mofetil in children with multidrug-resistant nephrotic syndrome.

  Clinical nephrology 20040101

• The management of immunosuppression: the art and the science.

  Critical care nursing quarterly 20040101

• Mycophenolate mofetil combined with prednisone for diffuse proliferative lupus nephritis: a histopathological study.

  Lupus 20040101

• Cerebral vasculitis in a patient with hereditary complete C4 deficiency and systemic lupus erythematosus.

  Lupus 20040101

• [Autoimmune liver disease: diagnosis and therapy].

  Zeitschrift fur Gastroenterologie 20040101

• Population pharmacokinetics and Bayesian estimation of mycophenolic acid concentrations in stable renal transplant patients.

  Clinical pharmacokinetics 20040101

• [Cyclosporin pharmacokinetic modeling in renal transplant patients].

  Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20040101

• The role of generics in transplantation: TM-MMF versus Cellcept in healthy volunteers.

  Transplantation proceedings 20040101

• Protocol core needle biopsy and histological chronic allograft damage index as surrogate endpoint for Long-Term graft survival.

  Transplantation proceedings 20040101

• Influence of tacrolimus plus mycophenolate mofetil regimens on acute rejection rate and diabetes mellitus development in renal transplant recipients.

  Transplantation proceedings 20040101

• A randomized controlled trial of mycophenolate mofetil in patients with IgA nephropathy [ISRCTN62574616].

  BMC nephrology 20040101

• [Treatment of steroid-dependent minimal change-nephrotic syndrome with mycophenolate mofetil].

  Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20040101

• [Nocardiosis--is it frequently observed after the introduction of new immunosuppressive agents in renal transplantation?].

  Nephrologie 20040101

• New immunosuppressive strategies in renal transplant recipients.

  Journal of nephrology 20040101

• Ex vivo lymphocyte proliferative function is severely inhibited in renal transplant patients on mycophenolate mofetil treatment.

  Transplant immunology 20040101

• Augmentation of T-cell apoptosis by immunosuppressive agents.

  Clinical transplantation 20040101

• [De novo hemolytic uremic syndrome in a kidney-pancreas recipient in the postoperative period].

  Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20040101

• [Interstitial pneumonitis associated with sirolimus administration in a renal transplantation patient: a clinical case].

  Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20040101

• [Calcineurin-inhibitor-free immunosuppression in early renal transplantation].

  Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20040101

• [Fever and cavitary infiltrate in a renal transplant recipient].

  Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20040101

• [Encephalitis in a renal transplantation patient].

  Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20040101

• Monocyte-mediated acute renal rejection after combined treatment with preoperative Campath-1H (alemtuzumab) and postoperative immunosuppression.

  Annals of clinical and laboratory science 20040101

• Mycophenolate mofetil in extensive Alopecia areata: no effect in seven patients.

  Dermatology (Basel, Switzerland) 20040101

• Evaluation of pharmacokinetic interactions after oral administration of mycophenolate mofetil and valaciclovir or aciclovir to healthy subjects.

  Clinical pharmacokinetics 20040101

• Mycophenolate mofetil in multiple sclerosis.

  Clinical neuropharmacology 20040101

• Low-dose sirolimus in combination with mycophenolate mofetil improves kidney graft function late after renal transplantation and suggests pharmacokinetic interaction of both immunosuppressive drugs.

  Kidney & blood pressure research 20040101

• [Sequential protocols with thymoglobuline and delayed introduction of calcineurin: effects on renal function in renal transplant recipients with non immunological risk and low risk of delayed graft function].

  Nephrologie 20040101

• Time-related clinical determinants of long-term tacrolimus pharmacokinetics in combination therapy with mycophenolic acid and corticosteroids: a prospective study in one hundred de novo renal transplant recipients.

  Clinical pharmacokinetics 20040101

• Stable renal transplant recipients can be safely converted from MMF to enteric-coated mycophenolate sodium tablets: Interim results of a multicenter Latin American study.

  Transplantation proceedings 20040101

• Use of mycophenolate mofetil in the experimental allo-transplantation of hepatocytes in rats with fulminant hepatic failure.

  Transplantation proceedings 20040101

• Cyclosporine levels at 2 hours after dose and body mass index in relation to graft function in renal transplant patients treated with azathioprine or mycophenolate mofetil.

  Transplantation proceedings 20040101

• First international meeting on mycophenolate mofetil: an advance in the treatment of lupus 27 April 2004, St Thomas' Hospital, London, UK.

  Lupus 20040101

• Effect of mycophenolate mofetil on the pharmacokinetics of antiretroviral drugs and on intracellular nucleoside triphosphate pools.

  Clinical pharmacokinetics 20040101

• Effect of mycophenolate mofetil (Cell Cept) in the treatment of immune glomerulopathies.

  Folia medica 20040101

• Nonmyeloablative stem cell transplantation in patients with ALL and AML results in low nonrelapse mortality despite high rate of infections and GVHD.

  The hematology journal : the official journal of the European Haematology Association 20040101

• Prospective randomised trial of the use of Daclizumab in renal transplantation using kidneys from non heart beating donors.

  Annals of transplantation 20040101

• Effects of mycophenolate mofetil and lisinopril on collagen deposition in unilateral ureteral obstruction in rats.

  American journal of nephrology 20040101

• Treatment options for severe lupus nephritis.

  Archivum immunologiae et therapiae experimentalis 20040101

• An unusual case of Behçet's syndrome: triggered by typhoid vaccination?

  Clinical and experimental rheumatology 20040101

• Mycophenolate mofetil and post-transplant glomerular disease.

  Nephron. Clinical practice 20040101

• High-dose mycophenolate mofetil in the treatment of posttransplant glomerular disease in the allograft: a case series.

  Nephron. Clinical practice 20040101

• Lack of toxic effects following acute overdose of cellcept (mycophenolate mofetil).

  Journal of toxicology. Clinical toxicology 20040101

• Evidence-based evaluation of immunomodulatory therapy for the cutaneous manifestations of lupus.

  Advances in dermatology 20040101

• [Pills, capsules, and tablets. The new medicines for HIV].

  SIDAhora : un proyecto del Departamento de Publicaciones del PWA Coalition, NY 20040101

• Immunomodulatory therapy in ophthalmology - is there a place for topical application?

  Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde 20040101

• Therapeutic monitoring of immunosuppressant drugs. Where are we?

  Clinical chemistry and laboratory medicine 20040101

• [Treatment of idiopathic membranous nephropathy].

  Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia 20040101

• The association of bullous pemphigoid and ulcerative colitis.

  Digestive diseases and sciences 20040101

• Mycophenolate mofetil: a promising immunosuppressive agent.

  The Journal of the Association of Physicians of India 20040101

• Mechanism of action and emerging role of immune response modifier therapy in dermatologic conditions.

  Journal of cutaneous medicine and surgery 20040101

• Branch retinal artery occlusions as the presenting feature of primary central nervous system vasculitis.

  Clinical and experimental rheumatology 20040101

• CNI-sparing regimens within the liver transplant setting: experiences of a single center.

  Clinical transplants 20040101

• The impact of sirolimus, mycophenolate mofetil, cyclosporine, azathioprine, and steroids on wound healing in 513 kidney-transplant recipients.

  Transplantation 20031227

• Mycophenolate mofetil increases adhesion capacity of tumor cells in vitro.

  Transplantation 20031227

• Composite tissue allotransplantation in chimeric hosts part II. A clinically relevant protocol to induce tolerance in a rat model.

  Transplantation 20031215

• Immunosuppression with FK778 and mycophenolate mofetil in a rat cardiac transplantation model.

  Transplantation 20031215

• Low-dose immunosuppression in a rat hind-limb transplantation model.

  Transplant international : official journal of the European Society for Organ Transplantation 20031201

• Synergistic antiherpetic effect of acyclovir and mycophenolate mofetil following keratoplasty in patients with herpetic eye disease: first results of a randomised pilot study.

  Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 20031201

• Outcomes of early and late immunomodulatory treatment in patients with HLA-B27-associated chronic uveitis.

  Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 20031201

• Mycophenolate mofetil ameliorates arteriolopathy and decreases transforming growth factor-beta1 in chronic cyclosporine nephrotoxicity.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20031201

• Comparison of three tacrolimus-based immunosuppressive regimens in lung transplantation.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20031201

• Equivalent pharmacokinetics of mycophenolate mofetil in African-American and Caucasian male and female stable renal allograft recipients.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20031201

• Novel therapies in pediatric rheumatic diseases.

  Current opinion in pediatrics 20031201

• Mycophenolate pharmacokinetics in early period following lung or heart transplantation.

  The Annals of pharmacotherapy 20031201

• Two doses of daclizumab in conjunction with low-dose cyclosporine, mycophenolate mofetil and steroids resulted in a low incidence of acute rejection after renal transplantation.

  Scandinavian journal of immunology 20031201

• TDM: report concentration, Css, rather than area under the curve, AUC.

  Therapeutic drug monitoring 20031201

• Differences and similarities among expert opinions on the diagnosis and treatment of pemphigus vulgaris.

  Journal of the American Academy of Dermatology 20031201

• Treatment of severe lichen planus with mycophenolate mofetil.

  Journal of the American Academy of Dermatology 20031201

• Mycophenolate mofetil in solid-organ transplantation.

  Expert opinion on pharmacotherapy 20031201

• Long-term efficacy of mycophenolate mofetil in the control of severe intraocular inflammation.

  Clinical & experimental ophthalmology 20031201

• Mycophenolate mofetil and prednisolone therapy in children with steroid-dependent nephrotic syndrome.

  American journal of kidney diseases : the official journal of the National Kidney Foundation 20031201

• Assessment of immunosuppressive drug interactions: inhibition of lymphocyte function in peripheral human blood.

  Journal of immunological methods 20031201

• Mycophenolate in dermatology.

  The Journal of dermatological treatment 20031201

• Correction of a large animal model of type I Glanzmann's thrombasthenia by nonmyeloablative bone marrow transplantation.

  Experimental hematology 20031201

• Kidney transplantation from living-unrelated donors: comparison of outcome with living-related and cadaveric transplants under current immunosuppressive protocols.

  Urology 20031201

• Bowel-associated dermatitis-arthritis syndrome associated with ileo-anal pouch anastomosis, and treatment with mycophenolate mofetil.

  The British journal of dermatology 20031201

• Triple immunosuppression with or without basiliximab in pediatric renal transplantation: acute rejection rates at one year.

  Transplantation proceedings 20031201

• Use of basiliximab with mycophenolate mofetil in kidney transplantation.

  Transplantation proceedings 20031201

• Gastric emptying time in renal transplant recipients treated with cyclosporine.

  Transplantation proceedings 20031201

• [Immunomodulation in penetrating keratoplasty. Current status and perspectives].

  Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 20031201

• Kinetics of diabetes-associated autoantibodies after sequential intraportal islet allograft associated with kidney transplantation in type 1 diabetes.

  Diabetes & metabolism 20031201

• Current immunosuppressive agents: efficacy, side effects, and utilization.

  Pediatric clinics of North America 20031201

• Pharmacokinetics of daclizumab and mycophenolate mofetil with cyclosporine and steroids in renal transplantation.

  Clinical transplantation 20031201

• Mycophenolate mofetil in pediatric liver transplant patients with renal dysfunction: preliminary data.

  Pediatric transplantation 20031201

• Immunoglobulin deficiency in kidney allograft recipients: comparative effects of mycophenolate mofetil and azathioprine.

  Transplant infectious disease : an official journal of the Transplantation Society 20031201

• Pemphigus vulgaris with nail involvement presenting with vegetating and verrucous lesions.

  Dermatology online journal 20031201

• Prevalence and treatment of decreased bone density in renal transplant recipients: a randomized prospective trial of calcitriol versus alendronate.

  Transplantation 20031127

• Mycophenolate mofetil for myasthenia gravis: an analysis of efficacy, safety, and tolerability.

  Neurology 20031125

• Mycophenolate mofetil-induced reversal of glomerular filtration loss in children with chronic allograft nephropathy.

  Transplantation 20031115

• Continued superior outcomes with modification and lengthened follow-up of a steroid-avoidance pilot with extended daclizumab induction in pediatric renal transplantation.

  Transplantation 20031115

• Calcineurin inhibitor-free immunosuppression based on antithymocyte globulin and mycophenolate mofetil in cadaveric kidney transplantation: results after 5 years.

  Transplant international : official journal of the European Society for Organ Transplantation 20031101

• Cytoskeletal reorganization by mycophenolic acid alters mesangial cell migration and contractility.

  Hypertension (Dallas, Tex. : 1979) 20031101

• Enteric-coated mycophenolate sodium.

  The Annals of pharmacotherapy 20031101

• Inhibition of monocyte/endothelial cell interactions and monocyte adhesion molecule expression by the immunosuppressant mycophenolate mofetil.

  Spinal cord 20031101

• Pharmacodynamic approach to immunosuppressive therapies using calcineurin inhibitors and mycophenolate mofetil.

  Clinical chemistry 20031101

• The role of immunosuppression in recurrence of hepatitis C.

  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20031101

• The use of mycophenolate mofetil in liver transplant recipients.

  Expert opinion on pharmacotherapy 20031101

• Mycophenolate mofetil inhibits human Tenon fibroblast proliferation by guanosine depletion.

  The British journal of ophthalmology 20031101

• Controlling treatment allocation bias in a registry analysis when comparing calcineurin inhibitors.

  Transplantation proceedings 20031101

• Induction immunosuppressive therapy stratified according to risk categories in renal transplantation.

  Transplantation proceedings 20031101

• IL-2 receptor blockers in liver transplantation: initial experience with daclizumab in Chile.

  Transplantation proceedings 20031101

• Primary tuberculosis 1 year after conversion from azathioprine to mycophenolate in recipient kidney transplantation: a case report.

  Transplantation proceedings 20031101

• Omission of azathioprine and mycophenolate mofetil in immunosuppressive regimen in kidney transplantation.

  Transplantation proceedings 20031101

• Rapid resolution of mycophenolate associated diarrhea with a small dose of octreotide: a case report.

  Transplantation proceedings 20031101

• The immunosuppressive drug mycophenolate mofetil impairs the adhesion capacity of gastrointestinal tumour cells.

  Clinical and experimental immunology 20031101

• Lichen planus pemphigoides evolving into pemphigoid nodularis.

  Clinical and experimental dermatology 20031101

• [Quadruple therapy with CsA, MTX, MMF and ATG for preventing graft-versus-host disease in unrelated donor hematopoietic stem cell transplantation].

  Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA 20031101

• Pancreatitis and duodenitis from sarcoidosis: successful therapy with mycophenolate mofetil.

  Digestive diseases and sciences 20031101

• A short course of mycophenolate immunosuppression inhibits rejection, but not tolerance, of rat liver allografts in association with inhibition of interleukin-4 and alloantibody responses.

  Transplantation 20031027

• [Can we predict the risk of malignancy associated with dermatomyositis?].

  Praxis 20031008

• Rapamycin-based rescue therapy after chronic rejection in a pediatric liver transplant patient.

  Transplant international : official journal of the European Society for Organ Transplantation 20031001

• Mycophenolate mofetil inhibits differentiation, maturation and allostimulatory function of human monocyte-derived dendritic cells.

  Clinical and experimental immunology 20031001

• Twelve-month evaluation of the clinical pharmacokinetics of total and free mycophenolic acid and its glucuronide metabolites in renal allograft recipients on low dose tacrolimus in combination with mycophenolate mofetil.

  Therapeutic drug monitoring 20031001

• [Systemic therapy of atopic dermatitis].

  Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete 20031001

• [Mycophenolate mofetil as effective therapy option in scarring pemphigoid].

  Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete 20031001

• Renal transplantation in a case of acute intermittent porphyria.

  Journal of clinical pharmacology 20031001

• Mycophenolate mofetil significantly reduces leukocyte graft infiltration after heterotopic cardiac transplantation in a rat model: comparative study with cyclosporine and FK 506.

  The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20031001

• Excellent short-term results with steroid-free maintenance immunosuppression in low-risk simultaneous pancreas-kidney transplantation.

  Archives of surgery (Chicago, Ill. : 1960) 20031001

• Histologic features of mycophenolate mofetil-related colitis: a graft-versus-host disease-like pattern.

  International journal of surgical pathology 20031001

• The use of daclizumab as induction therapy in combination with tacrolimus and mycophenolate mofetil in recipients with previous transplants.

  Clinical transplantation 20031001

• Review of the antiproliferative properties of mycophenolate mofetil in non-immune cells.

  International journal of clinical pharmacology and therapeutics 20031001

• Effect of mycophenolate mofetil on IMP dehydrogenase after the first dose and after long-term treatment in renal transplant recipients.

  International journal of clinical pharmacology and therapeutics 20031001

• Use of prophylactic lamivudine and mycophenolate mofetil in renal transplant recipients with chronic hepatitis B infection.

  Pediatric transplantation 20031001

• HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies.

  Blood 20030915

• Effect of immunosuppression on damage, leukocyte infiltration, and regeneration after severe warm ischemia/reperfusion renal injury.

  Kidney international 20030901

• Mycophenolate mofetil (MMF) therapeutic approach in patients with chronic glomerulonephritis (GN).

  Kidney international 20030901

• Surgical complications of graft nephrectomy in the modern transplant era.

  The Journal of urology 20030901

• Comparison of sirolimus vs. mycophenolate mofetil on surgical complications and wound healing in adult kidney transplantation.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20030901

• Tacrolimus dose requirement in renal transplant recipients is significantly higher when used in combination with corticosteroids.

  British journal of clinical pharmacology 20030901

• The long-term effect of switching from cyclosporin A to mycophenolate mofetil in chronic renal graft dysfunction compared with conventional management.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20030901

• Mycophenolate mofetil dose reduction and the risk of acute rejection after renal transplantation.

  Journal of the American Society of Nephrology : JASN 20030901

• Immunosuppression with mycophenolic acid: one size does not fit all.

  Journal of the American Society of Nephrology : JASN 20030901

• The long-term survival of baboon-to-monkey kidney and liver xenografts.

  Xenotransplantation 20030901

• The immunosuppressant mycophenolate mofetil attenuates neuronal damage after excitotoxic injury in hippocampal slice cultures.

  The European journal of neuroscience 20030901

• Influence of food on plasma concentration of mycophenolic acid in a heart transplant patient receiving concomitant tacrolimus.

  The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20030901

• Mycophenolate mofetil in the treatment of autoimmune HCV-associated haematological disorders showing steroid resistance or dependence.

  Journal of viral hepatitis 20030901

• Treatment of linear IgA bullous dermatosis of childhood with mycophenolate mofetil.

  Archives of dermatology 20030901

• Mycophenolate mofetil for the treatment of scleritis.

  Ophthalmology 20030901

• [Transcorneal-paracorneal penetration route for topical application of drugs to the eyt. Mycophenolate mofetil as a model substance].

  Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 20030901

• Patients with steroid refractory acute vascular rejection develop agonistic antibodies targeting angiotensin II type 1 receptor.

  Transplantation proceedings 20030901

• 36-month follow-up of 75 renal allograft recipients treated with steroids, tacrolimus, and azathioprine or mycophenolate mofetil.

  Transplantation proceedings 20030901

• The role of the protocol biopsies in renal allograft recipients.

  Transplantation proceedings 20030901

• Mycophenolate mofetil severely depresses antibody response to CMV infection in early posttransplant period.

  Transplantation proceedings 20030901

• Effect of immunosuppressive regimen on acute rejection and liver graft function.

  Transplantation proceedings 20030901

• The influence of calcineurin inhibitors on mycophenolic acid pharmacokinetics.

  Transplantation proceedings 20030901

• JC virus leukoencephalopathy complicating Wegener's granulomatosis.

  Joint, bone, spine : revue du rhumatisme 20030901

• [Successful treatment of refractory acute GVHD with mycophenolate mofetil after peripheral blood stem cell transplantation from the patient's one locus-mismatched mother].

  [Rinsho ketsueki] The Japanese journal of clinical hematology 20030901

• Mycophenolate mofetil for myasthenia gravis: a double-blind, placebo-controlled pilot study.

  Annals of the New York Academy of Sciences 20030901

• Simultaneous determination of ochratoxin A and cyclopiazonic, mycophenolic, and tenuazonic acids in cornflakes by solid-phase microextraction coupled to high-performance liquid chromatography.

  Journal of agricultural and food chemistry 20030827

• What role for mycophenolate mofetil in allogeneic hematopoietic cell transplantation?

  Transplantation 20030827

• [The place of mycophenolate mofetil in glomerular diseases].

  Presse medicale (Paris, France : 1983) 20030823

• A comparison of discharge immunosuppressive drug regimens in primary cadaveric kidney transplantation.

  Transplantation 20030815

• Use of mycophenolate mofetil in immunosuppressive protocols in elderly renal transplant recipients.

  Transplantation 20030815

• Functional distinctions between IMP dehydrogenase genes in providing mycophenolate resistance and guanine prototrophy to yeast.

  The Journal of biological chemistry 20030801

• Use of mycophenolate mofetil in steroid-dependent and -resistant nephrotic syndrome.

  Pediatric nephrology (Berlin, Germany) 20030801

• Novel therapy of focal glomerulosclerosis with mycophenolate and angiotensin blockade.

  Pediatric nephrology (Berlin, Germany) 20030801

• The use of daclizumab, tacrolimus and mycophenolate mofetil in african-american and Hispanic first renal transplant recipients.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20030801

• Acquired and reversible Pelger-Huët anomaly of polymorphonuclear neutrophils in three transplant patients receiving mycophenolate mofetil therapy.

  American journal of hematology 20030801

• Anemia in children after transplantation: etiology and the effect of immunosuppressive therapy on erythropoiesis.

  Pediatric transplantation 20030801

• Alterations of cyclosporin A metabolism induced by mycophenolate mofetil.

  Pediatric transplantation 20030801

• [Improvement of graft vasculopathy following mycophenolate mofetil administration in a child].

  Revista espanola de cardiologia 20030801

• Pathophysiological insights from a case of reversible pulmonary arterial hypertension.

  Journal of the Royal Society of Medicine 20030801

• Population pharmacokinetic analysis of mycophenolic acid in renal transplant recipients following oral administration of mycophenolate mofetil.

  British journal of clinical pharmacology 20030801

• Tacrolimus and mycophenolate mofetil provide effective immunosuppression in rat laryngeal transplantation.

  The Laryngoscope 20030801

• The first case of sarcoidosis treated with mycophenolate mofetil.

  The British journal of dermatology 20030801

• Mycophenolate mofetil (MMF) for refractory chronic graft versus host disease (cGvHD).

  Haematologica 20030801

• Four cases of red blood cell aplasia in association with the use of mycophenolate mofetil in renal transplant patients.

  Clinical nephrology 20030801

• Pharmacokinetics of mycophenolic acid in kidney transplant recipients treated with a low dose (1 gram/day) of mycophenolate mofetil.

  Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20030801

• Long-term changes in mycophenolic acid exposure in combination with tacrolimus and corticosteroids are dose dependent and not reflected by trough plasma concentration: a prospective study in 100 de novo renal allograft recipients.

  Journal of clinical pharmacology 20030801

• [Cyclosporine A and mycophenolate mofetile as prophylactics for GVHD in a murine model of H-2 haploidentical nonmyeloablative bone marrow transplantation].

  Zhongguo shi yan xue ye xue za zhi 20030801

• Daclizumab induction as an immunosuppressive regimen for renal transplant recipients from non-heart-beating donors.

  Transplantation proceedings 20030801

• Tacrolimus in induction immunosuppressive treatment in renal transplantation: comparison with cyclosporine.

  Transplantation proceedings 20030801

• Disseminated varicella infection in adult renal allograft recipients: role of mycophenolate mofetil.

  Transplantation proceedings 20030801

• Comparison of C0 and C2 cyclosporine monitoring in long-term renal transplant recipients.

  Transplantation proceedings 20030801

• Assessment of cyclosporine therapeutic monitoring with C2 concentrations in stable renal allograft recipients.

  Transplantation proceedings 20030801

• Effectiveness and safety of mycophenolate mofetil as monotherapy in liver transplantation.

  Transplantation proceedings 20030801

• Conversion from calcineurin inhibitors to mycophenolate mofetil in liver transplant recipients with diabetes mellitus.

  Transplantation proceedings 20030801

• Lung transplants with tacrolimus and mycophenolate mofetil: a review.

  Transplantation proceedings 20030801

• Tacrolimus in heart transplantation.

  Transplantation proceedings 20030801

• [Vacuum sealing of extensive wound healing disorders after kidney transplantation].

  Der Urologe. Ausg. A 20030801

• The effect of mycophenolate acid on hepatitis B virus replication in vitro.

  Hepatobiliary & pancreatic diseases international : HBPD INT 20030801

• Higher surgical wound complication rates with sirolimus immunosuppression after kidney transplantation: a matched-pair pilot study.

  Transplantation 20030727

• Use of mycophenolate mofetil in immunosuppressive protocols in elderly renal transplant recipients.

  Transplantation 20030727

• [Treatment of autoimmune hepatitis].

  Orvosi hetilap 20030727

• Anti-HIV-1 activity of leflunomide: a comparison with mycophenolic acid and hydroxyurea.

  AIDS (London, England) 20030725

• The BMP homolog Gbb provides a retrograde signal that regulates synaptic growth at the Drosophila neuromuscular junction.

  Neuron 20030717

• Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation.

  Blood 20030715

• Role of tissue transglutaminase in GTP depletion-induced apoptosis of insulin-secreting (HIT-T15) cells.

  Biochemical pharmacology 20030715

• Graft survival following living-donor renal transplantation: a comparison of tacrolimus and cyclosporine microemulsion with mycophenolate mofetil and steroids.

  Transplantation 20030715

• Efficacy of mycophenolate mofetil combined with very low-dose cyclosporine microemulsion in long-term liver-transplant patients with renal dysfunction.

  Transplantation 20030715

• Mycophenolatemofetil for immunosuppression after liver transplantation: a follow-up study of 191 patients.

  Transplantation 20030715

• Rapamycin for cardiac transplant rejection and vasculopathy: one stone, two birds?

  Circulation 20030708

• Curing of foot-and-mouth disease virus from persistently infected cells by ribavirin involves enhanced mutagenesis.

  Virology 20030705

• Lower serum beta-CrossLaps in male cardiac transplant recipients treated without prednisolone.

  Transplant international : official journal of the European Society for Organ Transplantation 20030701

• Sirolimus and mycophenolate mofetil after liver transplantation.

  Transplant international : official journal of the European Society for Organ Transplantation 20030701

• Mycophenolate mofetil prevents development of urinary protein in autoimmune nephritis.

  Kidney international 20030701

• Maintenance triple immunosuppression with cyclosporin A, mycophenolate sodium and steroids allows prolonged survival of primate recipients of hDAF porcine renal xenografts.

  Xenotransplantation 20030701

• Treatment by mycophenolate mofetil of advanced graft vascular disease in non-human primate recipients of orthotopic aortic allografts.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20030701

• Immunosuppression minimization: current and future trends in transplant immunosuppression.

  Journal of the American Society of Nephrology : JASN 20030701

• Effect of atorvastatin on postcardiac transplant increase in low-density lipoprotein cholesterol reduces development of intimal hyperplasia and progression of endothelial dysfunction.

  The American journal of cardiology 20030701

• Response to mycophenolate mofetil therapy in refractory chronic graft-versus-host disease.

  Haematologica 20030701

• Tolerability of mycophenolate mofetil in patients with systemic lupus erythematosus.

  The Journal of rheumatology 20030701

• [Indication and effect of immunosuppression in patients with scleritis].

  Klinische Monatsblatter fur Augenheilkunde 20030701

• An evaluation of the usefulness of mycophenolate mofetil in pemphigus.

  The British journal of dermatology 20030701

• Treatment of pulmonary hemorrhage in childhood systemic lupus erythematosus with mycophenolate mofetil.

  Southern medical journal 20030701

• [Mycophenolate mofetil for lupus nephritis refractory to cyclophosphamide].

  Medicina clinica 20030628

• Randomized trial of tacrolimus + mycophenolate mofetil or azathioprine versus cyclosporine + mycophenolate mofetil after cadaveric kidney transplantation: results at three years.

  Transplantation 20030627

• Mycophenolate mofetil-based immunosuppression and cytokine genotypes: effects on monokine secretion and antigen presentation in long-term renal transplant recipients.

  Transplantation 20030627

• Mycophenolate mofetil monotherapy in patients who have had kidney transplants.

  Transplantation 20030627

• Inhibitors of inosine monophosphate dehydrogenase: SARs about the N-[3-Methoxy-4-(5-oxazolyl)phenyl moiety.

  Bioorganic & medicinal chemistry letters 20030616

• Selective T-cell ablation with bismuth-213-labeled anti-TCRalphabeta as nonmyeloablative conditioning for allogeneic canine marrow transplantation.

  Blood 20030615

• Induction of apoptosis in IL-3-dependent hematopoietic cell lines by guanine nucleotide depletion.

  Blood 20030615

• Short-term immunosuppressive treatment of the donor ameliorates consequences of ischemia/ reperfusion injury and long-term graft function in renal allografts from older donors.

  Transplantation 20030615

• The effect of ribavirin and IMPDH inhibitors on hepatitis C virus subgenomic replicon RNA.

  Virology 20030605

• A possible mechanism of gastrointestinal toxicity posed by mycophenolic acid.

  Pharmacological research 20030601

• Incidence of polyomavirus-nephropathy in renal allografts: influence of modern immunosuppressive drugs.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20030601

• Mycophenolate mofetil is associated with less death with function than azathioprine in cadaveric renal transplantation.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20030601

• Mycophenolate mofetil in treatment of idiopathic stages III-IV membranous nephropathy.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20030601

• Mycophenolate mofetil (MMF) for the treatment of steroid-resistant idiopathic thrombocytopenic purpura.

  European journal of haematology 20030601

• Tacrolimus vs. cyclosporine A as primary immunosuppression in pediatric renal transplantation: a NAPRTCS study.

  Pediatric transplantation 20030601

• Mycophenolate mofetil prevents a clinical relapse in patients with systemic lupus erythematosus at risk.

  Annals of the rheumatic diseases 20030601

• Automated determination of free mycophenolic acid and its glucuronide in plasma from renal allograft recipients.

  Therapeutic drug monitoring 20030601

• Influence of SDZ RAD vs. MMF on gastric emptying in renal transplant recipients.

  Clinical transplantation 20030601

• The impact of mycophenolate mofetil dosing patterns on clinical outcome after renal transplantation.

  Clinical transplantation 20030601

• Effect of cyclosporin pharmacokinetics on renal allograft outcome in African-Americans.

  Clinical transplantation 20030601

• The use of an anti-CD25 monoclonal antibody and mycophenolate mofetil enables the use of a low-dose tacrolimus and early withdrawal of steroids in renal transplant recipients.

  Clinical transplantation 20030601

• Mycophenolate mofetil in refractory inflammatory bowel disease.

  Alimentary pharmacology & therapeutics 20030601

• Successful treatment of bcr/abl-positive acute mixed lineage leukemia by unmanipulated bone marrow transplantation from an HLA-haploidentical (3-antigen-mismatched) cousin.

  Bone marrow transplantation 20030601

• Treatment of pemphigus vulgaris and pemphigus foliaceus with mycophenolate mofetil.

  Archives of dermatology 20030601

• Bacterial IMPDH gene used for the selection of mammalian cell transfectants.

  BioTechniques 20030601

• Calcineurin-free protocols with basiliximab induction allow patients included in 'old to old' programs achieve standard kidney transplant function.

  Transplantation proceedings 20030601

• Effect of mycophenolate mofetil regimen on peripheral blood lymphocyte subsets in kidney transplant recipients.

  Transplantation proceedings 20030601

• Report of a renal transplanted patient with fibroadenoma occurring in a short time.

  Transplantation proceedings 20030601

• Renal function and safety of heart transplant recipients switched to mycophenolate mofetil and low-dose cyclosporine.

  Transplantation proceedings 20030601

• Addition of a low fixed number of CD3+ cells to CD34-enriched allografts: effects on engraftment, graft-versus-host disease, and survival after related and unrelated peripheral stem cell transplantation.

  Journal of hematotherapy & stem cell research 20030601

• Can xipamide or tacrolimus inhibit the glucuronidation of mycophenolic acid in rat liver slices?

  Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie 20030601

• Unusual presentation of herpes virus infections in renal transplant recipients exposed to high mycophenolic acid plasma concentrations.

  Transplant infectious disease : an official journal of the Transplantation Society 20030601

• Clinical observations of mycophenolate mofetil therapy in refractory primary nephrotic syndrome.

  Nephrology (Carlton, Vic.) 20030601

• Pneumonitis associated with the use of mycophenolate mofetil.

  Transplantation 20030527

• A prospective, randomized clinical trial of cyclosporine reduction in stable patients greater than 12 months after renal transplantation.

  Transplantation 20030515

• Modulation of autoantibody production by mycophenolate mofetil: effects on the development of SLE in (NZB x NZW)F1 mice.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20030501

• Pharmacokinetics of mycophenolate mofetil for autoimmune disease in children.

  Pediatric nephrology (Berlin, Germany) 20030501

• New insights into the immunopathogenesis and treatment of small vessel vasculitis of the kidney.

  Current opinion in nephrology and hypertension 20030501

• Mycophenolic acid inhibits activation of inducible nitric oxide synthase in rodent fibroblasts.

  Clinical and experimental immunology 20030501

• Transplant immunosuppressant agents and their role in autoimmune rheumatic diseases.

  Current opinion in rheumatology 20030501

• Mycophenolic acid is a potent inhibitor of the expression of tumour necrosis factor- and tumour necrosis factor-receptor superfamily costimulatory molecules.

  Immunology 20030501

• Follow-up of patients with progressive multiple myeloma undergoing allografts after reduced-intensity conditioning.

  British journal of haematology 20030501

• Pharmacokinetics of tacrolimus-based combination therapies.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20030501

• [Aortic valve replacement in a renal transplant recipient].

  Kyobu geka. The Japanese journal of thoracic surgery 20030501

• Pharmacokinetics of mycophenolic acid associated with calcineurin inhibitors: long-term monitoring in stable lung recipients with and without cystic fibrosis.

  The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20030501

• Design of a trial comparing sirolimus plus mycophenolate mofetil versus sirolimus plus cyclosporine.

  Transplantation proceedings 20030501

• Sirolimus in combination with tacrolimus or mycophenolate mofetil for minimizing acute rejection risk in renal transplant recipients--a single center experience.

  Transplantation proceedings 20030501

• Minimizing calcineurin inhibitor drugs in renal transplantation.

  Transplantation proceedings 20030501

• Kidney transplantation without calcineurin inhibitors using sirolimus.

  Transplantation proceedings 20030501

• Conversion to sirolimus in solid organ transplantation: a single-center experience.

  Transplantation proceedings 20030501

• Mycophenolate mofetil as an immunomodulatory agent in the treatment of chronic ocular inflammatory disorders.

  Ophthalmology 20030501

• Mycophenolic acid pharmacodynamics and pharmacokinetics provide a basis for rational monitoring strategies.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20030501

• [Combined immunosuppression of FK506 and RS-61443 in rat limb allotransplantation].

  Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery 20030501

• Mycophenolate mofetil and cyclosporine therapy in membranous nephropathy.

  Seminars in nephrology 20030501

• [Auto-immune hepatitis: therapeutic management].

  Gastroenterologie clinique et biologique 20030501

• C0/C2 cyclosporine levels monitoring in renal transplantation.

  Transplantation proceedings 20030501

• Mycophenolate mofetil in stable liver transplant patients with calcineurin inhibitor-induced renal impairment: single-center experience.

  Transplantation proceedings 20030501

• Randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: results at 6 months.

  Transplantation 20030427

• Predicting long-term kidney graft survival: can new trials be performed?

  Transplantation 20030427

• Mycophenolate mofetil versus azathioprine therapy is associated with a significant protection against long-term renal allograft function deterioration.

  Transplantation 20030427

• Steroid-free liver transplantation using rabbit antithymocyte globulin and early tacrolimus monotherapy.

  Transplantation 20030427

• [Human leukocyte antigen mismatched hemopietic stem cell transplants for the treatment of leukemia].

  Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences 20030418

• B19 virus infection in renal transplant recipients.

  Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 20030401

• Impact of St John's wort treatment on the pharmacokinetics of tacrolimus and mycophenolic acid in renal transplant patients.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20030401

• Focal segmental glomerulosclerosis: pathogenesis and treatment.

  Current opinion in pediatrics 20030401

• Mycophenolate mofetil without antibody induction in cadaver vs. living donor pediatric renal transplantation.

  Pediatric transplantation 20030401

• Mycophenolate mofetil for solid organ transplantation: does the evidence support the need for clinical pharmacokinetic monitoring?

  Therapeutic drug monitoring 20030401

• Induction of remission in a child with autoimmune enteropathy using mycophenolate mofetil.

  Journal of pediatric gastroenterology and nutrition 20030401

• Mycophenolic acid pharmacokinetics in pediatric liver transplant recipients.

  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20030401

• Treatment of systemic lupus erythematosus-associated type B insulin resistance syndrome with cyclophosphamide and mycophenolate mofetil.

  Arthritis and rheumatism 20030401

• Optimizing lung transplant immunosuppression: beyond calcineurin inhibition.

  The Journal of thoracic and cardiovascular surgery 20030401

• Cyclosporine A versus tacrolimus in combination with mycophenolate mofetil and steroids as primary immunosuppression after lung transplantation: one-year results of a 2-center prospective randomized trial.

  The Journal of thoracic and cardiovascular surgery 20030401

• Impact of cyclosporine 2-h level and mycophenolate mofetil dose on clinical outcomes in de novo heart transplant patients receiving anti-thymocyte globulin induction.

  Clinical transplantation 20030401

• A neutropenia suggesting an interaction between valacyclovir and mycophenolate mofetil.

  Clinical transplantation 20030401

• Allografting after nonmyeloablative conditioning as a treatment after a failed conventional hematopoietic cell transplant.

  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20030401

• Prediction of cyclosporine dosage in patients after kidney transplantation using neural networks.

  IEEE transactions on bio-medical engineering 20030401

• Microvascular transplantation of tracheal allografts model in the canine.

  The Annals of otology, rhinology, and laryngology 20030401

• Intraocular availability of topically applied mycophenolate mofetil in rabbits.

  Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20030401

• Oral ulcers in kidney transplant recipients treated with sirolimus and mycophenolate mofetil.

  Transplantation 20030327

• Basiliximab (Simulect) for the treatment of steroid-resistant rejection in pediatric liver transpland recipients: a preliminary experience.

  Transplantation 20030327

• Formation of donor-specific human leukocyte antigen antibodies after kidney transplantation: correlation with acute rejection and tapering of immunosuppression.

  Transplantation 20030327

• Erosive enterocolitis in mycophenolate mofetil-treated renal-transplant recipients with persistent afebrile diarrhea.

  Transplantation 20030315

• Pharmacokinetics of mycophenolate mofetil in patients with autoimmune diseases compared renal transplant recipients.

  Journal of the American Society of Nephrology : JASN 20030301

• Alternative immunomodulators.

  European journal of gastroenterology & hepatology 20030301

• Multicenter randomized prospective trial of steroid withdrawal in renal transplant recipients receiving basiliximab, cyclosporine microemulsion and mycophenolate mofetil.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20030301

• Mycophenolate mofetil prevents arteriolopathy and renal injury in subtotal ablation despite persistent hypertension.

  Kidney international 20030301

• A new immunosuppressive protocol for lung transplantation: early promising results.

  Transplantation proceedings 20030301

• Rejection rate in living donor kidney transplantation with and without basiliximab in tacrolimus/mycophenolate mofetil-based protocol.

  Transplantation proceedings 20030301

• Usefulness of mycophenolate mofetil in patients with chronic renal insufficiency after liver transplantation.

  Transplantation proceedings 20030301

• Beneficial effects of low-toxicity regimens with MMF in renal recipients with late allograft dysfunction.

  Transplantation proceedings 20030301

• Efficacy and safety of daclizumab induction for primary kidney transplant recipients in combination with tacrolimus, mycophenolate mofetil, and steroids as maintenance immunosuppression.

  Transplantation proceedings 20030301

• Mycophenolic acid pharmacokinetics in stable pediatric renal transplantation.

  Pediatric nephrology (Berlin, Germany) 20030301

• Lowered-intensity preparative regimen for allogeneic stem cell transplantation delays acute graft-versus-host disease but does not improve outcome for advanced hematologic malignancy.

  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20030301

• Efficacy of mycophenolate mofetil on recurrent glomerulonephritis after renal transplantation.

  Clinical nephrology 20030301

• Improving results in solitary pancreas transplantation with portal-enteric drainage, thymoglobin induction, and tacrolimus/mycophenolate mofetil-based immunosuppression.

  Transplant international : official journal of the European Society for Organ Transplantation 20030301

• [Study on graft-versus-host disease in the allogeneic peripheral blood stem cell transplantation for the treatment of leukemia].

  Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 20030301

• Other immunosuppressive agents for focal segmental glomerulosclerosis.

  Seminars in nephrology 20030301

• Tufted hair folliculitis associated with pemphigus vulgaris.

  Journal of the European Academy of Dermatology and Venereology : JEADV 20030301

• Daclizumab as induction therapy in kidney and simultaneous pancreas-kidney transplantation.

  Minerva urologica e nefrologica = The Italian journal of urology and nephrology 20030301

• Mycophenolate mofetil in pediatric renal transplantation.

  Minerva urologica e nefrologica = The Italian journal of urology and nephrology 20030301

• Pediatric renal transplantation with mycophenolate mofetil-based immunosuppression without induction: results after three years.

  Transplantation 20030227

• Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissions in patients with hematological diseases.

  Blood 20030215

• Synergistic effects of mycophenolate mofetil and losartan in a model of chronic cyclosporine nephropathy.

  Transplantation 20030215

• Crystal structures of Tritrichomonasfoetus inosine monophosphate dehydrogenase in complex with substrate, cofactor and analogs: a structural basis for the random-in ordered-out kinetic mechanism.

  Journal of molecular biology 20030214

• Comparison of mycophenolate mofetil and azathioprine in obstructive nephropathy.

  Pediatric nephrology (Berlin, Germany) 20030201

• Increased expression of cytotoxic effector molecules: different interpretations for steroid-based and steroid-free immunosuppression.

  Pediatric transplantation 20030201

• Five-year results of renal transplantation on immunosuppressive triple therapy with mycophenolate mofetil.

  Clinical transplantation 20030201

• Dog leukocyte antigen-haploidentical stem cell allografts after anti-CD44 therapy and reduced-intensity conditioning in a preclinical canine model.

  Experimental hematology 20030201

• Randomized trial of tacrolimus in combination with mycophenolate mofetil versus cyclosporine with mycophenolate mofetil in cadaveric renal transplant recipients with delayed graft function.

  Transplantation proceedings 20030201

• Effect of mycophenolate mofetil on progression of chronic allograft nephropathy.

  Transplantation proceedings 20030201

• Sirolimus antirejection therapy for renal transplantation with cyclosporine-based immunosuppression: case reports.

  Transplantation proceedings 20030201

• Posttransplantation Kaposi sarcoma-experience in a patient receiving FK-506 and MMF.

  Transplantation proceedings 20030201

• Single-center experience: tacrolimus and mycophenolate mofetil in early stage of kidney transplantation with liver dysfunction.

  Transplantation proceedings 20030201

• Abdominal pain is a critical complication of mycophenolate mofetil in renal transplant recipients.

  Transplantation proceedings 20030201

• Mycophenolic acid-induced apoptotic signal transduction in MOLT-4 T-cell.

  Transplantation proceedings 20030201

• The influence of early steroid withdrawal on body composition and bone mineral density in renal transplantation patients.

  Transplant international : official journal of the European Society for Organ Transplantation 20030201

• High-performance liquid chromatographic method for mycophenolic acid and its glucuronide in serum and urine.

  Journal of clinical pharmacy and therapeutics 20030201

• [The rheumatologist's conflict between 'off-label' prescription and failure to render assistance].

  Zeitschrift fur Rheumatologie 20030201

• [Ulcers of the mouth in a renal transplant recipient: the role of mycophenolate mofetil (Cellcept)].

  Annales de dermatologie et de venereologie 20030201

• FR252921, a novel immunosuppressive agent isolated from Pseudomonas fluorescens no. 408813 III. In vivo activities.

  The Journal of antibiotics 20030201

• Immunosuppressive drug use in pregnancy.

  Autoimmunity 20030201

• Effects of selected immunouppressive drugs on prostaglandin release, protein synthesis and cell proliferation in human gingival fibroblasts and on the growth of plaque bacteria.

  European journal of medical research 20030128

• Long-term mycophenolate mofetil monotherapy in combination with calcineurin inhibitors for chronic renal dysfunction after liver transplantation.

  Transplantation 20030127

• Randomized double-blind study of immunoprophylaxis with basiliximab, a chimeric anti-interleukin-2 receptor monoclonal antibody, in combination with mycophenolate mofetil-containing triple therapy in renal transplantation.

  Transplantation 20030115

• Combination therapy of mycophenolate mofetil and rapamycin in prevention of chronic renal allograft rejection in the rat.

  Transplantation 20030115

• Mycophenolate mofetil prevents the development of glomerular injury in experimental diabetes.

  Kidney international 20030101

• Use of mycophenolate mofetil in the treatment of primary sclerosing cholangitis.

  Journal of clinical gastroenterology 20030101

• Long-term use of mycophenolate mofetil is associated with a reduction in the incidence and risk of late rejection.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20030101

• Lack of antiviral effect of a short course of mycophenolate mofetil in patients with chronic hepatitis C virus infection.

  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20030101

• [Cytomegalovirus hepatitis and ductopenia in a heart transplant recipient].

  Gastroenterologia y hepatologia 20030101

• Mycophenolate mofetil may serve as a steroid-sparing agent for sarcoidosis.

  The British journal of dermatology 20030101

• Mycophenolic acid inhibits inosine 5'-monophosphate dehydrogenase and suppresses immunoglobulin and cytokine production of B cells.

  International immunopharmacology 20030101

• [Chronically active Crohn's disease].

  Zeitschrift fur Gastroenterologie 20030101

• Mycophenolate mofetil: new applications for this immunosuppressant.

  Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20030101

• Steroid-refractory graft-vs.-host disease: past, present and future.

  Pediatric transplantation 20030101

• [IMP dehydrogenase].

  Nihon rinsho. Japanese journal of clinical medicine 20030101

• Mycophenolate mofetil (CellCept) for psoriasis: a two-center, prospective, open-label clinical trial.

  Journal of cutaneous medicine and surgery 20030101

• Effective treatment of relapsing idiopathic nodular panniculitis (Pfeifer-Weber-Christian disease) with mycophenolate mofetil.

  The Journal of dermatological treatment 20030101

• The treatment of atopic dermatitis with systemic immunosuppressive agents.

  Clinics in dermatology 20030101

• Morphological and biochemical effects of immunosuppressive drugs in a capillary tube assay for endothelial dysfunction.

  Clinical transplantation 20030101

• A pilot protocol of a calcineurin-inhibitor free regimen for kidney transplant recipients of marginal donor kidneys or with delayed graft function.

  Clinical transplantation 20030101

• Long-term experience with simultaneous kidney-pancreas transplantation with portal-enteric drainage and tacrolimus/mycophenolate mofetil-based immunosuppression.

  Clinical transplantation 20030101

• [Therapeutic drug monitoring of mycophenolate mofetil, sirolimus and cyclosporine at C2].

  Annales de biologie clinique 20030101

• Diagnosis and treatment of steroid resistant cellular rejection in heart transplant recipients--single center experience.

  Annals of transplantation 20030101

• Meta-analysis of basiliximab for immunoprophylaxis in renal transplantation.

  BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 20030101

• [Abnormal chromatin clumping syndrome during treatment with mycophenolate mofetil].

  Annales de biologie clinique 20030101

• Refractory immune thrombocytopenia in systemic lupus erythematosus: response to mycophenolate mofetil.

  Lupus 20030101

• Mycophenolate mofetil as a treatment for autoimmune haemolytic anaemia in patients with systemic lupus erythematosus and antiphospholipid syndrome.

  Lupus 20030101

• Stability of mycophenolic acid in plasma samples from patients during mycophenolate mofetil therapy.

  Acta poloniae pharmaceutica 20030101

• Effects of mycophenolate mofetil on renal interstitial fibrosis after Unilateral ureteral obstruction in rats.

  Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban 20030101

• Acute adenoviral infection of a graft by serotype 35 following renal transplantation.

  Pathology, research and practice 20030101

• Renal transplantation: basic concepts and evolution of therapy.

  Journal of clinical apheresis 20030101

• Mycophenolate mofetil in epidermolysis bullosa acquisita.

  Dermatology (Basel, Switzerland) 20030101

• Effect of mycophenolate mofetil on glomerulosclerosis and renal oxidative stress in rats.

  Nephron. Experimental nephrology 20030101

• Mycophenolate mofetil inhibits the development of Coxsackie B3-virus-induced myocarditis in mice.

  BMC microbiology 20030101

• Single fiber EMG as an outcome measure in myasthenia gravis: results from a double-blind, placebo-controlled trial.

  Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society 20030101

• Use of RNA yeast polymerase II mutants in studying transcription elongation.

  Methods in enzymology 20030101

• Immunosuppressive antimetabolites inhibit induction of contact hypersensitivity while lymphoablative drugs also prevent its expression.

  European journal of dermatology : EJD 20030101

• Management of refractory systemic rheumatic diseases.

  Acta clinica Belgica 20030101

• Erythropoiesis after nonmyeloablative stem-cell transplantation is not impaired by inadequate erythropoietin production as observed after conventional allogeneic transplantation.

  Transplantation 20021227

• Cyclosporine withdrawal from a mycophenolate mofetil-containing immunosuppressive regimen in stable kidney transplant recipients: a randomized, controlled study.

  Transplantation 20021227

• Mycophenolic acid inhibits dengue virus infection by preventing replication of viral RNA.

  Virology 20021220

• Immunosuppression and BKV Nephropathy.

  The New England journal of medicine 20021219

• Ethnic disparity in clinical outcome after heart transplantation is abrogated using tacrolimus and mycophenolate mofetil-based immunosuppression.

  Transplantation 20021215

• Stability of i.v. mycophenolate mofetil in 5% dextrose injection in polyvinyl chloride infusion bags.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20021215

• A case of Wegener's granulomatosis treated with mycophenolate mofetil.

  Nephron 20021201

• Influence of the new immunosuppressive combinations on arterial hypertension after renal transplantation.

  Kidney international. Supplement 20021201

• Experimental and clinical rationale for use of MMF in nontransplant progressive nephropathies.

  American journal of physiology. Renal physiology 20021201

• Reduced dose Thymoglobulin, tacrolimus, and mofetil mycophenolate results in excellent solitary pancreas transplantation outcomes.

  Clinical transplantation 20021201

• Mycophenolate mofetil in combination with recombinant interferon alfa-2a in interferon-nonresponder patients with chronic hepatitis C.

  Journal of hepatology 20021201

• Use of mycophenolate mofetil in erythema nodosum.

  Journal of the American Academy of Dermatology 20021201

• Optimal immunosuppression in teenagers.

  Pediatric transplantation 20021201

• Yersinia pseudotuberculosis bacteraemia in a kidney transplant patient.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20021201

• An unusual recurrence of crescentic nephritis after renal transplantation for IgA nephropathy.

  American journal of kidney diseases : the official journal of the National Kidney Foundation 20021201

• Dextran sulfate (Selesorb) plasma apheresis improves vascular changes in systemic lupus erythematosus.

  Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis 20021201

• Severe scleritis and urticarial lesions.

  American journal of ophthalmology 20021201

• Recurrent erythema multiforme/Stevens-Johnson syndrome: response to mycophenolate mofetil.

  Archives of dermatology 20021201

• Mycophenolate mofetil for the treatment of cutaneous lupus erythematosus with smoldering systemic involvement.

  Archives of dermatology 20021201

• G-CSF-primed haploidentical marrow transplantation without ex vivo T cell depletion: an excellent alternative for high-risk leukemia.

  Bone marrow transplantation 20021201

• Mycophenolic acid reduces renin-angiotensin-system activity in cultured mouse medullary thick ascending limb cells.

  Transplant international : official journal of the European Society for Organ Transplantation 20021201

• Myelodysplastic syndrome complicated by autoimmune hemolytic anemia: remission of refractory anemia following mycophenolate mofetil.

  Annals of hematology 20021201

• Secretory defects induced by immunosuppressive agents on human pancreatic beta-cells.

  Acta diabetologica 20021201

• Rates of acute rejection by recipient race and type of calcineurin inhibitor with mycophenolate mofetil.

  Transplantation proceedings 20021201

• Use of mycophenolate mofetil in kidney transplant recipients with viral hepatitis infection: is it justified?

  Transplantation proceedings 20021201

• Improved survival after lung transplantation in patients treated with tacrolimus/mycophenolate mofetil as compared with cyclosporine/azathioprine.

  Transplantation proceedings 20021201

• Comparative gastrointestinal effects of mycophenolate mofetil capsules and enteric-coated tablets of sodium-mycophenolic acid in beagle dogs.

  Transplantation proceedings 20021201

• [Successful engraftment of T-cell undepleted haploidentical transplants by donor primed with G-CSF and additional use of ATG and MMF for recipients].

  Zhongguo shi yan xue ye xue za zhi 20021201

• Efficacy of mycophenolate sodium as monotherapy and in combination with FTY720 in a DA-to-Lewis-rat heart-transplantation model.

  Transplantation 20021127

• Simple determination of mycophenolic acid in human serum by column-switching high-performance liquid chromatography.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20021115

• Overload proteinuria is followed by salt-sensitive hypertension caused by renal infiltration of immune cells.

  American journal of physiology. Renal physiology 20021101

• Therapeutic drug monitoring of immunosuppressive drugs in kidney transplantation.

  Current opinion in nephrology and hypertension 20021101

• Mycophenolate mofetil in primary biliary cirrhosis.

  Hepatology (Baltimore, Md.) 20021101

• Systemic arterial pressure and brachial arterial flow-mediated dilatation in young cardiac transplant recipients.

  The American journal of cardiology 20021101

• Mycophenolate mofetil in the treatment of resistant idiopathic nephrotic syndrome.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20021101

• Impairment of mycophenolate mofetil absorption by calcium polycarbophil.

  Journal of clinical pharmacology 20021101

• Immunosuppressive treatment protects against angiotensin II-induced renal damage.

  The American journal of pathology 20021101

• Mycophenolate mofetil treatment in conditions different from organ transplantation.

  Transplantation proceedings 20021101

• Mechanisms of action of mycophenolate mofetil in preventing chronic rejection.

  Transplantation proceedings 20021101

• Fibrogenesis in chronic allograft rejection: underlying mechanisms and pharmacological control.

  Transplantation proceedings 20021101

• Assessment of immunosuppression by lymphocyte functions in human blood.

  Transplantation proceedings 20021101

• Effects of mycophenolate sodium with or without FTY720 in a DA-to-Lewis rat heart transplantation model.

  Transplantation proceedings 20021101

• Mycophenolate mofetil for the prophylaxis of acute graft-versus-host disease in stem cell transplant recipients.

  Transplantation proceedings 20021101

• Significance of mycophenolate mofetil treatment in patients with HCV reinfection after liver transplantation: impact on clinical course and histologic damage.

  Transplantation proceedings 20021101

• Mycophenolate mofetil reduces calcineurin inhibitor-induced side effects after liver transplantation.

  Transplantation proceedings 20021101

• Mycophenolate mofetil for treatment of ongoing or chronic rejections after liver transplantation.

  Transplantation proceedings 20021101

• Inhibition of autoimmune diabetes by mycophenolate mofetil is associated with down-regulation of TH1 cytokine-induced apoptosis in the target tissue.

  Transplantation proceedings 20021101

• High mycophenolic acid area under-the-curve values in renal transplant recipients on long-term mycophenolate mofetil treatment.

  Transplantation proceedings 20021101

• The efficacy of mycophenolate mofetil treatment in the prevention of acute renal rejection is related to plasma level of mycophenolic acid.

  Transplantation proceedings 20021101

• Mycophenolate in treatment-resistant inflammatory neuropathies.

  European journal of neurology 20021101

• Influence of ferrous sulfate on the solubility, partition coefficient, and stability of mycophenolic acid and the ester mycophenolate mofetil.

  Drug development and industrial pharmacy 20021101

• [Treatment of diabetes mellitus in patients after renal transplantation].

  Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 20021101

• [Effect of immunosuppressive treatment on diurnal profile of blood pressure].

  Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 20021101

• Inhibitors of the IMPDH enzyme as potential anti-bovine viral diarrhoea virus agents.

  Antiviral chemistry & chemotherapy 20021101

• Cryopreservation and mycophenolate therapy are detrimental to hematopoietic progenitor cells.

  Transplantation 20021027

• Mycophenolate mofetil suppresses the production of anti-blood type anitbodies after renal transplantation across the abo blood barrier: ELISA to detect humoral activity.

  Transplantation 20021027

• Renal failure after liver transplantation: outcome after calcineurin inhibitor withdrawal.

  Clinical transplantation 20021001

• Mycophenolate mofetil treatment for primary glomerular diseases.

  Kidney international 20021001

• Mycophenolate mofetil attenuates renal ischemia/reperfusion injury.

  Journal of the American Society of Nephrology : JASN 20021001

• Mycophenolic acid and mycophenolic acid glucuronide pharmacokinetics in pediatric liver transplant recipients: effect of cyclosporine and tacrolimus comedication.

  Therapeutic drug monitoring 20021001

• Non-myeloablative haematopoietic stem cell transplantation for severe aplastic anaemia with various complications.

  Clinical and laboratory haematology 20021001

• Impact of immunosuppressive therapy on recurrence of hepatitis C.

  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20021001

• Caspofungin: new preparation. A last resort in invasive aspergillosis.

  Prescrire international 20021001

• Cyclosporin A-related Raynaud's phenomenon in a renal transplant recipient.

  Transplant international : official journal of the European Society for Organ Transplantation 20021001

• Mycophenolate, tacrolimus and post-transplant lymphoproliferative disorder: a report of the North American Pediatric Renal Transplant Cooperative Study.

  Pediatric transplantation 20021001

• Universal approach to pharmacokinetic monitoring of immunosuppressive agents in children.

  Pediatric transplantation 20021001

• Prospective, pilot, open-label, short-term study of conversion to leflunomide reverses chronic renal allograft dysfunction.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20021001

• Effect of mycophenolate mofetil therapy on lymphocyte activation in heart transplant recipients.

  The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20021001

• [Preliminary results in the therapy of psoriatic arthritis with mycophenolate mofetil].

  Zeitschrift fur Rheumatologie 20021001

• Mycophenolate mofetil and leflunomide: promising compounds for the treatment of skin diseases.

  Clinical and experimental dermatology 20021001

• Case 2: strategies to minimize the use of calcineurin inhibitors (CNIs).

  Transplantation 20020915

• Rapid determination of mycophenolic acid in plasma by reversed-phase high-performance liquid chromatography.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20020905

• Mycophenolic acid antagonizes the activation of cultured human mesangial cells.

  Kidney international 20020901

• Glucocorticoids interfere with mycophenolate mofetil bioavailability in kidney transplantation.

  Kidney international 20020901

• Depletion of intracellular GTP results in nuclear factor-kappaB activation and intercellular adhesion molecule-1 expression in human endothelial cells.

  Molecular pharmacology 20020901

• Mycophenolic acid inhibits IL-2-dependent T cell proliferation, but not IL-2-dependent survival and sensitization to apoptosis.

  Journal of immunology (Baltimore, Md. : 1950) 20020901

• Limited sampling strategy for the estimation of mycophenolic acid area under the curve in adult renal transplant patients treated with concomitant tacrolimus.

  Clinical chemistry 20020901

• Effects of mycophenolate mofetil on hematocrit after renal transplantation.

  The Annals of pharmacotherapy 20020901

• Mycophenolate mofetil in lupus glomerulonephritis.

  American journal of kidney diseases : the official journal of the National Kidney Foundation 20020901

• Mycophenolic acid downregulates inducible nitric oxide synthase induction in astrocytes.

  Glia 20020901

• Mycophenolate mofetil for the treatment of acute and chronic GVHD is effective and well tolerated but induces a high risk of infectious complications: a series of 21 BM or PBSC transplant patients.

  Bone marrow transplantation 20020901

• [Efficiency of mycophenolate mofetil in the treatment of intermediate and posterior uveitis].

  Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 20020901

• Cyclosporin withdrawal with concomitant conversion from azathioprine to mycophenolate mofetil in renal transplant recipients with chronic allograft nephropathy: a 2-year follow-up.

  Transplant international : official journal of the European Society for Organ Transplantation 20020901

• Enhanced response to basiliximab in a patient with aplastic anemia after treatment with standard immunosuppression.

  American journal of hematology 20020901

• Reversal of chronic cyclosporine nephrotoxicity after heart transplantation-potential role of mycophenolate mofetil.

  The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20020901

• Comparative study of cyclosporine and tacrolimus vs newer immunosuppressants mycophenolate mofetil and rapamycin on coronary endothelial function.

  The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20020901

• Pharmacodynamics of mycophenolate mofetil after heart transplantation: new mechanisms of action and correlations with histologic severity of graft rejection.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20020901

• Lack of correlation between serum levels of mycophenolate mofetil and kidney transplant outcome in tacrolimus-based immunosupression.

  Transplantation proceedings 20020901

• Mycophenolate mofetil in renal transplantation: five years experience.

  Transplantation proceedings 20020901

• Effect of mycophenolate mofetil on the prevention of acute renal allograft rejection.

  Transplantation proceedings 20020901

• Side effects of mycophenolate mofetil versus azathioprine in iranian renal transplant recipients (single-center experience).

  Transplantation proceedings 20020901

• Effects of mycophenolate mofetil on the gastrointestinal system and kidney graft function: early experience at one center.

  Transplantation proceedings 20020901

• Prevalence of arterial hypertension and its morbidity in children and adolescents 3 years after renal transplantation with mycophenolate mofetil-based immunosuppression.

  Transplantation proceedings 20020901

• Mig, IP-10, and CXCR3 gene expression is predictive for the individual response of children with chronic allograft nephropathy to mycophenolate mofetil.

  Transplantation proceedings 20020901

• Onset of liver regeneration after subtotal resection is inhibited by the use of new immunosuppressive drugs.

  Transplantation proceedings 20020901

• Pharmacodynamics of the immunosuppressive effects of the combination of tacrolimus with mycophenolate mofetil.

  Transplantation proceedings 20020901

• Effects of three immunosuppressive regimens on CD4 helper function, B cell monocyte and cytokine responses in renal transplant recipients: 4-month follow-up of a prospective randomized study.

  Transplantation proceedings 20020901

• The addition of mycophenolate mofetil to antiretroviral therapy including abacavir is associated with depletion of intracellular deoxyguanosine triphosphate and a decrease in plasma HIV-1 RNA.

  Journal of acquired immune deficiency syndromes (1999) 20020901

• [Mycophenolate mofetil, a possible new immunosuppresant].

  Ceska a Slovenska farmacie : casopis Ceske farmaceuticke spolecnosti a Slovenske farmaceuticke spolecnosti 20020901

• Efficacy of low-dose mycophenolate mofetil therapy for Taiwanese renal transplantation patients receiving primary cyclosporine immunosuppression.

  Journal of the Formosan Medical Association = Taiwan yi zhi 20020901

• Short-term combination of mycophenolate mofetil with cyclosporine as a therapeutic option for renal transplant recipients: A prospective, multicenter, randomized study.

  Transplantation 20020827

• Immunosuppressants leflunomide and mycophenolic acid inhibit fibroblast IL-6 production by distinct mechanisms.

  Cytokine 20020821

• CTP:phosphocholine cytidylyltransferase and protein kinase C recognize different physical features of membranes: differential responses to an oxidized phosphatidylcholine.

  Biochimica et biophysica acta 20020819

• Comparison of two drug regimens upon clinical outcome among renal transplant recipients with positive flow cytometric crossmatches.

  Clinical transplantation 20020801

• Mycophenolate mofetil for systemic lupus erythematosus refractory to other immunosuppressive agents.

  Rheumatology (Oxford, England) 20020801

• Down-regulation of multiple low dose streptozotocin-induced diabetes by mycophenolate mofetil.

  Clinical and experimental immunology 20020801

• In vivo test of two low doses of mycophenolate mofetil in an experimental model of islet allotransplantation.

  Transplantation proceedings 20020801

• Influence of immunosuppressive drugs on intestinal epithelial transport function.

  Transplantation proceedings 20020801

• Mycophenolate mofetil for treatment of chronic rejection in liver allograft under tacrolimus.

  Transplantation proceedings 20020801

• Steroid-free regimen with daclizumab, mycophenolate mofetil, and tacrolimus in liver transplant recipients.

  Transplantation proceedings 20020801

• Use of mycophenolate mofetil in liver transplant recipients experiencing renal dysfunction on cyclosporine or tacrolimus-randomized, prospective, multicenter study results.

  Transplantation proceedings 20020801

• Renal sparing effects of mycophenolate when used in long-term liver transplant recipients [correction of receipients].

  Transplantation proceedings 20020801

• Mycophenolate's influence in the treatment of recurrent hepatitis c following liver transplantation.

  Transplantation proceedings 20020801

• Delay of hepatitis C recurrence in liver transplant recipients: impact of mycophenolate mofetil on transplant recipients with severe acute rejection or with renal dysfunction.

  Transplantation proceedings 20020801

• Recurrence of hepatitis C in liver transplant recipients treated with mycophenolate mofetil.

  Transplantation proceedings 20020801

• First results from a prospective randomized trial comparing steroid-free induction therapy with tacrolimus and MMF versus tacrolimus and steroids in patients after liver transplantation for HCV.

  Transplantation proceedings 20020801

• Osteoporosis screening in an outpatient liver transplant clinic: impact of primary immunosuppression.

  Transplantation proceedings 20020801

• Safe withdrawal of corticosteroids or mycophenolate mofetil: results of a large, prospective, multicenter, randomized study.

  Transplantation proceedings 20020801

• Benelux experience with a combination of tacrolimus and mycophenolate mofetil: 4-year results.

  Transplantation proceedings 20020801

• Randomized trial of three different immunosuppressive regimens to prevent chronic renal allograft rejection.

  Transplantation proceedings 20020801

• Effect of daclizumab, tacrolimus and mycophenolate mofetil in racial minority first renal transplant recipients.

  Transplantation proceedings 20020801

• Early experience using calcineurin-free protocol in recipients of high-risk cadaver renal transplants.

  Transplantation proceedings 20020801

• Two-year outcome in renal allograft recipients comparing neoral-led with tacrolimus-led therapy.

  Transplantation proceedings 20020801

• Mycophenolate mofetil reduces late renal allograft loss: a 4-year study.

  Transplantation proceedings 20020801

• Conversion to tacrolimus immunosuppression in renal transplant recipients: 12-month follow-up.

  Transplantation proceedings 20020801

• Low-dose and rapid steroid withdrawal in renal transplant patients treated with tacrolimus and mycophenolate mofetil.

  Transplantation proceedings 20020801

• Low-dose tacrolimus, trough-monitored mycophenolate mofetil, and planned steroid withdrawal for cadaveric kidney transplantation: a single center experience.

  Transplantation proceedings 20020801

• Risk of adrenal insufficiency with steroid maintenance therapy in renal transplantation.

  Transplantation proceedings 20020801

• Successful steroid withdrawal at the end of the 1st year after renal transplantion in mycophenolate mofetil-treated patients.

  Transplantation proceedings 20020801

• Prospective randomized pilot study of steroid withdrawal with mycophenolate mofetil in long-term cyclosporine-treated patients: 4-year follow-up.

  Transplantation proceedings 20020801

• Steroid withdrawal from tacrolimus-based therapy in renal transplant patients.

  Transplantation proceedings 20020801

• Sirolimus-based steroid-free maintenance immunosuppression.

  Transplantation proceedings 20020801

• Two-hour blood tacrolimus levels are not superior to trough levels as estimates of the area under the curve in tacrolimus-treated renal transplant patients.

  Transplantation proceedings 20020801

• Pharmacokinetics and pharmacodynamics of mycophenolate mofetil under oral and intravenous therapy.

  Transplantation proceedings 20020801

• Pharmacodynamic monitoring of mycophenolate mofetil in stable renal allograft recipients.

  Transplantation proceedings 20020801

• Patients with high cholesterol levels benefit most from early withdrawal of corticosteroids.

  Transplantation proceedings 20020801

• Design and preliminary results of a randomized study on the conversion of treatment with calcineurin inhibitors to mycophenolate mofetil in chronic renal graft failure: effect, on serum cholesterol levels.

  Transplantation proceedings 20020801

• Replacement of calcineurin inhibitors by mycophenolate mofetil: effect on hemoglobine levels.

  Transplantation proceedings 20020801

• A randomized trial of mycophenolate mofetil versus azathioprine as calcineurin inhibitor sparing agents in the treatment of chronic allograft nephropathy.

  Transplantation proceedings 20020801

• Adverse events in renal transplantation under tacrolimus/mycophnolate mofetil immunosuppression: a single-center experience.

  Transplantation proceedings 20020801

• Mycophenolate mofetil reduces anti-HLA antibody production and cellular rejection in heart transplant recipients.

  Transplantation proceedings 20020801

• Immunosuppressive regimen in lung transplantation: initial intravenous mycophenolate mofetil and cyclosporine avoid cytolytic induction and allow for rapid steroid tapering.

  Transplantation proceedings 20020801

• Value of mycophenolic acid trough level monitoring after lung transplantation.

  Transplantation proceedings 20020801

• Tacrolimus for treatment of bronchiolitis obliterans syndrome after unilateral and bilateral lung transplantation.

  Transplantation proceedings 20020801

• Daclizumab and ATG versus ATG in combination with tacrolimus, mycophenolate mofetil, and steroids in simultaneous [correction of simultaneus] pancreas-kidney transplantation: analysis of early outcome.

  Transplantation proceedings 20020801

• Steroid-resistant acute rejection following SPK: importance of maintaining therapeutic dosing in a triple-drug regimen.

  Transplantation proceedings 20020801

• Tacrolimus/mycophenolate mofetil vs cyclosporine A/Azathioprine after simultaneous pancreas and kidney transplantation: five-year results of a randomized study.

  Transplantation proceedings 20020801

• Effect of daclizumab, tacrolimus, and mycophenolate mofetil in pediatric first renal transplant recipients.

  Transplantation proceedings 20020801

• Conversion from cyclosporine to tacrolimus is preferred by pediatric renal transplant recipients: a focus on opinions and outcomes.

  Transplantation proceedings 20020801

• Mycophenolate mofetil without antibody induction in pediatric renal transplantation.

  Transplantation proceedings 20020801

• Induction with basiliximab reduces acute rejection in pediatric liver transplant patients treated with tacrolimus and steroids.

  Transplantation proceedings 20020801

• The immunosuppressive drug mycophenolic acid reduces endothelin-1 synthesis in endothelial cells and renal epithelial cells.

  Clinical science (London, England : 1979) 20020801

• Treatment strategies in autoimmune hepatitis.

  Clinics in liver disease 20020801

• Evolving new therapies of autoimmune hepatitis.

  Clinics in liver disease 20020801

• Psoralen plus ultraviolet-A-bath photochemotherapy as an adjunct treatment modality in cutaneous chronic graft versus host disease.

  Photodermatology, photoimmunology & photomedicine 20020801

• Related and unrelated nonmyeloablative hematopoietic stem cell transplantation for malignant diseases.

  International journal of hematology 20020801

• Screening the yeast 'disruptome' for mutants affecting resistance to the immunosuppressive drug, mycophenolic acid.

  The Journal of biological chemistry 20020726

• Successful management of an ABO-mismatched lung allograft using antigen-specific immunoadsorption, complement inhibition, and immunomodulatory therapy.

  Transplantation 20020715

• A double-hand transplant can be worth the effort!

  Transplantation 20020715

• Cytotoxicity and cellular differentiation activity of methylenebis(phosphonate) analogs of tiazofurin and mycophenolic acid adenine dinucleotide in human cancer cell lines.

  Cancer letters 20020708

• Dose proportional inhibition of HIV-1 replication by mycophenolic acid and synergistic inhibition in combination with abacavir, didanosine, and tenofovir.

  Antiviral research 20020701

• Identification of active antiviral compounds against a New York isolate of West Nile virus.

  Antiviral research 20020701

• Subacute prurigo variant of bullous pemphigoid: autoantibodies show the same specificity compared with classic bullous pemphigoid.

  Journal of the American Academy of Dermatology 20020701

• Cyclosporine withdrawal and mycophenolate mofetil treatment effects on the progression of chronic cyclosporine nephrotoxicity.

  Kidney international 20020701

• Immune responsiveness in renal transplant recipients: mycophenolic acid severely depresses humoral immunity in vivo.

  Kidney international 20020701

• Successful treatment of subacute cutaneous lupus erythematosus with mycophenolate mofetil.

  The British journal of dermatology 20020701

• Sirolimus steady-state trough concentrations are not affected by bolus methylprednisolone therapy in renal allograft recipients.

  British journal of clinical pharmacology 20020701

• Inhibition of mycophenolic acid on NF-kappaB activity in human endothelial cells.

  Acta pharmacologica Sinica 20020701

• Mycophenolate mofetil inhibits regenerative repair in uranyl acetate-induced acute renal failure by reduced interstitial cellular response.

  The American journal of pathology 20020701

• Limited dose monoclonal IL-2R antibody induction protocol after primary kidney transplantation.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20020701

• [Tubulointerstitial nephritis and uveitis (TINU syndrome) - comorbidity and complications in four patients].

  Klinische Monatsblatter fur Augenheilkunde 20020701

• [A randomized control trial of mycophenolate mofeil treatment in severe IgA nephropathy].

  Zhonghua yi xue za zhi 20020625

• Quantification of the influence of mycophenolic acid on the release of endothelial adhesion molecules.

  Clinica chimica acta; international journal of clinical chemistry 20020601

• Mycophenolic acid concentrations in long-term heart transplant patients: relationship with calcineurin antagonists and acute rejection.

  Clinical transplantation 20020601

• Pharmacokinetics and protein adduct formation of the pharmacologically active acyl glucuronide metabolite of mycophenolic acid in pediatric renal transplant recipients.

  Therapeutic drug monitoring 20020601

• Atypical pharmacokinetics and metabolism of mycophenolic acid in a young kidney transplant recipient with impaired renal function.

  Therapeutic drug monitoring 20020601

• Mycophenolate mofetil for the treatment of refractory auto-immune haemolytic anaemia and auto-immune thrombocytopenia purpura.

  British journal of haematology 20020601

• Effects of immunomodulators on acute Trypanosoma Cruzi infection in mice.

  Medical science monitor : international medical journal of experimental and clinical research 20020601

• Combined immunosuppression with cyclosporine, rapamycin, and mycophenolate mofetil controls rejection with minimal nutritional impact in experimental small intestinal transplantation.

  Transplantation proceedings 20020601

• Role of immunosuppressive drugs in the development of tissue-invasive cytomegalovirus infection in renal transplant recipients.

  Transplantation proceedings 20020601

• Staggered immunosuppression with the interleukin-2 receptor antagonist daclizumab combined with tacrolimus, prednisolone, and mycophenolate mofetil after orthotopic liver transplantation: a pilot efficacy and safety study.

  Transplantation proceedings 20020601

• Primary immunosuppression with tacrolimus and mycophenolate mofetil versus cyclosporine and azathioprine in heart transplant recipients.

  Transplantation proceedings 20020601

• Short-term treatment with mycophenolic acid increases bile flow in continuously perfused and cold-preserved rat livers and does not affect hepatic ischemia-reperfusion injury.

  Transplant international : official journal of the European Society for Organ Transplantation 20020601

• Tolerance of mycophenolate mofetil in end-stage renal disease patients with ANCA-associated vasculitis.

  Clinical nephrology 20020601

• Increased risk of complicated CMV infection with the use of mycophenolate mofetil in allogeneic stem cell transplantation.

  Bone marrow transplantation 20020601

• Neutrophil dysplasia characterised by a pseudo-Pelger-Huet anomaly occurring with the use of mycophenolate mofetil and ganciclovir following renal transplantation: a report of five cases.

  Pathology 20020601

• [Metabolic modifications related to immunosuppressive drugs].

  Revue medicale de Bruxelles 20020601

• Novel assays of multiple lymphocyte functions in whole blood measure: new mechanisms of action of mycophenolate mofetil in vivo.

  Transplant immunology 20020601

• Restoration of glomerular haemodynamics and renal injury independent of arterial hypertension in rats with subtotal renal ablation.

  Journal of hypertension. Supplement : official journal of the International Society of Hypertension 20020601

• The role of immune cells infiltrating the kidney in the pathogenesis of salt-sensitive hypertension.

  Journal of hypertension. Supplement : official journal of the International Society of Hypertension 20020601

• Discovery of N-[2-[2-[[3-methoxy-4-(5-oxazolyl)phenyl]amino]-5-oxazolyl]phenyl]-N-methyl-4- morpholineacetamide as a novel and potent inhibitor of inosine monophosphate dehydrogenase with excellent in vivo activity.

  Journal of medicinal chemistry 20020523

• Activation of caspase-2 mediates the apoptosis induced by GTP-depletion in insulin-secreting (HIT-T15) cells.

  Endocrinology 20020501

• Withdrawal of cyclosporine or prednisone six months after kidney transplantation in patients on triple drug therapy: a randomized, prospective, multicenter study.

  Journal of the American Society of Nephrology : JASN 20020501

• Influence of mycophenolic acid and tacrolimus on homocysteine metabolism.

  Kidney international 20020501

• Reassessing the impact of cytomegalovirus infection in kidney and kidney-pancreas transplantation.

  American journal of kidney diseases : the official journal of the National Kidney Foundation 20020501

• A new acute inflammatory syndrome related to the introduction of mycophenolate mofetil in patients with Wegener's granulomatosis.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20020501

• The child with initially refractory skin infection after renal transplantation.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20020501

• How should the immunosuppressive regimen be managed in patients with established chronic allograft failure?

  Kidney international. Supplement 20020501

• Induction of apoptosis and modulation of activation and effector function in T cells by immunosuppressive drugs.

  Clinical and experimental immunology 20020501

• Efficacy of myoblast transplantation in nonhuman primates following simple intramuscular cell injections: toward defining strategies applicable to humans.

  Experimental neurology 20020501

• Inhibition of mycophenolic acid glucuronidation by niflumic acid in human liver microsomes.

  European journal of clinical pharmacology 20020501

• Safety of the allopurinol-mycophenolate mofetil combination in the treatment of hyperuricemia of kidney transplant recipients.

  Nephron 20020501

• Mycophenolate mofetil monotherapy in stable liver transplant recipients with progressive renal failure.

  Transplantation proceedings 20020501

• Effect of immunosuppression on damage, leukocyte infiltration, and regeneration after severe warm ischemia/reperfusion renal injury.

  Transplantation proceedings 20020501

• Effect of mycophenolate mofetil in combination with standard immunosuppression on chronic transplant nephropathy: 1 year experience.

  Transplantation proceedings 20020501

• Monitoring mycophenolic acid.

  Annals of clinical biochemistry 20020501

• Antiproliferative effect of mycophenolate mofetil on cultured human Tenon fibroblasts.

  Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 20020501

• [The effect of mycophenolic acid on activation antigen expression and in vitro T lymphocytes proliferation in peripheral blood].

  Zhonghua nei ke za zhi 20020501

• Mycophenolate mofetil vs cyclophosphamide therapy for patients with diffuse proliferative lupus nephritis.

  Chinese medical journal 20020501

• Mycophenolate sodium: tolerability and efficacy in transplantation in the rat.

  Transplant immunology 20020501

• [Combination of mycophenolate mofetil with cyclosporine A and methotrexate for the prophylaxes of acute graft versus host disease in allogeneic peripheral stem cell transplantation].

  Zhonghua yi xue za zhi 20020425

• Daclizumab induction, tacrolimus, mycophenolate mofetil and steroids as an immunosuppression regimen for primary kidney transplant recipients.

  Transplantation 20020415

• Is mycophenolate mofetil less safe than azathioprine in elderly renal transplant recipients?

  Transplantation 20020415

• Influence of mycophenolic acid on inosine 5'-monophosphate dehydrogenase activity in human peripheral blood mononuclear cells.

  Clinica chimica acta; international journal of clinical chemistry 20020401

• Pharmacokinetics and protein binding of mycophenolic acid in stable lung transplant recipients.

  Therapeutic drug monitoring 20020401

• Effects of mycophenolate mofetil in mercury-induced autoimmune nephritis.

  Journal of the American Society of Nephrology : JASN 20020401

• Quiz page. Urinary obstruction.

  American journal of kidney diseases : the official journal of the National Kidney Foundation 20020401

• Hepatitis C and mycophenolate mofetil--a clarification.

  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20020401

• Long-term care of pediatric renal transplant patients: from bench to bedside.

  Current opinion in pediatrics 20020401

• Mycophenolate mofetil: selective T cell inhibition.

  The American journal of the medical sciences 20020401

• Antidiabetogenic effect of mycophenolate mofetil is associated with down-regulation of adhesive interactions and autoreactive cell activation.

  Annals of the New York Academy of Sciences 20020401

• Induction of islet allotolerance in nonhuman primates.

  Annals of the New York Academy of Sciences 20020401

• [Prophylaxis of acute graft-versus-host disease after allogeneic bone marrow transplantation by mycophenolate mofetil in a murine model].

  Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 20020401

• [Treatment of two case childhood acute lymphoblastic leukemia by HLA-mismatched unrelated umbilical cord blood transplantation].

  Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 20020401

• Compared to mycophenolate mofetil, rapamycin induces significant changes on growth factors and growth factor receptors in the early days post-kidney transplantation.

  Transplantation 20020327

• Tacrolimus-associated severe bilateral corneal ulcer after renal transplantation.

  Transplantation 20020327

• A long-term comparison of tacrolimus (FK506) and cyclosporine in kidney transplantation: evidence for improved allograft survival at five years.

  Transplantation 20020315

• Intravenous pulse administration of cyclophosphamide is an effective and safe treatment for sensitized cardiac allograft recipients.

  Circulation 20020312

• Mycophenolate mofetil treatment for primary glomerular diseases.

  Kidney international 20020301

• Toxicity of mycophenolate mofetil in patients with inflammatory bowel disease.

  Inflammatory bowel diseases 20020301

• The pharmacokinetic-pharmacodynamic relationship for total and free mycophenolic Acid in pediatric renal transplant recipients: a report of the german study group on mycophenolate mofetil therapy.

  Journal of the American Society of Nephrology : JASN 20020301

• Comparison of the Emit immunoassay with HPLC for therapeutic drug monitoring of mycophenolic acid in pediatric renal-transplant recipients on mycophenolate mofetil therapy.

  Clinical chemistry 20020301

• The inflammatory component in progressive renal disease--are interventions possible?

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20020301

• Reversible abnormal chromatin clumping in granulocytes from six transplant patients treated with mycophenolate mofetil: a rare adverse effect mimicking abnormal chromatin clumping syndrome.

  British journal of haematology 20020301

• Strategies to reduce toxicities and improve outcomes in renal transplant recipients.

  Pharmacotherapy 20020301

• Long-term viability of articular cartilage after microsurgical whole-joint transplantation and immunosuppression with rapamycin, mycophenolate mofetil, and tacrolimus.

  The Journal of hand surgery 20020301

• Infections in renal transplant recipients receiving mycophenolate versus azathioprine-based immunosuppression.

  European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20020301

• [Mycophenolate mofetil induced acute hepatitis].

  Gastroenterologie clinique et biologique 20020301

• Liver function tests in mycophenolate mofetil-treated hepatitis C virus-positive kidney allograft recipients.

  Transplantation proceedings 20020301

• Mycophenolate mofetil in the treatment of chronic rejection in renal transplantation: 3-year follow-up.

  Transplantation proceedings 20020301

• Mycophenolate mofetil in renal graft recipients with increased immune risk of graft loss.

  Transplantation proceedings 20020301

• Results of renal transplantation with different immunosuppressive regimens.

  Transplantation proceedings 20020301

• Steroid withdrawal after renal transplantation--risks and benefits.

  Transplantation proceedings 20020301

• Mycophenolate mofetil reduces graft loss due to chronic allograft nephropaty.

  Transplantation proceedings 20020301

• Effects of changing immunosuppressive regimen on the incidence, duration, and viral load of cytomegalovirus infection in renal transplantation: a single center report.

  Transplant infectious disease : an official journal of the Transplantation Society 20020301

• Inhibitory effects of immunosuppressive drugs on insulin secretion from HIT-T15 cells and Wistar rat islets.

  Transplantation 20020215

• Reduction of renal immune cell infiltration results in blood pressure control in genetically hypertensive rats.

  American journal of physiology. Renal physiology 20020201

• Open randomized trial comparing early withdrawal of either cyclosporine or mycophenolate mofetil in stable renal transplant recipients initially treated with a triple drug regimen.

  Journal of the American Society of Nephrology : JASN 20020201

• International Federation of Clinical Chemistry/International Association of Therapeutic Drug Monitoring and Clinical Toxicology working group on immunosuppressive drug monitoring.

  Therapeutic drug monitoring 20020201

• Monitoring of mycophenolic acid in clinical transplantation.

  Therapeutic drug monitoring 20020201

• Disappearance of measurable mycophenolate mofetil (Cell Cept) in a patient with a renal transplant and an ileostomy.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20020201

• Rationale for trials of long-term mycophenolate mofetil therapy for primary biliary cirrhosis.

  Hepatology (Baltimore, Md.) 20020201

• Mycophenolate mofetil decreases antibody production after cardiac transplantation.

  The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20020201

• Mycophenolate mofetil in the therapy of polymyositis associated with a polyautoimmune syndrome.

  Muscle & nerve 20020201

• [Systemic lupus erythematosus. International Conference on Systemic Lupus Erythematosus, Barcelona, March 24-28, 2001].

  La Revue de medecine interne 20020201

• Pyoderma gangrenosum associated with Wegener's granulomatosis: partial response to mycophenolate mofetil.

  Rheumatology (Oxford, England) 20020201

• Mycophenolate mofetil aggravates postischemic acute renal failure in rats.

  Transplantation proceedings 20020201

• Immunosuppression using tacrolimus/mycophenolate versus neoral/mycophenolate following kidney transplantation: a single-center experience.

  Transplantation proceedings 20020201

• Role of immunosuppressive treatments based on mycophenolate mofetil in posttransplantation renal surgical complications.

  Transplantation proceedings 20020201

• Mycophenolate mofetil immunosuppressive therapies increase the incidence of cytomegalovirus infection in renal transplantation.

  Transplantation proceedings 20020201

• Results of a triple induction regime with tacrolimus, mycophenolate mofetil, and prednisone in renal transplantation.

  Transplantation proceedings 20020201

• Efficacy and safety of basiliximab in pediatric renal transplantation.

  Transplantation proceedings 20020201

• Histopathological findings in heart transplant patients under tacrolimus-mycophenolate mofetil versus cyclosporine microemulsion-azathioprine.

  Transplantation proceedings 20020201

• Steroids withdrawal after 3 months of successful renal transplantation using a tacrolimus- and mycophenolate-based immunosuppression.

  Transplantation proceedings 20020201

• Use of mycophenolate mofetil in patients with transplanted heart and renal insufficiency: the relevance of the pharmacokinetic study.

  Transplantation proceedings 20020201

• Preliminary results of rescue therapy with tacrolimus and mycophenolate mofetil in lung transplanted patients with bronchiolitis obliterans.

  Transplantation proceedings 20020201

• Histology and immunopathology of heart and liver xenografts under low-dose tacrolimus.

  Transplantation proceedings 20020201

• Treatment of chronic allograft nephropathy with mycophenolate mofetil after kidney transplantation: a Spanish multicenter study.

  Transplantation proceedings 20020201

• A multicenter, open-label, comparative trial of two daclizumab dosing strategies vs. no antibody induction in combination with tacrolimus, mycophenolate mofetil, and steroids for the prevention of acute rejection in simultaneous kidney-pancreas transplant recipients: interim analysis.

  Clinical transplantation 20020201

• Novel mycophenolic adenine bis(phosphonate) analogues as potential differentiation agents against human leukemia.

  Journal of medicinal chemistry 20020131

• Effect of felodipine on tacrolimus pharmacokinetics in a renal transplant recipient.

  Transplantation 20020115

• A prospective randomized trial of mycophenolate mofetil in liver transplant recipients with hepatitis C.

  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20020101

• Mycophenolate and hepatitis C: salve on a wound or gasoline on a fire?

  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20020101

• Update on the treatment of systemic lupus erythematosus: therapeutic highlights from the Sixth International Lupus Conference.

  The Israel Medical Association journal : IMAJ 20020101

• Case series assessing the safety of mycophenolate as part of multidrug rescue treatment regimens.

  HIV clinical trials 20020101

• Simultaneous estimation of cyclosporin and mycophenolic acid areas under the curve in stable renal transplant patients using a limited sampling strategy.

  European journal of clinical pharmacology 20020101

• Immunosuppressive therapy for paediatric transplant patients: pharmacokinetic considerations.

  Clinical pharmacokinetics 20020101

• Current immunosuppression in liver transplantation.

  American journal of therapeutics 20020101

• Novel pharmacotherapeutic approaches to prevention and treatment of GVHD.

  Drugs 20020101

• Newer immunosuppressive drugs: their potential role in rheumatoid arthritis therapy.

  Drugs 20020101

• [Open trial of mycophenolate mofetil in the treatment of resistant pemphigus vulgaris].

  Annales de dermatologie et de venereologie 20020101

• [Mycophenolate mofetil in refractory Crohn's disease after failure of treatments by azathioprine or methotrexate].

  Gastroenterologie clinique et biologique 20020101

• [Mycophenolate mofetil in lupus nephritis].

  Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20020101

• Potential role of immune modulation in the effective long-term control of HIV-1 infection.

  Journal of biological regulators and homeostatic agents 20020101

• Rapid failure of pig islet transplantation in non human primates.

  Xenotransplantation 20020101

• Therapeutic monitoring of mycophenolate mofetil in organ transplant recipients: is it necessary?

  Clinical pharmacokinetics 20020101

• [New trends in chemotherapy of systemic lupus erythematosus: treatment with mycophenolate mofetil].

  Klinicheskaia meditsina 20020101

• Mycobacterium haemophilum infection in an SLE patient on mycophenolate mofetil.

  Lupus 20020101

• [Graft vs. tumor effect in chronic granulocytic leukemia].

  Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion 20020101

• European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.9.2. Haematological complications. Leukopenia.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20020101

• European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.13 Analysis of patient and graft survival.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20020101

• Immunoprophylaxis with basiliximab compared with antithymocyte globulin in renal transplant patients receiving MMF-containing triple therapy.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20020101

• Mycophenolate mofetil: a pharmacoeconomic review of its use in solid organ transplantation.

  PharmacoEconomics 20020101

• Effect of mycophenolate mofetil on severity of nephritis and nitric oxide production in lupus-prone MRL/lpr mice.

  Lupus 20020101

• Paraneoplastic pemphigus: a refractory autoimmune mucocutaneous disease.

  Journal of cutaneous medicine and surgery 20020101

• Mycophenolic acid and methotrexate inhibit lymphocyte cytokine production via different mechanisms.

  European cytokine network 20020101

• Successful treatment of linear IgA bullous dermatosis with mycophenolate mofetil.

  Acta dermato-venereologica 20020101

• [Atypical cytomegalovirus in renal transplantation: a new form of presentation].

  Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20020101

• Thymoglobulin for induction or rejection therapy in pancreas allograft recipients: a single centre experience.

  Clinical transplantation 20020101

• Can a pharmacokinetic approach to immunosuppression eliminate ethnic disparities in renal allograft outcome?

  Clinical transplantation 20020101

• [Intestinal infection by cytomegalovirus in kidney transplantation: diagnostic difficulty in the course of mycophenolate mofetil therapy].

  Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia 20020101

• Mycophenolic acid inhibits inosine 5'-monophosphate dehydrogenase and suppresses production of pro-inflammatory cytokines, nitric oxide, and LDH in macrophages.

  Cellular immunology 20020101

• Successful treatment of steroid-resistant minimal change disease with mycophenolate mofetil.

  American journal of nephrology 20020101

• New immunosuppressive drugs in dermatology (mycophenolate mofetil, tacrolimus): unapproved uses, dosages, or indications.

  Clinics in dermatology 20020101

• Effect of mycophenolate mofetil on kallikrein expression in the kidney of 5/6 nephrectomized rats.

  Kidney & blood pressure research 20020101

• [Early, severe and transient arthralgia induced by mycophenolate mofetil in a patient with erythrodermal psoriasis].

  Annales de dermatologie et de venereologie 20020101

• Myasthenia gravis after allogeneic bone marrow transplantation treated with mycophenolate mofetil monitored by peripheral blood OX40+ CD4+ T cells.

  European journal of haematology 20020101

• Freedom from rejection and stable kidney function are excellent criteria for steroid withdrawal in tacrolimus-treated kidney transplant recipients.

  Annals of transplantation 20020101

• Evidence-based Rheumatology.

  Clinical and experimental rheumatology 20020101

• Experimental therapies for psoriasis.

  Archivum immunologiae et therapiae experimentalis 20020101

• Are wound complications after a kidney transplant more common with modern immunosuppression?

  Transplantation 20011227

• Comparative efficacy of mycophenolate sodium (MPS) and mycophenolate mofetil (MMF) with and without cyclosporine in rat transplantation models.

  Transplantation 20011215

• Proteome analysis and morphological studies reveal multiple effects of the immunosuppressive drug mycophenolic acid specifically resulting from guanylic nucleotide depletion.

  The Journal of biological chemistry 20011207

• Influence of hepatocyte growth factor, epidermal growth factor, and mycophenolic acid on endothelin-1 synthesis in human endothelial cells.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20011201

• Pharmacokinetics help optimizing mycophenolate mofetil dosing in kidney transplant patients.

  Clinical transplantation 20011201

• A randomized prospective trial of OKT3 induction in the current immunosuppression era.

  Clinical transplantation 20011201

• The immunomodulatory drugs cyclosporin A, mycophenolate mofetil, and sirolimus (rapamycin) inhibit allergen-induced proliferation and IL-5 production by PBMCs from atopic asthmatic patients.

  The Journal of allergy and clinical immunology 20011201

• Anti-interleukin-2 receptor therapy in combination with mycophenolate mofetil is associated with more severe hepatitis C recurrence after liver transplantation.

  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20011201

• Initial clinical experience with interleukin-2 receptor antagonist induction in combination with tacrolimus, mycophenolate mofetil and steroids in simultaneous kidney-pancreas transplantation.

  Transplant international : official journal of the European Society for Organ Transplantation 20011201

• The use of mycophenolate mofetil suspension in pediatric renal allograft recipients.

  Pediatric nephrology (Berlin, Germany) 20011201

• Analytic validation of the enzyme multiplied immunoassay technique for the determination of mycophenolic acid in plasma from renal transplant recipients compared with a high-performance liquid chromatographic assay.

  Therapeutic drug monitoring 20011201

• Effect of cyclosporine withdrawal on mycophenolic acid pharmacokinetics in kidney transplant recipients with deteriorating renal function: preliminary report.

  Therapeutic drug monitoring 20011201

• Potential lack of specificity using electrospray tandem-mass spectrometry for the analysis of mycophenolic acid in serum.

  Therapeutic drug monitoring 20011201

• Investigation of the penetration behaviour of mycophenolate mofetil from a semisolid formulation into human skin ex-vivo.

  The Journal of pharmacy and pharmacology 20011201

• Nephrotoxicity of immunosuppressive drugs: new insight and preventive strategies.

  Current opinion in critical care 20011201

• Reducing adverse effects of immunosuppressive agents in kidney transplant recipients.

  Progress in transplantation (Aliso Viejo, Calif.) 20011201

• Consideration of mycophenolate mofetil for idiopathic pulmonary fibrosis.

  Medical hypotheses 20011201

• Multicenter survey of daclizumab induction in simultaneous kidney-pancreas transplant recipients.

  Transplantation 20011127

• Mycophenolate mofetil versus azathioprine in patients surviving the initial cardiac transplant hospitalization: an analysis of the Joint UNOS/ISHLT Thoracic Registry.

  Transplantation 20011127

• Steroid elimination 24 hours after liver transplantation using daclizumab, tacrolimus, and mycophenolate mofetil.

  Transplantation 20011127

• Determination of mycophenolic acid and its phenol glucuronide metabolite in human plasma and urine by high-performance liquid chromatography.

  Journal of chromatography. B, Biomedical sciences and applications 20011105

• Renal cortical vasoconstriction contributes to development of salt-sensitive hypertension after angiotensin II exposure.

  Journal of the American Society of Nephrology : JASN 20011101

• Plasmapheresis-induced remission in otherwise therapy-resistant FSGS.

  Pediatric nephrology (Berlin, Germany) 20011101

• The glucuronidation of mycophenolic acid by human liver, kidney and jejunum microsomes.

  British journal of clinical pharmacology 20011101

• Recent advances in the treatment of autoimmune bullous diseases.

  The Journal of dermatology 20011101

• Allogeneic stem cell transplantation for Evans syndrome.

  Bone marrow transplantation 20011101

• [A clinical study of haploidentical transplantation using granulocyte colony-stimulating factor stimulating donor bone marrow].

  Zhonghua nei ke za zhi 20011101

• Antiviral activity and mode of action studies of ribavirin and mycophenolic acid against orthopoxviruses in vitro.

  Antiviral chemistry & chemotherapy 20011101

• Provocative effects of the immunosuppressants rapamycin, tacrolimus, and dexamethasone on pneumonitis in contrast to the anti- pneumonitis effects of mycophenolate mofetil.

  Transplantation 20011027

• Sirolimus and mycophenolate mofetil for calcineurin-free immunosuppression in renal transplant recipients.

  American journal of kidney diseases : the official journal of the National Kidney Foundation 20011001

• Effect of cyclosporine on mycophenolic acid area under the concentration-time curve in pediatric kidney transplant recipients.

  Therapeutic drug monitoring 20011001

• In vivo higher glucuronidation of mycophenolic acid in male than in female recipients of a cadaveric kidney allograft and under immunosuppressive therapy with mycophenolate mofetil.

  Therapeutic drug monitoring 20011001

• Mycophenolic acid levels in pediatric heart transplant recipients receiving mycophenolate mofetil.

  The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20011001

• [Treatment of steroid-resistant polymyositis and dermatomyositis].

  Nihon rinsho. Japanese journal of clinical medicine 20011001

• Current and emerging lupus treatments.

  The American journal of managed care 20011001

• Non-radioactive determination of inosine 5'-monophosphate dehydro-genase (IMPDH) in peripheral mononuclear cells.

  Clinical biochemistry 20011001

• Intraoral psoralen ultraviolet A irradiation (PUVA) treatment of refractory oral chronic graft-versus-host disease following allogeneic stem cell transplantation.

  Bone marrow transplantation 20011001

• Adjuvant therapy of bullous pemphigoid with mycophenolate mofetil: old drug, new use.

  Singapore medical journal 20011001

• A prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone and mycophenolate mofetil in primary adult liver transplantation: a single center report.

  Transplantation 20010927

• The effect of mycophenolate mofetil on hepatitis B viral load in stable renal transplant recipients with chronic hepatitis B.

  Transplantation 20010927

• A pilot study of steroid-free immunosuppression in the prevention of acute rejection in renal allograft recipients.

  Transplantation 20010915

• Oral ulcerations in a renal transplant recipient: a mycophenolate mofetil-induced complication?

  Transplantation 20010915

• Combined treatment with mycophenolate mofetil and an angiotensin II receptor antagonist fully protects from chronic rejection in a rat model of renal allograft.

  Journal of the American Society of Nephrology : JASN 20010901

• Mycophenolate mofetil: implications for the treatment of glomerular disease.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20010901

• Pseudomembraneous colitis under therapy with mycophenolate mofetil following pancreas-kidney double transplantation.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20010901

• Mycophenolate mofetil treatment of severe renal disease in pediatric onset systemic lupus erythematosus.

  The Journal of rheumatology 20010901

• Mycophenolate mofetil treatment accelerates recovery from experimental allergic encephalomyelitis.

  International immunopharmacology 20010901

• Late recurrence of lupus nephritis in a renal transplant recipient: response to mycophenolate mofetil.

  The American journal of the medical sciences 20010901

• [Minimization of immunosuppression].

  Presse medicale (Paris, France : 1983) 20010901

• Combined mycophenolate mofetil and cyclosporin therapy for severe recalcitrant psoriasis.

  Clinical and experimental dermatology 20010901

• Effect of mycophenolate mofetil on the progression of adriamycin nephropathy.

  Renal failure 20010901

• Rapid discontinuation of steroids in living donor kidney transplantation: a pilot study.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20010901

• Membranous lupus nephritis in a renal allograft: response to mycophenolate mofetil therapy.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20010901

• Regulation of an IMP dehydrogenase gene and its overexpression in drug-sensitive transcription elongation mutants of yeast.

  The Journal of biological chemistry 20010831

• Graft survival in a rhesus renal transplant model after immunotoxin-mediated T-cell depletion is enhanced by mycophenolate and steroids.

  Transplantation 20010827

• Calcineurin-inhibitor related nephrotoxicity- reversibility in paediatric liver transplant recipients.

  Transplantation 20010827

• Regulatory T cells induced by 1 alpha,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance.

  Journal of immunology (Baltimore, Md. : 1950) 20010815

• Measurement of mycophenolate mofetil effect in transplant recipients.

  Transplantation 20010815

• A controlled trial comparing two doses of cyclosporine in conjunction with mycophenolate mofetil and corticosteroids.

  Journal of the American Society of Nephrology : JASN 20010801

• Mycophenolate mofetil does not modify the incidence of cytomegalovirus (CMV) disease after kidney transplantation but prevents CMV-induced chronic graft dysfunction.

  Journal of the American Society of Nephrology : JASN 20010801

• Treatment of cicatricial pemphigoid with mycophenolate mofetil as a steroid-sparing agent.

  Journal of the American Academy of Dermatology 20010801

• Quantification of mycophenolic acid in plasma samples collected during and immediately after intravenous administration of mycophenolate mofetil.

  Clinical chemistry 20010801

• Single-center experience with mycophenolate mofetil in pediatric renal transplant recipients.

  Pediatric transplantation 20010801

• Introduction of mycophenolate mofetil and cyclosporin reduction in children with chronic transplant nephropathy.

  Pediatric transplantation 20010801

• Mycophenolate mofetil combined with a cyclooxygenase-2 inhibitor ameliorates murine lupus nephritis.

  Kidney international 20010801

• The evidence base for the treatment of lupus nephritis in the new millennium.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20010801

• Effect of mycophenolate mofetil on nitric oxide production and inducible nitric oxide synthase gene expression during renal ischaemia-reperfusion injury.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20010801

• Mycophenolate mofetil causing deep venous thrombosis in a renal transplant patient with factor V Leiden.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20010801

• Current issues in therapeutic drug monitoring of mycophenolic acid: report of a roundtable discussion.

  Therapeutic drug monitoring 20010801

• Uric acid or urate nephropathy?

  American journal of kidney diseases : the official journal of the National Kidney Foundation 20010801

• Determination of the effects of mycophenolic acid on the nucleotide pool of human peripheral blood mononuclear cells in vitro by high-performance liquid chromatography.

  Clinica chimica acta; international journal of clinical chemistry 20010801

• In vitro effects of mycophenolic acid on the nucleotide pool and on the expression of adhesion molecules of human umbilical vein endothelial cells.

  Clinica chimica acta; international journal of clinical chemistry 20010801

• Improved primary transplant success rates using a triple regimen of cyclosporine microemulsion, mycophenolate mofetil and prednisone.

  Transplantation proceedings 20010801

• Therapeutic drug level monitoring for mycophenolate mofetil: is it justified?

  Transplantation proceedings 20010801

• The cost effectiveness of mycophenolate mofetil in the first year after living related renal transplantation.

  Transplantation proceedings 20010801

• Comparison of azathioprine and mycophenolate mofetil for the prevention of acute rejection in recipients of pancreas transplantation.

  Journal of clinical pharmacology 20010801

• The effect of selective bowel decontamination on the pharmacokinetics of mycophenolate mofetil in liver transplant recipients.

  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20010801

• Treatment of atopic dermatitis with mycophenolate mofetil.

  The British journal of dermatology 20010801

• [Acquired epidermolysis bullosa with a highly varied clinical picture and successful treatment with mycophenolate mofetil].

  Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete 20010801

• Mycophenolate-mofetil in the treatment of refractory multiple sclerosis.

  Journal of neurology 20010801

• Severe oral manifestations of chronic graft-vs.-host disease.

  Journal of the American Dental Association (1939) 20010801

• Polyoma viral infection in renal transplantation: the role of immunosuppressive therapy.

  Clinical transplantation 20010801

• Impact of mycophenolate mofetil on recurrent rejection in kidney transplant patients.

  Clinical transplantation 20010801

• Randomized trial of tacrolimus plus mycophenolate mofetil or azathioprine versus cyclosporine oral solution (modified) plus mycophenolate mofetil after cadaveric kidney transplantation: results at 2 years.

  Transplantation 20010727

• Cyclosporine microemulsion- and mycophenolate mofetil-related lymphoid aggregates are not associated with acute rejection.

  Transplantation 20010727

• Promising early outcomes with a novel, complete steroid avoidance immunosuppression protocol in pediatric renal transplantation.

  Transplantation 20010715

• Combined immunosuppression of mycophenolate mofetil and FK506 for myoblast transplantation in mdx mice.

  Transplantation 20010715

• Dose optimization of mycophenolate mofetil when administered with a low dose of tacrolimus in cadaveric renal transplant recipients.

  Transplantation 20010715

• Control of antidonor antibody production with tacrolimus and mycophenolate mofetil in renal allograft recipients with chronic rejection.

  Transplantation 20010715

• [Effect of mycophenolic acid and dexamethasone on the angiogenic activity of human umbilical vein endothelial cells].

  Zhonghua yi xue za zhi 20010710

• Mycophenolate mofetil prevents salt-sensitive hypertension resulting from nitric oxide synthesis inhibition.

  American journal of physiology. Renal physiology 20010701

• Treatment of resistant discoid lupus erythematosus of the palms and soles with mycophenolate mofetil.

  Journal of the American Academy of Dermatology 20010701

• Mycophenolate mofetil reduces renal cortical inducible nitric oxide synthase mRNA expression and diminishes glomerulosclerosis in MRL/lpr mice.

  The Journal of laboratory and clinical medicine 20010701

• Suggested guidelines for the use of tacrolimus in cardiac transplant recipients.

  The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20010701

• Mycophenolate mofetil is effective in the treatment of atopic dermatitis.

  Archives of dermatology 20010701

• [Immunosuppressive therapy with mycophenolate mofetil (CellCept) in treatment of uveitis].

  Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 20010701

• Failure of sustained engraftment after non-myeloablative conditioning with low-dose TBI and T cell-reduced allogeneic peripheral stem cell transplantation.

  Bone marrow transplantation 20010701

• Treatment of lupus nephritis: art or science?

  Internal medicine journal 20010701

• Mycophenolate mofetil for treatment of refractory lupus nephritis.

  Internal medicine journal 20010701

• The effect of different immunosuppressants on alloantigen dependent and independent factors involved in the development of chronic rejection in an animal model.

  Annals of the Royal College of Surgeons of England 20010701

• New developments in the prophylaxis and treatment of graft versus host disease.

  Expert opinion on pharmacotherapy 20010701

• Results of a randomized, prospective, multicenter trial of mycophenolate mofetil versus azathioprine in the prevention of acute lung allograft rejection.

  Transplantation 20010627

• Sirolimus rescue therapy for refractory rejection in renal transplantation.

  Transplantation 20010615

• Clinical trials in lupus nephritis.

  Current rheumatology reports 20010601

• Accurate estimation of mycophenolic acid AUC.

  Therapeutic drug monitoring 20010601

• Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects.

  Blood 20010601

• Mycophenolate mofetil prevents salt-sensitive hypertension resulting from angiotensin II exposure.

  Kidney international 20010601

• Pharmacokinetics of intravenous mycophenolate mofetil after allogeneic blood stem cell transplantation.

  Clinical transplantation 20010601

• Genetic evidence supports a role for the yeast CCR4-NOT complex in transcriptional elongation.

  Genetics 20010601

• Is complete avoidance of calcineurin inhibitors or steroids now possible? Importance of patient selection and choice of regimen.

  Transplantation proceedings 20010601

• Methods and outcomes of calcineurin inhibitor reduction or withdrawal in patients with chronic allograft nephropathy after the first year posttransplantation.

  Transplantation proceedings 20010601

• Mycophenolate mofetil monotherapy: an optimal, safe, and efficacious immunosuppressive maintenance regimen in kidney transplant patients.

  Transplantation proceedings 20010601

• Topical application of mycophenolate mofetil in plaque-type psoriasis.

  The British journal of dermatology 20010601

• Nonmyeloablative hematopoietic cell transplantation. Replacing high-dose cytotoxic therapy by the graft-versus-tumor effect.

  Annals of the New York Academy of Sciences 20010601

• Inosine monophosphate dehydrogenase (IMPDH) inhibition in vitro suppresses lymphocyte proliferation and the production of immunoglobulins, autoantibodies and cytokines in splenocytes from MRLlpr/lpr mice.

  Clinical and experimental immunology 20010601

• Systemic mycophenolate mofetil in comparison with systemic cyclosporin A in high-risk keratoplasty patients: 3 years' results of a randomized prospective clinical trial.

  Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 20010601

• Non-myeloablative hematopoietic stem cell transplantation.

  Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine 20010601

• F13459, a new derivative of mycophenolic acid. I. Taxonomy, isolation, and biological properties.

  The Journal of antibiotics 20010601

• F13459, a new derivative of mycophenolic acid. II. Physico-chemical properties and structural elucidation.

  The Journal of antibiotics 20010601

• Mycophenolate mofetil for the prevention and treatment of graft-versus-host disease following stem cell transplantation: preliminary findings.

  Bone marrow transplantation 20010601

• Mycophenolate mofetil impairs healing of left-sided colon anastomoses.

  Transplantation 20010527

• Multicenter trial exploring calcineurin inhibitors avoidance in renal transplantation.

  Transplantation 20010515

• Characterization of Penicillium roqueforti strains used as cheese starter cultures by RAPD typing.

  International journal of food microbiology 20010510

• [Mycophenolate mofetil in the treatment of primary nephrotic syndrome].

  Zhonghua yi xue za zhi 20010510

• Quantification of mycophenolate mofetil in human skin extracts using high-performance liquid chromatography-electrospray mass spectrometry.

  Journal of chromatography. B, Biomedical sciences and applications 20010505

• Improved results after lung transplantation--analysis of factors.

  Swiss medical weekly 20010505

• Role of immunocompetent cells in nonimmune renal diseases.

  Kidney international 20010501

• Novel approaches to the treatment of chronic graft-versus-host disease.

  Expert opinion on investigational drugs 20010501

• CD69 expression on peripheral CD4+ T cells parallels disease activity and is reduced by mycophenolate mofetil therapy in uveitis.

  Investigative ophthalmology & visual science 20010501

• Tacrolimus versus cyclosporine after lung transplantation: a prospective, open, randomized two-center trial comparing two different immunosuppressive protocols.

  The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20010501

• A randomized double-blind comparative study of mycophenolate mofetil and azathioprine in combination with cyclosporine and corticosteroids in primary liver transplant recipients.

  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20010501

• General considerations of immunosuppressive therapies--efficacy versus toxicity.

  Transplantation proceedings 20010501

• Mycophenolate mofetil interferes with interferon gamma production in T-cell activation models.

  Transplantation proceedings 20010501

• Assessment of mechanisms of action of immunosuppressive drugs using novel whole blood assays.

  Transplantation proceedings 20010501

• Mycophenolate Mofetil in the treatment of acute and chronic GVHD in hematopoietic stem cell transplant patients: four years of experience.

  Transplantation proceedings 20010501

• Low doses of mycophenolate mofetil with low doses of tacrolimus prevent acute rejection and long-term function loss after lung transplantation.

  Transplantation proceedings 20010501

• Trough level-guided mycophenolate mofetil rejection prophylaxis in liver transplantation.

  Transplantation proceedings 20010501

• The value of routine monitoring of mycophenolic acid plasma levels after clinical heart transplantation.

  Transplantation proceedings 20010501

• Chronic allograft nephropathy: a prospective randomised trial of cyclosporin reduction with or without mycophenolate mofetil.

  Transplantation proceedings 20010501

• Mycophenolate mofetil pharmacodynamics and pharmacokinetics correlate with rejection score in a BN-to-LEW heterotopic heart transplant model.

  Transplantation proceedings 20010501

• The effect of differing immunosuppressive regimes on the functional and morphologic changes in a rat renal allograft model of chronic rejection.

  Transplantation proceedings 20010501

• Chronic allograft nephropathy: prospective randomised trial of cyclosporin withdrawal and mycophenolate mofetil or tacrolimus substitution.

  Transplantation proceedings 20010501

• New immunosuppressants in BMT/GVHD.

  Transplantation proceedings 20010501

• Immunosuppression in ANCA-associated vasculitis.

  Transplantation proceedings 20010501

• Graft-versus-host disease-like features in mycophenolate mofetil-related colitis.

  Transplantation proceedings 20010501

• T-cell reactivity during azathioprine therapy compared with mycophenolate mofetil therapy.

  Transplantation proceedings 20010501

• New mechanisms of action of mycophenolate mofetil in transplant recipients by assessment of its pharmacodynamics.

  Transplantation proceedings 20010501

• Inhibition of cyclosporin-resistant B-cell antigen responses by pyrazoles: a tool for the identification of novel molecular mechanisms of B-cell activation.

  Transplantation proceedings 20010501

• Management of massive proteinuria following renal transplantation with mycophenolate mofetil and blood pressure normalization.

  Transplantation proceedings 20010501

• Mycofenolate mofetil-cyclosporine immunosuppression of kidney transplantation recipients with two different corticosteroid doses.

  Transplantation proceedings 20010501

• Tolerability of mycophenolate mofetil in organ transplant recipients.

  Transplantation proceedings 20010501

• Evaluation of various immunosuppressive regimes in second renal transplants.

  Transplantation proceedings 20010501

• Immunocompetence assay for net effect of combined immunosuppression.

  Transplantation proceedings 20010501

• beta-herpesvirus activation after kidney transplantation with mycophenolate mofetil-based maintenance immunosuppression.

  Transplantation proceedings 20010501

• ATP-binding cassette transporters and calcineurin inhibitors: potential clinical implications.

  Transplantation proceedings 20010501

• Transcending conventional therapies: the role of biologic and other novel therapies.

  Inflammatory bowel diseases 20010501

• Diabetic rats transplanted with adult porcine islets and immunosuppressed with cyclosporine A, mycophenolate mofetil, and leflunomide remain normoglycemic for up to 100 days.

  Transplantation 20010427

• Steroid-free immunosuppression in renal transplantation: a long-term follow-up of 100 consecutive patients.

  Transplantation 20010427

• Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: three-year follow-up. The Mycophenolate Mofetil Acute Renal Rejection Study Group.

  Transplantation 20010427

• Polyoma virus infection after renal transplantation. Use of immunostaining as a guide to diagnosis.

  Transplantation 20010415

• Kidney transplantation during the first trimester of pregnancy: immunosuppression with mycophenolate mofetil, tacrolimus, and prednisone.

  Transplantation 20010415

• A pilot study of the use of mycophenolate mofetil as a component of therapy for multidrug-resistant HIV-1 infection.

  Journal of acquired immune deficiency syndromes (1999) 20010415

• Rapid and simultaneous determination of mycophenolic acid and its glucuronide conjugate in human plasma by ion-pair reversed-phase high-performance liquid chromatography using isocratic elution.

  Journal of chromatography. B, Biomedical sciences and applications 20010405

• Long-term impact of discontinued or reduced calcineurin inhibitor in patients with chronic allograft nephropathy.

  Kidney international 20010401

• Differential influence of azathioprine and mycophenolate mofetil on the disposition of basiliximab in renal transplant patients.

  Clinical transplantation 20010401

• The use of intravenous tacrolimus and mycophenolate mofetil as induction and maintenance immunosuppression in simultaneous pancreas--kidney recipients with previous transplants.

  Clinical transplantation 20010401

• Hepatitis C-associated glomerulonephritis--a novel therapeutic approach.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20010401

• Comparison of the effects of tacrolimus and cyclosporine on the pharmacokinetics of mycophenolic acid.

  Therapeutic drug monitoring 20010401

• Prevention of neointimal proliferation by immunosuppression in synthetic vascular grafts.

  European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 20010401

• Mycophenolate (CellCept) treatment of myasthenia gravis, chronic inflammatory polyneuropathy and inclusion body myositis.

  Journal of the neurological sciences 20010401

• Mycophenolate mofetil in pediatric heart transplant recipients: a single-center experience.

  Pediatric transplantation 20010401

• Elevated tacrolimus trough levels in association with mycophenolate mofetil-induced diarrhea: a case report.

  Pediatric transplantation 20010401

• Mycophenolate mofetil therapy for children with lupus nephritis refractory to both intravenous cyclosphosphamide and cyclosporine.

  Clinical nephrology 20010401

• [Acute pancreatitis after kidney transplantation].

  Magyar sebeszet 20010401

• [Editorial on 'Clinical findings with mycophenolate mofetil in immunosuppressive therapy of ocular pemphigoid' by J.Zurdel, Bilal Aboalchamat, Manfred Zierhut, Nicole Stubiger, Alexander Bialasie et al. in Klin Monatsbl Augenheilkd 2001:218:222-8].

  Klinische Monatsblatter fur Augenheilkunde 20010401

• [Early clinical results with mycophenolate mofetil in immunosuppressive therapy of ocular pemphigoid].

  Klinische Monatsblatter fur Augenheilkunde 20010401

• [New inflammatory bowel disease drugs targeting the inflammatory cascade].

  Gastroenterologie clinique et biologique 20010401

• Safety profile of mycophenolate mofetil: a response.

  Bone marrow transplantation 20010401

• Mycophenolate mofetil in pediatric renal transplantation without induction therapy: results after 12 months of treatment. German Pediatric Renal Transplantation Study Group.

  Transplantation 20010315

• Novel therapies for anti-neutrophil cytoplasmic antibody-associated vasculitis.

  Current opinion in nephrology and hypertension 20010301

• Glucuronide and glucoside conjugation of mycophenolic acid by human liver, kidney and intestinal microsomes.

  British journal of pharmacology 20010301

• Effect of mycophenolate mofetil therapy on inosine monophosphate dehydrogenase induction in red blood cells of heart transplant recipients.

  Clinical pharmacology and therapeutics 20010301

• Mycophenolate mofetil as a systemic antipsoriatic agent: positive experience in 11 patients.

  The British journal of dermatology 20010301

• Successful long-term treatment of severe atopic dermatitis with mycophenolate mofetil.

  The British journal of dermatology 20010301

• Pharmacokinetics of mycophenolic acid after mycophenolate mofetil administration in liver transplant patients treated with tacrolimus.

  Journal of clinical pharmacology 20010301

• Is mycophenolate mofetil an effective alternative in azathioprine-intolerant patients with chronic active Crohn's disease?

  The American journal of gastroenterology 20010301

• Comparison of long-term immunosuppression for limb transplantation using cyclosporine, tacrolimus, and mycophenolate mofetil: implications for clinical composite tissue transplantation.

  Plastic and reconstructive surgery 20010301

• Immunosuppressive and cytotoxic drugs in the treatment of rheumatic skin disorders.

  Seminars in cutaneous medicine and surgery 20010301

• [Highly active antiviral and immunosuppressive combination therapy with acyclovir and mycophenolate mofetil following keratoplasty in patients with herpetic eye disease].

  Klinische Monatsblatter fur Augenheilkunde 20010301

• Patterns of cytomegalovirus infection in simultaneous kidney-pancreas transplant recipients receiving tacrolimus, mycophenolate mofetil, and prednisone with ganciclovir prophylaxis.

  Transplant infectious disease : an official journal of the Transplantation Society 20010301

• Searching for a balance when applying immunosuppression after liver transplantation.

  Transplantation 20010227

• A novel management strategy of steroid-free immunosuppression after liver transplantation: efficacy and safety of tacrolimus and mycophenolate mofetil.

  Transplantation 20010227

• Immunosuppressant substitutes in liver transplantation.

  Lancet (London, England) 20010224

• Replacement of calcineurin inhibitors with mycophenolate mofetil in liver-transplant patients with renal dysfunction: a randomised controlled study.

  Lancet (London, England) 20010224

• Mycophenolate mofetil monotherapy in liver transplantation.

  Lancet (London, England) 20010224

• Interaction of mycophenolate mofetil and HLA matching on renal allograft survival.

  Transplantation 20010215

• Gender differences in the risk for chronic renal allograft failure.

  Transplantation 20010215

• Establishment of a chemical synthetic lethality screen in cultured human cells.

  Genome research 20010201

• Impaired phosphate handling of renal allografts is aggravated under rapamycin-based immunosuppression.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20010201

• Post-transplant diabetes mellitus: increasing incidence in renal allograft recipients transplanted in recent years.

  Kidney international 20010201

• Chilblain lupus erythematosus Hutchinson: successful treatment with mycophenolate mofetil.

  Archives of dermatology 20010201

• Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis.

  The New England journal of medicine 20010201

• Mycophenolic acid plasma concentrations: influence of comedication.

  Therapeutic drug monitoring 20010201

• [Pharmacological profiles of mycophenolate mofetil (CellCept), a new immunosuppressive agent].

  Nihon yakurigaku zasshi. Folia pharmacologica Japonica 20010201

• Pharmacokinetic, pharmacodynamic, and outcome investigations as the basis for mycophenolic acid therapeutic drug monitoring in renal and heart transplant patients.

  Clinical biochemistry 20010201

• A retrospective analysis of mycophenolic acid and cyclosporin concentrations with acute rejection in renal transplant recipients.

  Clinical biochemistry 20010201

• The anti-herpesvirus activity of (1'S,2'R)-9-[[1',2'-bis(hydroxymethyl)-cycloprop-1'-yl]methyl]guanine is markedly potentiated by the immunosuppressive agent mycophenolate mofetil.

  Antiviral research 20010201

• Severe recalcitrant pyoderma gangrenosum responding to a combination of mycophenolate mofetil with cyclosporin and complicated by a mononeuritis.

  The British journal of dermatology 20010201

• B-cell dysfunction and depletion using mycophenolate mofetil in a pediatric combined liver and kidney graft recipient.

  Pediatric transplantation 20010201

• [Immunology-related chronic progressive cicatricial conjunctival diseases: diagnosis, therapy and prognosis].

  Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 20010201

• [Mycophenolate mofetil: a new approach by immunosuppressive treatment].

  Pathologie-biologie 20010201

• Rapid and simple determination of mycophenolic acid in human plasma by ion-pair RP-LC with fluorescence detection.

  Journal of pharmaceutical and biomedical analysis 20010201

• [Combination of mycophenolate mofetil with cyclosporine A and methotrexate as acute GVHD prophylaxis after unrelated donor allogeneic bone marrow transplantation].

  Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 20010201

• Use of mycophenolate mofetil as rescue therapy after pediatric liver transplantation.

  Transplantation 20010127

• Tolerability profile of sodium mycophenolate (ERL080) and mycophenolate mofetil with and without cyclosporine (Neoral) in the rat.

  Toxicology 20010126

• [A new immunosuppressor: CellCept].

  Presse medicale (Paris, France : 1983) 20010120

• Apoptosis of superantigen-activated T cells induced by mycophenolate mofetil treatment.

  Transplantation 20010115

• The addition of mycophenolate mofetil for suppressing hepatitis B virus replication in liver recipients who developed lamivudine resistance--no beneficial effect.

  Transplantation 20010115

• Transcriptional regulation of the yeast gmp synthesis pathway by its end products.

  The Journal of biological chemistry 20010112

• Mycophenolate mofetil: a safe and promising immunosuppressant in neuromuscular diseases.

  Neurology 20010109

• Mycophenolate mofetil for myasthenia gravis: an open-label pilot study.

  Neurology 20010109

• Liquid chromatographic assay for simultaneous determination of abacavir and mycophenolic acid in human plasma using dual spectrophotometric detection.

  Journal of chromatography. B, Biomedical sciences and applications 20010105

• Inosine-5'-monophosphate dehydrogenase is required for mitogenic competence of transformed pancreatic beta cells.

  Endocrinology 20010101

• Correlation of mycophenolic acid pharmacokinetic parameters with side effects in kidney transplant patients treated with mycophenolate mofetil.

  Clinical chemistry 20010101

• Pilot study of anti-thymocyte globulin plus mycophenolate mofetil in recent-onset diffuse scleroderma.

  Rheumatology (Oxford, England) 20010101

• Advances in the treatment of lupus nephritis.

  Annual review of medicine 20010101

• Evolving treatment strategies for inflammatory bowel disease.

  Annual review of medicine 20010101

• Determination of mycophenolic acid and mycophenolate mofetil by high-performance liquid chromatography using postcolumn derivatization.

  Analytical chemistry 20010101

• Fatal cytomegalovirus disease in a high-risk renal transplant recipient.

  Pediatric nephrology (Berlin, Germany) 20010101

• Mycophenolate mofetil reduces tissue damage and inflammation in an experimental model of colitis in rats.

  Scandinavian journal of gastroenterology 20010101

• Immunosuppressive drugs in paediatric liver transplantation.

  Paediatric drugs 20010101

• Transplantation tolerance by 1,25-dihydroxyvitamin D(3)-induced costimulation blockade.

  Transplantation proceedings 20010101

• Effects of dose and duration of anti-CD154 antibody therapy in preventing renal allograft rejection in a nonhuman primate model.

  Transplantation proceedings 20010101

• Donor pretreatment of grafts from marginal donors improves long-term graft outcome.

  Transplantation proceedings 20010101

• Place of mycophenolate mofetil in renal transplantation.

  Transplantation proceedings 20010101

• The role of newer monoclonal antibodies in renal transplantation.

  Transplantation proceedings 20010101

• Mycophenolate mofetil decreases the risk for chronic renal allograft failure.

  Transplantation proceedings 20010101

• Treatment with the chimeric anti-IL-2Ralpha basiliximab affects both the IL-2 and IL-15 signalling pathways after clinical kidney transplantation.

  Transplantation proceedings 20010101

• Rapid steroid withdrawal versus standard steroid therapy in patients treated with basiliximab, cyclosporine, and mycophenolate mofetil for the prevention of acute rejection in renal transplantation.

  Transplantation proceedings 20010101

• Daclizumab induction for primary kidney transplant recipients using tacrolimus, mycophenolate mofetil, and steroids as maintenance immunosuppression.

  Transplantation proceedings 20010101

• Drug regimens affect cadaveric kidney graft survival.

  Transplantation proceedings 20010101

• Monitoring of mycophenolic acid in pediatric renal transplant recipients.

  Transplantation proceedings 20010101

• Tacrolimus, MMF, steroid, and ALG immunotherapy for high immunological risk renal transplant recipients.

  Transplantation proceedings 20010101

• Determination of mycophenolate area under the curve by limited sampling strategy.

  Transplantation proceedings 20010101

• Induction strategy using basiliximab combined with mycophenolate MMF and immediate low-dose cyclosporin is steroid sparing and more effective than OKT3.

  Transplantation proceedings 20010101

• Mycophenolate mofetil is superior in combination with tacrolimus compared to cyclosporine for immunosuppressive therapy after liver transplantation.

  Transplantation proceedings 20010101

• The acyl glucuronide metabolite of mycophenolic acid inhibits the proliferation of human mononuclear leukocytes.

  Transplantation proceedings 20010101

• Mofetil mycophenolate in renal transplantation.

  Transplantation proceedings 20010101

• CMV in kidney transplants in the tacrolimus-mycophenolate era.

  Transplantation proceedings 20010101

• Treatment of calcineurin inhibitor toxicity by dose reduction plus introduction of mycophenolate mofetil.

  Transplantation proceedings 20010101

• Successful withdrawal of steroid after renal transplantation.

  Transplantation proceedings 20010101

• Canadian multicentre trial of tacrolimus/azathioprine/steroids versus tacrolimus/mycophenolate mofetil/steroids versus neoral/mycophenolate mofetil/steroids in renal transplantation.

  Transplantation proceedings 20010101

• Positive effect of steroid withdrawal on bone mineral density in renal allograft recipients.

  Transplantation proceedings 20010101

• Prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone, and mycophenolate mofetil: complete report on 350 primary adult liver transplantations.

  Transplantation proceedings 20010101

• Racial differences in clinical outcome using tacrolimus and mycophenolate mofetil immunosuppression in heart transplantation.

  Transplantation proceedings 20010101

• Incidence and spectrum of infections in lung transplanted patients: comparison of four different immunosuppressive protocols.

  Transplantation proceedings 20010101

• Steroid withdrawal for pancreas transplants under tacrolimus immunosuppression.

  Transplantation proceedings 20010101

• Outcome of simultaneous kidney-pancreas transplantation in African-American recipients: a case control study.

  Transplantation proceedings 20010101

• Fate of the pancreas after asynchronous kidney loss in patients undergoing simultaneous kidney/pancreas transplantation.

  Transplantation proceedings 20010101

• Limited benefits of induction with monoclonal antibody to interleukin-2 receptor in combination with tacrolimus, mycophenolate mofetil, and steroids in simultaneous kidney-pancreas transplantation.

  Transplantation proceedings 20010101

• Ganciclovir prophylaxis for cytomegalovirus infection in simultaneous kidney-pancreas transplant recipients receiving tacrolimus, mycophenolate mofetil, and prednisone.

  Transplantation proceedings 20010101

• Effect of mycophenolate mofetil on the Anti-CMV serologic response after renal transplantation.

  Transplantation proceedings 20010101

• Treatment of systemic lupus erythematosus with mycophenolate mofetil.

  Lupus 20010101

• [Treatment of uveitis with immunosuppressives: antimetabolites and alkylating agents].

  Bulletin de la Societe belge d'ophtalmologie 20010101

• Cytomegalovirus infection and abdominal pain with mycophenolate mofetil: is there a link?

  Drug safety 20010101

• Elective withdrawal of mycophenolate mofetil in renal transplant recipients treated with mycophenolate mofetil, cyclosporine, and prednisone.

  Transplant international : official journal of the European Society for Organ Transplantation 20010101

• Pharmacokinetic basis for the efficient and safe use of low-dose mycophenolate mofetil in combination with tacrolimus in kidney transplantation.

  Clinical chemistry 20010101

• Mycophenolate mofetil: suggested guidelines for use in kidney transplantation.

  BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 20010101

• Mycophenolate mofetil for dermatomyositis.

  Dermatology (Basel, Switzerland) 20010101

• Mycophenolate mofetil: a new immunosuppressive approach. Successful treatment in a case of myasthenia gravis associated with incomplete lupus erythematosus syndrome and hepatitis C virus infection.

  European neurology 20010101

• [Use of mycophenolate mofetil in patients with a transplanted kidney and cyclosporin nephrotoxicity].

  Vojnosanitetski pregled 20010101

• Adverse gastrointestinal effects of mycophenolate mofetil: aetiology, incidence and management.

  Drug safety 20010101

• Mycophenolate mofetil in the therapy of severe myasthenia gravis.

  European neurology 20010101

• [Replacement of mycophenolate mofetil with azathioprine in patients with renal transplants].

  Vojnosanitetski pregled 20010101

• Effects of extending the duration of postgrafting immunosuppression and substituting granulocyte-colony-stimulating factor-mobilized peripheral blood mononuclear cells for marrow in allogeneic engraftment in a nonmyeloablative canine transplantation model.

  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20010101

• The safety and efficacy of MMF in lupus nephritis: a pilot study.

  Lupus 20010101

• Therapy of pemphigus.

  Clinics in dermatology 20010101

• [Use of mycophenolate mofetil in kidney transplantation].

  Vojnosanitetski pregled 20010101

• Neoral drug monitoring in stable kidney allotransplant recipients: C(0) versus C(2).

  Transplantation proceedings 20010101

• Single-center study utilizing C(2) level as monitoring tool in de novo renal transplant recipients treated with Neoral.

  Transplantation proceedings 20010101

• Abbreviated cyclosporine pharmacokinetic profiling in clinical renal transplantation: from principles to practice.

  Transplantation proceedings 20010101

• Simulect, calcineurin inhibitor, mycophenolate mofetil, and prednisone is more effective than OKT3, calcineurin inhibitor, hycophendate mofetil, and prednisone in African American kidney recipients in reducing acute rejections and prolonging graft survival.

  Transplantation proceedings 20010101

• CSA/MMF/steroids versus CSA/AZA/steroids with and without basiliximab in cadaveric kidney transplantation.

  Transplantation proceedings 20010101

• Use of basiliximab in conjunction with either Neora/MMF/steroids or Prograf/MMF/steroids in simultaneous pancreas-kidney transplantation.

  Transplantation proceedings 20010101

• Interleukin-2R antagonists in the prevention of acute rejection in living donor transplantation.

  Transplantation proceedings 20010101

• Low rate of acute rejection and cytomegalovirus infection in kidney transplant recipients with basiliximab.

  Transplantation proceedings 20010101

• The role of Certican (everolimus, rad) in the many pathways of chronic rejection.

  Transplantation proceedings 20010101

• Sirolimus and low-dose tacrolimus with antibody induction in kidney transplantation: preliminary results of a pilot study.

  Transplantation proceedings 20010101

• Enteric coating of mycophenolate sodium: a rational approach to limit topical gastrointestinal lesions and extend the therapeutic index of mycophenolate.

  Transplantation proceedings 20010101

• Enteric-coated mycophenolate sodium: results of two pivotal global multicenter trials.

  Transplantation proceedings 20010101

• Therapeutic equivalence of mycophenolate sodium versus mycophenolate mofetil in de novo renal transplant recipients.

  Transplantation proceedings 20010101

• Mycophenolate mofetil conversion or addition in patients with chronic progressive deterioration of renal allograft function.

  Transplantation proceedings 20010101

• Effects of mycophenolate mofetil and azathioprine on the erythropoietin production in renal transplant recipients.

  Transplantation proceedings 20010101

• Steroid withdrawal in renal transplantation.

  Transplantation proceedings 20010101

• Pharmacodynamic monitoring of mycophenolate mofetil in renal allograft recipients.

  Transplantation proceedings 20010101

• Effects of mycophenolate mofetil in the development of systemic lupus erythematosus in (NZBxNZW)F1 mice.

  Transplantation proceedings 20010101

• Efficacy and safety of antithymocyte globulin treatment of steroid-resistant acute rejection in kidney transplantation.

  Transplantation proceedings 20010101

• Simulect, Neoral, Cellcept, and prednisone in kidney recipients with delayed graft function: a prospective controlled study.

  Transplantation proceedings 20010101

• Mycophenolate mofetil is ineffective in the treatment of mucocutaneous Adamantiades-Behçet's disease.

  Dermatology (Basel, Switzerland) 20010101

• G-CSF-mobilized peripheral blood mononuclear cells added to marrow facilitates engraftment in nonmyeloablated canine recipients: CD3 cells are required.

  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20010101

• [Factors influencing prevalence and clinical course of cytomegalovirus (CMV) infection in kidney transplant patients].

  Przeglad lekarski 20010101

• [Use of Cyclosporine A and new immunosuppressive drugs in the therapy of glomerulonephritis].

  Przeglad lekarski 20010101

• [Response to mycophenolate mofetil in a case of lupus nephropathy resistant to cyclophosphamide IV and cyclosporin A].

  Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20010101

• Ulcerative lichen planus: a case responding to recombinant platelet-derived growth factor BB and immunosuppression.

  Acta dermato-venereologica 20010101

• Progress in understanding humoral rejection in kidney transplantation: implications for patient management.

  Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20010101

• [Hemolytic anemia caused by graft-versus-host reaction in ABO-nonidentical renal transplants from blood group O donors].

  Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20010101

• [Pharmacology of mycophenolate mofetil: recent data and clinical consequences].

  Nephrologie 20010101

• [Lupus nephritis: treatments for today and tomorrow].

  Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20010101

• [Toward an evidence-based immunosuppression].

  Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20010101

• Positive effect on T-cell regulatory apoptosis by mycophenolate mofetil.

  Clinical transplantation 20010101

• Cyclosporine withdrawal in stable renal transplant recipients after azathioprine-mycophenolate mofetil conversion.

  Clinical transplantation 20001201

• Ribavirin and mycophenolic acid potentiate the activity of guanine- and diaminopurine-based nucleoside analogues against hepatitis B virus.

  Antiviral research 20001101

• Mycophenolate mofetil-induced ischemic colitis.

  Transplantation proceedings 20001101

• Metabolism of O6-propyl and N6-propyl-carbovir in CEM cells.

  Nucleosides, nucleotides & nucleic acids 20000401

• Changes in hepatitis C virus RNA viremia concentrations in long-term renal transplant patients after introduction of mycophenolate mofetil.

  Transplantation 20000315

• The effect of mycophenolate mofetil and polyphenolic bioflavonoids on renal ischemia reperfusion injury and repair.

  The Journal of urology 20000301

• Abacavir and mycophenolic acid, an inhibitor of inosine monophosphate dehydrogenase, have profound and synergistic anti-HIV activity.

  Journal of acquired immune deficiency syndromes (1999) 19990815

• Mycophenolate mofetil in cadaveric renal transplantation. US Renal Transplant Mycophenolate Mofetil Study Group.

  American journal of kidney diseases : the official journal of the National Kidney Foundation 19990801

• Nucleoside and non-nucleoside IMP dehydrogenase inhibitors as antitumor and antiviral agents.

  Current medicinal chemistry 19990701

• Novel mycophenolic adenine bis(phosphonate)s as potential immunosuppressants.

  Current medicinal chemistry 19990701

• The antiherpesvirus activity of H2G [(R)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine] is markedly enhanced by the novel immunosuppressive agent mycophenolate mofetil.

  Antimicrobial agents and chemotherapy 19981201

• Mycophenolate mofetil strongly potentiates the anti-herpesvirus activity of acyclovir.

  Antiviral research 19981201

• Mycophenolate mofetil for the treatment of acute and chronic GVHD in bone marrow transplant patients.

  Bone marrow transplantation 19980701

• The novel immunosuppressive agent mycophenolate mofetil markedly potentiates the antiherpesvirus activities of acyclovir, ganciclovir, and penciclovir in vitro and in vivo.

  Antimicrobial agents and chemotherapy 19980201

• Immunosuppressive therapy in high-risk transplant patients: dose-dependent efficacy of mycophenolate mofetil in African-American renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group.

  Transplantation 19971115

• The cost effectiveness of mycophenolate mofetil in the first year after primary cadaveric transplant. U.S. Renal Transplant Mycophenolate Mofetil Study Group.

  Journal of the American Society of Nephrology : JASN 19971001

• Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.

  Clinical transplantation 19970801

• Novel anti-Pneumocystis carinii effects of the immunosuppressant mycophenolate mofetil in contrast to provocative effects of tacrolimus, sirolimus, and dexamethasone.

  The Journal of infectious diseases 19970401

• Mycophenolate mofetil in renal allograft recipients: a pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection. The International Mycophenolate Mofetil Renal Transplant Study Groups.

  Transplantation 19970115

• Mycophenolate mofetil (MMF, RS-61443) inhibits inflammation and smooth muscle cell proliferation in rat aortic allografts.

  Transplant immunology 19951201

• Polymerase substrate depletion: a novel strategy for inhibiting the replication of the human immunodeficiency virus.

  Virology 19950820

• Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group.

  Transplantation 19950815

• Novobiocin-induced anti-proliferative and differentiating effects in melanoma B16.

  British journal of cancer 19920201

• Inhibitors of IMP dehydrogenase stimulate the phosphorylation of the antiviral nucleoside 2' ,3'-dideoxyguanosine.

  Biochemical and biophysical research communications 19900928

• Synthesis and immunosuppressive activity of some side-chain variants of mycophenolic acid.

  Journal of medicinal chemistry 19900201

• Inhibition of infectivity of human immunodeficiency virus by a novel nucleoside, oxetanocin, and related compounds.

  Antimicrobial agents and chemotherapy 19890501